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Previous work suggests vasodilating prostaglandins (PGs) are released during isometric 
handgrip exercise in an O2-dependent manner in young men. This project investigates their 
contribution to the exercise hyperaemia of isometric and rhythmic handgrip contraction 
performed by healthy, recreationally-active young and older men. Hyperoxia (40% O2), aspirin, 
and their combination equally attenuated exercise and post-exercise hyperaemia, and venous 
efflux of PGE2 and PGI2 in both age groups: efflux of these PGs was not attenuated with age, but 
their contribution to the hyperaemic response was. Further, the release of COX products evoked 
reflex vasoconstriction in an O2-dependent manner. Moreover, 40% O2, aspirin, and their 
combination equally inhibited the exercise-evoked vasoconstriction in both age groups. However, 
both the exercise-evoked attenuation in perfusion of resting skeletal muscles and the contribution 
of COX products were attenuated with age. Additional experiments showed that adenosine 
contributes to the hyperaemia of electrically evoked isometric twitch contractions in an O2-
dependent manner; adenosine may contribute to the increase in the concentrations of 
vasodilating PGs. Importantly, unlike 60% and 100% O2, 40% O2 did not attenuate acetylcholine-
evoked endothelium-dependent dilatation in either age group, supporting the argument that the 
effect of 40% O2 during exercise is independent of hyperoxia-related oxidative stress.  
DEDICATION 
 
To my grandparents, parents, siblings, 
and dearest wife. 
  
ACKNOWLEDGEMENTS 
I express my gratitude to my supervisors: Prof. Janice Marshall and Dr. Clare Ray for always 
offering encouragement, support, guidance, and constructive critique during the course of this 
study, and in the preparation of this thesis. I am also particularly thankful to Dr. Andrew Coney 
and Dr. Samuel Lucas for generously sparing their time for me, and for their endless help and 
guidance. I am also grateful to David Westwood, Stephanie Watson, Tony Daley, and Terry 
Daley for all their help and technical guidance. I am also indebted to all my colleagues for their 
generous company, especially to Hafsa, Emma, Abubacarr, Mohammad, and Abdullah. Lastly, I 
thank every single person who volunteered to take part in these studies; without them, none of 
this would have been possible. 
  
AUTHOR’S DECLEARATION 
I hereby explicitly state that I personally undertook all of the experimental work presented in this 
thesis; including human and animal experimental work. To this end, UK Home Office license 
training (Animals (Scientific Procedures) Act 1986 – Accredited Training Scheme for Licensees) 
was undertaken and a personal license was acquired. All of the experimental design, data 
extraction, statistical analysis, presentation of Figures, and Tables is also my own work. The only 
exception is the young subject data presented in Chapter 8: these experiments were undertaken 
by Florentyna D’Souza for her BMedSc (3rd year) project. Nonetheless, data from her 
experiments were independently extracted and analyzed by me, and are presented here. Lastly, 
it is also explicitly acknowledged that I am the author of this thesis. Guidance, feedback, and 
supervision during the course of this entire project and during the preparation of this thesis were 
provided by Prof. Janice M Marshall and Dr. Clare J Ray.  
Rehan T Junejo  
TABLE OF CONTENTS 
Chapter 1  General Introduction       1 
1.1 Overview        2 
1.2 Exercise hyperaemia       4 
1.2.1 Neural control       4 
1.2.2 Mechanical control      7 
1.2.3 Metabolic control      10 
1.2.4 Shear stress       36 
1.3 Effect of aging on exercise hyperaemia     38 
1.4 Exercise-evoked vasoconstriction     43 
1.5 General aims and hypotheses of the project    45 
 
Chapter 2 General materials and methods     47 
2.1 Subjects        48 
2.2 General experimental conditions      48 
2.3 Handgrip exercise       49 
2.4 Delivery of medical air or 40% O2     50 
2.5 Measurements        51 
2.5.1 Blood pressure       51 
2.5.2 Limb blood flow       52 
2.5.3 Near-infrared spectroscopy     53 
2.5.4 Red cell flux       53 
2.6 Drug administration       54 
2.7 Data acquisition        54 
2.8 Statistical analysis       55 
 
Chapter 3 Methodological considerations: Comparison of measurements 
of forearm blood flow using strain-gauge venous occlusion 
plethysmography with manual or rapid inflation of the venous 
occlusion cuff        60 
3.1 Introduction        61 
3.2 Methods        66 
3.3 Results         71 
3.4 Discussion        80 
 
Chapter 4 40% O2 and COX blockade similarly attenuate forearm post-exercise 
hyperaemia and venous efflux of PGs following handgrip 
contractions in young and older men     86 
4.1 Introduction        87 
4.2 Methods        92 
4.3 Results         99 
4.4 Discussion        135 
 
Chapter 5 40% O2 and COX blockade attenuate reflex vasoconstriction evoked 
in resting leg by isometric handgrip contraction in young men 148 
5.1 Introduction        149 
5.2 Methods        153 
5.3 Results         156 
5.4 Discussion        164 
 
Chapter 6 Effects of 40% O2 and COX blockade on muscle oxygenation 
and haemodynamics in exercising and resting arms of young 
and older men        169 
6.1 Introduction        170 
6.2 Methods        176 
6.3 Results         182 
6.4 Discussion        191 
 
Chapter 7 40% O2 attenuates exercise hyperaemia of twitch contractions; 
the role of adenosine A2A-receptors     201 
7.1 Introduction        202 
7.2 Methods        205 
7.3 Results         209 
7.4 Discussion        213 
 
Chapter 8 Acetylcholine (ACh) induced endothelial dilatation is blunted by 
60% and 100% O2, but not by 40% O2     218 
8.1 Introduction        219 
8.2 Methods        222 
8.3 Results         230 
8.4 Discussion        245 
 
Chapter 9 General Discussion       254 
9.1 Exercise and post-exercise hyperaemia     255 
9.2 Exercise-evoked vasoconstriction     259 
9.3 O2-induced generation of ROS      2633 
9.4 Contribution of other factors to exercise hyperaemia   264 
9.5 Mechanism of action of 40% O2 on PG generation   265 
9.6 Future Work        269 
 
Appendix 1 Ethics Approval for the Project     271 
Appendix 2 Screening Questionnaire 1 (Chapters 3 – 6)    271 
Appendix 3 Screening Questionnaire 2 (Chapter 8)    280 
Appendix 4 Consent Form        286 
Appendix 5 Supplemental Data (Chapter 4)     289 
Appendix 6 Published Abstracts       294 
References          297 
  
INDEX TO FIGURES / ILLUSTRATIONS 
Figure 2.1 Illustration of equipment used for handgrip.    56 
Figure 2.2 Arrangement used for venous occlusion plethysmography and 
and handgrip exercise.       56 
Figure 2.3 Arrangement of gas cylinders relative to the subject.   57 
Figure 2.4 Raw plethysmograph and ABP traces.     58 
Figure 2.5 Raw traces showing plethysmograph output, ABP, HR, and force 
recordings immediately before, during, and after rhythmic and isometric 
handgrip contractions.       59 
Figure 3.1 Schematic diagram of the protocol.     68 
Figure 3.2 Baseline plethysmograph traces of manual and automatic rapid cuff 
inflation with corresponding ABP trace.     68 
Figure 3.3 Plethysmograph and ABP traces during manual cuff inflation and  
automatic rapid cuff inflation protocols, immediately after corresponding 
handgrip contractions.       69 
Figure 3.4 Plethysmograph trace with corresponding pulsatile ABP for FBF 
measurements made automatic rapid cuff inflation immediately after  
exercise.        70 
Figure 3.5 TTI recorded from the isometric handgrip contraction at 70% MVC 
for 1 min.        73 
Figure 3.6 HR and MABP responses of isometric handgrip contraction at 70% MVC. 75 
Figure 3.7 FBF responses evoked before and following isometric handgrip contraction 
at 70% MVC for 1 min.       76 
Figure 3.8 Comparison of FBF values recorded before and after isometric handgrip 
contraction with automatic rapid cuff inflation and manual cuff inflation. 77 
Figure 3.9 Graph comparing mean FBF values from 1st, 2nd, and 3rd beat of rapid 
cuff inflation with mean FBF values from manual cuff inflation.  78 
Figure 3.10 Graph comparing individual FBF values from 1st, 2nd, and 3rd beat of 
rapid cuff inflation with individual FBF values from manual cuff inflation. 79 
Figure 4.1 Schematic diagram of the protocol.     97 
Figure 4.2 Arrangement of the cannula in the antecubital vein.   97 
Figure 4.3 Standard curve calculated from the standards prepared for 
6-ketoPGF1α ELISA.       98 
Figure 4.4 Standard curve calculated from the standards prepared for PGEM ELISA. 98 
Figure 4.5 HR and MABP responses of rhythmic handgrip contractions performed 
by young men.        110 
Figure 4.6 HR and MABP responses of isometric handgrip contractions performed 
by young men.        111 
Figure 4.7 FBF and FVC responses of rhythmic handgrip contractions performed 
by young men.        112 
Figure 4.8 FBF and FVC responses of isometric handgrip contractions performed 
by young men.        113 
Figure 4.9 PGI2 measured in the venous plasma samples and normalized PGI2 
values recorded before and immediately after rhythmic and isometric 
handgrip contractions performed by young men.    116 
Figure 4.10 Correlation between baseline and post-exercise FBF and PGI2 
(6-keto-PGF1α) concentrations for rhythmic and isometric exercise 
performed by young men.      117 
Figure 4.11 PGEM measured in the venous plasma and the normalized PGEM 
values recorded before and immediately after rhythmic and isometric 
handgrip contractions performed by young men.    118 
Figure 4.12 Correlation between baseline and post-exercise FBF and PGEM 
concentrations for rhythmic and isometric exercise performed by young 
men.         119 
Figure 4.13 HR and MABP responses of rhythmic handgrip contractions performed 
by older men.        122 
Figure 4.14 HR and MABP responses of isometric handgrip contractions performed 
by older men.        123 
Figure 4.15 FBF and FVC responses of rhythmic handgrip contractions performed by 
older men.        124 
Figure 4.16 FBF and FVC responses of isometric handgrip contractions performed by 
older men.        125 
Figure 4.17 Comparison of percentage reduction in FVC following rhythmic and 
isometric handgrip contractions performed by young and older men. 126 
Figure 4.18 PGI2 measured in the venous plasma samples and normalized PGI2 
values recorded before and after rhythmic and isometric handgrip 
contractions performed by older men.     129 
Figure 4.19 Correlation between baseline and post-exercise FBF and PGI2 
(6-keto-PGF1α) concentrations for rhythmic and isometric exercise 
performed by older men.      130 
Figure 4.20 Comparison of percentage reduction in PGI2 efflux following rhythmic 
and isometric handgrip contractions performed by young and older men. 131 
Figure 4.21 PGEM measured in the plasma samples of venous efflux and normalized 
PGEM values recorded before and after rhythmic and isometric handgrip 
contractions performed by older men.     132 
Figure 4.22 Correlation between baseline and post-exercise FBF and PGEM 
concentrations for rhythmic and isometric exercise performed by older 
men.         133 
Figure 4.23 Comparison of percentage reduction in PGEM efflux following 
rhythmic and isometric handgrip contractions performed by young 
and older men.        134 
Figure 4.24 Possible mechanisms by which 40% O2 attenuates the release of 
vasodilator PGs.       144 
Figure 5.1 Experiment setup showing arrangement of equipment.   155 
Figure 5.2 Venous occlusion plethysmography and EMG electrodes.   155 
Figure 5.3 Schematic diagram of the protocol.     155 
Figure 5.4 HR responses to isometric handgrip contractions performed at 60% 
  MVC for 2 min during NO PECO and PECO conditions.   159 
Figure 5.5 MABP responses to isometric handgrip contractions performed by 60% 
MVC for 2 min during NO PECO and PECO conditions.   160 
Figure 5.6 ∆ CVR responses to isometric handgrip contractions performed at 60% 
MVC for 2 min during NO PECO trial.     163 
Figure 5.7 ∆ CVR responses to isometric handgrip contractions performed at 60% 
MVC for 2 min during PECO trial.     163 
Figure 6.1 Schematic diagram of the protocol.     179 
Figure 6.2 Arrangement of the NIRS probes.     179 
Figure 6.3 Experiment setup showing the arrangement of the equipment.  180 
Figure 6.4 An original trace showing NIRS, isometric handgrip exercise tension, 
and ABP.        181 
Figure 6.5 TTI recorded for isometric handgrip contractions performed by young 
and older men.        185 
Figure 6.6 Changes in TOI, THI, and HHb recorded from exercising arm of young 
men.         187 
Figure 6.7 Changes in TOI, THI, and HHb recorded from exercising arm of older 
men.         188 
Figure 6.8 Changes in TOI, THI, and HHb recorded from non-exercising arm of the 
young men.        189 
Figure 6.9 Change in TOI, THI, and HHb recorded from the non-exercising arm of 
the older men.        190 
Figure 7.1 Schematic diagram of surgical preparation for protocol.   208 
Figure 7.2 Schematic diagram of the protocol.     208 
Figure 7.3 Hyperaemia responses following intra-vascular adenosine infusion. 210 
Figure 7.4 HR and MABP recorded before, during, and after rhythmic twitch 
contractions of the hindlimb.      211 
Figure 7.5 FABF and FAVC recorded before, during, and after rhythmic twitch 
contractions of the hindlimb.      212 
Figure 8.1 Schematic of the protocol.      227 
Figure 8.2 Schematic showing the arrangement of iontophoresis electrodes and 
Laser-Doppler probes.       227 
Figure 8.3 Arrangement of equipment on the subject.    228 
Figure 8.4 Original trace recorded during one of the experiments.   229 
Figure 8.5 Cutaneous vasodilator responses evoked by ACh-iontophoresis in 
young men.        239 
Figure 8.6 Cutaneous vasodilator responses evoked by ACh-iontophoresis in young 
men during placebo, 40, 60, and 100% O2.    240 
Figure 8.7 Cutaneous vasodilator responses evoked by ACh-iontophoresis in young 
men during combination of Vitamin-C and different O2 concentrations. 241 
Figure 8.8 Cutaneous vasodilator responses evoked by ACh-iontophoresis in older 
individuals.        242 
Figure 8.9 Cutaneous vasodilator responses evoked by ACh-iontophoresis in older 
participants during placebo, 40, 60, and 100% O2.   243 
Figure 8.10 Cutaneous vasodilator responses evoked by ACh-iontophoresis in older 
participants during combination of Vitamin-C and different O2 
concentrations.        244 
Figure 9.1 Possible mechanisms by which 40% O2 attenuates the release of 
vasodilator PGs.       268  
INDEX TO TABLES 
Table 3.1 Anthropometric data of subjects.      73 
Table 3.2 Baseline FBF responses measured with manual cuff inflation and 
  automatic rapid cuff inflation.      74 
Table 4.1 Anthropometric data of young and older men.    106 
Table 4.2 TTI and time recorded from rhythmic and isometric handgrip contraction 
performed by young and older men.     107 
Table 4.3 Baseline HR, MABP, FBF, and FVC responses of young men during 
rhythmic handgrip exercise.      108 
Table 4.4 Baseline HR, MABP, FBF, and FVC responses of young men during 
isometric handgrip exercise.      109 
Table 4.5 PO2, PCO2, K+, pH, and lactate concentration in the venous efflux 
recorded before and after rhythmic handgrip contractions performed by 
young men.        114 
Table 4.6 PO2, PCO2, K+, pH, and lactate concentrations in the venous efflux 
recorded before and after isometric handgrip contractions performed by 
young men.        115 
Table 4.7 Baseline HR, MABP, FBF, and FVC responses of older men during 
rhythmic handgrip exercise.      120 
Table 4.8 Baseline HR, MABP, FBF, and FVC responses of older men during 
isometric handgrip exercise.      121 
Table 4.9 PO2, PCO2, K+, pH, and lactate concentrations in the venous efflux 
recorded before and after rhythmic handgrip contractions performed by 
older men.        127 
Table 4.10 PO2, PCO2, K+, pH, and lactate concentrations in the venous efflux 
recorded before and after isometric handgrip contractions performed 
by older men.        128 
Table 5.1 Anthropometric data of subjects.      158 
Table 5.2 TTI and time recorded from NO PECO and PECO conditions while 
subjects performed isometric handgrip contractions at 60% MVC for 
2 min.         158 
Table 5.3 Baseline CBF responses during NO PECO and PECO conditions.  161 
Table 5.4 Baseline CVR responses during NO PECO and PECO conditions. 161 
Table 5.5 CBF and CVR responses to isometric handgrip contractions performed 
at 60% MVC for 2 min during NO PECO and PECO conditions.  162 
Table 6.1 Anthropometric data of young and older men.    184 
Table 6.2 HR and MABP recorded from young and older men.   186 
Table 7.1 TTI responses of rhythmic twitch contractions.    210 
Table 8.1 Anthropometric data of young and older subjects.    232 
Table 8.2 Baseline haemodynamic values of young subjects.   233 
Table 8.3 Baseline haemodynamic values of older subjects.    234 
Table 8.4 Baseline and post ACh-iontophoresis HR of young men.   235 
Table 8.5 Baseline and post ACh-iontophoresis HR values of older subjects.  236 
Table 8.6 Baseline and post ACh-iontophoresis MABP values of young men. 237 
Table 8.7 Baseline and post ACh-iontophoresis MABP values of older subjects. 238 
  
LIST OF ABBREVIATIONS 
 
~  Approximately 
∆  Delta 
A  Aspirin 
AA  Arachidonic Acid 
ABP  Arterial Blood Pressure 
ACh  Acetylcholine 
ADP  Adenosine Di-phosphate 
AMP  Adenosine Mono-phosphate 
ANOVA  Analysis of Variance 
ATP  Adenosine Tri-phosphate 
AU  Arbitrary Unit(s) 
AUC  Area under the Curve 
BMI  Body Mass Index 
Ca2+  Calcium 
CBF  Calf Blood Flow 
CO  Carbon-monoxide 
CO2  Carbon-dioxide 
COX  Cyclooxygenase 
CU  Conductance Units 
CVR  Calf Vascular Resistance 
EDHF  Endothelium Derived Hyperpolarizing Factor 
ELISA  Enzyme linked immune-sorbent assay 
eNOS  Endothelial Nitric Oxide Synthase 
FABF  Femoral Artery Blood Flow 
FAC  Forearm Circumference 
FAVC  Femoral Artery Vascular Conductance 
FBF  Forearm Blood Flow 
FMD  Flow Mediated Dilatation 
FVC  Forearm Vascular Conductance 
H+  Hydrogen / Proton 
HHb  Deoxy-haemoglobin 
HR  Heart Rate 
iNOS  Inducible Nitric Oxide Synthase 
K+  Potassium 
KATP  Adenosine Tri-phosphate Sensitive Potassium Channel(s) 
KCa  Calcium Activated Potassium Channel(s) 
KCl  Potassium-Chloride 
L-NAME Nω-nitro-L-arginine 
L-NMMA Nω-monomethyl-L-arginine 
L-NNA  Nω-nitro-L-arginine 
MABP  Mean Arterial Blood Pressure 
MBF  Muscle Blood Flow 
min  Minute(s) 
MSNA  Muscle Sympathetic Nerve Activity 
MVC  Maximum Voluntary Contraction 
NADPH  Nicotinamide Adenine Di-nucleotide Phosphate 
NIRS  Near-Infrared Spectroscopy 
NO  Nitric Oxide 
nNOS  Neuronal Nitric Oxide Synthase 
NOS  Nitric Oxide Synthase 
NSAID(s) Non Steroidal Anti-Inflammatory Drug(s) 
O2  Oxygen 
O  Older 
P  Placebo 
PECO  Post Exercise Circulatory Occlusion 
PET  Positron Emission Tomography 
PG(s)  Prostaglandin(s) 
PGE2  Prostaglandin-E2 
PGI2  Prostacyclin / Prostaglandin-I2 
Pi  Inorganic Phosphate 
PO2  Partial Pressure of Oxygen 
RBC(s)  Red Blood Cell(s) 
RCF  Red Cell Flux 
ROS  Reactive Oxygen Species 
RU  Resistance Units 
s  Second(s) 
SNP  Sodium-Nitroprusside 
SO2  Oxygen Saturation 
THI  Tissue Haemoglobin Index 
TOI  Tissue Oxygenation Index 
TPR  Total Peripheral Resistance 
TTI  Tension Time Integral 
TX(s)  Thromboxane(s) 
V  Volt 
VO2  Oxygen Uptake 
VO2-max Maximal Oxygen Uptake / Maximal Aerobic Capacity 
W  Watt 
Y  Young 
8-PT  8-Phenyltheophylline 























Humans perform some form of exercise every day; whether it is sitting up in a bed or high 
performance training. In order to maintain any level of activity, exercising body requires harmony 
between respiratory, circulatory, and metabolic aspects, along with the neural control of 
musculoskeletal system. The unabated continuation of exercise causes profound metabolic 
alterations in the working muscles leading to a painfully exhausting feeling: fatigue. An increase 
in cardiac output with a parallel decrease in vascular resistance are parts of an integrated 
response that helps to preserve the balance between supply and demand of nutrients (328). The 
phenomena of increased limb / muscle blood flow (MBF) and parallel the decrease in vascular 
resistance (i.e., vasodilatation) is termed “Active, Functional, or Exercise Hyperaemia”. To help 
meet the metabolic demands of active musculature, blood vessels supplying inactive muscles 
and viscera are known to constrict. 
Blood flow is regulated by mechanistic pump-action of the heart, elastic recoil within arteries, 
mechanical compression of veins, and negative pressure within the thoracic cavity (135). From 
the left ventricle, it enters systemic circulation through the aorta which divides to form ever 
smaller arteries and arterioles, eventually turning primarily into a single layer of endothelial cells 
approximately (~) 1 µm thick (135). Although exchange of gases and nutrients takes place 
throughout the vasculature, these thin vessels termed capillaries remain the primary site for 
equilibration with peri-vascular interstitium (135). Blood is then collected into venules, draining 
into veins, and is returned to the right side of the heart to pass through the pulmonary circulation. 
A parallel closed lymphatic transport system also exists which transports tissue fluids into the 
venous circulation (135). Resistance to blood flow is provided by the luminal diameter of the feed 
arteries and arterioles; terminal arterioles regulate blood flow through the capillary bed (135). 
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These vessels make the major contribution to total peripheral resistance (TPR), and within 
skeletal muscle, changes in their diameter influence local vascular resistance and MBF. 
As mentioned above, continuation of exercise is dependent on the metabolic environment of the 
musculature: hyperaemia’s function is to match the supply to demand of nutrients and oxygen 
(O2) (135). Pathological examples where the supply and demand of nutrients and O2 remains 
mismatched include anaemia, chronic obstructive pulmonary disease (COPD), and chronic heart 
failure. Alternatively, environmental factors (for example, high-altitude) can also induce a state of 
hypoxia (reduced O2) that requires supplementary O2 for relief (313). In all these cases, hypoxia 
affects O2 equilibrium all the way down to the mitochondria. Therefore, its contribution to 
exercise and by extension exercise hyperaemia has been the subject of scientific enquiry. For 
example, dynamic and isometric exercise studies with supplementary O2 have revealed delayed 
fatigue onset (2, 236), reduced time to complete a required task (317, 319), and decreased blood 
flow to the vessels supplying the exercising muscles (123, 437). 
The work described in this thesis was carried out to investigate the role of O2 and its dependent 
products in the regulation of blood flow during exercise in recreationally active, healthy, young 
and older individuals. The discussion below primarily focuses on the potential mediators of 
exercise / post-exercise hyperaemia and briefly, the role of some of these metabolites to 
exercise-evoked vasoconstriction. The results Chapters focus on the role of O2 and its 
dependent products to exercise / post-exercise hyperaemia of young and older individuals, their 
influence on exercise-evoked / reflex vasoconstriction, and the contribution of adenosine and its 
receptors to the O2-dependent regulation of exercise hyperaemia. Moreover, the production of 
radical O2 species (ROS) with different supplementary O2 concentrations and their effect on 
endothelial dilatation was also investigated in both age groups. 
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1.2 Exercise hyperaemia 
In late 1700s, Hunter must have used good intuition to state, “blood goes where it is needed” 
(351). However, the first observation of change in vessel diameter was recorded by Jones during 
his work on bat wings (33). Gaskell’s work provides a detailed record of early experiments 
conducted to appreciate the effect of muscle contraction on local MBF. He observed a marked 
change in the vessel diameter supplying frog’s mylohyoid muscle during the contractile stimulus 
(138). Similarly, he also observed a massive increase in blood flow of vessels supplying the 
contracting muscles of dogs (136, 138). These studies led him to propose that the metabolic 
products of muscle contraction were the primary reason for the observed vasodilatation (136, 
137). Since then, experiments involving differing techniques have been employed to better 
understand this hyperaemic response. Neural, mechanical, metabolic, and shear stress related 
factors are now the most popular ideas explaining these changes. All of these are briefly 
discussed below; particular attention is paid to the metabolic aspects. 
1.2.1 Neural control 
Bernard, in the mid 1800s observed that transection of the cervical spine caused a significant fall 
in arterial blood pressure (ABP) (139); and Gaskell while working on frog’s mylohyoid muscles 
observed that sectioning of nerve always caused muscle reddening (138). Gaskell’s 
examinations revealed rapid dilatation of the arteries peaking 20 – 30 seconds (s) after 
sectioning, but by 4 – 5 minutes (min), dilatation waned until the original diameter was reached 
(138). These observations pointed towards the neural control of local circulation and showed an 
active basal sympathetic vascular tone. These early experiments paved way for the neurological 
understanding of the cardiovascular system.  
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Exercise hyperaemia occurs almost instantaneously with the onset of exercise (192). Following 
is the discussion regarding the three main ideas that explain neural control of exercise 
hyperaemia. Firstly, it is hypothesized that active dilator fibres in the neural pathway cause 
vasodilatation of exercise hyperaemia (192). In agreement with this hypothesis is evidence which 
shows that mammalian skeletal muscle in some species is innervated by sympathetic vasodilator 
nerves (1, 38, 41, 85, 121). Wilkins and Eichna showed that the emotional stress induced by 
performing arithmetic led to an increase in forearm blood flow (FBF) (26). It was suggested that 
similar to animals (1, 38, 41, 85, 121), sympathetic cholinergic vasodilator nerves were 
responsible for this observation in humans. Later, Barcroft and Edholm’s work on post-
haemorrhagic syncope in normal and sympathectomised individuals led to a similar conclusion 
(21). However, the lack of any anatomical / histochemical evidence of these nerves in humans 
has cast doubt on this hypothesis (191, 192). Evidence also shows that FBF responses to mental 
stress in humans are nitric oxide (NO) dependent; not the result of an active neural dilatation (89, 
191, 336). Simultaneous measurement of FBF and muscle sympathetic nerve activity (MSNA) 
during mental stress in humans has revealed a decrease in vascular resistance that is 
associated with a parallel decrease in MSNA; dilatation is attenuated after selective β-adrenergic 
blockade (151). Separately however, Carter and Ray’s work revealed that during five min of 
mental stress, arm vascular resistance decreased while no such change occurred in the calf 
vascular resistance; MSNA activity during this time failed to change in either limb (53).  
Therefore, collectively these data do not implicate sympathetic influences as a primary cause of 
active vasodilatation during mental stress. 
The second theory is that the motor pathways responsible for muscle contraction “spill-over” 
acetylcholine (ACh), and thereby contribute to exercise hyperaemia (195). This pathway would 
ensure vasodilatation is localized to the active musculature and would be in accord with the near-
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instantaneous exercise hyperaemia. Work on hamster retractor muscle preparations by Segal et 
al. showed that arterioles dilated in response to micro-iontophoresis of ACh, and this dilatation 
travelled into the feed artery (195, 429). More importantly, their work also showed that when 
muscle contractions were abolished by tubocurarine (nicotinic-receptor antagonist), stimulation of 
the motor nerve still resulted in dilatation of feed arteries and arterioles; muscarinic antagonist 
atropine inhibited this phenomenon (429). However, Buckwalter et al. failed to observe any 
change in exercise hyperaemia of dogs with atropine infusion, including the response time to 
peak hyperaemia (38, 40). The same group also showed that ganglionic blockade with 
hexamethonium (nicotinic-receptor antagonist) or atropine did not alter the rate and magnitude of 
exercise hyperaemia (36). Moreover, when muscle contractions are inhibited by the use of 
neuromuscular inhibitors in anesthetized dogs, electrical stimulation of nerves does not lead to 
any change in blood flow (9, 296). These results are consistent with the lack of any observable 
difference in exercise hyperaemia in conscious rats following atropine infusion (11). Similarly, 
intra-arterial infusion of atropine did not attenuate exercise hyperaemia induced by single 
handgrip contraction at 20% maximum voluntary contraction (MVC) (32). Moreover no change 
occurred in blood flow of the arm when subjects attempted to exercise following post-synaptic 
neuromuscular blockade with pipecuronium (105). Thus, it appears from these studies that ACh 
spill-over is not a major contributor to exercise hyperaemia in humans. The disparity between the 
findings of Welsh and Segal and others might lie between methods of motor nerve stimulation 
(field vs. remote or voluntary stimulation; i.e., very few arterioles are in the close proximity of 
neuromuscular junction for ACh to have a significant effect). 
The third neurogenic theory of exercise hyperaemia relies on the withdrawal of sympathetic 
vasoconstrictor influences during exercise. However, in both active and inactive muscle mass, 
MSNA is known to increase during exercise in an intensity-dependent manner (158, 159); i.e., an 
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increase in the vasoconstrictor influence. Indeed, although exercise hyperaemia may well be 
mainly due to local metabolic vasodilator influences (See below) (92, 93, 158, 343, 414), 
sympatho-excitation does impose vasoconstriction during exercise. An early study observed that 
local administration of phentolamine (non-selective α-adrenoceptor antagonist) during isometric 
exercise led to an increase in FBF (432). Further, in dynamically exercising dogs, iliac artery 
injection of selective α1-adrenergic antagonist prazosin increased local vascular conductance 
(39). Since these studies, α1 and α2 adrenergic-receptors have been identified as important 
mediators of sympatho-excitation related vasoconstriction (37, 154). However, inhibition of 
sympathetic vasoconstriction due to vasodilatory influence of metabolites (i.e., functional-
sympatholysis) also appears to be intensity-dependent, beginning at exercise intensities of 10 – 
20% MVC (158, 414). This important response helps maintain perfusion through the exercising 
musculature. Separately, increased central venous pressure leads baro-receptor loading that is 
shown to consequently reduce exercise associated increase in MSNA (330). 
Therefore considering afore mentioned studies, it is to reasonable assume lack of a significantly 
active neural contribution to exercise hyperaemia. 
1.2.2 Mechanical control 
The “Muscle-pump” as a mechanical phenomenon that regulates blood flow was initially 
mentioned by Hunter who described its contribution in reducing orthostatic oedema (351). Put 
simply, the hypothesis proposes that muscle contraction mechanically expels blood from the 
vasculature towards the heart, and the subsequent relaxation assists flow into the muscles due 
to the change in perfusion pressure (i.e., arterio-venous gradient) (86, 227). In theory this would 
result in increased limb / MBF with or without vasodilatation. 
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The extent to which this mechanical action on vasculature contributes to initial and steady-state 
functional hyperaemia is controversial. Sheriff et al. showed that functional hyperaemia is 
initiated within 1 – 2 s of contraction (364). A single, passive knee-extension also causes an 
increase in leg blood flow at a similar rate, consistent with a mechanical component to initial part 
of functional hyperaemia (328). Further, Wunsch et al. individually tested potassium-chloride 
(KCl), adenosine, ACh, and NO donor sodium-nitroprusside (SNP) and concluded that it took at 
least 4 s for any of these substances to cause arteriolar vasodilatation (441). Studies have also 
shown that the initial rise in blood flow during the first 10 s of exercise is dependent on stride 
frequency, rather than the contraction intensity (363-365). For example, Sheriff et al. changed 
treadmill speed and/or inclination for exercising rats and observed an immediate (within 1 s) 
hyperaemic response, even at -10° incline (363, 365). In humans, Gotshall et al. observed that 
despite a constant work rate (200 W), an increase in cycling frequency was found to result in an 
increase in vascular conductance (144). However, O2 uptake measured as arterio-venous 
difference also increased with the increase in pedal frequency (144). 
Another way of investigating the contribution of the muscle-pump to the hyperaemic response is 
to investigate the role of venous pressure. Shiotani et al. observed that when subjects performed 
low-intensity (5 Watt; W) cycling exercise for 10 s in an upright position, mean ankle venous 
pressure decreased, parallel with a 5.3 fold increase in femoral artery blood flow (FABF) (367). 
However, subjects with venous return incompetence due to heart failure showed a reduced drop 
in mean ankle venous pressure and only a 1.7 fold increase in FABF. These observations led 
them to propose that in healthy individuals ~ 67% of hyperaemia was due to the effect of muscle-
pump. Recently, Nådland et al. showed a greater rise in FABF of healthy individuals following leg 
exercise in 30° head-up tilted rather than supine position (294). In agreement, removal of the 
great saphenous vein from symptomatic varicose vein patients results in a modest accentuation 
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of the increase in leg blood flow at the onset of exercise; seemingly due to the greater 
effectiveness of muscle-pump (293). However, it is important to note here that similar to the 
observations of Gotshall et al. (144), Shiotani et al. (367) observed increased muscle O2 uptake 
(VO2) during the low intensity 10 s exercise. 
Alternatively, evidence for concomitant rapid metabolic vasodilatation at the onset of exercise is 
also present. Tschakovsky et al. observed that a single handgrip contraction elicited a greater 
increase in FBF than that evoked by mechanical compression of the forearm to a similar intensity 
by inflation of a cuff (410). The same research group also showed that the immediate 
hyperaemic response following single handgrip contractions was intensity-dependent (5 – 70% 
MVC); venous emptying was already maximum at 5% MVC (412). Further, Shoemaker et al. 
found the early component of the hyperaemia to be related to handgrip contraction intensity 
rather than frequency (369).  
Pharmacological investigations have also revealed some interesting results. For example, 
Dobson and Gladden observed that if muscle blood vessels were already dilated due to a 
combination of localized hypoxia along with adenosine and SNP infusions, electrically stimulated 
isometric tetanic contractions of gastrocnemius plantaris muscles caused a decrease in blood 
flow (95). In agreement, when Hamann et al. infused their dogs with adenosine in one hind leg 
and saline in the other, treadmill exercise did not further increase blood flow in the hind limb with 
adenosine infusion; control leg showed normal hyperaemic response (155). Such results indicate 
that muscle-pump does not play a major role in the regulation of exercise hyperaemia. In a 
different study, continuous intra-arterial infusion of potassium (K+) used as an in-vivo clamp for 
membrane depolarization virtually abolished all of the hind limb exercise hyperaemia elicited by 1 
s tetanic contraction in dogs (153). Nonetheless, ~ 10% increase in blood flow was still recorded. 
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It is important to mention here that studies which utilize electrical stimulation of the motor nerve 
to evoke muscle contraction can be criticised because they cause un-physiological fibre 
recruitment patterns (228, 413). Further, use of conscious quadrupedal animals might fail to 
reveal a significant muscle-pump effect because positioning of limb below the heart increases 
limb volume and venous pressure, making it more difficult for muscle contraction to increase the 
pressure gradient across muscle (228, 369, 410, 412, 413). 
On balance however, it is likely that both muscle-pump and metabolic factors contribute to 
exercise hyperaemia, including the initial hyperaemic response; but the part played by the 
muscle-pump is likely to be minor under most circumstances and unlikely to be O2-dependent.  
1.2.3 Metabolic control 
The idea that metabolic products of muscle contraction influence vascular tone was proposed in 
1870s by Gaskell (136, 137). This implies that not only is hyperaemia proportional to the 
influence of vasoactive metabolites, but its magnitude is proportional to the metabolic demands 
of the working muscles. Since Gaskell’s early work, our understanding of the vasoactive 
metabolites has evolved considerably to include substances produced from muscles, vascular 
endothelium, red blood cells (RBCs), and those carried and delivered by blood (193). In 2007, 
Joyner and Wilkins republished the criteria describing a potential vasodilator substance; 
originally written by Shepherd in Handbook of Physiology (193). These are: 
1. The substance(s) or its precursor(s) should be present in skeletal muscle (or perhaps 
blood or nerves). 
2. The substance(s) should have access to the muscle resistance vessels. 
3. The concentration in the interstitial fluid (or at the endothelium) must be sufficient to 
cause dilatation and the concentration should be proportional to the contractile activity. 
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4. Exogenous administration of the substance(s) should be capable of causing prolonged 
dilatation without sensation in humans. 
5. Pharmacological agents or physiological manoeuvres which modify the blood flow 
responses to exercise should also modify the dilator responses to any putative 
substance given exogenously. 
Considering these criteria, the following discussion systematically addresses each major 
vasoactive metabolite’s contribution to hyperaemia, their interdependency, and the issue of 
redundancy. Furthermore, the recent evidence that the synthesis, release, and/or action of 
certain vasoactive metabolites changes with age is also addressed. 
1.2.3.1 Oxygen (O2) 
Exercise is not only accompanied by a hyperaemic response but O2 uptake of the working 
muscles also increases; unsurprising considering its importance to metabolism. Early studies into 
the effect of exercise on partial pressure of O2 (PO2) concentrations used O2-electrodes. 
Gorczynski and Duling observed that the twitch contractions of hamster cremaster muscle were 
accompanied by arteriolar dilatation that was restricted to the region of muscle that contracted, 
while tissue PO2 declined (143). However, peri-arteriolar PO2 recorded with an O2-electrode 
placed immediately adjacent to the arteriole, remained unchanged. Superfusion of the exposed 
area with hyperoxic solution decreased resting arteriolar diameter, and increased tissue PO2, but 
also largely prevented the fall in tissue PO2 during twitch contractions and attenuated the 
arteriolar dilatation. These observations led Gorczynski and Duling to propose that ~ 38 – 55% of 
the vasodilator response was due the decline in tissue PO2. They suggested an indirect O2-
dependent mechanism was responsible for exercise hyperaemia but did not propose where the 
substance/s might be released from (143). 
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Subsequently, Marshall and Tandon reported that venules and arterioles in the spinotrapezius 
muscle of the rat, showed active dilatator responses, which were graded with twitch frequency, 
and were localised to the region of muscle that was made to contract (250). Further, Lash and 
Bohlen again using an in-vivo preparation of rat spinotrapezius muscle showed that periarteriolar 
PO2 remained unchanged with exercise but perivenular PO2 decreased significantly (226). This 
led them to suggest that the change in PO2 on the venous side was the cause of the observed 
vasodilatation. In humans, Bylund-Fellenius et al. showed by inserting an O2-electrode in the 
medial-gastrocnemius that exercise at 8 kg workload caused ~ 70% decline in muscle PO2, 
which was even more pronounced at the higher workload (12 kg) (47). 
Since these early observations, studies have utilized proton nuclear magnetic resonance 
spectroscopy (3H-NMR) to detect myoglobin de-oxygenation. This technique sheds important 
light not only on intramuscular PO2, but also on the potential source of O2-dependent factors that 
contribute to hyperaemia. Richardson et al. observed that at rest, human skeletal muscle 
intracellular PO2 under normoxic conditions is ~ 34 mmHg (339). When competitive cyclists 
performed graded knee-extension exercise at 25 to 100% MVC, venous PO2 decreased 
progressively with each increment in exercise intensity (338); mean capillary PO2 declined from ~ 
44 mmHg at rest to ~ 37 mmHg at maximal exercise (338, 339). However, quadriceps muscle 
myoglobin PO2 decreased to 3.1 mmHg within the first 20 s and remained as such until exercise 
ceased (338). In a subsequent study, comparable decrease in intracellular PO2 (~ 4 mmHg) 
occurred in recreationally active men performing a similar exercise protocol (337). Further, in a 
study performed by Soller et al. rhythmic handgrip contractions performed at 15, 30, and 45% 
MVC by untrained subjects caused a fall in interstitial PO2 within flexor digitorum-profundus to ~ 
8 mmHg at 15% MVC, and to a near zero at 30 and 45% MVC (376). Collectively, these studies 
show that intramuscular PO2 declines profoundly during exercise, raising the possibility that O2-
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dependent substances that contribute to exercise hyperaemia are released from skeletal muscle 
fibres. 
Such pronounced changes in tissue PO2, particularly towards the venous end of the capillaries 
and in the intramuscular PO2, in both in animals and humans, suggest that substance/s are 
generated and/or released at these locations when PO2 falls; i.e., O2-dependent substances may 
contribute to the hyperaemic response. In fact, Saito et al. evoked twitch contractions of hamster 
cremaster muscle by electrical stimulation with and without disruption of venular endothelium and 
showed that this significantly attenuated the dilator response of the arteriole that was running 
alongside the venule (354). The most likely explanation of this observation is the diffusion of 
vasodilator substances from venules towards arterioles (169). 
Given the evidence that decline in tissue and/or venular PO2 results in vasodilatation during 
exercise, several studies have changed inspired O2 content as a way of investigating the 
influence of PO2 on vasodilatation and hyperaemia. For example Rowell et al. showed that the 
increase in leg blood flow and vascular conductance were higher when dynamic quadriceps 
exercise was performed during hypoxia (10 – 11% inspired O2), than normoxia (352). Similarly, 
Koskolou et al. found that breathing 11% O2 increased leg blood flow and conductance during 
sub-maximal exercise (221). By contrast, Richardson et al. showed no difference in leg blood 
flow between normoxia and hypoxia (12% O2) during single leg dynamic quadriceps exercise; 
although there was an increase in O2 extraction during hypoxia (340) Thus, collectively these 
studies suggest that the magnitude of exercise hyperaemia is enhanced when the fall in tissue 
PO2 is accentuated. 
Supplementary O2 has also been administered to healthy subjects as an alternative way of 
investigating the role of O2 in exercise hyperaemia. Welch et al. observed that hyperoxia (100% 
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O2) during cycling exercise at 55 – 70% of maximal aerobic capacity (VO2-max) caused an 11% 
decline in the exercise-induced increase in leg blood flow (428). As ABP did not differ between 
conditions, this reflected a smaller fall in vascular resistance. A similar attenuation of exercise 
hyperaemia (~ 12%) was also recorded when 60% O2 was used during knee-extensor exercise 
(316). Alternatively, Macdonald et al. did not find any significant changes in leg vascular 
resistance when subjects breathed 14, 21, or 70% O2 during dynamic leg exercise (242). 
However, their data did show the expected changes in blood flow, femoral artery diameter, 
cardiac output, and heart rate (HR): i.e., both during rest and exercise, hypoxia and hyperoxia 
induced an increase and decrease in these responses respectively. However, their data are not 
conclusive as the group size was only 6 subjects and the variability of the data was high.  
The effect of modest hyperoxia on post-exercise hyperaemia has been investigated by our 
group. Win and Marshall who used isometric handgrip exercise at 60% MVC found that 40% O2 
had no effect on baseline FBF or forearm vascular conductance (FVC), but caused ~ 30% 
reduction in post-exercise hyperaemia; similar to that observed with lone cyclooxygenase (COX) 
blockade (See Section 1.2.3.4 for further discussion) (437). Further, in a separate study, Fordy 
and Marshall asked subjects to perform two exhaustive isometric handgrip contractions at 100% 
MVC separated by 7 min of recovery (123). Subjects either breathed 40% O2 during the handgrip 
contractions or during the recovery period between them while normoxia was used as a control. 
They observed that breathing 40% O2 during contraction attenuated the increase in FVC by ~ 
25%. By contrast, when 40% O2 was breathed during the 7 min between two exercise bouts, this 
had no effect on the hyperaemia. These studies suggested that exercise hyperaemia is mediated 
by O2-dependent vasoactive metabolites that are generated and released during the period of 
exercise and continue to act when contraction ceases. Based on the preceding discussion, it is 
possible that during isometric contraction at least, O2-dependent metabolites may be released 
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from the blood vessels and/or in the contracting muscle fibres. Comparable experiments using a 
relatively modest concentration of supplementary O2 have not been done during rhythmic 
contractions when O2 delivery would be compromised less by the mechanical effect of muscle 
contraction. Further, no attempt has yet been made to determine whether breathing 40% O2 
does in fact raise the PO2 in exercising muscle, or prevent it from falling to such low levels during 
exercise. 
1.2.3.2 Adenosine and adenine nucleotides 
The idea of adenosine and adenine nucleotides contributing towards exercise hyperaemia 
comes from the “adenosine hypothesis”. Berne proposed that the mismatch between supply and 
demand of O2 led to adenosine tri-phosphate (ATP) breakdown in working cardiac muscles (25). 
Additional breakdown of adenosine di-phosphate (ADP) and adenosine mono-phosphate (AMP) 
augmented adenosine concentrations, which moved out of the cardiac cells and caused 
vasodilatation. The subsequent increase in blood flow alleviated the decline in O2, thereby 
prevented further nucleotide breakdown. In 1971, Dobson et al. extended this hypothesis to 
propose a similar role for adenosine in exercise hyperaemia in skeletal muscles (94). 
1.2.3.2.1 Adenosine 
Interstitial adenosine is mainly produced by skeletal and smooth muscle cell membrane bound 
5’ectonucleotidase (164, 314, 315). However, adenosine and its nucleotides are also released 
into the interstitium from motor nerves upon their activation (80). On the other hand, intravascular 
adenosine is most likely produced by soluble and endothelial 5’ectonucleotidase from ATP that is 
released from deoxygenated RBCs (112, 167, 314, 315) and from endothelial cells when they 
become hypoxic (407). Adenosine is also released from endothelial cells when PO2 falls as a 
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consequence of the competition between O2 and NO for the same binding site on cytochrome-
oxidase; ATP synthesis is attenuated and adenosine is generated (109).  
Venous adenosine concentrations increase substantially following electrical muscle stimulation 
(18, 130). Comparison of the vasodilatation associated with muscle contractions, and that with 
adenosine infusion, with the arterio-venous difference in adenosine concentrations showed that ~ 
15% of vasodilatation at 1 min and 40% between 5 and 20 min were due to the contribution of 
adenosine (18). Similarly in rats, Ray and Marshall have also observed an increased contribution 
of adenosine towards hyperaemia in the later part of 5 min exercise (333). In humans, adenosine 
concentrations increase both in skeletal muscle and the peritendinous connective tissue in 
response to planter-flexion exercise (223). 
Measurements made with microdialysis showed that exercise causes an increase in interstitial 
adenosine and nucleotide concentrations (70, 165, 223). Thus, following 10 W knee-extension 
exercise, Hellsten et al. observed a near 5 fold increase in the concentrations of vastus-lateralis 
interstitial adenosine and its precursor nucleotides (AMP, ADP, and ATP): only modest further 
increases being observed with greater workload (165). Nonetheless, the rate of increase was 
proportional to the exercise-intensity and a good correlation (r = 0.98) was found between 
interstitial adenosine and blood flow; consistent with adenosine being causally implicated in the 
vasodilatation. Interestingly, Costa et al. measured flexor digitorum-superficialis interstitium 
concentrations while their subjects performed low-intensity (15% MVC) rhythmic handgrip 
contractions without or with ischemia (70). Consistent with the idea that tissue hypoxia is 
causally important in the release of adenosine during muscle contraction, adenosine 
concentrations were significantly higher during ischemic exercise. 
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Early studies showed that adenosine-deaminase reduced exercise hyperaemia in dog and cat 
oxidative muscles (210, 360). On the other hand, increasing adenosine concentrations by either 
preventing adenosine reuptake or its breakdown with dipyridamole and erythro-9(2-hydroxy-3-
nonyl)adenine respectively, augmented the hyperaemic response (210, 229). In humans, even 
theophylline or aminophylline (theophylline-ethylenediamine) which are rather weak adenosine-
receptor antagonists that have no selectivity between adenosine-receptor subtypes, and that 
inhibit phosphodiesterase activity (249), significantly attenuate adenosine-induced vasodilatation 
(392) and exercise hyperaemia (327). However, their weak receptor antagonism makes it 
impossible to deduce the full extent of adenosine’s involvement in the exercise hyperaemia in 
people. 
Adenosine-receptor antagonists that are selective between the receptor subtypes are not 
licensed for use in humans; however they have been used in studies on cats and rats. Thus, 
Poucher observed in the cat that exercise hyperaemia was attenuated by ~ 30% following 
selective A2A-adenosine receptor blockade with ZM241385 and also following the non-selective 
adenosine-receptor blockers theophylline and 8-phenyltheophylline (8-PT) (324). This indicates 
that the adenosine component of exercise hyperaemia is mainly due to stimulation of A2A-
receptors. Similarly, Ray and Marshall (333) showed that ZM241385 and 8-
sulphophenylthrophylline (8-SPT; non-selective adenosine-receptor blocker) had comparable 
attenuating effects on exercise hyperaemia of twitch and tetanic hindlimb contractions by 14 and 
25% respectively (333). In humans, immnunohistochemical examination of skeletal muscle 
biopsy samples by Lynge and Hellsten showed that A1, A2A, and A2B receptors are all localized to 
endothelial and vascular smooth muscle cells (241). However, skeletal muscle cell plasma 
membrane and cytosol are devoid of A1-receptors. Thus, it may be that the A2A-receptor is 
functionally important in exercise hyperaemia in humans as well, but as yet this cannot be tested. 
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It should be noted here that exogenous adenosine does not produce vasodilatation in all 
individuals (251-253). Martin et al. investigated exercise hyperaemia of handgrip exercise 
performed at 3 different intensities (7, 14, and 21% MVC) with intra-arterial adenosine infusions 
(252). In some individuals (responders), both adenosine infusion and exercise resulted in similar 
hyperaemic response. However in others (non-responders), adenosine infusion was 
accompanied by blunted FBF responses compared to exercise hyperaemia. Nitric oxide 
synthase (NOS) inhibition however attenuated exercise hyperaemia in both groups. In a later 
study, the same group also observed that aminophylline attenuated adenosine infusion 
hyperaemia only in responders (253). Moreover while lower intensity exercise hyperaemia was 
not attenuated by aminophylline in some individuals, this was not the case at higher workload 
(21% MVC); aminophylline equally attenuated exercise hyperaemia in both responders and non-
responders. This suggests an intensity-dependent contribution of vasoactive adenosine in 
exercise hyperaemia regulation. When dipyridamole was used to block adenosine transport 
across cell membrane, adenosine infusion hyperaemia was similar in both groups; suggesting 
increased activity of nucleoside transporters in non-responders (251). 
Consistent with the idea of adenosine being a metabolite that is released in muscle as a 
consequence of a fall in PO2, adenosine has been implicated in the muscle vasodilator 
responses evoked by systemic hypoxia (71, 237, 265, 274, 297). Using intra-vital microscopy, 
Mian and Marshall showed that during systemic hypoxia (6% O2) some arterioles and venules 
supplying rat spinotrapezius dilated while others constricted (265). Topical application of 8-PT 
attenuated dilator responses in arterioles and venules, but had no effect on the constricting 
vessels. The authors therefore suggested that the vasodilating adenosine was produced locally 
by vascular 5’nucleotidase. In agreement with this, Mo and Ballard showed in dogs that under 
systemic hypoxia, venous adenosine concentrations increased while interstitial adenosine 
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remained unchanged (274). However, during muscle contraction, adenosine concentrations 
increased both in venous blood and interstitium. Similar observations were made by Lo et al. in 
rat muscle (237), while Costa et al. showed that 3 min of forearm ischemia had no effect on 
interstitial adenosine concentrations but increased venous adenosine by two-fold (71). 
Studies performed with selective adenosine-receptor antagonists in the rat have shown that 
during systemic hypoxia, adenosine’s dilatation is largely due to A1-receptor stimulation with 
some input from A2A-receptors during severe hypoxia (34, 35, 243, 331, 334, 425). These results 
are consistent with the adenosine-receptor localization study performed by Lynge and Hellsten 
(241). Although adenosine may act preferentially from the interstitium to induce dilatation during 
muscle contraction as discussed above, the evidence that adenosine can also be released by 
vascular endothelium when PO2 falls, leaves the possibility that adenosine may also be released 
from the endothelium during exercise; probably from the capillaries and venules, given that peri-
arteriolar PO2 does not fall during muscle contraction (143, 226). Indeed, Hester has shown that 
application of adenosine in a venule leads to the dilatation of a paired arteriole (168). Clearly, 
these ideas cannot be tested in humans at the current time due to the lack of A1- or A2A-receptor 
antagonists for human use. However, they could be more fully tested in rats. 
1.2.3.2.2 ATP 
In 1969 Forrester and Lind measured arterial and venous ATP concentrations during and 
following sustained handgrip exercise and noticed a significant increase in plasma ATP 
particularly in the veins (124) In 1992 Bergfeld and Forrester showed that human RBCs release 
ATP under hypoxic / hypercapnic conditions (24). These findings were later confirmed by 
Ellsworth et al. who by using hamster cheek pouch muscle also observed significant 
vasodilatation in response to the application of intra-luminal ATP (112). Therefore, it was 
suggested that RBCs not only deliver O2 to working muscles but also act as indirect sensors / 
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modulators of vascular tone (24, 112). Work done by Jagger et al. showed that ATP release from 
RBCs was due to the change in the state of the haemoglobin; i.e., from relaxed liganded 
oxygenated to deoxygenated (186). They lowered O2 saturation (SO2), PO2, and used carbon-
monoxide (CO), which has a higher affinity for haemoglobin than O2 to prevent any change in 
haemoglobin conformation. The results revealed that CO lowered the ATP release from RBCs 
when PO2 was decreased. Furthermore, ATP concentrations correlated better with changes in 
SO2 than PO2 (r2 = 0.88 vs. 0.54), confirming the release of ATP from erythrocytes was due to 
the change in their oxygenated state.  
Subsequently, Gonzalez-Alonso et al. investigated the contribution of human erythrocytes and 
their release of ATP to exercise hyperaemia evoked by incremental knee-extension during 
normoxia, hypoxia (10%), hyperoxia (100%), and CO with normoxia (142). They showed that 
venous ATP efflux increased with incremental exercise, but ATP concentrations and muscle 
vascular conductance were significantly higher when exercise was performed during hypoxia 
than during normoxia. Whereas both hyperoxia, and CO with normoxia decreased plasma ATP 
release during exercise. These findings are entirely consistent with the role of RBCs as O2 
sensors / vascular modulators, and consistent with ATP contributing to exercise hyperaemia 
(142).  
Recently, it has been suggested that mechanical deformation / shear stress also act as stimuli 
for ATP release. Mortensen et al. investigated this using passive leg-movement without and with 
rapid sphygmomanometer cuff compressions (60/min) around the thigh (290). Despite an 
increase in vascular conductance, venous ATP concentration increased only when vascular 
compression was applied. 
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Extra-luminal application of ATP is known to result in vasoconstriction, whereas intra-luminal 
application causes concentration-dependent vasodilatation (44, 254). Thus, the ATP that is 
released into interstitium during exercise (165) is unlikely to directly contribute to exercise 
hyperaemia; it must act from inside the luminal side. Indeed, intravascular ATP acts on 
endothelial and smooth muscle P2Y-receptors to cause vasodilatation (44, 286, 344, 444). 
However, Mortensen et al. showed that in humans these receptors are actually present on 
endothelium, smooth, and skeletal muscle cells (286). Moreover, they showed that the 
vasodilatation induced by ATP infusion was not attenuated following theophylline; indicating that 
dilatation by ATP is not solely by its degradation to adenosine (286). The contribution of ATP to 
exercise hyperaemia is difficult to test directly because there are no ATP-receptor antagonists 
that are selective between the P2-receptor subtypes. However, Mortensen et al. did show that 
reactive blue, a putative P2-receptor antagonist, attenuated exercise hyperaemia in miniature 
swine during treadmill exercise (288). 
In summary, it is clear that the interstitial and plasma adenosine and adenine nucleotide 
concentrations increase in response to exercise. Moreover, adenosine-receptor blockade 
attenuates exercise hyperaemia, and the evidence suggests it acts largely from the extra-luminal 
surface of arterioles but may also be released and act from endothelial cells on the venous side 
of the capillary bed. Although ATP is also released into plasma from RBCs when haemoglobin 
off-loads O2; whether it plays a significant role in exercise hyperaemia has yet to be finally 
established but it seems very likely. A number of studies have suggested that adenosine and 
ATP work interdependently with other vasoactive substances, including NO and prostacyclin 
(PGI2) (65, 101, 156, 254, 286, 289, 304, 306, 332, 333, 444). This evidence is considered below 
in the relevant sections. 
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1.2.3.3 Vasoactive ions 
1.2.3.3.1 Lactic acid 
Lactate is produced due to anaerobic glycolysis; its efflux into the vasculature is linearly 
correlated with the concentrations in the muscle (20, 63). The increase in interstitial and 
circulating lactate during exercise has led to consideration of whether it plays an active role in 
exercise hyperaemia. Its exact mechanism of action is not clear, but the cyclic guanosine mono-
phosphate pathway, K+-channels, and neuronal NOS (nNOS) have all been implicated. In the 
study performed by Chen et al., lactate application to isolated rat cremaster arterioles led to their 
dose-dependent dilatation which was not affected by COX blockade (indomethacin), NOS 
blockade (NG-nitro-L-arginine; L-NNA), their combination, or by the removal of endothelium (60). 
However, it was inhibited by the cyclic guanosine mono-phosphate blockers methylene-blue and 
6-anilino-5,8-quinolinedione. Further, Mori et al. showed that KCl contracted pig coronary arteries 
dilated in a dose-dependent manner in response to lactate; calcium (Ca2+) activated K+-channel 
(KCa) blockade with tetraethylammonium reversed the vasodilatation, whereas the ATP-sensitive 
K+-channel (KATP) blocker (glibenclamide) did not (282). KCa-channel activation was also induced 
by lactate in coronary smooth muscle cells under patch-clamp technique (282). On the other 
hand, Mendrinos et al. used NOS antagonist Nω-nitro-L-arginine (L-NAME) in an in-vivo porcine 
model to investigate the lactate induced retinal arteriolar dilatation (260). Some pigs received an 
intra-venous L-NAME infusion for an hour followed by lactate infusion into the vitreous-humour 
using a micropipette. 10 min later, a juxta-arteriolar intra-vitreous infusion delivered L-NAME into 
the eyes. Pigs without NOS blockade only received lactate injection which resulted in 
reproducible retinal arteriolar dilatation, a response similar to those receiving intra-venous L-
NAME. However, intra-vitreous L-NAME infusion reversed the vasodilatation. This implicates 
nNOS in the lactate induced vasodilatory response. 
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However, the major problem with lactate as an important contributor to exercise hyperaemia is 
the lack of any temporal relationship between its concentrations and blood flow (205, 239). By 
using microdialysis, Lott et al. showed that quadriceps exercise performed at 30 and 60% MVC 
resulted in similar increases in interstitial lactate concentration, and during recovery limb blood 
flow declined whereas interstitial lactate concentrations continued to increase (239). Separately, 
although Fordy and Marshall observed that 40% O2 attenuated venous lactate concentrations of 
100% MVC but the increase in these concentrations was completely unrelated to FBF; i.e., by 7 
min post-exercise, FBF returned to baseline while venous lactate still remained significantly 
elevated (123). Additionally, McArdle’s syndrome patients who do not produce much lactate have 
exercise hyperaemic responses that are similar in magnitude to those observed in normal 
individuals (205). Therefore, even though lactate can induce dilatation, it seems unlikely that 
lactic acid makes an essential contribution to exercise hyperaemia in an O2-dependent or 
independent manner. 
1.2.3.3.2 Hydrogen ions (H+) 
Exercise leads to a decrease in interstitial and intravascular pH (20, 239); raising the possibility 
that H+ may be involved in the active regulation of the vascular tone. Indeed, hypercapnic and 
normocapnic acidosis evoke dilatation of the isolated rat cerebral arteries with a concomitant 
decrease in smooth muscle intracellular Ca2+ (318). This vasodilatation is understood to involve 
KCa, KATP, and NO (58, 235). For example, when Lindauer et al. decreased extra-luminal pH of 
isolated rat cerebral arteries from 7.4 to 7.0, their diameter increased ~ 35% (235). KCa-
antagonist etraethylammonium attenuated this dilatation and it was then abolished by KATP-
channel blockade with glibenclamide. Recently, Celotto et al. observed attenuation of acidosis 
induced dilatation of rat aortic segment with L-NAME; glibenclamide and small conductance KCa-
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channel inhibitor apamine on their own or in combination with L-NAME nearly abolished the 
dilator response whereas indomethacin had no such affect (58)  
Despite these observations, in-vivo evidence for a direct correlation between pH and the 
magnitude or pattern of exercise hyperaemia has not been produced. Lott et al. observed that 
despite a clear difference in blood flow when leg exercise was performed at 30 or 60% MVC, 
vastus-lateralis interstitial pH concentrations were fairly similar (239). In a different study, 
interstitial pH concentrations declined progressively with incremental leg exercise but this decline 
continued even after the end of exercise; peak acidification occurring 1 min after cessation of 
exercise (388). The inescapable conclusion of these studies is that although pH changes do 
modify vascular tone, a direct / significant role for H+ in exercise hyperaemia is unlikely. 
1.2.3.3.3 Inorganic phosphate (Pi) 
Pi has also been implicated in exercise hyperaemia. In a series of elegant experiments 
performed by Hilton et al. in 1978, they observed that contraction evoked stimulation of the motor 
nerve to cat gastrocnemius muscle resulted in increased venous efflux of Pi; concentrations of 
venous Pi were closely related to the changes in blood flow (176). Further, when Pi was applied 
topically on the spinotrapezius muscle, this evoked arteriolar dilatation with a latency of ~ 5 s.  
However, the study of Lott et al. mentioned above also measured interstitial Pi in quadriceps 
during 5 min single leg knee-extension exercise performed at 30 and 60% MVC (239). They 
found that although the hyperaemia was greater at the higher workload, the interstitial Pi 
concentrations were similar. Moreover when exercise hyperaemia was decreasing at the end of 
exercise, interstitial Pi was still increasing. This dyssynchrony between exercise hyperaemia and 
interstitial Pi concentrations argues against an important role for Pi in exercise hyperaemia. 
However, its contribution is difficult to test as there is no obvious antagonist. 
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1.2.3.3.4 Potassium (K+) 
Active vasodilatation induced by K+ has been proposed for a long time. The earliest 
unambiguous experiments were published by Dawes in 1941 (84). He showed that KCl infusion 
into the external iliac artery resulted in cat and dog hindlimb vasodilatation. Later Kjellmer 
observed K+ release from working muscles into venous blood; concentrations being 
accompanied by a proportionate vasodilator response (216). This correlation between increased 
interstitial and venous K+ with appropriate vasodilatation has been confirmed by a number of 
other studies (10, 208, 239). Evidence has also been presented that K+ concentrations in 
interstitium and venous blood are related to the amount of work done (194, 239).  
Importantly, when Kiens et al. measured venous concentrations of a number of metabolites 
during quadriceps contraction performed at 10% MVC for 5 or 30 s, it was shown that shorter 5 s 
contraction significantly increased venous K+ only, but 30 s contraction increased concentrations 
of lactate, Pi, and K+ (208). As hyperaemia accompanied both contractions, K+ was suggested as 
a potential mediator of initial increase in blood flow. This case is strengthened by the 
observations of Armstrong et al. (10). They stimulated hamster cremaster muscle preparations at 
multiple frequencies (4 to 80 Hz; 250 ms) and showed that the rapid dilatation of arterioles (at 4 
s) was attenuated by ~ 60%, by either 3,4-diaminopyridine (voltage-dependent K+-channel 
antagonist) which was expected to prevent release of K+ from the muscle fibres, or by ouabain 
(Na+/K+-ATPase antagonist), or barium-chloride (inward-rectifying K+-channel antagonist) which 
were expected to interfere with the action of K+ on the vascular smooth muscle (10, 43). Perhaps 
the role of inward-rectifying K+-channels in K+ induced vasodilatation may be more important as 
mice deficient of these channels lack a K+ induced vasodilator response (445). However, the 
release of K+ from muscles during action potentials does seem unlikely to be O2-dependent. 
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1.2.3.4 Prostaglandin (PG) 
Arachidonic acid (AA) is released from the membrane phospholipids by phospholipase enzymes; 
acted on by COX to produce vasoconstricting endoperoxides, prostaglandin G2 (PGG2), and the 
subsequent H2 (PGH2) (63, 277-279). These intermediates are further acted upon by specific 
synthases to produce an array of vasodilators and constrictors; including prostaglandins D2 
(PGD2), E2 (PGE2), F2α (PGF2α), PGI2, and thromboxane A2 (TX; TXA2) (279, 397). The idea that 
the potent vasodilators PGE2 and PGI2 contribute to exercise hyperaemia has been in the 
literature for many years. 
In 1976, Moncada et al. published their observations describing the anticoagulant and potent 
vasodilating properties of a certain PG which they termed X (277). The following year, while 
describing the production of this compound within the blood vessels, they named it as 
prostacyclin or PGI2 (278). The mechanism by which it causes vasorelaxation involves adenylyl-
cyclase / cyclic AMP transduction system and smooth muscle hyperpolarization (63, 312). Its 
release in the intravascular compartment occurs from the endothelial cells (266, 306) and is 
linked to exercise (198, 390), tissue hypoxia (45, 264), presence of the other vasodilators (i.e., 
adenosine and ATP; See Section 1.2.3.7) (304, 306), and shear stress (See Section 1.2.4) (127). 
However as PGI2 concentrations also increase in the interstitial compartment in response to 
exercise and the presence of other exogenous vasoactive metabolites (304, 306); PGI2 release 
may also occur from the abluminal surface of capillaries and/or from non-endothelial structures 
(306). Skeletal muscle fibres are understood to predominantly release the vasodilator PGE2 
(400): exercise-intensity and tissue hypoxia have been linked to its release (198, 199, 390). 
The first study to investigate the role of COX derived vasodilating PGs in human exercise 
hyperaemia was performed 40 years ago by Kilbom and Wennmalm (209). Using venous 
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occlusion plethysmography, they showed that rectal administration of indomethacin substantially 
attenuated peak and total post-exercise hyperaemia evoked by 5 min of isometric (15% MVC) 
and rhythmic handgrip contractions (0.83 and 1.67 W for women and men, respectively). Since 
this initial study, knowledge of the role of vasodilator PGs in exercise hyperaemia has increased 
considerably. Cowley et al. showed that COX inhibition with aspirin attenuated post-exercise calf 
blood flow (CBF) following cycling exercise (73, 74) and similar attenuation was observed when 
COX blockade with aspirin and indomethacin were compared (74). Later, Duffy et al. showed 
that intra-arterial infusion of aspisol (COX inhibitor) decreased exercise hyperaemia evoked by 
rhythmic wrist-flexion exercise; this effect was not added to by simultaneous NOS inhibition 
(100). Similarly Schrage et al. who used Doppler-ultrasound to measure FBF showed that COX 
inhibition with Ketorolac infusion decreased exercise hyperaemia of relatively weak rhythmic 
handgrip exercise (20 min, 10% MVC) by ~ 12% (359). Moreover our group reported that COX 
inhibition attenuated post-exercise hyperaemia evoked by isometric handgrip contraction at 60% 
MVC (437). 
By analysing biopsies of cat triceps-surae, which would have included vascular tissue as well as 
muscle fibres, it was shown that isometric contractions increased the concentrations of both 
PGE2 and 6-keto-PGF1α, the stable metabolite of PGI2, (by 45 and 53%, respectively) (390). The 
study also observed that a separate low intensity isometric contraction with arterial occlusion 
increased PGE2 by ~ 70%, whereas similar intensity contraction without occlusion failed to 
change the muscle PGE2 concentration. These results not only suggest an important relationship 
between O2 availability (tissue hypoxia) and PG production, but also suggest that the release of 
PGs could be exercise intensity dependent (See below).  
In humans, Nowak and Wennmalm observed that exercise performed at 75% VO2-max 
significantly increased venous concentrations of PGE (302). In a subsequent study, Wilson and 
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Kapoor showed that rhythmic wrist-flexion exercise increased both, FBF and venous 
concentrations of PGE2 and PGI2; indomethacin attenuated exercise hyperaemia by ~ 20% and 
virtually abolished the release of PGs (435). Further, using microdialysis Karamouzis et al. 
showed that 60 min of 20 W knee-extensor exercise-induced a significant increase in the 
interstitial concentrations of PGE2 (199) In their second study, dynamic leg exercise at 100 and 
150 W induced an intensity-dependent increase in interstitial PGE2 and 6-keto-PGF1α 
concentrations, but a parallel decrease in the concentration of the stable derivative of the 
vasoconstrictor TXA2; TXB2 (198). 
The observation of a relationship between exercise intensity and PG release is supported by a 
number of other studies (29, 447, 448). Boushel et al. measured quadriceps micro-vascular 
blood flow using near-infrared spectroscopy (NIRS) and found that combined NOS and COX 
blockade attenuated exercise hyperaemia evoked by graded dynamic knee-extension at 30, 45, 
and 60 W, but not at 15 W (29). Further, increases in interstitial PGE2 concentrations were 
measured only at the higher workloads (45 and 60 W). Regarding PGI2, Zoladz et al. recently 
showed that venous plasma 6-keto-PGF1α concentrations were positively correlated to an 
individual’s VO2-max (447, 448). In their first study, venous plasma 6-keto-PGF1α concentrations 
of subjects performing exhaustive cycling exercise were higher in subjects who had a higher 
VO2-max (447). Their subsequent cycling study found that five weeks of endurance training led 
to an overall increase in VO2-max, power output, and the venous 6-keto-PGF1α efflux of their 
subjects (448). These observations indicate that the release of both PGE2 and PGI2 during 
exercise is positively related to the intensity of muscle contractions. 
Evidence also suggests that systemic and localized hypoxia increase the synthesis of vasodilator 
PGs (45, 46, 264, 266), while severe hypoxia / anoxia may prevent PGI2 production by 
endothelial cells (375). Since extreme intravascular hypoxia / anoxia is not likely during exercise 
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under normal conditions, the discussion here focuses on PG synthesis in physiological levels of 
hypoxia. Michiels et al. showed that hypoxia increased PG production in cultured human 
endothelial cells (266). Moreover, Busse et al. showed that the intra-luminal hypoxia (20 – 40 
mmHg) in perfused rat tail and dog femoral artery preparations resulted in their dilatation; 
response that was abolished by either endothelium removal or COX blockade (45, 46). In a 
subsequent study, they showed that this hypoxia induced vasodilatation was accompanied by a 
2 – 3 fold increase in 6-keto-PGF1α concentrations (45). Similarly, Messina et al. showed that 
isolated rat cremaster arteries dilated when bath PO2 was reduced from 150 to 15 mmHg, and 
this dilatation was abolished by either endothelium removal or COX inhibition with indomethacin 
(264). In accord with these findings, Win and Marshall showed that breathing 40% O2 during 
isometric handgrip exercise attenuated post-contraction hyperaemia to the same extent as COX 
inhibition (437). Moreover, combined COX inhibition and 40% O2 had no further effect on the 
response. Based on these observations our group therefore proposed that the contribution of 
vasodilator PGs to exercise hyperaemia induced by isometric handgrip contractions is O2-
dependent. 
Despite these observations, a number of studies on the role of PGs in exercise hyperaemia have 
revealed conflicting results. For example, Mortensen et al. showed that indomethacin infusion 
had no effect on hyperaemia evoked by knee-extensor exercise at 20% MVC for 5 min (287). 
Schrage et al. observed 12% attenuation in hyperaemia evoked by 10% MVC handgrip 
contractions when ketorolac was infused during the contractions, but this reduction was transient 
in nature (359). By contrast, when the NOS inhibitor L-NAME was infused during the 
contractions, exercise hyperaemia was attenuated by ~ 20%. Co-infusion of NOS and COX 
inhibitor decreased FBF by ~ 30%, but again only transiently. The authors therefore proposed 
that although vasodilator PGs participate in exercise hyperaemia, their contribution is not 
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essential, and other substances can restore / replace their contribution. Indeed, Shoemaker et al. 
who also used a similar exercise protocol and methodology failed to observe any attenuation in 
exercise hyperaemia when ibuprofen was used for COX inhibition (368). The results of both 
these studies may be explained by the observations that exercise-evoked release of PGs does 
not occur in all individuals, even when they are performing the same amount of exercise 
(responders and non-responders) (448), and is minimal or non-existent at light levels of exercise 
(29). Interestingly, Zoldaz et al. showed that the concentrations of PGI2 released during exercise 
are increased by endurance training (448). The effect of training on PG production may therefore 
complicate the outcome of many studies in this field. 
In summary, the exact contribution of PGs to exercise hyperaemia in humans is unclear. 
However, results of most studies indicate that in most individuals, PGs, probably PGE2 and PGI2 
contribute significantly, especially during moderate to intense exercise, and that at least one of 
these PGs makes a contribution that is O2-dependent. 
1.2.3.5 Nitric oxide (NO) 
Ever since the discovery of NO in 1980s (311), its importance as a possible regulator of the 
vascular tone has increased tremendously. NO is produced from L-arginine by the enzyme NOS, 
which is present in three different isoforms: endothelial NOS (eNOS), neuronal NOS (nNOS), 
and inducible NOS (iNOS) (116, 384). In humans the constitutive NOS isoforms, eNOS and 
nNOS are localized to the vascular endothelium, and to skeletal muscles, neurones, and 
vascular smooth muscle, respectively (126). Their activation has been attributed to Ca2+ 
concentrations (63, 248, 332). The process of NO production is a two-step procedure requiring 
NADPH and O2; L-arginine is converted to Nω-hydroxy-L-arginine which is then converted to 
citrulline and NO (248). Moreover, NO can also bind to haemoglobin as S-nitrosohaemoglobin 
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which is released in response to RBCs offloading O2 (383). However, deoxyhaemoglobin 
molecules also produce NO from the nitrate present in the blood (68). 
Despite the evidence that NOS activity is increased by acute and chronic exercise (19, 341), 
studies into the role of NO in active exercise hyperaemia regulation have yielded conflicting 
results. In humans, Wilson and Kapoor found that despite the decrease in resting FBF induced 
by Nω-monomethyl-L-arginie (L-NMMA; NOS inhibitor), the magnitude of the exercise 
hyperaemia of wrist flexion exercise (0.2 and 0.4 W) did not change (434). This suggested no 
role for NO in exercise hyperaemia. Endo et al. also came to similar conclusions when they 
asked subjects to perform isometric handgrip contractions for 3 min without and with L-NMMA 
infusion: the resting and post-exercise FBF was decreased, but the magnitude of change in FBF 
during exercise was similar between conditions (113). 
Shoemaker et al. who used Doppler-ultrasound showed that atropine and L-NMMA given 
together had no effect on exercise hyperaemia evoked by rhythmic handgrip contractions at 10% 
MVC, but the time course of post-exercise hyperaemia was shortened (370). Similarly, Radegran 
and Saltin discovered that L-NMMA infusion did not attenuate exercise hyperaemia evoked by 
graded knee-extension exercise, but attenuated the post-exercise hyperaemia by ~ 34% (329). 
These findings suggest that NO is important in regulating resting and post-exercise blood flow.  
By contrast, a number of older and more recent studies suggest that NO does actively participate 
in exercise hyperaemia. Gilligan and colleagues who asked their subjects to perform rhythmic 
handgrip contractions at 15, 30, and 45% MVC (5 s contraction: 15 s relaxation – 5 min each 
intensity) and measured FBF during relaxation periods between contractions using venous 
occlusion plethysmography concluded that NOS inhibition by L-NMMA infusion attenuated the 
increase in vascular conductance by ~ 18% (140). Similarly, Dyke et al. found that FBF was 
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reduced by 20 – 30% if L-NMMA was infused in the brachial artery of subjects while they 
performed rhythmic handgrip contractions (1s contraction: 1s relaxation; 15% MVC) (106). 
However, it could be argued that both studies were reporting on the effects of NOS inhibition on 
post-exercise hyperaemia, for both recorded FBF between rhythmic contractions because they 
used venous occlusion plethysmography (106, 140). 
More recent studies in which Doppler-ultrasound was used to measure blood flow have also 
suggested an active role of NO in exercise hyperaemia. Schrage et al. reported that L-NAME 
infused during rhythmic handgrip contractions at 10% MVC attenuated steady-state hyperaemia 
by ~ 17% (359). Similarly, Casey et al. showed that NOS blockade with L-NMMA attenuated the 
increase in FVC evoked by rhythmic handgrip contractions at 20% MVC by ~ 20%, and 
increased the time to reach steady-state hyperaemia; but had no affect on hyperaemia of 10% 
MVC contractions (55). Further, Wray et al. showed that NOS blockade with L-NMMA attenuated 
exercise hyperaemia evoked by rhythmic handgrip contractions at 8, 12, 16, 20, and 24 kg; but 
not 4 kg (440). However, when these data were normalized to take account of the NOS-induced 
decrease in resting flow, NOS blockade attenuated hyperaemia only at higher (20 and 24 kg) 
workloads. This suggests an intensity-dependent contribution of NO and raises the possibility 
that in some of the other studies, exercise intensity was not high enough to engage NO. 
However, this would contradict with the evidence showing that even low-intensity exercise’s 
hyperaemia is regulated by NO (358, 359). 
In conclusion, collectively these results show that NO does contribute towards resting blood flow 
and active exercise hyperaemia regulation. However, it is interesting to note that no one has so 
far shown that NO concentrations actually increase in the interstitium or in the venous blood 
during muscle contraction; i.e. the question whether exercise hyperaemia is NO-dependent or 
whether NO plays more of a mediating role remains for now unanswered. 
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1.2.3.6 Endothelium derived hyperpolarizing factor (EDHF) 
The concept of EDHF originated from the observations that bradykinin and ACh induce 
endothelium-dependent hyperpolarization and relaxation of porcine coronary artery smooth 
muscles in the presence of NOS and COX blockade (63, 295). Current consensus is that a 
number of substances / factors may contribute to the endothelium-dependent hyperpolarization 
of smooth muscle cells (for review see Feletou and Vanhoutte, 2009) (116). The products of 
cytochrome-P450 enzyme are discussed here due to their proposed relevance in exercise 
hyperaemia. 
Rosolowsky and Campbell observed that AA induced vasodilatation of bovine coronary arteries 
was partially inhibited by indomethacin and partially by SKF-525a (cytochrome-P450 inhibitor) 
(345). Combination of COX and cytochrome-P450 inhibitors completely abolished the response. 
This implicated cytochrome-P450 in AA-mediated dilatation of vessels. It is also known that 
epoxyeicosatrienoic-acids are produced from AA metabolism by the cytochrome-P450 pathway 
(50, 116, 345). Campbell et al. showed that the cytochrome-P450 inhibitors SKF-525a and 
miconazole attenuated metacholine (muscarinic-receptor agonist) induced dilatation of bovine 
coronary arteries, and completely abolished smooth muscle hyperpolarization (50). Further, 
vessels pre-treated with AA released epoxyeicosatrienoic-acids and showed relaxation; a 
response that was abolished in response to KCa-channel inhibition. Isolated human coronary 
artery preparations also showed similar smooth muscle cell hyperpolarization involving 
cytochrome-P450 and KCa-channels (272). Later Halcox and colleagues showed that arterial 
infusion of bradykinin in the presence of NOS and COX blockade induced an increase in FBF 
that was inhibited by KCl infusion or miconazole (150). Thus, the results of these studies show 
that in the absence of the NOS and COX pathways, human forearm smooth muscle cells can 
show endothelium-dependent hyperpolarization via cytochrome-P450 pathway. 
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Regarding exercise hyperaemia, Hillig et al. found that when the cytochrome-P450-2C9 inhibitor 
sulfaphenazole was infused alone during single leg knee-extensor exercise (10 min; near-
maximal workload), there was no change in the exercise hyperaemia (175). However, when 
sulfaphenazole was co-infused with L-NMMA, at a dose that was ineffective in attenuating 
exercise hyperaemia in a similar protocol (329), then exercise hyperaemia was attenuated by ~ 
16% (175). Thus, they proposed that the products of the cytochrome-P450-2C9 and NOS 
contribute to exercise hyperaemia in an interdependent manner during sub-maximal exercise 
such that NOS inhibition up-regulates the contribution of epoxyeicosatrienoic-acids. Mortensen et 
al. reached a different conclusion when they investigated relative weak intensity exercise (287). 
They found that COX inhibition alone failed to attenuate exercise hyperaemia evoked by knee-
extensor exercise at ~ 20% of maximum, combined COX and NOS inhibition attenuated exercise 
hyperaemia by ~ 36%, and that addition of the KCa-channel tetraethylammonium-chloride 
inhibitor reduced the hyperaemia by ~ 28% compared to control. These results indicated that at 
light workloads, epoxyeicosatrienoic-acids do not contribute towards exercise hyperaemia; i.e., 
their production is not up-regulated by COX and NOS inhibition. 
1.2.3.7 Interdependency and redundancy 
The complexity of the vasodilators that contribute to exercise hyperaemia becomes clear from 
the discussion above. Lack of a single essential mediator of exercise hyperaemia means that 
pharmacological blockade of a single vasodilator during exercise can apparently lead to an 
increase in the contribution of another. Therefore, due to its importance, the interdependent / 




Mortensen et al. noticed that independent NOS or COX blockade failed to attenuate exercise 
hyperaemia evoked by 5 min of one leg knee-extension exercise, but their combined use 
attenuated the hyperaemia by ~ 36% (287, 329). Similar results were obtained in a recent study 
performed by Heinonen et al. (162). NOS blockade alone reduced resting blood flow (measured 
using positron emission tomography), but exercise hyperaemia evoked by single leg knee-
extension exercise with an average workload of 4.5 kg was unaffected. By contrast, combined 
NOS and COX inhibition attenuated exercise hyperaemia by ~ 13%. These studies exemplify the 
complex relationship that exists between vasodilator metabolites. 
Current understanding regarding the interdependency between vasodilators and their 
contribution towards exercise hyperaemia focuses on adenosine and ATP. In 2010, Nyberg et al. 
reported that exogenous adenosine infused intra-arterially into the leg or into the interstitium of 
vastus-lateralis increased muscle NO and PGI2 concentrations (306). They also showed that 
adenosine stimulated endothelial cells release both NO and PGI2, while skeletal muscle cell 
cultures released NO. Thus, their study showed that adenosine can increase NO and PGI2 
production on either side of the blood vessel in humans. The same group obtained similar results 
upon exposure of rat endothelial and skeleto-muscle cells to ATP (304). Further, in that study, 
ATP superfusion over rat gluteus-maximus evoked ~ 400% increase in blood flow that was 
attenuated by NOS inhibition, and abolished by combined NOS and COX inhibition. In humans, 
ATP infusion in vastus-lateralis increased local interstitial NO and PGI2 concentrations by 60 and 
40% respectively (304). By contrast, Crecelius et al. showed that dilatation induced by intra-
arterial ATP was unaffected by NOS blockade with L-NMMA (5 mg/min) (77). However, a study 
performed by Mortensen et al. used a higher dose of L-NMMA (12 mg/min) which attenuated 
ATP induced vasodilatation by ~ 14%; similar to that observed with COX inhibition (286). 
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However, both studies showed higher attenuation in ATP induced vasodilatation when NOS and 
COX (ketorolac or indomethacin: ~ 600 µg/min) inhibitions were combined (77, 286).  
Moreover, Ray and Marshall reported that L-NAME infusion attenuated exercise hyperaemia of 
twitch contraction by ~ 32% with a further 28% reduction due to subsequent A2A-blockade (335). 
Following restoration of vascular conductance with NO-donor SNP, L-NAME failed to attenuate 
increase in blood flow, but A2A-blockade still reduced hyperaemia by ~ 25%. Together these 
results suggest that adenosine influences the release / action of NO; while NO itself does not 
contribute towards the release / action of adenosine. Regarding human exercise hyperaemia, 
Mortensen et al. observed that theophylline attenuated the exercise hyperaemia by ~ 14%, while 
combined NOS and COX inhibition (L-NMMA+indomethacin) attenuated the increase in flow by ~ 
29% (289). However, combination of all three drugs did not result in any added attenuation 
suggesting that adenosine contributes towards the release / action of NO and vasodilating COX 
products. Recently Casey et al. failed to observe attenuation in exercise hyperaemia with 
aminophylline, while combined use of L-NMMA and aminophylline reduced limb blood flow (56). 
In conclusion, collectively these studies suggests that not only do adenosine and ATP mediate 
exercise hyperaemia, but they also influence the production of NO and PGs (286, 289, 304, 306, 
332, 333). However, the exact extent to which this interdependent relationship between 
metabolites dictates limb / MBF is still not clear. 
1.2.4 Shear stress 
Shear stress can be defined as the physical / mechanical force applied on the vascular walls due 
to their deformation during exercise or due to an increase in blood flow. This mechanical force is 
a stimulus for the release of vasodilator metabolites; making it an important regulator of vascular 
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tone at rest and that may have an increased role during exercise. Indeed, both PGs and NO are 
released due to an increase in shear stress. 
When Frangos et al. exposed a cultured monolayer of human endothelial cells to steady (10 
dyne/cm2 for 7 – 8 hr) and pulsatile (8-12 dyne/cm2 at 1 Hz) shear stress, there was an 
immediate increase in PGI2 concentration with flow onset, which declined steadily towards a 
stable concentration; ~ 16 times greater than those observed in stationary culture (127). A 
pulsatile increase in shear stress to mimic normal blood flow patterns doubled the steady 
concentrations of PGI2. These observations were later confirmed on rat aortic smooth muscle 
cells subjected to four different shear stress levels: even a small increase of 0.5 dyne/cm2 
caused a significant increase in PGI2 release which remained elevated for 3 hours, but PGE2 
release did not increase until shear stress was increased to 5 dyne/cm2 (7). In line with these 
results, Koller et al. showed that shear stress related dilatation of isolated rat gracilis muscle 
arterioles and venules was attenuated by COX inhibition with indomethacin (217, 219). 
Moreover, in rat cremaster muscle, the arteriolar dilatation caused by release of arterial occlusion 
was attenuated by COX inhibition (218).  
Similarly, NO synthesis is increased by shear stress. For example, Koller et al. also observed 
that NOS inhibition attenuated shear stress related vasodilatation in gracilis arterioles, and 
venules (217, 219). Moreover, combined NOS and COX inhibition nearly abolished the flow-
induced dilatation in both studies (217, 219). The mechanism by which increased shear stress 
leads to NO synthesis involves activation of phosphatidylinositol-3-kinase, which acts on protein-
kinase-B, leading to serine phosphorylation and eNOS activation (90, 120). In humans, NO has 
received important consideration as a modulator of reactive hyperaemia; a number of studies 
have observed an attenuation in blood flow following NOS inhibition (98, 146, 220). It has been 
argued that NO synthesis increases in response to increased shear stress secondary to the 
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increase in blood flow that results from myogenic and metabolic vasodilatation caused by 
circulatory occlusion. 
Recently, shear stress has directly been linked to the exercise-related modulation of the 
production of vasodilator metabolites and endothelial function (90, 403, 405, 406). Tinken et al. 
tested the effects of 8 week bilateral handgrip training on endothelial function (406). In order to 
prevent the increase in FBF induced by handgrip, and any associated increase in shear stress 
from affecting endothelial function in one arm, the change in FBF was attenuated during each 
period of handgrip throughout the 8 weeks by inflating a cuff around this (control) arm to 60 
mmHg. By measuring brachial artery diameter and blood flow velocity, they established that 
brachial artery shear stress did indeed increase during handgrip in the un-cuffed arm but not in 
the cuffed arm. Although similar increases in girth, strength, and volume were observed in both 
arms, flow mediated dilatation (FMD) of the brachial artery improved only in the un-cuffed arm. 
This selective improvement also extended to peak reactive hyperaemia.  
1.3 Effect of aging on exercise hyperaemia 
Muscle wasting, weakness, change in the fibre type, skeletal motor unit decline, and reduced 
exercise capacity are all hallmarks of the aging process (42, 49, 160). Moreover, a general 
decline in VO2, VO2-max, and cardiac output also accompany aging: effects which are 
attenuated in healthy, active (trained) elderly individuals (307). In recent years, the effect of 
ageing on exercise hyperaemia has also been the subject of investigation. The discussion below 
focuses on this topic because a question arises as to whether the age-related changes to 
exercise hyperaemia may be related to its O2-dependency. 
In 1987, Irion et al. showed that exercise hyperaemia was attenuated by ~ 30% in older (24 
months) Fischer rats relative to young (12 months), when tetanic planter flexor contractions were 
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evoked by stimulating the sciatic nerve at the frequency of 2 Hz, and hind-limb blood flow was 
measured using microspheres (185). In humans, the effects of age on exercise hyperaemia are 
equivocal. Jasperse et al. showed that when young (19 – 29 years) and older (60 – 74 years) 
individuals were matched for the chronic physical activity and forearm size, exercise hyperaemia 
evoked by brief or sustained handgrip exercise was not different between them (188). Moreover, 
peak FBF and FVC of these individuals was also very similar, indicating that healthy active aging 
does not attenuate human exercise hyperaemia. In contrast, Proctor et al. noticed that exercise 
hyperaemia of incremental cycling exercise was attenuated by ~ 20 – 30% in older men (326). 
However, this study failed to measure baseline blood flow, therefore the percentage change in 
flow could not be compared between age groups. In agreement, Poole et al. found that 
hyperaemic response evoked by intense exercise was significantly attenuated in sedentary old 
compared to sedentary young (322). However, when work rate and VO2-max were matched 
between age groups, vasodilatation evoked by knee-extensor exercise was more pronounced in 
the older individuals (230). 
Investigating the effects of aging on exercise hyperaemia, Donato et al. employed rhythmic 
handgrip and knee-extension exercise model and noticed that FBF and FVC were not affected 
by aging; either when expressed as absolute workloads or as relative to the muscle mass at a 
given exercise intensity (97). However leg blood flow was attenuated, indicating a limb specific 
age-related decline in exercise hyperaemia. However, Carlson et al. noticed that exercise 
hyperaemia of 1 s handgrip contractions was attenuated in older individuals (52). It is interesting 
to note that despite similar muscle mass between young and old in both studies, the conclusions 
regarding forearm exercise hyperaemia contrast (52, 97), perhaps reflecting the activity level of 
subjects in each study (See below). 
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In relation to exercise and the factors affecting hyperaemia, Schrage et al. observed that aging 
significantly attenuated the hyperaemic response when subjects (55 – 81 years) performed 
rhythmic handgrip contractions at 10% MVC for 20 min (358). Further, when L-NAME and 
ketorolac were infused during the rhythmic contractions, and the results were compared to their 
previous study on young subjects (359), it was concluded that the contribution of NO to exercise 
hyperaemia was attenuated by ~ 45% and the contribution of PGs was completely abolished in 
the older individuals. Subsequently, Kirby et al. asked older subjects to perform either short 
single handgrip contractions at 10, 20, and 40% MVC, or rhythmic contractions at 10% MVC for 
10 – 15 min without and with infusion of the antioxidant ascorbic-acid into the brachial artery 
(214). Although ascorbic-acid did not improve the hyperaemia of single contractions, responses 
to rhythmic handgrip contraction were improved by ~ 30% leading them to propose that oxidative 
stress blunted the endothelium-dependent components of exercise hyperaemia in older 
individuals. Subsequently, Crecelius et al. used a similar rhythmic handgrip exercise protocol 
(10% MVC) and showed ascorbic-acid infusion restored the effect of NOS infusion on exercise 
hyperaemia, but not that of COX inhibition (78). Thus, they proposed that oxidative stress 
attenuated NO availability, but did not explain loss of the dilator contribution of PGs to exercise 
hyperaemia. 
In agreement with the hypothesis that the decline in endothelial function is a main cause of the 
age-related attenuation of vasodilatation, Woodman et al. showed an age-related decline in flow 
and ACh-induced dilatation of rat soleus feed arteries; response to SNP remained intact (438). 
Moreover, combined NOS and COX inhibition in young arteries attenuated the dilatation to such 
an extent that the response was similar to that observed in old arteries. This is in agreement with 
the findings of Spier et al. (380). In humans, Taddei et al. showed a negative correlation (r = - 
0.86) between the increase in age and intra-brachial ACh-induced dilatation (393). Further, 
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Nicholson et al. showed that the dilatation of intra-arterial PGI2 administered is attenuated with 
age, reflecting perhaps altered responsiveness of vessels to vasodilator PGs (300). Similar 
results were found recently by Eisenach et al. (110). These results indicate that despite no 
obvious direct functional impairment in the vascular smooth muscles, endothelial function is 
compromised with aging. 
Interestingly, the expression of PGI2-synthase in endothelial and vascular smooth muscle cells is 
unaffected by aging, at least in 36 and 72 week old rats; thromboxane-synthase expression is 
significantly increased with aging (396). Further, Woodman et al. showed that COX inhibition 
improved flow-mediated dilatation in isolated arteries taken from older rats (438), and Taddei et 
al. showed that ACh-induced forearm dilatation was improved in older subjects by COX inhibition 
(394). Collectively, this indicates an age-related increase in the role of vasoconstrictor COX 
products and/or the action of PGI2 on the thromboxane-prostanoid receptors (418). 
Recently, a decline in plasma ATP concentrations has also been implicated in age associated 
attenuation in exercise hyperaemia (213). Kirby et al. showed that the venous efflux of ATP was 
not increased during either systemic hypoxia (~ 80% SO2; 5 min), or graded rhythmic handgrip 
contractions (5, 15 and 25% MVC; 5 min each) in older subjects, in contrast to the substantial 
increases in young (213). This reflected a near complete loss of ATP release from deoxygenated 
RBCs in the older subjects, rather than any age-related differences in ATP hydrolysis. 
The age-related decline in exercise hyperaemia may also be affected by, or dependent on a 
relatively sedentary life style; i.e., lifelong activity prevents this decline. Spier et al. showed 
treadmill exercise training of Fisher-344 rats prevented age-related decline in endothelial function 
of isolated soleus and gastrocnemius arterioles; ACh-induced dilatation was not different 
between young and old (380). Additionally, training elevated eNOS mRNA and protein 
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expression in old. Independent NOS blockade, or combined NOS and COX inhibition attenuated 
the ACh’s dilatation to values that were comparable with younger rats. Separately, the same 
group have shown that exercise training preserves FMD, predominantly due to improved function 
of NOS pathway (381). Although age and training did not affect COX pathway’s contribution 
towards FMD, nonetheless exercise did increase basal and stimulated increases in PGI2 
concentrations in older rats. 
The effect of lifelong activity on human vasodilatory responses was the subject of interest in two 
recent studies (285, 305). Nyberg et al. showed that arterial infusion of N-acetylcysteine 
(antioxidant) increased the concentrations of metabolites of NO (NO2- and NO3-; NOx) measured 
during one leg knee-extension exercise in older sedentary individuals, but not in young 
sedentary, or older lifelong active individuals (305). Leg biopsy samples also showed that eNOS 
and nNOS protein expression were 32% and 24% higher in older active subjects than sedentary 
old subjects. The blood flow during exercise was also significantly higher in the older active 
individuals and similar to those observed in young individuals. In a separate study they showed 
that leg blood flow and vascular conductance were lower during exercise while lactate 
concentrations were higher in the sedentary old than in the young, and active old (285). 
Moreover, interstitial ATP concentrations and P2Y2-receptor expression were significantly higher 
in the active old. Lastly, arterial infusions of ACh and ATP were used to examine endothelial 
function; their vasodilatory responses were lowest in the sedentary old. Although the exact 
mechanisms by which exercise prevents the age associated decline in vascular function is not 
known, nonetheless exercise is associated with increased shear stress (403, 405, 406) which 
itself has been shown to improve mRNA expression of eNOS (439). 
In conclusion, evidence does suggest that in less active individuals, aging does lead to 
attenuated exercise hyperaemia responses; reduction in NO- and ATP-mediated vasodilatation 
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contribute towards this decline. However, it is not clear whether or not exercise hyperaemia is 
blunted in older subjects who are recreationally active, rather than involved in regular intense 
training. Further, it is not known whether the contribution of PGs to exercise hyperaemia induced 
by moderate levels of exercise is attenuated by ageing, and/or whether the O2-dependency of 
PGs persists. 
1.4 Exercise-evoked vasoconstriction 
Exercise, particularly strenuous exercise is accompanied by localized hyperaemia along with 
certain systemic changes; increase in HR, mean ABP (MABP), MSNA, and peripheral 
vasoconstriction (5, 72, 119, 172, 246, 371, 421); mechanisms responsible for them remain 
poorly understood. Nonetheless, mainly two theories are presented to explain these responses 
which are not mutually exclusive in nature (200, 433). The first, “Central Command” proposes 
that these systemic responses are also dictated by the motor cortex; i.e., parallel activation of 
central circuits that control movement and cardiovascular / ventilatory responses (200, 433). The 
second theory proposes that responses are reflex in nature, originating within the contracting / 
exercising muscles (200). Focusing on the second theory, this thesis addresses the issue of 
exercise-evoked reflex vasoconstriction and O2’s direct and/or indirect involvement in this 
response. The following discussion briefly introduces this topic. 
The pioneering experiments of Alam and Smirk showed that the pressor responses were 
maintained following cessation of activity if post-exercise circulatory occlusion (PECO) were 
applied / maintained to trap the arterial and venous blood within the contracting muscles (5). 
Subsequent studies have confirmed this finding, and the response is now termed “Chemoreflex, 
Metaboreflex, or Exercise Pressor Reflex” (117, 128, 200, 246). For example, Mark et al. 
observed that an increase in HR, MABP, and peroneal nerve MSNA evoked in response to 
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isometric handgrip exercise returned to control values soon after cessation of exercise (246). 
However, application of PECO maintained the increase in MABP and MSNA. Later, the same 
group showed that this response was also evoked by rhythmic exercise (3, 421). 
Experiments of Kaufman and colleagues are of vital importance regarding modern scientific 
understanding of neural pathways that are involved in reflex vasoconstriction; i.e., thinly 
myelinated group III afferents largely respond to mechanical stimuli while un-myelinated group IV 
afferents respond to metabolic factors. Following the discussion regarding the contribution of 
metabolic factors to exercise hyperaemia (See section 1.2.3), their involvement in the peripheral 
reflex responses is of particular interest. Metabolites such as lactate (347, 372), K+ (261), and 
those involved in COX pathway (AA, PGE2, and TXA2) (207, 231, 262, 347) have all been shown 
to stimulate the group III and IV afferents. For example, Rotto and Kaufman showed that activity 
of group III and IV afferents in the triceps-surae of anesthetized cats significantly increased 
following intra-arterial injection of either lactate or AA (347); interesting observations considering 
the concentrations of these metabolites increase with exercise (10, 198, 199, 208, 216, 239, 
435). 
The presence of a relationship between exercise and hypoxic stimulation of the metaboreceptors 
is also of particular interest. For example, Hill et al. noticed that the contraction sensitive group III 
and IV afferents of cat triceps-surae are also stimulated by ~ 3 min of hypoxic breathing (3 – 5% 
O2) at rest (174). Moreover, the responsiveness of group III and IV afferents to rhythmic and 
isometric contractions is compounded by blood flow occlusion (3, 4, 203). In agreement with 
these observations, Victor and Seals failed to observe any increase in peroneal MSNA with zero-
load arm cycling, but under ischemia the same exercise evoked 120% increase in MSNA (421). 
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The relevance of these results lies in the observation that while responsiveness of group III and 
IV afferents is increased by ischemic exercise, maximal-effort physical activity is associated with 
profound decline in interstitial / intramuscular PO2 (47, 337-339). Furthermore, as the response is 
not just related to the increase in concentrations of H+ and lactate (4, 371) but has also been 
linked to COX pathway (207, 262, 347), blockade of this pathway attenuates the stimulation of 
these metaboreceptor afferents not only under rest but also during exercise (79, 267, 346, 347). 
These results clearly implicate COX products in the reflex vasoconstriction response. However 
Win and Marshall’s observations regarding COX pathway’s involvement in exercise hyperaemia 
of isometric handgrip contractions in an O2-dependent manner raise questions regarding the O2-
dependent nature of the exercise-evoked reflex vasoconstriction response. Further, it is also not 
known whether the role of these hypothesized O2-dependent metabolites changes with age. 
Chapter 5 and 6 address this topic in further detail.  
1.5 General aims and hypotheses of the project 
The general aim of the project was to investigate the relationship between O2 and COX products 
that contribute towards exercise hyperaemia and exercise-evoked / reflex vasoconstriction of 
recreationally active healthy young and older individuals. Moreover, their relationship with 
adenosine / adenosine-receptors and the affect of different O2 concentrations on endothelial 
function was also investigated. 
Hypotheses of different experimental studies included in this thesis were as follows: 
 Chapter 3 (Methodology Chapter) – Reduction in time taken to inflate the venous 
occlusion cuff for venous occlusion plethysmography would allow significantly higher 
FBF values to be recorded; reflecting the original rate of arterial inflow. 
46 
 
 Chapter 4 – Similar to the isometric handgrip contractions, post-exercise hyperaemia of 
rhythmic handgrip contractions is also contributed to by O2-dependent vasodilating 
prostaglandins (PGs). COX inhibition and 40% O2 would similarly attenuate post-
exercise hyperaemia response, along with the venous concentrations / efflux of these 
PGs. Lastly, post-exercise hyperaemia of older recreationally active individuals is also 
contributed to by O2-dependent PGs. 
 Chapter 5 – O2-dependent COX products produced in the exercising arms of young men 
contribute to the exercise-evoked vasoconstriction in the resting calf: this contribution to 
vasoconstriction is reflex in nature. 
 Chapter 6 – Isometric handgrip contractions at 60% MVC would not completely occlude 
muscle perfusion. Moreover, the increased muscle perfusion during these contractions 
would be similarly attenuated by 40% O2 and COX inhibition in both age groups. Lastly, 
the O2-dependent COX products contribute to exercise-evoked vasoconstriction in the 
resting arm / muscle in both age groups. 
 Chapter 7 – Adenosine’s direct contribution to exercise / post-exercise hyperaemia is 
also O2-dependent; further COX inhibition following adenosine-receptor antagonism 
would not add to the attenuation of the hyperaemic response. 
 Chapter 8 – 40% O2 does not attenuate the endothelium-dependent dilation in either age 
group (i.e., young and old), but higher O2 concentrations do; this attenuation is related to 
oxidative stress. 
The specific aims and hypotheses of each study will be properly introduced and clearly stated in 
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The majority of the studies described in this thesis were performed on human subjects; 
exceptions were the experiments described in Chapter 7 which were performed using a rat 
model. The methodology used in that study is described within Chapter 7. 
2.1 Subjects 
Participants of the studies were mainly young and older men; female participation was restricted 
to two studies (Chapter 3 & 8) in order to avoid the effects of female hormones on cardiovascular 
system. All subjects were non-smoking, recreationally active individuals who consumed less than 
21 units of alcohol/week. Health and activity status of subjects was assessed with help of a 
questionnaire (See Appendix 2 and 3). Younger subjects were recruited from the University of 
Birmingham’s student body while the older subjects were either recruited from the University’s 
faculty, or via the Birmingham 1000 Elders group. All subjects were required to refrain from 
caffeinated drinks and heavy meals for 12 hours prior to the experiments. They were also 
required to refrain from any alcohol consumption, use of any non-steroidal anti-inflammatory 
drugs (NSAIDs), or participation in any strenuous exercise / activity for 24 hours prior to each 
experimental visit. Studies were approved by the University of Birmingham’s Science, 
Technology, Engineering, and Mathematics Ethical Review Committee (application number ERN 
12-1377) and complied with the Deceleration of Helsinki (15). 
2.2 General experimental conditions 
Experiments were performed at room temperature while the subjects were seated on a couch 
with backrest at ~ 65° to the horizontal. In general, legs were stretched out horizontally and both 
arms rested at approximately the level of the heart. The exception was the experiments 
discussed in Chapter 8 for which the subjects were seated in a chair with backrest at ~ 85° to the 
horizontal. In order to minimise any distractions, the room was organised so that the subjects 
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were unable to see the recording traces and equipment while the noise and visual distractions 
were kept at an absolute minimum. Subjects were allowed to watch a movie of their choice 
during long periods of rest. 
In each study, subjects attended an initial familiarization visit followed by the relevant 
experimental visits. After completing the health / activity questionnaire and providing written and 
informed consent (See Appendix 4), subjects who were accepted were habituated to the 
equipment and the protocol of the study during the familiarization visit. All of the experiments 
were performed in a randomized single-blind cross-over manner. 
2.3 Handgrip exercise 
The familiarization visit was also used to record the maximum voluntary contraction (MVC) force. 
Each subject was asked to sit in the experimental position, grip the handgrip dynamometer with 
their dominant hand as powerfully as possible and hold the contraction for 5 s. The force 
measured at the end of the 5th s was recorded as the MVC. This was done 3 times separated by 
at least 30 s in order to confirm reproducibility, and avoid snap contraction readings. The 
average of the 3 contractions was taken as 100% MVC. 
As shown Figure 2.1, a handgrip dynamometer (Lafayette 70718, Loughborough, UK) with a 
voltage-output and an interfaced visual display-unit was used for all studies in which subjects 
were required to perform handgrip contractions. The dynamometer was calibrated before each 
experiment so that 1.0 volt on the display-unit represented subject’s 100% MVC; allowing each 
subject to visualize the percentage of force produced and maintain the level requested. The 
voltage-output also allowed tension time integral (TTI) to be computed; this was done as the area 
under the tension curve from exercise onset to cessation. During experimental protocols, 
handgrip contractions were performed in either a rhythmic (1:1 s duty cycle) or an isometric 
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manner at 60% or 70% MVC intensities. Termination criteria included inability to maintain the 
force for 5 s and/or decrease in the generated isometric force by 5% of the MVC despite 
vigorous verbal encouragement; for example 55% when the target force required was 60% MVC. 
A Web-based metronome was used to aid subjects with rhythmic contractions. Figure 2.2 shows 
that the elbow of each subject’s exercising arm rested on a polystyrene block and as the 
dynamometer was fastened to the bench, this allowed the subject to release their grip when 
asked to do so and completely relax the arm, thus facilitating blood flow measurements. 
2.4 Delivery of medical air or 40% O2 
As shown in Figure 2.3, gas cylinders were used for the delivery of both normoxic medical air 
(Medical Air, BOC Medical, UK) and hyperoxic gas (Medical Oxygen, BOC Medical, UK). Gas 
was delivered to a facemask via tubing and a Venturi-valve (Intersurgical, Wokingham, UK). The 
mask was secured over the nose and mouth with help of elastic straps, which encircled the head. 
According to Bernoulli’s principle of pressure differential, the velocity of a liquid or gas being 
forced from an area of high-pressure to an area of low-pressure through a narrow aperture 
accelerates the flow of the stream. This increase in velocity of flow simultaneously decreases 
surface pressure around it, allowing an influx of gas though the sides of the stream until the 
pressure is normalised. Thus, when a 40% Venturi-valve is supplied with 100% O2 at 10 L/min, it 
entrains approximately 31 L/min of air with a final volume of 41 L/min. As the atmospheric air 
contains approximately 21% O2 which equates to 6.5 L/min, the total O2 delivery is (10 + 6.5) 
16.5 L/min making the final O2 concentration in the mixture approximately 40%. 
In Chapter 8, 60 and 100% O2 concentrations were also delivered to the subjects in a similar 
manner. For 60% O2, the flow of 100% O2 was 15 L/min which draws in a further 15 L/min of 
room air making the final volume of gas mixture to be 30 L/min. In this situation, the entrained 
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room air contains 3.15 L/min of O2 making the final O2 delivery (15 + 3.15) 18.15 L/min; the final 
O2 concentration is 60.5%. For 100% O2 delivery, the small openings which draw the room air in 
the Venturi-valve were sealed and a comparable flow rate of ~ 15 L/min was maintained. As 
shown in Figure 2.3, the concentration of gas that was delivered to the subjects was checked at 
regular intervals by using an O2-sensor connected to a display-unit (ProOx 100, BioSpherix, 
USA). As a control for the hyperoxic gas, medical air was delivered in a similar fashion with 
similar flow rates via the facemask and Venturi-valve. Subject were blinded to the treatment 
conditions by ensuring that they did not see when gas flow was switched from one gas cylinder 
to another. 
2.5 Measurements 
2.5.1 Blood pressure 
An automatically-calibrating Finapres monitor (Ohmeda 2300, Englewood, USA) was used to 
measure arterial blood pressure (ABP) from the non-dominant hand at the level of the heart. As 
shown in Figure 2.3, this was done by wrapping a finger-cuff around the middle phalanx of the 
middle finger. The monitor uses the principles of infrared photo-plethysmography in combination 
with an inflatable bladder. The photo-sensor detects the scatter and absorption of the infrared 
light while the bladder inflates and deflates in response to changes in volume and pressure, 
allowing a continuous measure of ABP. To ensure Finapres recordings closely reflected the 
actual blood pressure, initial readings were also taken with help of either an electronic (microlife, 
BP3BXO, Windnau, Switzerland) or a traditional mercury sphygmomanometer (Metpak MK3, 
Accoson, UK).  
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2.5.2 Limb blood flow 
Depending on the protocol (See Methods Section of relevant Chapters; i.e., 3, 4, and 5), either 
FBF or calf blood flow (CBF) was measured using the technique of venous occlusion 
plethysmography (430). As shown in Figure 2.2, an appropriate-sized Indium-Gallium silastic 
strain-gauge was mounted on the widest part of the limb. A small (6.5 cm wide) 
sphygmomanometer cuff was wrapped around either the wrist or ankle, and a large (10.5 cm 
wide) sphygmomanometer cuff was wrapped around either the upper arm or the thigh. Blood 
flow measurements were made by inflating the small cuff to ≥ 250 mmHg which occluded blood 
flow to the hand or foot, and thereby allowed the focus of measurement to be on the skeletal 
muscle of the limb. This was done manually using a commercially available sphygmomanometer 
cuff. The larger cuff was then inflated to ~ 50 mmHg which restricted the venous drainage but 
allowed arterial flow. This was generally done by using a rapid cuff inflation system (E20, Rapid 
Cuff-Inflator, D.E. Hokanson Inc., USA); except in Chapter 3 where comparison was made 
between blood flow recordings made following manual inflation or automatic rapid inflation of the 
venous occlusion cuff. The smaller cuff was always inflated ~ 5 – 10 s before the larger cuff.  
An electrically calibrating strain-gauge plethysmograph device (EC6 Plethysmograph, D.E. 
Hokanson Inc., USA) was used to measure limb blood flow (178). As shown in Figure 2.4, the 
device was calibrated by generating a step deflection of 1% in the voltage-output of the trace. 
This method of 2 point calibration (0 and 1%) simulates 1% change in the length of the mounted 
strain-gauge (i.e., limb circumference), and a similar change in limb volume (178, 411) (See 
Chapter 3). This was done 3 times and the average calibration value along with the initial 




Limb Blood Flow (ml/dl/min) = 
2 x b x  0
c
 
Where;  b = “initial” gradient of the plethysmograph trace 
 c = value of 1% calibration deflection 
The technique of venous occlusion plethysmography, the importance of the “initial” gradient of 
the plethysmograph trace, and the algorithm are further discussed in Chapter 3. Nonetheless for 
the sake of completeness, Figure 2.4 shows a typical plethysmograph recording along with a 
corresponding ABP trace used for the measurement of blood flow during rest and immediately 
after exercise. If the plethysmograph trace moved off scale during exercise (See Figure 2.4), the 
device was re-balanced so as to move the plethysmograph trace to the middle of the chart. This 
did not affect the calibration of the mounted strain-gauge and allowed for blood flow recordings to 
be made following handgrip contractions. 
2.5.3 Near-infrared spectroscopy 
Near-infrared spectroscopy (NIRS) was used to measure an index of change in deoxygenated 
and total haemoglobin in the flexor digitorum-superficialis of the exercising and non-exercising 
forearm in response to isometric handgrip contractions. This is discussed in Chapter 6. 
2.5.4 Red cell flux 
Laser-Doppler (Laser-Doppler Perfusion and Temperature Monitor, DRT4, Moor Instruments Ltd, 
UK) was used to record cutaneous red cell flux (RCF) from the ventral surface of the forearm in 
response to ACh-iontophoresis. This is discussed in Chapter 8.  
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2.6 Drug administration 
Pharmacological agents were given orally in a drink (250 ml) before the experiment; details are 
provided in the relevant Chapters. In most studies, it contained 600 mg of aspirin (A; Aspirin 
Dispersible Tablets, Boots Pharmaceuticals, UK), or orange-flavoured squash alone acted as 
placebo treatment. In Chapter 8, 2000 mg of Vitamin-C (Effervescent Vitamin-C, Boots 
Pharmaceuticals, UK) was used instead of aspirin as a treatment. The dose of aspirin used here 
has previously been shown to provide near-maximal COX inhibition for 0.5 to 1.5 hours (161, 
437). 
2.7 Data acquisition 
Data was recorded on a desktop computer (Dell Inc., USA) using a bridge amplifier unit (Power-
Lab, AD Instruments, USA) and Lab-Chart data acquisition software (Version 7.3.3, AD 
Instruments, USA) at the sampling frequency of 400 Hz. 
Heat rate (HR) was derived and monitored online with the help of Finapres and Lab-Chart 
software from the interval between successive systolic blood pressure peaks; MABP was derived 
off-line using the blood pressure trace. FBF and CBF were also calculated off-line. FVC was 
calculated as (FBF/MABP) while calf vascular resistance (CVR) was calculated as (MABP/CBF) 
on Microsoft Excel: data for this purpose was extracted from the same cardiac-cycle. If this was 
not possible due to automatic re-calibration of the Finapres monitor, MABP (and HR) was taken 
from the most adjacent cardiac-cycle. Their values are expressed in either conductance units 
(CU) or resistance units (RU), respectively. TTI data were computed offline using the tension 
recording. Figure 2.5 shows examples of the raw data recordings made during rhythmic and 
isometric handgrip contractions in a venous occlusion plethysmography study. For the purpose 
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of analysis, measurements of variables were taken at different time points (See Methods Section 
of relevant Chapter).  
2.8 Statistical analysis 
Appropriate Analysis of Variance (ANOVA) was used to identify time, treatment, age, condition, 
and their interaction effects. Once a significant main effect was detected, the data was further 
analyzed using an appropriate post-hoc test (Tukey’s HSD) to detect the exact point of 
difference. Where appropriate other comparisons were made by using Student’s t-test, Pearson’s 
correlation coefficient (r), and coefficient of determination (r2). Statistical significance was 





Figure 2.1 Illustration of equipment used for handgrip. (A) shows the handgrip dynamometer 
and (B) shows the visual display-unit that was used to perform rhythmic and isometric handgrip 
contractions at required MVC intensities. 
 
 
Figure 2.2 Arrangement used for venous occlusion plethysmography and handgrip 
exercise. Strain-gauge (A) was placed around the widest part of the forearm and secured with 
paper tape. Handgrip dynamometer (B) was secured with a clamp and elbow of each subject 





Figure 2.3 Arrangement of gas cylinders relative to the subject. Medical Air / O2 cylinders 
were kept behind the subject to keep them blinded while the gas was delivered to the facemask 
via a Venturi-valve. O2-sensor with its display-unit (A) was connected to the facemask to monitor 
O2 concentration of the delivered gas. The contra-lateral hand rested at the level of the heart 






Figure 2.4 Raw plethysmograph and ABP traces. These examples show application of 0 – 1% calibration deflection, recording made following inflation 
of venous occlusion cuff under baseline condition, and a recording under post-exercise condition. Dotted lines represent the time of venous occlusion cuff 












Figure 2.5 Raw traces showing plethysmograph output, ABP, HR, and Force recordings immediately before, during, and after rhythmic (left) 
and isometric handgrip contractions (right). The small gaps in ABP and HR trace show regular auto-calibration of Finapres monitor. Exercise often 
drove the plethysmograph trace off scale. Thus, immediately after cessation of contraction, Wheatstone-bridge was rebalanced before venous occlusion 





Methodological considerations: Comparison of 
measurements of forearm blood flow using 
strain-gauge venous occlusion plethysmography 














Our group have previously employed Whitney Plethysmograph with manual inflation of the 
venous occlusion cuff to study FBF in response to different stimuli (122, 123, 437). However in 
this thesis, the Hokanson strain-gauge venous occlusion plethysmograph with automatic rapid 
cuff inflation system was used to record blood flow in 3 studies (including this one). The initial 
pilot experiments conducted to replicate our group’s established protocols consistently revealed 
FBF values following exercise that were approximately twice those previously observed (122, 
123, 437). As the technique employed by Whitney and Hokanson strain-gauge plethysmographs 
is similar (explained below), this initial study was undertaken to investigate the influence of the 
speed of venous occlusion on the observed / calculated limb blood flow values. 
In order to appreciate venous occlusion plethysmography, a brief history of the technique and the 
basic principles utilized in its development need to be understood. Venous occlusion 
plethysmography was first used by Schafer and Moore (357) to measure blood flow in the 
spleen; and later employed by Hewlett and Van Zwaluwenburg (170) to measure limb blood flow. 
The basic idea of plethysmography is that when the venous occlusion cuff (also known as 
collecting cuff) is inflated below diastolic but above venous pressure; blood comes in (i.e. into the 
limb) but cannot escape (431). The limb increases in size due to the continuing arterial inflow 
that gradually fills the venous vessels so increasing limb volume: measurement of the rate of 
change in volume reflects the arterial inflow (191, 431). This in theory implies that the rate of 
change of volume depends on the difference between arterial and venous pressures; i.e., any 
decrease in arterial pressure or an increase in venous pressure would negatively affect perfusion 
pressure, and subsequently, limb perfusion. This means that with venous occlusion 
plethysmography, inflation of the collecting cuff would over time increase the venous pressure 
within the limb with each successive heart beat and subsequently influence rate of arterial inflow. 
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In the original volume plethysmographs, the limb was sealed in a rigid box containing water and 
the rate of blood flow was measured on a volume recorder by inflating the venous occlusion cuff 
and measuring the displacement of water surrounding the limb (191, 430). This method had two 
main limitations to it. Firstly, the subject had to remain completely still as any movement on their 
part would separately influence the displacement of water around the limb (430). However, the 
biggest limitation of the technique was trying to maintain the perfect watertight seal around the 
limb (191, 430).  
Whitney used mathematical considerations to address these problems (430). In an ideal cylinder, 
the percentage change in a specific area of any given section will always be twice the 
percentage change in the circumference (∆ V/V = 2 ∆ C/C or ∆ V = 2 ∆ C). Assuming that the 
length of a cylinder (limb) remains unaltered, the volume change following venous occlusion 
would be accommodated in the cross-sectional area. Theoretically, the length would only remain 
unaltered if no restrictions are to be applied to the cross-sectional area. However, as this would 
remain nearly impossible if ∆ C was to be measured, a calibrated girth measuring device could 
overcome this limitation. He employed these two assumptions with Ohm’s Law (voltage = current 
x resistance) to provide the basis for the use of one such device (i.e., silastic strain-gauge), 
which could record change in limb circumference; and used it to measure the change in volume. 
Thus in Whitney’s Plethysmograph, thin mercury-in-rubber silastic tubing attached to a strain-
gauge with a small amount of current passing through it was used to encircle the widest part of 
the limb. Occlusion of venous outflow increased the circumference of the limb which lengthened 
the tubing of the strain-gauge and caused an increase in the electrical resistance (191, 430). The 
circuit was connected to a galvanometer which showed voltage deflections corresponding to the 
volume change in the limb: “initial” gradient (i.e., the rate of change) of these deflections has 
since been employed to calculate blood flow (147, 430). Traditionally, this involved measuring 
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the gradient over at least 3 – 4 heart beats (411). The device itself was calibrated by stretching 
the strain-gauge with help of an adjustment screw by a known length and recording the change 
in voltage (191, 430). The blood flow recordings made with venous occlusion plethysmography 
have typically been expressed as changes relative to dl of tissue volume per unit time; but can 
be expressed as ml/min using the volume displacement method (325, 430, 431). This expression 
of flow as a percentage unit “normalizes” the readings to allow for easier comparison of flow 
values recorded from different limbs (explained in discussion) (178). The algorithm employed in 
measuring limb blood flow with Whitney plethysmograph is: 
Blood Flow (ml/dl/min) = 
2 x b x  0 (s/min) x 100
c (volts/turn) x no. of turns for 1 cm change in strain-gauge x initial ilmb circumference (cm)
 
(325) 
Where; b = “initial” gradient of the plethysmograph trace (∆ voltage / unit time) (147) 
 c = calibration factor 
In the 1970s Hokanson et al. noted that if the length of a strain-gauge is exactly the same as the 
circumference of the limb, the linearly proportional relationship between resistance and volume 
can simply be expressed as: ∆ R/R = ∆ V/V or ∆ R = ∆ V (178, 411). Using this observation, 
they developed a system that allowed 1 arm of the Wheat-stone bridge to be altered by 1% to 
provide a simpler electrical calibration of the mounted strain-gauge (178). In the Hokanson 
plethysmograph a step deflection of the plethysmograph trace provides a 2-point calibration (c) 
signal and the difference between the two values not only signifies 1% change in volume, but 
also a similar change in the length of the mounted strain-gauge (i.e. limb circumference) (411). 




Limb Blood flow (ml/dl/min) = 
2 x b x  0 (s/min) x 100
c (difference between 0 and 1% voltage-deflection with 1% change in limb circumference)
 
Alternatively, this could simply be expressed as: 
Limb Blood Flow (ml/dl/min) = 
2 x b x  0 (s/min) 
c
 
Where; b = “initial” gradient of the plethysmograph trace 
 c = value of calibration deflection (voltage difference between 0 and 1% deflection) 
It might appear that the initial gradient of the plethysmograph trace always rises linearly; and this 
has sometimes been suggested in the literature (147, 431). For example, Greenfield et al. 
mentioned that the rate of arterial inflow is rarely affected by mild degrees of rise in venous 
pressure (147). Further, while discussing the examples of plethysmograph traces, they 
mentioned that if the rate of inflow appeared to decline from one heart beat to the next, the data 
could be interpreted with less confidence, but the solution to the problem was “to reduce the 
jump to a minimum” (147). However, they did acknowledge that this phenomenon occurred when 
the rate of arterial inflow was high (147), raising the possibility of perfusion pressure being 
affected by changes in arterio-venous pressure. Experiments conducted by Tschakovsky et al. 
using a rapid cuff inflation system (similar to the one used in this study) provided evidence that 
the inflation of venous occlusion cuff at 50 mmHg decreased the rise in the slope of 
plethysmograph trace (i.e. arterial inflow) over subsequent beats, and that this decrease in blood 
flow was not due to any changes in arterial diameter (411). This important observation not only 
provides experimental evidence for the curvilinear nature of the plethysmograph trace but 
underlines the need to measure blood flow as quickly as possible after cuff inflation to obtain the 
actual blood flow (411).  
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However consideration of these findings raises additional issues. As flow measurements can 
only be made once the venous occlusion cuff has reached the desired pressure (for example, 50 
mmHg), the rate of inflation of the venous occlusion cuff itself might affect the arterio-venous 
pressure; and therefore the gradient of the plethysmograph trace. Recommendations of 
Tschakovsky et al. following their study to only use the 1st heart beat’s gradient for calculation of 
blood flow addresses the issue of underestimation of arterial inflow by measuring gradient over 
multiple heart beats. However, it fails to address the influence of time taken to inflate the venous 
occlusion cuff. Traditionally venous occlusion cuffs were inflated manually with help of 
sphygmomanometers. Indeed, as mentioned previously, our group has also used manual 
inflation of venous occlusion of cuff to record FBF (122, 123, 437). The observations made by 
Tschakovsky et al. and in our own pilot experiments underlined the need to investigate the 
influence on FBF values of an apparently negligible time delay (~ 1 – 2 s) in inflation of venous 
occlusion cuff when done manually vs. by automatic rapid cuff inflation. To our knowledge, no 
study has compared the FBF values calculated from the “initial” rising slopes by the two different 
venous occlusion methods. 
3.1.1 Aims and hypothesis 
The aim of the present study was to compare FBF values recorded when the venous occlusion 
cuff was inflated either manually or by the use of a rapid cuff inflation system. This was 
investigated under baseline and post-exercise conditions within the same individuals. Our 
hypothesis was that reduction in an apparently negligible time delay (~ 1 – 2 s) in inflation of 
venous occlusion cuff by inflating automatically, rather than manually, would allow significantly 




Nine subjects (20 – 30 years) participated in the study. HR, MABP, and TTI were measured as 
described in Chapter 2. 
3.2.1 Protocol 
Each subject visited the laboratory on one occasion. Once a subject had been accepted and had 
consented to the study, anthropometric measurements of age, weight, height, body mass index 
(BMI), and forearm circumference (FAC) of the widest part were taken. This was followed by 
recording each subject’s MVC (See Section 2.3). Subjects were then allowed to rest for 30 min 
before 3 baseline FBF measurements were taken, 15 s apart. Following these, subjects were 
asked to produce and maintain an isometric handgrip contraction at 70% MVC for 1 min. As 
shown in Figure 3.1, FBF was measured at 0, 15, 30 s, and 1 min after exercise, and then at 1 
min intervals for further 9 min. Subjects were then allowed to rest for a further 30 min before the 
entire protocol was repeated. The only difference between both exercise bouts was the use of 
either manual inflation of the venous occlusion cuff using a normal sphygmomanometer (Metpak 
MK3, Accoson, UK), or rapid inflation with an automatic rapid cuff inflation system (E20, Rapid 
Cuff-Inflator, D.E. Hokanson Inc., USA). Manual inflation of the upper arm cuff occurred in < 2 s 
while automatic rapid inflation took ≤ 0.3 s. The order of venous occlusion was randomized. 
However due to the nature of experiments, subjects could not be blinded to the treatment 
condition. 
3.2.2 Blood flow measurements 
Blood flow was measured as described in Chapter 2 (See Section 2.5.2) using a Hokanson 
plethysmograph with an appropriate size Indium-Gallium strain-gauge for each subject. The 
average value of calibration signal was used in the aforementioned Hokanson plethysmograph 
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algorithm. Venous occlusion cuffs were inflated for approximately 8 s to 50 mmHg. Figure 3.2 
shows the gradient of plethysmograph trace used for calculation of baseline FBF, while Figure 
3.3 shows an example of the plethysmograph slopes used for calculation of FBF immediately 
after exercise when the cuff was inflated either manually or by rapid inflation system. Notice that 
the gradient was calculated from the “initial” rising slope of the plethysmograph deflection 
following venous occlusion. Using average gradient calculation (best-fitting line) option on the 
Lab-Chart, the gradient is drawn from the initial complete beat (or 2 – 3 beats) of manual cuff 
inflation and only the 1st complete pulsatile beat of rapid cuff inflation. The use of more than one 
beat was employed in manual inflation only when no difference was observed in the gradient 
between them. This was done based on the traditional recommendations of Greenfield et al. 
(147). Use of only the 1st pulsatile beat for rapid cuff inflation was employed because of the 
observations made by Tschakovsky et al. to the subsequent pulsatile beats in their studies (411). 
In addition, 3 different gradients from the 3 successive beats after inflation of venous occlusion 
cuff with rapid cuff inflation were taken for comparison with FBF values calculated from “initial” 
rising slopes of manual cuff inflation. An example of these gradients is shown in Figure 3.4. 
3.2.3 Data analysis 
Cardiovascular / haemodynamic data were analyzed using 2-way repeated-measures ANOVA 
for the detection of time, treatment, and time*treatment effects. 1-way repeated-measures 
ANOVA was also used to detect time effects within each treatment. Tukey’s HSD was used as a 
post-hoc test after a significant main effect was detected. Degree of correlation between FBF 
values from 2 different cuff inflation methods was tested using Pearson’s correlation coefficient 
(r) and coefficient of determination (r2) along with a regression-line fitted through 0 on axes. 




Figure 3.1 Schematic diagram of the protocol. ↓ represents the times at which FBF 
measurements were made using either manual inflation or automatic rapid cuff inflation of the 
venous occlusion cuff.  
 
 
Figure 3.2 Baseline plethysmograph traces of manual and automatic rapid cuff inflation 
with corresponding ABP trace. Dashed lines represent the point of venous cuff inflation while 
the blue → lines represent the gradient of the plethysmograph trace used for FBF 
measurements. Pulsatile ABP trace aids in visualization of the pulsatile increments on the 
plethysmograph trace. 
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Figure 3.3 Plethysmograph and ABP traces during manual cuff inflation (upper panel) and 
automatic rapid cuff inflation (lower panel) protocols, immediately after corresponding 
handgrip contractions. Dashed lines represent the point of venous occlusion cuff inflation while 
the blue → lines represent the “initial” rising gradient calculated from the initial complete beats 





























Figure 3.4 Plethysmograph trace with corresponding pulsatile ABP for FBF measurements made with automatic rapid cuff inflation immediately 
after exercise. Blues → lines represent the 3 gradients drawn from the 3 successive pulsatile deflections shown here as individual beat complexes after 




















Anthropometric data of subjects is presented in Table 3.1: 3 female and 6 male subjects 
participated in the study. All subjects were healthy individuals with no diagnosed medical 
conditions. 
TTI generated by subjects during the two isometric handgrip contractions was not different 
between manual and rapid cuff inflation trials (P = 0.82; Figure 3.5). HR and MABP were also not 
different between the treatment conditions before, during, and after handgrip contractions (Figure 
3.6). However, as expected, HR and MABP increased significantly from baseline values during 
exercise (P < 0.01), and after cessation of handgrip contractions both returned back to resting 
values. 
3.3.1 FBF responses 
Baseline FBF values recorded from the “initial” gradients of plethysmograph trace were not 
different between manual and automatic rapid cuff inflation (Table 3.2). However, as shown in 
Figure 3.7, comparison of FBF values recorded from cuff inflation during rest and post-exercise 
revealed significant treatment (P < 0.01) and time (P < 0.001) effects. With manual cuff inflation 
FBF values increased from ~ 9.6±1.3 ml/dl/min at rest to 33.8±4.2 ml/dl/min immediately after 
handgrip contraction (P < 0.001), and remained significantly elevated for 4 min post-contraction. 
By contrast, FBF values recorded with automatic rapid cuff inflation increased from baseline of ~ 
10.5±1.4 ml/dl/min to as high as 54.6±5.1 ml/dl/min immediately after handgrip contraction (P < 
0.001). These values remained significantly elevated from baseline FBF values for 7 min post-
contraction; confirming our hypothesis that rapid cuff inflation would show FBF values which 
were much higher than those recorded by manual cuff inflation. 
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However, when FBF was calculated from the 2nd and 3rd pulsatile beat of the plethysmograph 
trace after rapid inflation of the venous occlusion cuff as shown in Figure 3.8, the FBF recorded 
from the gradient of the 1st pulsatile beat was significantly higher than those recorded from the 
2nd (P < 0.05) and 3rd pulsatile beats (P < 0.01). FBF recorded from the 2nd pulsatile deflection 
remained elevated for 6 min post-contraction from its respective baseline, while that recorded 
from 3rd pulsatile deflection remained elevated for only 4 min. Interestingly, FBF values recorded 
from 3rd complete pulsatile beat after rapid cuff inflation were similar to those recorded from the 
“initial” gradient of the manual cuff inflation (P = 0.  ). 
Comparison of mean FBF values recorded from the 1st, 2nd, and 3rd individual pulsatile beats 
following rapid cuff inflation with mean FBF recorded from manual cuff inflation revealed high 
correlation with r values of 0.98, 0.98, and 0.96; and r2 values of 0.91, 0.95, and 0.92, 
respectively (Figure 3.9). Similarly, when individual FBF values from 1st, 2nd, and 3rd pulsatile 
beats following rapid inflation were compared with individual FBF values of manual cuff inflation, 
a reasonably high correlation of 0.79, 0.82, and 0.79; and r2 values of 0.61, 0.68, and 0.61 





Table 3.1 Anthropometric data of subjects (n=9). 
 
Figure 3.5 TTI recorded from the isometric handgrip contraction at 70% MVC for 1 min. No 
significant difference was found between manual cuff inflation (red bar) and automatic rapid cuff 
inflation (blue bar) treatment conditions. 
 
Age (yr) Weight (Kg) Height (m)
BMI 
(Kg/m2)
MVC (N) FAC (cm)
27♂ 72 1.73 24.06 196 27
30♂ 80 1.80 24.69 196 28
20♀ 51 1.60 19.92 137 20
26♀ 57 1.60 22.27 108 20
24♀ 86 1.70 28.31 157 25
30♂ 99 1.87 28.31 177 29
28♂ 70 1.65 25.71 186 24
28♂ 82 1.74 27.08 157 25
26♂ 70 1.68 24.80 137 25
Mean 26.56 73.78 1.71 25.08 161.32 24.78
SEM 1.04 4.69 0.03 0.97 10.09 1.05










Table 3.2 Baseline FBF responses measured with manual cuff inflation and automatic 














9.44±0.91 11.09±1.80 8.41±1.94 8.27±2.02 0.24
9.67±1.19 10.16±1.42 8.44±1.38 7.84±1.39 0.11
9.56±1.29 10.52±1.14 8.02±1.20 7.65±1.13 0.09




Figure 3.6 HR and MABP responses of isometric handgrip contraction at 70% MVC. 
Handgrip contraction is shown by grey bar. As expected, no significant treatment or 
time*treatment effect was detected between manual cuff inflation (red) or automatic rapid cuff 

































Figure 3.7 FBF responses evoked before and following isometric handgrip contraction at 70% MVC for 1 min. Handgrip contraction is shown by 
grey bar. FBF values recorded with manual cuff inflation (red) were significantly different from those measured with automatic rapid cuff inflation (blue). 

























Figure 3.8 Comparison of FBF values recorded before and after isometric handgrip contraction with automatic rapid cuff inflation and manual 
cuff inflation. Handgrip contraction is shown by grey bar. Values calculated from the “initial” gradient after manual cuff inflation (red)  and automatic rapid 
cuff inflation (blue) are shown alongside FBF values recorded from the 2nd (green) and 3rd (orange) pulsatile beats after rapid cuff inflation. Significant 
treatment effect was detected in FBF values measured from the 1st pulsatile beat gradient of automatic rapid cuff inflation, and those from 2nd, and 3rd 
pulsatile beats. */†/‡/§ represent FBF values significantly different from respective baselines (1st beat of rapid cuff inflation, manual cuff inflation, 2nd beat, 









  Baseline    0 1 2 3 4 5 6 7 8 9 10 



















Figure 3.9 Graph comparing mean FBF values from 1st, 2nd, and 3rd beat of rapid cuff inflation with mean FBF values from manual cuff inflation.  
FBF values from 1st beat (blue), 2nd beat (green), and 3rd beat (orange) showed a high correlation (r) values of ~ 0.9 and r2 values of ~ 0.9 when 
compared with FBF values recorded from manual inflation of the venous occlusion cuff. Regression line was forced to fit through 0 on both axes, 
revealing a slope of 1 for FBF values from 3rd beat (orange) vs. those from manual cuff inflation. 
  




































Figure 3.10 Graph comparing individual FBF values from 1st, 2nd, and 3rd beat of rapid cuff inflation with individual FBF values from manual cuff 
inflation. FBF values from 1st beat (blue), 2nd beat (green), and 3rd beat (orange) showed a high correlation (r) values of ~ 0.8 and fairly high r2 values of 
0.6, 0.7, and 0.6, respectively when compared with FBF values recorded from manual inflation of the venous occlusion cuff. Regression line was forced to 
fit through 0 on both axes, and revealed a slope of 0.98 for FBF values from 3rd beat (orange) vs. those from manual cuff inflation. 




































To our knowledge this is the first study to directly compare FBF values calculated by venous 
occlusion plethysmography when venous occlusion is done manually and by automatic rapid 
inflation under resting and post-exercise hyperaemia conditions. The principle finding of this 
study was that the FBF values recorded with the automatic rapid cuff inflation were ~ 2 fold 
higher compared with traditional manual cuff inflation immediately following isometric handgrip 
contractions. Secondly, consideration of the baseline and 10 min post-exercise recordings 
provides the important observation that the discrepancy in FBF values between the methods is 
not present during resting conditions, but only appears when FBF is substantially raised. 
Therefore, the results of this study offer evidence that the rise in initial gradient following rapid 
cuff inflation provides a “better” estimate of limb blood flow; especially when it is substantially 
elevated from baseline conditions. Furthermore, it also confirms the observations of Tschakovsky 
et al. (411) that FBF calculated from pulsatile beats following the 1st complete beat 
underestimates flow with each consecutive beat. The present study also shows that by the 3rd 
pulsatile beat, FBF is similar to that observed when the traditional manual inflation of the venous 
occlusion cuff is employed. 
It is important to mention here that despite the high correlation in FBF measurements made with 
two techniques, the actual magnitude of the exercise hyperaemia response, and its gradual 
attenuation were not similar in individual subjects. This is indicated by the significantly high r2 
values when mean FBF values from 1st, 2nd, and 3rd pulsatile beat following rapid cuff inflation 
are compared with mean FBF values from manual cuff inflation (Figure 3.9). Whereas 
comparison of individual FBF values reveals moderate r2 values (Figure 3.10). Figure 3.8 shows 
that as time passes, the magnitude of difference between FBF values measured with the two 
inflation techniques decreases following handgrip contraction. Moreover, as shown in Figure 
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3.10, the change in the magnitude of the difference in hyperaemia values is not consistent and is 
therefore the reason for moderate r2 values. This is understandable as the arterial inflow, the 
subsequent decline in perfusion pressure, and hence the measured blood flow values following 
venous occlusion would be dependent on each individual’s hyperaemia response and their 
unique arterio-venous architecture. Nonetheless, the mean data do show a high correlation (r) 
and degree of determination (r2) between FBF values measured from the two cuff inflation 
techniques.  
Work done by Tschakovsky et al. (411) provided the important observation that with each 
pulsatile beat following automatic rapid venous occlusion, the pulsatile voltage beats of the 
plethysmograph trace gradually “lose the rise in their gradient”. Therefore, calculation of FBF as 
an average over several beats as done traditionally underestimates flow. This means that flow 
calculations from 2nd or 3rd beat of plethysmograph trace following venous occlusion, or from the 
average gradient of the first few beats, do not reflect that “actual” hyperaemic response, but 
instead, underestimate it.  
In the light of the present study, it is apparent that the very short delay (1 – 2 s) induced by 
inflating the venous occlusion cuff by using traditional manual inflation method also leads to 
underestimation of peak hyperaemic response, and subsequent FBF during the ~ 7 min of post-
exercise hyperaemia. These observations therefore question the absolute values reported in 
previous studies performed when limb blood flow was measured under hyperaemic condition by 
either taking an average of the gradient of the first few beats or by employing manual inflation of 
the venous occlusion cuff. 
One explanation for the discrepancy in FBF values could be that the approximate 1 – 2 s delay in 
manual cuff inflation to ~ 50 mmHg allows the hyperaemic response to “decrease” before any 
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measurements can be made. Certainly, when FBF was measured following automatic rapid cuff 
inflation, the drop in FBF was nearly 12% from 0 to 15 s post-contraction (See Figure 3.7). 
However, this would not explain the discrepancy in FBF values recorded from manual and 
automatic rapid inflation of ~ 40%, with a time delay of only 1 – 2 s. The alternative explanation 
for the discrepancy between FBF values recorded with the two methods is related to the 
evidence provided by Tschakovsky et al. (411) regarding their observation of underestimating 
FBF with each successive pulsatile beat. They showed that the decrease in FBF was due to the 
reduction in pressure gradient caused by increased venous filling and subsequent back 
pressure, and not due to a decrease in arterial diameter. Certainly, the time of ~ 1 – 2 s in the 
inflation of venous occlusion cuff to 50 mmHg with manual inflation does not necessarily mean 
that venous occlusion only occurs at that pressure (148). It is more likely that some hindrance in 
venous drainage occurs during the process of cuff inflation, which allows blood to “accumulate” 
in the veins of the forearm before cuff pressure actually reaches 50 mmHg. This must cause 
reduction in the arterio-venous pressure gradient, and as flow can only be measured once the 
desired venous occlusion cuff pressure has been achieved, the result is underestimation of FBF. 
Indeed, the calculations of FBF from the 3 successive pulsatile beats after rapid inflation of 
venous occlusion cuff also seems to suggest that reduction in pressure gradient is the cause of 
underestimation of flow: by the 3rd beat (~ 1 – 2 s delay from the point of rapid cuff inflation) FBF 
was similar to that observed with traditional manual cuff inflation (Figure 3.8). This is also evident 
if a regression line is fitted between FBF values recorded from the 3rd beat of rapid cuff inflation 
and those from manual cuff inflation; the slope between them is ~ 1 and is independent of the 
use of mean or individual FBF data points (Figure 3.9 and Figure 3.10). Nonetheless, as the act 
of venous occlusion cuff inflation has previously been associated with attenuated arterial 
diameter (171), the results and conclusion of this study remain slightly ambiguous. Nonetheless, 
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keeping in mind the limitation of the technique of Doppler-ultrasound (discussed below), its use 
to monitor brachial artery diameter along with the two cuff inflation techniques may have further 
clarified the observed responses: this remains a small limitation of this study.  
Although there is no absolute or correct way of measuring limb blood flow, venous occlusion 
plethysmography has been compared with the popular flow-transducer and Doppler-ultrasound 
techniques in the past to reveal a consistently high correlation / linear relationship between them 
(238, 411). For example, Longhurst et al. compared discontinuous FBF measurements made 
with strain-gauge plethysmography to continuous recordings obtained from the brachial artery 
using an electromagnetic flow-transducer. They found a high correlation (0.8 – 0.9) between 
them (238). Comparison of FBF values measured from Hokanson strain-gauge plethysmograph 
with rapid inflation system and Doppler-ultrasound provided by Tschakovsky et al. over 
simultaneous beats also showed a tight linear relationship (~ 0.9) between them (411). These 
two studies provide validity for the robustness of the technique of strain-gauge venous occlusion 
plethysmography. However, these parallel techniques will only provide an accurate quantitative 
measure of changes in volume flow if the angle of insonation of the Doppler-probe is properly 
normalized, and the vessel diameter is continuously monitored. Tschakovsky et al. showed that it 
cannot be assumed that changes in velocity reflect changes in flow because vessel diameter can 
also change (411). Indeed, their observations led them to recommend that calibration of 
ultrasound flow-meters against venous occlusion plethysmography at the beginning and end of 
each experimental stimulus, along with continuous recording of vessel diameter change should 
be employed in order to truly reflect qualitative and quantitative changes to the limb volume.  
Further, observations made by Casey et al. (57) while investigating exercise hyperaemia in 
response to rhythmic handgrip contractions (1 s contraction: 2 s relaxation) during normoxia or 
hypoxia provide good examples of the importance of expressing limb blood flow relative to tissue 
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volume. In one of their study, FBF was recorded from the brachial artery using Doppler-
ultrasound, together with end-diastole diameter measurements. With rhythmic handgrip exercise 
performed at 10% MVC under systemic hypoxia, FBF was recorded to be ~ 289 and ~ 172 
ml/min in young men and women respectively (57): significantly greater in men than women. 
However, when arm volume was assessed by volume displacement, the same data analyzed as 
changes in blood flow relative to the original tissue volume showed that FBF was ~ 26 and ~ 23 
ml/dl/min in men and women respectively; with no gender difference between them (57). 
Thus, the simple technique of venous occlusion, which automatically allows FBF to be calculated 
relative to limb volume, holds considerable advantage over its main rival. The problem of cuff 
artefact hindering gradient calculation from the initial rise in plethysmograph trace can easily be 
avoided by use of computerized data collection software (for example, Lab-Chart). These 
software products are able to collect a detailed record of the experiments and can easily be used 
to exclude the inflation artefact from calculations. Nevertheless, the main drawback of venous 
occlusion plethysmography remains its inability to continuously record blood flow changes (191). 
As stated above, it is of profound importance that especially under hyperaemia conditions, 
venous occlusion cuff is inflated as quickly as possible and only the first complete pulsatile beat 
of the plethysmograph trace be used for blood flow calculation. Any delay in cuff occlusion to the 
required pressure level will result in underestimation of hyperaemia response. This would also be 
the case if the venous occlusion cuff were inflated quickly (using rapid cuff inflation systems), but 
the gradient is calculated from the average of a few pulsatile beats. An example of this second 
problem can be seen in the PhD thesis of Davies where Hokanson plethysmograph was used in 
combination with rapid cuff inflation system to record FBF responses (83). The estimated values 
for FBF in that thesis are actually similar to those observed with manual venous occlusion cuff 
inflation (122, 123, 437). Moreover, as the limb arterio-venous architecture of his subjects did not 
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change between treatments, calculation of averaged blood flow from a few pulsatile beats 
following rapid venous occlusion may well have been the reason for masked treatment effects 
between conditions: i.e., larger hyperaemia would negatively affect perfusion pressure more 
quickly than an attenuated response. 
In conclusion, the use of manual inflation of the venous occlusion cuff results in significant 
underestimation of FBF as compared with the values obtained with rapid cuff inflation. Therefore, 
our hypothesis that reduction in time taken to inflate the venous occlusion cuff will provide a 
better estimate of FBF was accepted. However, even when the automatic system is used, to be 
sure that the calculated FBF value is accurate, only the initial / first pulsatile beat of the 
plethysmograph trace should be used for calculation of the gradient of deflection; especially 





40% O2 and COX blockade similarly attenuate 
forearm post-exercise hyperaemia and venous 
efflux of PGs following handgrip contractions in 















As discussed in Chapter 1 (See Section 1.2.3.4), vasodilator COX products are generally 
considered to contribute towards exercise hyperaemia. Indeed, a large number of studies 
indicate that PG production increases during exercise (29, 198, 199, 302, 390, 435, 447, 448). 
For example, Symons et al. observed that PGE2 and 6-keto-PGF1α concentrations doubled in cat 
triceps-surae following their 30 s isometric contractions (390). In humans, Nowak and 
Wennmalm observed an exercise-related increase in the venous concentrations of PGE-like 
activity following isometric and rhythmic handgrip exercise (302). Further, Wilson and Kapoor 
observed an increase in the concentrations of both PGE2 and PGI2 in response to wrist-flexion 
exercise (435). This was completely abolished by COX inhibition, which also attenuated the 
hyperaemia by ~ 20%. In addition, PGE2 concentrations increase in vastus-lateralis and vastus-
medialis interstitial fluid following leg exercise (29, 199).  
Subsequently, a number of studies have confirmed that PGs contribute towards exercise 
hyperaemia regulation in that COX blockade attenuates the hyperaemic response (73, 74, 100, 
209, 359, 437). For example, Cowley et al. showed that the post-exercise hyperaemia of 30 min 
treadmill exercise halved in response to COX inhibition with either indomethacin or aspirin (74). 
Separately, Duffy et al. observed attenuation in peak-exercise hyperaemia following rhythmic 
wrist-flexion during intra-arterial aspisol infusion (100). Similarly, ~ 35% attenuation in post-
exercise hyperaemia of isometric handgrip contractions (60% MVC; 2 min) was observed by our 
group (437). Regarding the influence of COX inhibition on the vasodilatation that occurs during 
exercise, Schrage et al. showed that intra-brachial ketorolac infusion attenuated exercise 
hyperaemia recorded during rhythmic handgrip contractions by ~ 12% (358). 
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On the other hand, it should be noted (See Section 1.2.3.4 and 1.2.3.7) that some studies which 
have involved the use of COX inhibitors have concluded that PGs play a minor role in exercise 
hyperaemia; or that their contribution can only be demonstrated when NO synthase is also 
inhibited because the contributions of PGs and NO are interdependent (287, 329). Importantly, 
none of these studies have assayed PG release during contractions.  
Interestingly, the release of PGs during exercise was shown to be related to the work intensity / 
VO2 (29, 198, 447, 448). Moreover, isolated arterial vessels show augmented release of PGs 
under hypoxic conditions (45, 46, 266). Together this is suggestive of an intimate relationship 
between PG production and localized tissue hypoxia. Consistent with this idea, Win and Marshall 
reported that the post-exercise hyperaemia that followed 60% MVC isometric handgrip 
contraction was equally attenuated by COX inhibition and 40% O2 supplementation (437). As the 
combination of COX inhibition and 40% O2 did not yield any added attenuation in post-exercise 
hyperaemia, their results suggested O2-dependent PG production during isometric exercise. 
However, they did not directly test this idea by assaying PG release. Further, although studies 
have in the past indicated a contribution of vasodilator PGs to the exercise hyperaemia of 
rhythmic contractions, in that COX inhibition attenuated the response (74, 100, 435), it is not 
known whether PG production under these conditions is O2-dependent. The present study 
therefore addressed these very questions, including whether the release / action of PGE2 and/or 
PGI2 might be O2-dependent. 
 A question then arises regarding the primary site of the hypoxic stimulus that may cause 
increased PG production. Busse et al. measured intra-luminal PGE2 and PGI2 release from 
isolated but intact, canine coronary and femoral arteries, along with the rat tail artery segments 
(45). Under hypoxic perfusion, an increase was mainly observed in the concentration of PGI2 
which was abolished by either endothelium removal or pre-incubation of vessels with 
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indomethacin. Further, Messina et al. measured diameter of isolated cremaster muscle arterioles 
under hypoxic, normoxic, and hyperoxic conditions (263). Arteriolar dilatation evoked when bath 
O2 was reduced to ~ 0 was completely abolished by either endothelium’s removal or COX 
inhibition. Interestingly when bath O2 was raised to ~ 95%, arteriolar diameter decreased to 
become comparable to that measured when endothelium was removed or when COX was 
inhibited with indomethacin. Taken together, these studies suggest that PGI2 production during 
hypoxia is the result of the vascular endothelium sensing / responding to the changes in localized 
PO2.  
Fordy and Marshall’s work suggests an additional possibility (123). They asked their subjects to 
perform two bouts of exhaustive isometric exercise, separated by 7 min of recovery. Subjects 
were given 40% O2 either during the exercise or during the 7 min of recovery period. As post-
exercise hyperaemia was only attenuated if subjects were breathing supplementary O2 during 
exercise, the source of hypoxic stimulus for PG production during exercise must lie within the 
working muscles. Moreover, the fact that the increase in venous efflux of lactate was also 
reduced by breathing 40%, suggested that additional O2 must have reached the contracting 
muscle fibres and affected their metabolism. This observation is consistent with studies that have 
assessed intra-muscular PO2 concentrations and found that they decrease significantly during 
exercise (47, 337-339). As the primary PG shown to be released by the skeletal muscles belongs 
to the E series (400), the concentrations of the stable metabolites of both PGE2 and PGI2 were 
measured in the present study in hope of distinguishing the source / target of exercise-related 
hypoxic stimulus for PG production. 
Lastly, controversy exists regarding the influence of aging on the contribution of vasodilator PGs 
to exercise hyperaemia. Recent work by Schrage et al. suggested that their contribution is 
completely lost with aging (358). They measured FBF of 15 older subjects while they performed 
90 
 
rhythmic handgrip contractions (10% MVC; 20/min), and found no change in their steady-state 
exercise hyperaemia with intra-brachial infusion of the COX inhibitor, ketorolac. This raises an 
interesting question as to whether the results obtained by Schrage et al. were due to the use of 
light-exercise intensity, or to a global age-related decline in the generation of PGs, or in their 
effective contribution to exercise hyperaemia. Moreover, based on the recent data from Nyberg 
and colleagues (285, 305), a reduction in the contribution of PGs to exercise hyperaemia in the 
elderly might be a reflection of their relatively sedentary life styles, rather than age per-se. The 
present study tried to address these questions. 
4.1.1 Aims and hypotheses 
As stated above, the potential O2-dependent contribution of vasodilator PGs to hyperaemia 
associated with rhythmic exercise has not been investigated. Moreover, the idea that the 
vasodilator PGs involved in hyperaemia of isometric exercise are O2-dependent is based on 
indirect evidence: i.e., no one has measured changes in the release of PGs. This study was 
designed to address these questions. Furthermore, although the relative contributions of 
vasoactive ions to exercise hyperaemia were discussed in Chapter 1 (See Section 1.2.3.3); it 
remains unclear whether COX inhibition or supplementary O2 influence their production / 
function. Therefore, this study was also designed to allow pH, lactate, and K+ concentrations to 
be measured intermittently in the venous efflux. Lastly, the present study allowed the influence of 
age on the production / action of all these vasoactive molecules and exercise hyperaemia to be 
assessed. 
We hypothesized, that the post-exercise hyperaemia associated with rhythmic handgrip 
contractions would be similarly O2-dependent to that of isometric handgrip exercise. We also 
hypothesized that the concentrations of vasodilator PGs would be similarly attenuated by COX 
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blockade and by breathing 40% O2. Furthermore, based on the recent work from Copenhagen 
(285, 305), we hypothesized that PGs do play a significant role in exercise hyperaemia of 
recreationally active older individuals, and that their production will remain O2-dependent. To test 
these hypotheses, we investigated the effect of COX blockade, breathing 40% O2, and their 
combination on exercise hyperaemia following rhythmic and isometric handgrip contractions 





Twelve young (19 – 25 years) and eleven older (60 – 76 years) men were recruited; all were 
healthy, recreationally active, non-smoking adults (2 older subjects quit smoking over 40 years 
ago). Medication history included occasional use of anti-histamines for allergies by 1 young 
subject, occasional use of NSAIDs for knee pain by 1 older subject, use of sodium-valproate as a 
child by 1 older subject, and discontinued use of statins and low-dose aspirin (at least 3 months) 
by further 2 older men. Supplemental medication use included whey-protein, including creatine 
and glutamine by 3 young men, multivitamins by 3 young and 1 older male, fish-oil 
supplementation by 2 young and 1 older male, and occasional use of ascorbic-acid and 
glucosamine by 1 older male. All subjects were required to adhere to dietary, medicinal, and 
exercise restrictions previously described in Chapter 2 (See Section 2.1). Subjects were also 
asked to stop taking multivitamins / fish-oil for at least 7 days prior to the experiments. 
Administration of air or 40% O2, and placebo or aspirin along with measurements of MVC, TTI, 
HR, MABP, FBF, and FVC were done as described in Chapter 2.  
4.2.1 Protocol 
Subjects visited the laboratory on five occasions. The initial visit was used to complete the health 
and activity questionnaire, provide familiarization with the experimental protocol, and to record 
each subject’s MVC (See Section 2.3). The following four experimental visits were carried out in 
a randomized single-blind cross-over manner; placebo (P), aspirin (A), 40% O2, and a visit with 
combination of aspirin and 40% O2 (A+O2). 
On experimental days the handgrip dynamometer was set up for subject’s MVC. The subject was 
then allowed to rest for a few min before an intra-venous cannula was inserted into the 
antecubital vein of the exercising (dominant) arm and made secure. The subject then consumed 
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the treatment drink (P or A; 600 mg). All recording equipment (FBF and MABP) was then 
connected to the subject as described in Chapter 2. After ~ 25 min of rest, the facemask was put 
on the subject to deliver medical air or 40% O2; it was made secure with elastic-straps around 
the head. The subject was asked to breathe normally and after 5 min, a resting blood sample 
was taken. Immediately following this, three FBF measurements were made with venous 
occlusion plethysmography (See Section 2.5.2) to confirm their reproducibility; each ~ 15 s apart. 
As mentioned in Chapter 2, ABP and HR were recorded from the resting contra-lateral hand.  
30 s to 1 min following the last baseline FBF measurement, the subject performed rhythmic 
handgrip contractions (1 s contraction: 1 s relaxation) for 3 min at 60% MVC. As shown in Figure 
4.1 (protocol schematic), following the cessation of exercise, FBF was measured at 0, 30 s, and 
1 min, and then at 1 min intervals for 7 min; MABP was extracted from the same cardiac-cycles 
(See Section 2.7). Post-exercise venous blood samples were taken at 0 s for PG analysis and at 
0, 3, 5, and 7 min for blood gas and metabolite analysis. Gas flow was then ceased and the 
facemask was removed; the subject rested for a further 25 min.  
Following this, either medical air or 40% O2 was again delivered; resting blood samples and FBF 
data were taken as previously described after 5 min. The subject then performed an isometric 
handgrip contraction at 60% MVC for 3 min; FBF measurements and venous blood samples 
were taken as described above. At the end of the experiment, all recording equipment and the 
intra-venous cannula were disconnected. The subject rested for 5 – 10 min before leaving the 
laboratory. 
4.2.2 Blood sample collection 
An intra-venous cannula (22 – 24 G, BD Venflon, BD) was inserted in an easily accessible vein 
of the subject’s exercising forearm for the purpose of blood sampling (Figure 4.2). The cannula 
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was connected to a multiple-sample luer-adapter (BD Vacutainer Multiple-Sample Luer-Adapter, 
BD) via a plastic tube connector (10 cm BD Connecta, BD). Blood was collected into either 4 ml 
vacutainers (Sodium-Heparin BD Vacutainer, BD) for PG analysis or 1 ml syringes (BD 
Plastipak, BD) for blood gas and metabolite analysis at specific time points (See Figure 4.1). The 
samples collected into a syringe were immediately transferred into heparinised capillary tubes 
(Capillary Sample-Kit, Instrumentation Laboratory) and capped. The intra-venous cannula with its 
connector tube was periodically flushed with 3 ml bolus of 0.9% sterile-saline (BD PosiFlush SP 
Syringe, BD) to stop blood clotting. At each time point of blood sample collection, 0.8 ml of blood 
was initially drawn out and discarded in order to get rid of the dead-space volume from the 
connector tube. All blood samples were kept on ice during the period of experimentation. In order 
to prevent ex-vivo formation of PGs, 1 µl/ml of 10 µM Indomethacin (Sigma-Aldrich, UK) stock 
was added to the vacutainers immediately after the experiment; indomethacin stock was 
prepared using ethanol. All vacutainers were then centrifuged (Mistral 3000i, MSE Ltd) at 2500 
rpm at 4°C for 20 min; supernatant plasma was collected, snap frozen using liquid nitrogen, and 
then stored in a - 80°C freezer for later analysis. Capillary samples were immediately analyzed 
after each experiment using a blood gas analyzer (GEM Premier 4000, Instrumentation 
Laboratory) for venous PO2, PCO2, H+, lactate, and K+. In total, ~ 36 ml of blood was collected 
during each experiment. 
4.2.3 Enzyme linked immuno-sorbent assay 
4.2.3.1 Prostacyclin 
Enzyme linked immuno-sorbent assay (ELISA) of 6-keto-PGF1α was carried out on the venous 
blood samples of 6 randomly selected subjects from each age group using a commercially 
available kit (Item-515211, Cayman Chemical Company). This assay is based on the competition 
between 6-keto-PGF1α and 6-keto-PGF1α tracer (6-keto-PGF1α acetylcholinesterase conjugate) 
95 
 
for a restricted number of 6-keto-PGF1α-specific rabbit antiserum binding sites. The 6-keto-PGF1α 
antiserum binds to the mouse monoclonal anti-rabbit immunoglobulin-G (IgG) previously 
attached to the plate wells. The concentration of bound PGF1α is inversely proportional to the 
concentrations of bound tracer. Unbound reagents were washed away; Ellman’s reagent was 
added to develop the plate. The yellow substance produced as a result of the enzymatic reaction 
was measured by Spectrophotometery. 120 min after development of plate in the dark, it was 
read at 405 nm using a plate reader (VeraMax micro-plate reader, Molecular Devices LLC). Each 
sample was analyzed in duplicate and a mean absorbance was calculated: values converted into 
concentrations of 6-keto-PGF1α using the standard curve (Figure 4.3). 
4.2.3.2 Prostaglandin E metabolite 
ELISA of the stable metabolite of PGA2 and PGE2, Prostaglandin E metabolite (PGEM) was 
carried out on the same 6 subjects from each age group using a commercially available kit (Item-
514531, Cayman Chemical Company). Samples were left overnight in the dark at room 
temperature for derivation of 13,14-dihydro-15-keto-PGA2 and 13,14-dihydro-15-keto-PGE2 to 
stable PGEM for quantification. The competitive assay is between PGEM and PGEM-
acetylcholinesterase conjugate (PGEM Tracer) for limited PGEM-specific, rabbit antiserum 
binding sites. The antiserum binds to the mouse monoclonal anti-rabbit IgG which is already 
attached the wells. Ellman’s reagent was added to develop the plate after washing away 
unbound reagent and the substance produced was measured spectrophotometrically. The plate 
was read at 405 nm after 90 min of development in a dark room. Each sample was analyzed in 
duplicate and mean absorbance was calculated. Concentrations of PGEM were detected from 
the absorbance values using the standard curve (Figure 4.4). 
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4.2.4 Statistical analysis 
Factorial mixed-model ANOVA was used to identify time, treatment, exercise type, age, and their 
interaction effects. The data of each treatment condition were also individually analyzed using 1-
way repeated measures ANOVA to detect within time effects. Percentage changes in post-
exercise FVC, 6-keto-PGF1α, and PGEM efflux were compared between treatments and age 
groups using 2-way ANOVA. Once a statistically significant effect was detected, Tukey’s HSD 
was used to detect the exact point of statistical difference within and/or between conditions. 
Pearson’s correlation coefficient (r), regression analysis for best-fitting line, and the coefficient of 
determination (r2) were calculated for comparison between baseline and post-exercise FBF and 





Figure 4.1 Schematic diagram of the protocol. Initial ↓ (orange) represents the consumption of 
treatment drink. ↓ (black) represents times at which FBF was measured using venous occlusion 
plethysmography and ↓ (red) represents time points of blood sample collection. Blue area 
represents medical air or 40% O2 inhalation. Air or O2 flow was always turned on 5 min before 
any FBF measurements or blood samples were taken. Protocol was repeated 4 times in a single-
blind randomized manner with placebo, 40% O2, aspirin, and A + O2 as treatment conditions. 
 
 
Figure 4.2 Arrangement of the cannula in the antecubital vein (upper and lower panel). 
Blood samples were collected using the intra-venous cannula (A); connected to the luer-adapter 
via plastic tube connector (B). 0.9% sterile-saline was used to keep the cannula patent and dead 
space fluid in the plastic tube connector (~ 0.8 ml) was always discarded before any samples 






















Figure 4.3 Standard curve calculated from the standards prepared for 6-ketoPGF1α ELISA. 
 
 





































Anthropometric data of the young and older subjects is shown in Table 4.1.  
4.3.1 Young men 
TTI was not different between treatment conditions during either exercise bout. However, TTI 
recorded during rhythmic contractions was lower than that generated during isometric handgrip 
contractions (Table 4.2). Most young subjects stopped isometric handgrip contractions around 2 
min leading to statistically significant time difference between the two types of exercise (Table 
4.2). 
4.3.1.1 Hemodynamic responses 
The measured baseline hemodynamic responses were not affected by treatment conditions 
during rhythmic (Table 4.3) or isometric (Table 4.4) handgrip exercise bouts.  
HR and MABP were also not different between treatment conditions during rhythmic and 
isometric handgrip contractions (Figure 4.5 and Figure 4.6, respectively). However as expected, 
both HR and MABP increased significantly during handgrip exercise, returning back to normal 
following cessation of exercise. Under placebo conditions, following both rhythmic and isometric 
contractions, FBF and FVC were increased, gradually returning to baseline over 7 – 8 min 
(Figure 4.7 and Figure 4.8). The magnitude of increase in post-exercise FVC was higher during 
isometric handgrip exercise (P < 0.05 vs. rhythmic). 40% O2, aspirin, and A+O2 caused similar 
attenuation of both FBF and FVC following both rhythmic and isometric contractions (Figure 4.7 
and Figure 4.8, respectively). Supplemental data are shown in Appendix 5. 
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4.3.1.2 Venous efflux of K+, pH, lactate and blood gases 
K+: Under all treatment conditions, venous K+ concentrations were increased immediately 
following both rhythmic and isometric handgrip exercise (Table 4.5 and Table 4.6, respectively). 
However by 3 min post-exercise, venous K+ concentrations had returned back to baseline. 40% 
O2, aspirin, or A+O2 had no significant effect on the K+ concentrations in the venous efflux for 
either rhythmic or isometric contractions. 
pH and lactate: As expected venous pH decreased and venous lactate efflux increased 
immediately following rhythmic and isometric handgrip contractions (Table 4.5 and Table 4.6, 
respectively). A treatment effect was not detected during either handgrip contraction. Similarly, 
there was no difference between treatments following rhythmic or isometric contractions for 
lactate efflux (Table 4.5 and Table 4.6, respectively). 
PO2 and PCO2: Overall PO2 measured in venous blood samples following both rhythmic and 
isometric handgrip contractions were significantly higher during 40% O2 breathing conditions 
(40% O2 and A+O2) than air breathing (P < 0.05; Table 4.5 and Table 4.6). Immediately following 
rhythmic contraction, only PO2 values measured during air breathing (P and A) were lower than 
their respective baselines (P < 0.05 vs. baseline; Table 4.5) whereas following isometric handgrip 
contractions, venous PO2 values were significantly lower for all treatment conditions except 40% 
O2 (P < 0.05 vs. baseline; Table 4.6). By 3 min and onwards, venous PO2 values were higher 
than their respective baselines in all treatment conditions. Overall, PCO2 values measured in 
venous efflux following rhythmic and isometric handgrip contractions were not different between 
treatments (Table 4.5 and Table 4.6). Immediately following rhythmic and isometric handgrip, 
venous PCO2 values were increased significantly from their respective baselines (P < 0.01 vs. 
baseline), but by 3 min post-contraction, had returned to baseline (Table 4.5 and Table 4.6). 
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4.3.1.3. Venous PGs 
PGI2 (6-keto-PGF1α): PGI2 concentrations measured in the venous efflux before and immediately 
after rhythmic and isometric handgrip contractions and normalized PGI2 (the product of PGI2 
efflux and the appropriate FBF value) are shown in Figure 4.9 (upper and lower panels, 
respectively). During placebo, normalized PGI2 values increased significantly from baseline 
values of 18.03±5.98 pg/dl/min to 349.78±62.69 pg/dl/min following rhythmic handgrip 
contractions and from 20.13±8.55 pg/dl/min to 384.81±138.64 pg/dl/min following isometric 
contractions (Figure 4.9). As expected, COX inhibition with aspirin reduced baseline PGI2 
concentrations (P < 0.05 vs. P; Figure 4.9) but failed to influence baseline FBF or FVC (Table 4.3 
and Table 4.4). No treatment effect was detected for baseline normalized PGI2 during either 
handgrip trials. Further under interventional treatment conditions of 40% O2, aspirin, and their 
combination (A+O2), the post-exercise increase in PGI2 efflux was significantly attenuated 
following both rhythmic and isometric contractions (Figure 4.9). Correlation of each individual’s 
baseline and post-exercise FBF with venous PGI2 concentrations is shown in Figure 4.10. The 
line of best-fit shows an increase in the post-exercise FBF with PGI2 concentrations under 
placebo conditions during both rhythmic and isometric handgrip. This was not seen with the 
interventional treatments: i.e., the attenuated post-contraction hyperaemia during these 
interventional treatments was not accompanied by any significant increase in venous PGI2 
concentrations (Figure 4.10). 
PGEM: The PGEM concentrations in venous efflux before and immediately after rhythmic and 
isometric handgrip exercise and the normalized PGEM data are shown in Figure 4.11 (upper and 
lower panels respectively). Baseline PGEM efflux and the normalized PGEM data were not 
significantly decreased by the treatments for either the rhythmic or isometric handgrip trials 
(Figure 4.11). During placebo, normalized PGEM increased significantly following rhythmic 
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handgrip contractions from the baseline of 20.47±6.55 pg/dl/min to 559.46±133.38 pg/dl/min and 
from 33.12±12.47 to 733.77±163.27 pg/dl/min following isometric contractions (Figure 4.11). 
Similar to PGI2 efflux, under conditions of 40% O2, aspirin, and A+O2, these post-exercise PGEM 
values were similarly decreased following both rhythmic and isometric handgrip contractions 
(Figure 4.11). The correlation of each individual’s baseline and post-exercise FBF and venous 
PGEM concentrations is shown in Figure 4.12. The line of best-fit shows an increase in the post-
exercise FBF with PGEM concentrations under placebo conditions during rhythmic and isometric 
handgrip. Again, this was not seen with the interventional treatments (Figure 4.12). 
4.3.2 Older men 
The results obtained in older men were similar in almost every respect with those obtained in 
young men. Thus, in order to avoid repetition, the findings are described in brief with emphasis 
on the differences between young and older men; details are shown in Tables and Figures. 
TTI in older men was not influenced by treatments during either rhythmic or isometric handgrip 
contractions (Table 4.2), but as in young men the TTI generated during rhythmic contractions 
was significantly lower than that generated by isometric contractions (Table 4.2). In contrast to 
young men, older men performed both rhythmic and isometric handgrip contractions for the full 3 
min under all treatment conditions (Table 4.2). Despite the lower maximal handgrip contraction 
force of older men and thereby, the lower 60% MVC (See Table 4.1), TTIs recorded during 
rhythmic and isometric contractions were not significantly different between age groups (P > 0.05 
vs. young; Table 4.2). 
4.3.2.1 Hemodynamic responses 
As in young men, baselines were not affected by treatment conditions (Table 4.7 and Table 4.8). 
As expected, HR and MABP increased during both rhythmic and isometric contractions and by 1 
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min post-exercise had returned to the baselines; as in young men these changes were not 
affected by treatment condition (Figure 4.13 and Figure 4.14).  
Under placebo condition, FBF and FVC increased significantly from their respective baselines 
following both rhythmic and isometric handgrip contractions (Figure 4.15 and Figure 4.16). 
Similar to the results obtained in young subjects, 40% O2, aspirin, and A+O2 equally attenuated 
the post-exercise hyperaemia of both rhythmic and isometric handgrip contractions. However the 
magnitude of this attenuation was not similar between young and older subjects; i.e., the 
attenuation of the increase in post-exercise FVC was weaker in the older subjects. See Figure 
4.17 which compares the percentage attenuation of the 7 min period of post-exercise 
hyperaemia induced by 40% O2, aspirin, and A+O2 relative to the placebo responses. 
Supplemental data are shown in Appendix 5. 
4.3.2.2 Venous efflux of K+, pH, lactate and blood gasses 
K+: As in young men, venous K+ concentrations increased significantly after rhythmic and 
isometric handgrip trails under all treatments but by 3 min post-exercise, the values were similar 
to respective baselines (Table 4.9 and Table 4.10): treatment effect was not detected. The 
increase in venous K+ efflux was not different between young and older men.  
pH and lactate: Again, as expected venous pH decreased while venous lactate efflux increased 
following rhythmic and isometric handgrip contractions of the older men (Table 4.9 and Table 
4.10); these changes were not affected by treatment condition. Following both rhythmic and 
isometric handgrip contractions, the decline venous pH was slightly more in older, than young 
subjects when breathing air (placebo and aspirin; Table 4.9 and Table 4.10). Further, venous 
efflux of lactate was significantly lower in the older men following both handgrip contractions. 
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PO2 and PCO2: As in young men, venous PO2 decreased and PCO2 increased immediately 
following rhythmic and isometric contractions, (Table 4.9 and Table 4.10). In contrast to young, 
venous PO2 in older men was not affected by treatments at baseline or following contractions; 
values were not different between young and older subjects (Table 4.9 and Table 4.10). The 
increase in venous PCO2 evoked by either handgrip exercise was not different between 
treatments and age groups (Table 4.9 and Table 4.10). 
4.3.2.3 Venous PGs 
PGI2 (6-keto-PGF1α): PGI2 concentrations and normalized PGI2 efflux before and immediately 
after rhythmic and isometric handgrip contractions are shown in Figure 4.18 (upper and lower 
panels, respectively). In contrast to young subjects, baseline PGI2 values were not affected by 
treatment conditions (See Figure 4.18). However, as in young subjects, normalized PGI2 values 
increased significantly following rhythmic contractions from 14.34±6.79 pg/dl/min to 
284.36±43.43 pg/dl/min under placebo; and from 27.57±13.20 pg/dl/min to 404.51±155.84 
pg/dl/min following isometric contractions (Figure 4.18) Comparable to the observations made in 
young subjects, the treatment conditions 40% O2, aspirin, and A+O2 similarly attenuated these 
increases following both contractions (Figure 4.18). Correlation of each individual’s FBF and 
venous PGI2 concentrations is shown in Figure 4.19. The line of best-fit shows an increase in the 
post-exercise FBF with PGI2 concentration under placebo conditions, during both rhythmic and 
isometric handgrips. As in the young men, this was not seen with the interventional treatments: 
the attenuated hyperaemia was not accompanied by a significant increase in PGI2 concentration 
for either type of handgrip (Figure 4.19). Moreover, the values of degree of correlation (r) are in 
agreement with the idea that contribution of PGs to post-contraction hyperaemia responses 
decreases with age. The older group’s r values for 6-keto-PGF1α and FBF were ~ 0.5 compared 
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to ~ 0.8 of the young men. The percentage attenuation in PGI2 efflux was similar between 
treatments and not different between young and older subjects (Figure 4.20). 
PGEM: PGEM concentrations in venous efflux and the normalized PGEM data are shown in 
Figure 4.21). As described for PGI2, baseline PGEM concentrations were not affected by 
treatments. During placebo, normalized PGEM increased significantly from 16.64±6.62 pg/dl/min 
to 781.66±192.47 pg/dl/min following rhythmic handgrip contractions and from 47.12±15.62 
pg/dl/min to 1095.18±309.74 pg/dl/min (Figure 4.21). Similar to PGI2 efflux, the treatment 
conditions of 40% O2, aspirin, and A+O2 similarly attenuated the increases in PGEM (Figure 
4.21). Just as for PGI2 efflux (Figure 4.20), the percentage attenuation in PGEM efflux was 
similar between interventional treatments and the extent of this attenuation was not different 
between young and older men (Figure 4.23). Correlation of each individual’s FBF and venous 
PGEM concentrations for both handgrip contractions is shown in Figure 4.22. The line of best-fit 
shows an increase in the post-exercise FBF along with PGEM concentration under placebo 
during both rhythmic and isometric handgrip: again, this was not seen with the interventional 




Table 4.1 Anthropometric data of young (n=12) and older (n=11) men. 
Young Subjects Older Subjects
Age (yr) Weight (Kg) Height (m) BMI (Kg/m2) MVC (N) FAC (cm) Age (yr) Weight (Kg) Height (m) BMI (Kg/m2) MVC (N) FAC (cm)
21 80 1.73 26.73 216 27 60 86 1.80 26.54 216 25
21 88 1.88 24.90 294 28 65 65 1.78 20.52 177 22
20 90 1.89 25.20 451 29 67 70 1.80 21.60 226 26
20 65 1.72 21.97 186 25 66 88 1.76 28.41 196 25
19 77 1.84 22.74 196 25 65 75 1.65 27.55 137 26
22 81 1.84 23.92 255 29 61 78 1.73 26.06 137 25
19 66 1.75 21.55 177 26 63 100 1.94 26.57 147 29
21 74 1.73 24.73 157 26 63 76 1.75 24.82 196 24
19 68 1.75 22.20 163 23 75 70 1.81 21.37 196 25
25 66 1.70 22.84 235 25 76 66 1.67 23.67 128 24
24 56 1.63 21.08 147 23 69 76 1.70 26.30 137 24
22 88 1.88 24.90 275 29
Mean 21.08 74.92 1.78 23.56 229.31 26.25 66.39 77.27 1.78 24.85 172.12 25.00




Table 4.2 TTI and time recorded for rhythmic and isometric handgrip contractions performed by young and older men. No treatment effect was 
detected between Placebo, 40% O2, aspirin, and A+O2. However, significant difference was detected in TTI between rhythmic and isometric handgrip 
exercise bouts. Moreover, significant difference was also detected between young and old isometric exercise time. 
  
P 40% O2 A A + O2 P Value
Young
TTI (N.s)
Rhythmic 10596.40±1416.83 10777.21±1404.50 10647.45±1186.36 10844.35±1364.23 0.99
Isometric 16948.32±3125.62 16396.91±2496.92 17247.65±2071.54 16235.30±2587.68 0.99




Rhythmic 179.52±0.36 180.04±0.38 180.08±0.56 179.31±0.36 0.49
Isometric 139.71±8.61 138.28±7.94 156.28±8.86 138.29±9.34 0.39





Rhythmic 8332.82±736.70 7794.71±704.28 8121.06±788.83 8203.02±686.12 0.96
Isometric 15594.85±1394.80 15379.84±1439.94 16156.77±1270.94 15924.16±1261.73 0.98




Rhythmic 180.32±0.31 179.98±0.17 180.60±0.28 180.47±0.36 0.47
Isometric ‡ 180.68±0.26 180.63±0.19 180.84±0.16 178.03±2.70 0.41
P Value (between 
exercise type)
0.68




Table 4.3 Baseline HR, MABP, FBF, and FVC responses of young men during rhythmic 
handgrip exercise. Measurements were made just before the handgrip exercise bouts. No time 
or treatment effect was detected. 
Young
Rhythmic Handgrip
Baseline 1 Baseline 2 Baseline 3 Mean ± SEM P Value
HR (b.min-1)
P 65 ± 3 64 ± 2 64 ± 2 64 ± 1 0.83
40% O2 63 ± 3 62 ± 3 62 ± 3 62 ± 1 0.72
A 68 ± 3 67 ± 4 67 ± 3 67 ± 2 0.71
A + O2 64 ± 3 61 ± 3 61 ± 3 62 ± 2 0.27
P Value 0.52
MABP (mmHg)
P 79 ± 5 78 ± 6 78 ± 5 79 ± 3 0.71
40% O2 76 ± 6 76 ± 6 76 ± 5 76 ± 3 0.75
A 77 ± 5 78 ± 5 78 ± 5 77 ± 3 0.22
A + O2 73 ± 3 74 ± 4 73 ± 4 73 ± 2 0.25
P Value 0.81
FBF (ml.dl-1.min-1)
P 4.86 ± 0.94 4.57 ± 0.72 3.93 ± 0.54 4.45 ± 0.43 0.46
40% O2 4.74 ± 0.77 4.00 ± 0.59 4.27 ± 0.62 4.34 ± 0.38 0.43
A 5.42 ± 0.80 4.77 ± 0.95 4.14 ± 0.57 4.78 ± 0.45 0.13
A + O2 5.38 ± 0.86 4.19 ± 0.72 4.25 ± 0.56 4.59 ± 0.41 0.09
P Value 0.93
FVC (CU)
P 0.06 ± 0.01 0.06 ± 0.01 0.05 ± 0.01 0.06 ± 0.01 0.62
40% O2 0.07 ± 0.01 0.06 ± 0.01 0.06 ± 0.01 0.06 ± 0.01 0.51
A 0.06 ± 0.01 0.06 ± 0.01 0.05 ± 0.01 0.06 ± 0.01 0.35





Table 4.4 Baseline HR, MABP, FBF, and FVC responses of young men during isometric 
handgrip exercise. Measurements were made just before the handgrip exercise bouts. No time 
or treatment effect was detected. 
Young
Isometric Handgrip
Baseline 1 Baseline 2 Baseline 3 Mean ± SEM P Value
HR (b.min-1)
P 67 ± 3 67 ± 3 69± 3 68 ± 2 0.78
40% O2 64 ± 4 63 ± 3 63 ± 4 64 ± 2 0.87
A 71 ± 3 68 ± 3 67 ± 3 69 ± 2 0.14
A + O2 64 ± 2 63 ± 2 61 ±2 62 ± 1 0.18
P Value 0.32
MABP (mmHg)
P 81 ± 5 80 ± 5 79 ± 5 80 ± 3 0.46
40% O2 81 ± 6 79 ± 5 79 ± 5 80 ± 3 0.71
A 78 ± 3 79 ± 4 79 ± 4 79 ± 2 0.33
A + O2 77 ± 5 75 ± 5 76 ± 5 75 ± 3 0.92
P Value 0.85
FBF (ml.dl-1.min-1)
P 6.02 ± 0.99 6.13 ± 1.16 5.60 ± 0.73 5.92 ± 0.55 0.54
40% O2 6.58 ± 0.83 5.51 ± 0.67 5.85 ± 0.69 5.98 ± 0.42 0.31
A 6.86 ± 0.76 5.91 ± 0.75 5.90 ± 0.93 6.22 ± 0.46 0.22
A + O2 7.00 ± 1.37 8.11 ± 1.79 6.59 ± 1.06 7.23 ± 0.81 0.44
P Value 0.43
FVC (CU)
P 0.08 ± 0.01 0.08 ± 0.01 0.07 ± 0.01 0.08 ± 0.01 0.70
40% O2 0.09 ± 0.01 0.07 ± 0.01 0.07 ± 0.01 0.08 ± 0.01 0.21
A 0.10 ± 0.01 0.08 ± 0.01 0.08 ± 0.01 0.09 ± 0.01 0.16





Figure 4.5 HR and MABP responses of rhythmic handgrip contractions performed by 
young men. Placebo is represented in blue, and 40% O2 in red, aspirin (A) is shown in green, 
and their combination (A+O2) in purple. */†/‡/§ represents time effect for placebo, 40% O2, 




















Effect P  
Treatment 0.44
Time*treatment 0.99






Figure 4.6 HR and MABP responses of isometric handgrip contractions performed by 
young men. Placebo is represented in blue, and 40% O2 in red, aspirin (A) is shown in green, 
and their combination (A+O2) in purple. */†/‡/§ represents time effect for placebo, 40% O2, 




















Effect P  
Treatment 0.75
Time*treatment 0.97






Figure 4.7 FBF and FVC responses of rhythmic handgrip contractions performed by young 
men. Placebo is represented in blue, and 40% O2 in red, aspirin (A) is shown in green, and their 
combination (A+O2) in purple. */†/‡/§ represents time effect for placebo, 40% O2, aspirin, and A + 
























Effect P  
Treatment 0.02
Time*treatment 0.06






Figure 4.8 FBF and FVC responses of isometric handgrip contractions performed by 
young men. Placebo is represented in blue, and 40% O2 in red, aspirin (A) is shown in green, 
and their combination (A+O2) in purple. */†/‡/§ represents time effect for placebo, 40% O2, 
























Effect P  
Treatment 0.04
Time*treatment 0.002






Table 4.5 PO2, PCO2, K+, pH, and lactate concentrations in the venous efflux recorded 
before and after rhythmic handgrip contractions performed by young men. * represent 
values significantly different from respective baselines while † represents values different from 
placebo. 












Placebo 44 ± 5 34 ± 3 * 52 ± 3 51 ± 3 51 ± 3 0.02
40% O2 † 44 ± 4 39 ± 3 58 ± 4 * 60 ± 4 * 58 ± 4 * < 0.001
Aspirin 42 ± 3 32 ± 2 * 51 ± 3 51 ± 2 51 ± 3 < 0.001
A + O2 † 41 ± 3 35 ± 3 57 ± 2 * 58 ± 2  * 57 ± 2* < 0.001
† represents Treatment effect P Value = 0.04
Time*Treatment P Value = 0.12
PCO2
(mmHg)
Placebo 53 ± 2 99 ± 6 * 63 ± 2 54 ± 2 52 ± 2 < 0.001
40% O2 52 ± 3 93 ± 5 * 60 ± 1 51 ± 1 52 ± 1 < 0.001
Aspirin 50 ± 2 88 ± 6 * 58 ±1 55 ± 1 50 ± 1 < 0.001
A + O2 51 ± 3 94 ± 10 * 60 ± 2 54 ± 1 53 ± 2 < 0.001
Treatment P Value = 0.61
Time*Treatment P Value = 0.96
K+
(mmol.L-1)
Placebo 4.74±0.08 5.28±0.15 * 4.60±0.11 4.96±0.28 4.98±0.26 0.02
40% O2 4.72±0.11 5.07±0.30 * 4.45±0.10 4.41±0.07 4.70±0.17 0.03
Aspirin 4.61±0.15 5.32±0.18 * 4.42±0.09 4.45±0.10 4.56±0.09 < 0.001
A + O2 4.66±0.13 5.41±0.10 * 4.51±0.12 4.62±0.11 4.66±0.14 < 0.001
Treatment P Value = 0.16
Time*Treatment P Value = 0.20
pH
Placebo 7.36±0.01 7.17±0.01 * 7.25±0.01 * 7.29±0.01 * 7.31±0.01 * < 0.001
40% O2 7.36±0.01 7.19±0.02 * 7.26±0.01 * 7.32±0.01 7.32±0.01 < 0.001
Aspirin 7.38±0.01 7.20±0.02 * 7.28±0.01 * 7.30±0.02 * 7.33±0.01 * < 0.001
A + O2 7.37±0.02 7.18±0.02 * 7.26±0.01 * 7.29±0.01 * 7.32±0.01 < 0.001
Treatment P Value = 0.53
Time*Treatment P Value = 0.78
Lactate 
(mmol.L-1)
Placebo 1.3 ± 0.1 5.2 ± 0.6 * 5.0 ± 0.4 * 4.5 ± 0.4 * 4.0 ± 0.5 * < 0.001
40% O2 1.3 ± 0.2 5.0 ± 0.6 * 5.1 ± 0.5 * 4.5 ± 0.5 * 3.8 ± 0.4 * < 0.001
Aspirin 1.4 ± 0.2 4.7 ± 0.4 * 4.5 ± 0.4 * 4.1 ± 0.5 * 3.7 ± 0.4 * < 0.001
A + O2 1.3 ± 0.1 5.1 ± 0.4 * 5.2 ± 0.3 * 4.8 ± 0.4 * 4.2 ± 0.4 * < 0.001
Treatment P Value = 0.86




Table 4.6 PO2, PCO2, K+, pH, and lactate concentrations in the venous efflux recorded 
before and after isometric handgrip contractions performed by young men. * represent 
values significantly different from respective baselines while † represents values different from 
placebo. 












Placebo 47 ± 5 38 ± 5 * 58 ± 3 * 61 ± 5 * 59 ± 3 * < 0.001
40% O2 † 49 ± 3 46 ± 4 71 ± 4 * 69 ± 4 * 72 ± 12 * 0.002
Aspirin 45 ± 5 38 ± 2 * 55 ± 2 * 57 ± 2 * 60 ± 4 * < 0.001
A + O2 † 52 ± 5 39 ± 2 * 65 ± 3 * 63 ± 3 * 75 ± 12 * 0.01
† represents Treatment effect P Value = < 0.05
Time*Treatment P Value = 0 .83
PCO2
(mmHg)
Placebo 48 ± 2 96 ± 7 * 56 ± 3 50 ± 2 48 ± 2 < 0.001
40% O2 48 ± 1 87 ± 8 * 56 ± 2 52 ± 2 49 ± 1 < 0.001
Aspirin 49 ± 1 90 ± 7 * 55 ± 2 50 ± 2 48 ±1 < 0.001
A + O2 46 ± 3 88 ± 10 * 52 ± 2 51 ± 2 47 ±1 < 0.001
Treatment P Value = 0.77
Time*Treatment P Value = 0.99
K+
(mmol.L-1)
Placebo 4.74±0.10 6.32±0.36 * 5.16±0.44 4.93±0.27 4.95±0.21 < 0.001
40% O2 4.87±0.14 5.80±0.26 * 5.15±0.39 4.80±0.29 5.24±0.39 0.04
Aspirin 4.76±0.09 5.67±0.19 * 4.93±0.23 4.73±0.10 4.76±0.16 < 0.001
A + O2 4.63±0.21 6.00±0.27 * 4.74±0.12 5.19±0.45 5.04±0.24 0.04
Treatment P Value = 0.79
Time*Treatment P Value = 0.80
pH
Placebo 7.39±0.01 7.19±0.02 * 7.30±0.02 * 7.33±0.01 7.34±0.02 < 0.001
40% O2 7.38±0.01 7.19±0.03 * 7.28±0.01 * 7.29±0.02 * 7.33±0.01 < 0.001
Aspirin 7.37±0.01 7.19±0.03 * 7.29±0.02 * 7.33±0.02 7.35±0.02 < 0.001
A + O2 7.39±0.02 7.21±0.03 * 7.29±0.02 * 7.31±0.02 * 7.34±0.02 < 0.001
Treatment P Value = 0.33
Time*Treatment P Value = 0.36
Lactate 
(mmol.L-1)
Placebo 1.4 ±0.1 5.7 ± 0.7 * 4.8 ± 0.3 * 4.2 ± 0.4 * 3.6 ± 0.4 * < 0.001
40% O2 1.6 ± 0.2 5.8 ± 0.6 * 5.6 ± 0.6 * 5.0 ± 0.5 * 4.3 ± 0.5 * < 0.001
Aspirin 1.4 ± 0.1 5.7 ± 0.6 * 4.7 ± 0.6 * 4.3 ± 0.6 * 3.6 ± 0.4 * < 0.001
A + O2 1.6 ± 0.2 5.4 ± 0.5 * 5.1 ± 0.5 * 4.8 ± 0.6 * 3.8 ± 0.3 * < 0.001
Treatment P Value = 0.69




Figure 4.9 PGI2 (upper panel) measured in the venous plasma samples and normalized 
PGI2 (lower panel) values recorded before and immediately after rhythmic and isometric 
handgrip contractions performed by young men. P is represented in blue, 40% O2 is red, A is 
green, and their combination (A+O2) is shown in purple. * represent values significantly different 
from their respective baselines; † represents values significantly different from P condition (P < 
0.05). This includes all values within the brackets. 






























Effect       P  
Treatment            < 0.001
Time*Treatment   < 0.001
Effect                          P  
Treatment 0.02
Time*Treatment       0.02
Effect     P  
Treatment          < 0.001
Time*Treatment   < 0.05
Effect        P  
Treatment  < 0.001




Figure 4.10 Correlation between baseline and post-exercise FBF and PGI2 (6-keto-PGF1α ) 
concentrations for rhythmic (upper panel) and isometric (lower panel) exercise performed 
by young men. P is represented in blue, 40% O2 is red, A is green, and their combination 
(A+O2) is shown in purple. Each individual’s baseline and post-exercise response is shown by 
the dashed line while the solid line represents the line of best fit (regression analysis and r2 
values are provided for each treatment). 
y = 0.0575x + 2.3916
R = 0.74; R² = 0.55
y = 0.0187x + 1.5818
R = 0.41; R² = 0.18
y = 0.0038x + 0.955
R = 0.19; R² = 0.02
y = 0.0084x + 1.013
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y = 0.0944x + 2.0937
R = 0.85; R² = 0.72
y = 0.0179x + 1.6694
R = 0.49; R² = 0.25
y = 0.0083x + 1.4836
R = 0.22; R² = 0.05
y = 0.0055x + 1.0869























Figure 4.11 PGEM (upper panel) measured in the venous plasma and the normalized 
PGEM (lower panel) values recorded before and immediately after rhythmic and isometric 
handgrip contractions performed by young men. P is represented in blue, 40% O2 is red, A is 
green, and their combination (A+O2) is shown in purple. * represent values significantly different 
from their respective baselines; † represents values significantly different from P treatment 
condition (P < 0.05). This includes all values within the brackets. 
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Effect       P  
Treatment            0.002
Time*Treatment      0.003
Effect                          P  
Treatment < 0.001
Time*Treatment  < 0.001
Effect     P  
Treatment < 0.03
Time*Treatment   < 0.05
Effect        P  
Treatment  < 0.001




Figure 4.12 Correlation between baseline and post-exercise FBF and PGEM 
concentrations for rhythmic (upper panel) and isometric (lower panel) exercise performed 
by young men. P is represented in blue, 40% O2 is red, A is green, and their combination 
(A+O2) is shown in purple. Each individual’s baseline and post-exercise response is shown by 
the dashed line while the solid line represents the line of best fit (regression analysis and r2 
values are provided for each treatment).  
y = 0.0947x + 2.9361
R = 0.70; R² = 0.48
y = 0.0292x + 3.3068
R = 0.29; R² = 0.09
y = 0.0027x + 2.3846
R = 0.04; R² = 0.01
y = 0.0098x + 3.152
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R = 0.78; R² = 0.61
y = 0.0264x + 3.9767
R = 0.30; R² = 0.09
y = -0.0089x + 3.0872
R = 0.08; R² = 0.02
y = -0.0031x + 2.8689























Table 4.7 Baseline HR, MABP, FBF, and FVC responses of older men during rhythmic 
handgrip exercise. Measurements were made just before the handgrip exercise bouts. No time 
or treatment effect was detected. 
Older
Rhythmic Handgrip
Baseline 1 Baseline 2 Baseline 3 Mean ± SEM P Value
HR (b min-1)
P 66 ± 3 65 ± 3 64 ± 3 65 ± 2 0.28
40% O2 62 ± 3 62 ± 3 64 ± 3 63 ± 2 0.40
A 63 ± 3 61 ± 3 62 ± 3 62 ± 2 0.24




P 84 ± 3 83 ± 3 84 ± 3 84 ± 2 0.59
40% O2 87 ± 5 85 ± 4 86 ± 5 86 ± 3 0.17
A 89 ± 4 89 ± 4 87 ± 4 88 ± 2 0.29




P 7.14±1.02 6.11±0.74 6.53±2.00 6.59±0.77 0.72
40% O2 7.12±1.00 4.85±0.66 6.15±1.00 6.04±0.53 0.06
A 5.77±1.10 4.49±0.63 5.11±0.83 5.12±0.50 0.18
A + O2 5.35±0.56 5.33±0.49 4.37±0.50 5.02±0.30 0.12
P Value 0.49
FVC (CU)
P 0.09±0.01 0.07±0.01 0.08±0.03 0.08±0.01 0.79
40% O2 0.08±0.01 0.06±0.01 0.07±0.01 0.07±0.01 0.12
A 0.07±0.01 0.05±0.01 0.06±0.01 0.06±0.01 0.16





Table 4.8 Baseline HR, MABP, FBF, and FVC responses of older men during isometric 
handgrip exercise. Measurements were made just before the handgrip exercise bouts. No time 





Baseline 1 Baseline 2 Baseline 3 Mean ± SEM P Value
HR (b min-1)
P 62 ± 2 61 ± 2 62 ± 3 62 ± 1 0.26
40% O2 60 ± 3 60 ± 3 59 ± 3 60 ± 2 0.09
A 61 ± 2 61 ± 3 61 ± 3 61 ± 1 0.88




P 81 ± 3 81 ± 3 83 ± 3 81 ± 2 0.08
40% O2 85 ± 4 87 ± 4 85 ± 4 85 ± 2 0.23
A 84 ± 4 86 ± 3 86 ± 5 85 ± 2 0.44




P 7.18±1.25 6.76±1.07 6.07±1.22 6.67±0.67 0.37
40% O2 6.55±0.74 5.92±0.62 5.81±0.60 6.09±0.37 0.28
A 7.26±0.57 6.92±0.54 6.57±0.63 6.91±0.33 0.52
A + O2 7.20±0.94 6.80±0.67 6.56±0.82 6.85±0.46 0.49
P Value 0.71
FVC (CU)
P 0.09±0.02 0.08±0.02 0.07±0.02 0.08±0.01 0.10
40% O2 0.08±0.01 0.07±0.01 0.07±0.01 0.07±0.01 0.23
A 0.09±0.01 0.08±0.01 0.08±0.01 0.08±0.01 0.53





Figure 4.13 HR and MABP responses of rhythmic handgrip contractions performed by 
older men. Placebo is represented in blue, and 40% O2 in red, aspirin is shown in green, and 
their combination (A+O2) in purple. */†/‡/§ represents time effect for placebo, 40% O2, aspirin, 



















Effect P  
Treatment 0.93
Time*Treatment      0.71
Age*Treatment 0.90
Effect P  
Treatment 0.64





Figure 4.14 HR and MABP responses of isometric handgrip contractions performed by 
older men. Placebo is represented in blue, and 40% O2 in red, aspirin is shown in green, and 
their combination (A+O2) in purple. */†/‡/§ represents time effect for placebo, 40% O2, aspirin, 




















Effect P  
Treatment 0.97
Time*Treatment     0.99
Age*Treatment 0.71
Effect P  
Treatment 0.83





Figure 4.15 FBF and FVC responses of rhythmic handgrip contractions performed by older 
men. Placebo is represented in blue, and 40% O2 in red, aspirin is shown in green, and their 
combination (A+O2) in purple. */†/‡/§ represents time effect for placebo, 40% O2, aspirin, and A + 




































Figure 4.16 FBF and FVC responses of isometric handgrip contractions performed by 
older men. Placebo is represented in blue, and 40% O2 in red, aspirin is shown in green, and 
their combination (A+O2) in purple. */†/‡/§ represents time effect for placebo, 40% O2, aspirin, 




































Figure 4.17 Comparison of percentage reduction in FVC following rhythmic (upper panel) 
and isometric (lower panel) handgrip contractions performed by young and older men. 
40% O2 is red, aspirin is green, and their combination (A+O2) is shown in purple. 





























Table 4.9 PO2, PCO2, K+, pH, and lactate concentrations in the venous efflux recorded 
before and after rhythmic handgrip contractions performed by older men. * represent 
values significantly different from respective baselines while ‡ represents the age*treatment 
interaction. 
Older - Rhythmic Exercise
Baseline
Post Exercise Responses






Placebo 43 ± 5 30 ± 3 * 51 ± 2 48 ± 4 46 ± 4 < 0.001
40% O2 53 ± 6 31 ± 2 * 53 ± 2 54 ± 3 55 ± 4 < 0.001
Aspirin 52 ± 3 30 ± 1 * 51 ± 2 52 ± 2 53 ± 3 < 0.001
A + O2 53 ± 4 28 ± 2 * 50 ± 3 51 ± 4 49 ± 4 < 0.001
Treatment P Value = 0.91
Time*Treatment P Value = 0.71                             Age*Treatment P Value = 0.39
PCO2 (mmHg)
Placebo 47 ± 2 82 ± 5 * 55 ± 1 * 50 ± 1 48 ± 2 < 0.001
40% O2 46 ± 1 91 ± 6 * 56 ± 1 * 51 ± 1 50 ± 1 < 0.001
Aspirin 45 ± 1 80 ± 8 * 51 ± 2 * 46 ± 1 45 ± 1 < 0.001
A + O2 49 ± 2 84 ± 6 * 59 ± 2 * 53 ± 3 51 ± 3 < 0.001
Treatment P Value = 0.26 
Time*Treatment P Value = 0.87                             Age*Treatment P Value = 0.30
K+
(mmol.L-1)
Placebo 4.79 ± 0.24 6.29 ± 0.55 * 4.70 ± 0.23 4.66 ± 0.27 4.67 ± 0.21 < 0.001
40% O2 4.93 ± 0.11 5.78 ± 0.15 * 4.69 ± 0.11 4.86 ± 0.11 4.89 ± 0.17 < 0.001
Aspirin 5.03 ± 0.15 5.73 ± 0.23 * 4.96 ± 0.13 4.65 ± 0.07 4.91 ± 0.07 < 0.001
A + O2 4.79 ± 0.20 5.75 ± 0.23 * 4.80 ± 0.21 4.91 ± 0.24 4.97 ± 0.20 < 0.001
Treatment P Value = 0.91
Time*Treatment P Value = 0.06                             Age*Treatment P Value = 0.42
pH
Placebo ‡ 7.38 ± 0.01 7.22 ± 0.02 * 7.30 ± 0.01 * 7.33 ± 0.01 7.35 ± 0.02 < 0.001
40% O2 7.38 ± 0.00 7.19 ± 0.01 * 7.29 ± 0.01 * 7.33 ± 0.01 * 7.34 ± 0.01 * < 0.001
Aspirin ‡ 7.38 ± 0.01 7.22 ± 0.03 * 7.33 ± 0.02 * 7.36 ± 0.01 7.38 ± 0.01 < 0.001
A + O2 7.37 ± 0.01 7.21 ± 0.02 * 7.28 ± 0.02 * 7.33 ± 0.01 * 7.34 ± 0.02 * < 0.001
Treatment P Value = 0.30
Time*Treatment P Value = 0.54                           ‡ represents Age*Treatment P Value = < 0.05
Lactate 
(mmol.L-1)
Placebo ‡ 1.3 ± 0.2 4.2 ± 0.4 * 3.9 ± 0.3 * 3.3 ± 0.4 * 3.0 ± 0.4 * < 0.001
40% O2 ‡ 1.3 ± 0.1 4.3 ± 0.3 * 3.6 ± 0.3 * 3.4 ± 0.3 * 3.0 ± 0.3 * < 0.001
Aspirin ‡ 1.3 ± 0.1 3.7 ± 0.4 * 3.4 ± 0.3 * 3.0 ± 0.3 * 2.4 ± 0.2 * < 0.001
A + O2 ‡ 1.3 ± 0.1 3.7 ± 0.4 * 3.7 ± 0.4 * 3.3 ± 0.2 * 3.0 ± 0.3 * < 0.001
Treatment P Value = 0.77




Table 4.10 PO2, PCO2, K+, pH, and lactate concentrations in the venous efflux recorded 
before and after isometric handgrip contractions performed by older men. * represent 
values significantly different from respective baselines while ‡ represents the age*treatment 
interaction. 
Older - Isometric Exercise
Baseline
Post Exercise Responses






Placebo 50 ± 3 36 ± 4 * 54 ± 3 62 ± 7 53 ± 5 0.001
40% O2 49 ± 5 37 ± 3 * 60 ± 3 * 59 ± 5 56 ± 5 0.001
Aspirin 52 ± 2 34 ± 2 * 59 ± 2 * 56 ± 2 56 ± 3 < 0.001
A + O2 48 ± 5 33 ± 1 * 61 ± 3 58 ± 4 55 ± 5 < 0.001
Treatment P Value = 0.99
Time*Treatment P Value = 0.61                             Age*Treatment P Value = 0.06
PCO2 (mmHg)
Placebo 44 ± 1 75 ± 10 * 49 ± 2 45 ± 2 47 ± 2 < 0.001
40% O2 47 ± 1 67 ± 4 * 54 ± 2 48 ± 2 46 ± 1 < 0.001
Aspirin 42 ± 1 77 ± 8 * 48 ± 1 46 ± 1 44 ± 1 < 0.001
A + O2 47 ± 2 74 ± 6 * 53 ± 2 52 ± 1 46 ± 1 < 0.001
Treatment P Value = 0.73 
Time*Treatment P Value = 0.58                             Age*Treatment P Value = 0.41
K+
(mmol.L-1)
Placebo 4.73 ± 0.24 5.32 ± 0.35 * 4.96 ± 0.37 5.07 ± 0.32 5.18 ± 0.29 < 0.05
40% O2 4.84 ± 0.19 5.73 ± 0.30 * 4.87 ± 0.18 4.93 ± 0.07 4.81 ± 0.14 < 0.001
Aspirin 5.09 ± 0.09 5.70 ± 0.23 * 5.04 ± 0.15 5.11 ± 0.17 4.99 ± 0.16 0.02
A + O2 4.83 ± 0.19 5.37 ± 0.22 * 5.04 ± 0.19 5.22 ± 0.33 5.13 ± 0.22 0.002
Treatment P Value = 0.98
Time*Treatment P Value = 0.87                            Age*Treatment P Value = 0.38
pH
Placebo ‡ 7.39 ± 0.01 7.25 ± 0.03 * 7.35 ± 0.01 * 7.37 ± 0.01 7.37 ± 0.01 < 0.001
40% O2 7.37 ± 0.01 7.26 ± 0.02 * 7.31 ± 0.01 * 7.35 ± 0.01 7.37 ± 0.01 < 0.001
Aspirin ‡ 7.41 ± 0.01 7.24 ± 0.04 * 7.35 ± 0.01 * 7.37 ± 0.01 7.39 ± 0.01 < 0.001
A + O2 7.38 ± 0.01 7.25 ± 0.03 * 7.32 ± 0.01 * 7.33 ± 0.01 7.36 ± 0.01 < 0.001
Treatment P Value = 0.43
Time*Treatment P Value = 0.70                           ‡ represents Age*Treatment P Value = < 0.05
Lactate 
(mmol.L-1)
Placebo ‡ 1.4 ± 0.2 3.4 ± 0.5 * 3.0 ± 0.2 * 2.9 ± 0.3 * 2.7 ± 0.3 * < 0.001
40% O2 ‡ 1.3 ± 0.1 3.4 ± 0.3 * 3.3 ± 0.2 * 3.0 ± 0.3 * 2.6 ± 0.2 * < 0.001
Aspirin ‡ 1.3 ± 0.1 3.7 ± 0.5 * 3.1 ± 0.3 * 2.8 ± 0.2 * 2.3 ± 0.2 * < 0.001
A + O2 ‡ 1.4 ± 0.1 3.6 ± 0.5 * 3.3 ± 0.2 * 3.3 ± 0.3 * 2.8 ± 0.2 * < 0.001
Treatment P Value = 0.84




Figure 4.18 PGI2 (upper panel) measured in venous plasma samples and normalized PGI2 
(lower panel) values recorded before and after rhythmic and isometric handgrip 
contractions performed by older men. Placebo is represented in blue while 40% O2 
supplementation is red, aspirin is green, and their combination (A+O2) is shown in purple. * 
represent values significantly different from their respective baselines while † represents values 
significantly different from P treatment condition (P < 0.05). This includes all values within the 
brackets. 





























Effect       P  
Treatment             < 0.001
Time*Treatment    < 0.001
Age*Treatment 0.46















Figure 4.19 Correlation between baseline and post-exercise FBF and PGI2 (6-keto-PGF1α ) 
concentrations for rhythmic (upper panel) and isometric (lower panel) exercise performed 
by older men. P is represented in blue, 40% O2 is red, A is green, and their combination (A+O2) 
is shown in purple. Each individual’s baseline and post-exercise response is shown by the 
dashed line while the solid line represents the line of best fit (regression analysis and r2 values 
are provided for each treatment). 
y = 0.0408x + 1.9109
R = 0.55; R² = 0.34
y = 0.0172x + 1.4563
R = 0.28; R² = 0.08
y = -0.0005x + 1.193
R = - 0.01; = 0.002
y = 0.0043x + 1.8781
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y = 0.0556x + 3.2763
R = 0.47; R² = 0.22
y = 0.0065x + 2.1826
R = 0.18; R² = 0.03
y = -0.0007x + 1.2438
R = -0.02; R² = 0.01
y = 0.011x + 1.7286























Figure 4.20 Comparison of percentage reduction in PGI2 efflux following rhythmic (upper 
panel) and isometric (lower panel) handgrip contractions performed by young and older 





































Figure 4.21 PGEM (upper panel) measured in plasma sample of venous efflux and 
normalized PGEM (lower panel) values recorded before and after rhythmic and isometric 
handgrip contractions performed by older men. Placebo is represented in blue while 40% O2 
supplementation is red, aspirin is green, and their combination (A+O2) is shown in purple. * 
represent values significantly different from their respective baselines while † represents values 
significantly different from P treatment condition (P < 0.05). This includes all values within the 
brackets. 



























Effect       P  
Treatment              0.24
Time*Treatment 0.04
Age*Treatment 0.10















Figure 4.22 Correlation between baseline and post-exercise FBF and PGEM 
concentrations for rhythmic (upper panel) and isometric (lower panel) exercise performed 
by older men. P is represented in blue, 40% O2 is red, A is green, and their combination (A+O2) 
is shown in purple. Each individual’s baseline and post-exercise response is shown by the 
dashed line while the solid line represents the line of best fit (regression analysis and r2 values 
are provided for each treatment). 
y = 0.1104x + 8.8523
R = 0.49; R² = 0.24
y = 0.0322x + 5.893
R = 0.19; R² = 0.04
y = 0.0273x + 5.1479
R = 0.13; R² = 0.02
y = 0.0275x + 6.0581























Figure 4.23 Comparison of percentage reduction in PGEM efflux following rhythmic (upper 
panel) and isometric (lower panel) handgrip contractions performed by young and older 






































There were several novel findings of the present study. Firstly, COX inhibition with aspirin, 40% 
O2, and their combination substantially attenuated post-exercise hyperaemia associated with 
60% MVC rhythmic and isometric handgrip contractions in both recreationally active young and 
older men. This attenuation was not different between treatments. Secondly, both rhythmic and 
isometric contractions substantially increased the venous efflux of PGI2 (6-keto-PGF1α) and 
PGE2 (PGEM) in young and older men; COX inhibition and/or 40% O2 similarly attenuated this 
efflux. Finally, although there was no significant difference between young and old for the 
percentage attenuation in venous efflux of PGI2 (6-keto PGF1α) and PGE2 (PGEM) induced by 
40% O2 and COX inhibition, the accompanying attenuation of the exercise hyperaemia was 
significantly greater in young (~ 30%) than older men (~ 15%). 
4.4.1 Systemic cardiovascular responses 
It is well established that exercise leads to an increase in HR and MABP as recorded in the 
present study; responses which are attributable to central command and the reflex components 
mediated by peripheral inputs (200). A number of COX-related substances have been implicated 
in the reflex cardiovascular responses to exercise; including AA, PGE2, and TXA2 (200, 207, 262, 
347). Therefore COX inhibition with aspirin could potentially have influenced exercise-related 
reflex changes in the systemic cardiovascular system. Moreover according to our original 
hypothesis production of PGs during exercise is O2-dependent. Therefore 40% O2 could have 
influenced these systemic reflex responses by changing the input from afferents in the 
contracting muscles. However, in agreement with our laboratory’s previous work (123, 437), no 
such treatment effects were found regarding the changes in HR and MABP recorded in young 
men. Moreover, the interventional treatments also failed to influence exercise-related changes in 
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HR and MABP of the older men. The lack of effect on HR response is consistent with this being 
mainly centrally-mediated (5, 422); while the effect on vasoconstrictor component of exercise 
reflex may not have been apparent from MABP as this is dependent on both the cardiac output 
and TPR (163). The contributions of afferent neural inputs to the pressor reflex are addressed in 
more detail in the study described in Chapter 5 on the relationship between COX products, their 
O2-dependency, and the exercise-related reflex vasoconstriction. The influence of age on this 
relationship is also one of the primary questions in Chapter 6. Therefore, the present discussion 
primarily focuses on the contributions of COX products and O2-dependency to exercise 
hyperaemia and exercise-related changes in the efflux of different metabolites. 
4.4.2 Exercise hyperaemia responses 
4.4.2.1 Control responses in young men 
Before discussing the hyperaemia responses of rhythmic and isometric handgrip contractions, an 
important point that requires consideration is whether inflation of the venous occlusion cuff itself 
had an impact on the observed hyperaemia responses. Kirby et al. investigated the impact of 
external mechanical influences on the FVC by inflating a cuff around the forearm at different 
pressures (25 – 300 mmHg) (212). Their results revealed that the cuff pressures of 25, 50, 75, 
and 100 mmHg increased in FVC in a fairly linear manner. However from thereon, the observed 
hyperaemia remained quite stable. Thus, given the venous occlusion cuff was inflated around the 
upper arm to record FBF – a standard practice in the technique of venous occlusion 
plethysmography, it is possible this external pressure of ~ 50 mmHg on the upper arm had some 
myogenic impact on the baseline and post-contraction FVC changes recorded in the present 
study. However, any such effect was a consistent factor between treatments, and should not be 
the cause of any observed treatment effects. A second, related point that also requires 
consideration is whether these mechanical influences could affect the release of vasoactive 
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metabolites; in particular, PGs. It is possible they did influence the release of intravascular 
vasoactive ATP (76). However, independent NOS inhibition (32), and combined NOS and COX 
inhibition (356) did not attenuate the rapid component of the vasodilator response to muscle 
contraction. Therefore, it seems very unlikely that any increase in the vasoactive PGs observed 
in this study was the result of mechanical influences of cuff inflation; i.e., venous occlusion 
plethysmography cuff/s and/or Finapres cuff (Finapres cuff was on the non-exercising resting 
hand). 
Both rhythmic and isometric handgrip contractions resulted in an increase in post-exercise FBF 
(hyperaemia), attributable to a reduction in vascular tone: vasodilatation. As might have been 
expected from previous studies in which PGE2 and PGI2 efflux were assessed during rhythmic 
exercise (198, 199), and the early study in which PGE-like substances were assayed following 
isometric contraction of the forearm (209), both types of contractions increased the venous efflux 
of PGI2 (6-keto-PGF1α) and PGE2 (PGEM) in the present study. As indicated in the Introduction, 
concentrations of PGI2 and PGE2 in muscle interstitium also increase during rhythmic exercise. 
This result suggests active participation of both vasodilator PGs to exercise hyperaemia of 
isometric and rhythmic contractions. 
However, It is important to note that although a number of studies have reported exercise-related 
changes in the venous (302, 435) and interstitial PG concentrations (29, 198, 199, 224), the 
calculated values are not always comparable. This may reflect differences in the release of PG 
by the cannulated vessel during blood sampling (99, 302), ex-vivo (in-vitro) production of PGs 
(99), and/or the effect of different methodologies used to measure these PGs (99). In fact, when 
Dray et al. employed careful plasma extraction methodologies (i.e., anti-prostaglandin sera in 
cold vacutainers and careful removal of RBCs and platelets) to optimise measurement of human 
plasma PGFα, PGE1, and PGE2 concentrations (99), they measured values for 6-keto PGF1a of ~ 
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12 and PGE2 of ~ 4 pg/ml under baseline conditions; similar to those reported here. Therefore, it 
is reasonable to assume that the use of careful methodologies for sample collection (i.e., 
removal of 0.8 ml blood before each sample collection in ice-cold vacutainers, immediate 
addition of indomethacin, and supernatant plasma extraction after spinning at 2500 rpm at 4°C 
for 20 min; See Section 4.2.2), allowed the actual venous PG concentrations to be measured in 
the subjects who took part in the present study. Moreover, the range of “normal baseline PG 
concentrations” is quite wide (99, 447), which in itself allows for the variability in the reported PG 
concentrations data of different studies (198, 199, 302, 435). Lastly our results do concur with 
earlier studies (29, 198, 199, 302, 435, 447, 448) in that they are internally consistent (i.e., under 
placebo, venous efflux of PGs increased significantly following exercise).  
Regarding the venous concentrations of metabolites (K+, H+, and lactate), their participation in 
active vasodilatation of either rhythmic or isometric handgrip exercise is questionable; the time 
course of the change in post-exercise venous concentrations of these metabolites remained 
completely unrelated to the changes in FBF and FVC. 
4.4.2.2 Effect of COX inhibition and breathing 40% O2 in young men 
Before discussing the effect of aspirin (600mg) on hemodynamic responses and intra-venous PG 
concentrations, it is important to mention here that a similar dose of aspirin has previously been 
shown to effectively inhibit the COX enzyme for 30 – 90 min (161). Moreover, a comparison 
between aspirin and indomethacin regarding their effectiveness in attenuating exercise 
hyperaemia during cycling revealed no difference between them (74). In the present study, COX 
inhibition attenuated the post-exercise hyperaemia of isometric handgrip contractions (60% 
MVC); results which agree with our group’s previous observations (437). Moreover attenuation of 
post-exercise hyperaemia evoked by rhythmic handgrip contractions with COX inhibition in this 
study is also in agreement with previous observations (302, 303). However, in most previous 
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studies, the assessment of contribution of COX products to exercise hyperaemia was indirect: 
very few assayed PGs in same study in which blood flow was recorded and a COX inhibitor 
used. The measurements of venous PGI2 (6-keto-PGF1α) and PGE2 (PGEM) concentrations 
before and immediately after both types of handgrip contractions in present study clearly shows 
their release was indeed inhibited by aspirin and that the post-exercise hyperaemia responses 
were attenuated. Similar results were obtained by Kilbom and Wennmalm; indomethacin not only 
attenuated the hyperaemia responses but also significantly decreased the venous PGE 
concentrations. (209). Therefore, as the venous concentrations and efflux of PGs increase in 
response to either type of handgrip contraction and attenuate following COX inhibition, this study 
confirms their exercise-related release and is consistent with their (PGE2 and/or PGI2) active 
participation in the exercise hyperaemia response. In contrast, some previous studies have 
suggested that vasodilator PGs are not important mediators of exercise hyperaemia; at least 
following 10% MVC rhythmic handgrip contractions (359, 368). The results of the present study 
lend unequivocal support to vasodilator PGs being important contributors to exercise hyperaemia 
following isometric and rhythmic contractions at 60% MVC. 
Win and Marshall’s observation that 40% O2 and aspirin similarly attenuated the post-exercise 
hyperaemia of isometric handgrip contractions (60% MVC) led to their proposal that the release 
of PGs during exercise was O2-dependent (437). The present study confirmed this proposal, in 
that the efflux of both PGE2 and PGI2 following isometric contraction was attenuated by 40% O2; 
and showed for the first time, that the release of these PGs induced by rhythmic handgrip 
contraction and the associated post-exercise exercise hyperaemia are also O2-dependent. What 
makes the present findings really interesting is the observation that 40% O2 attenuated the 
effluxes of both PGE2 and PGI2 caused by both types of handgrip contractions to values that 
were similar to those observed with COX inhibition. This finding suggests that the synthesis of 
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PGs during these contractions is explained by a fall in tissue PO2; other stimuli for PG release 
such as shear stress are relatively less important. The finding that the combined use of O2 and 
aspirin had no greater effect on either the post-exercise hyperaemia or the venous PG 
concentrations is also significant. It seems that the fall in PO2 that occurs within forearm muscle 
during rhythmic and isometric handgrip contractions and the synthesis of PGE2 and PGI2 can be 
prevented by breathing supplementary O2 at the modest concentration of 40%. 
On the other hand, breathing 40% O2 did not affect the increase in venous efflux of K+ or lactate, 
or the fall in pH following either type of contraction. The lack of effect on K+ is not surprising, if 
this is mainly due to efflux from contacting muscle fibres during action potentials (See Section 
1.2.3.3.4). The lack of effect on lactate and pH contrasts with the finding of Fordy and Marshall; 
they were both attenuated when 40% O2 was breathed during isometric contraction at 100% 
MVC (123). This disparity is probably the result of a greater fall in tissue PO2 during maximal 
contraction that was ameliorated by breathing 40% O2. 
4.4.2.3 Responses of the older men 
The study performed by Schrage et al. raised interesting questions about the contribution of PGs 
towards exercise hyperaemia in older individuals (358). However, as the release of PGs is 
intensity-dependent (29, 198, 447, 448) and as they only used 10% MVC handgrip contractions 
and did not assay PG release, further investigations into the relationship between release of 
vasodilator PGs and their role in exercise hyperaemia of older individuals was warranted.  
Rhythmic and isometric handgrip contractions performed at 60% MVC evoked a substantial post-
exercise increase in FBF and FVC in older men, and interestingly, this increase was unaffected 
by aging. Although certain studies suggest the exercise-related increase in blood flow is 
attenuated with age (213, 322, 326), some have suggested that the hyperaemia responses of 
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older individuals are preserved with lifelong physical activity (87, 285, 305, 391, 395). Similar 
results have also been obtained in young and old, sedentary and exercise-trained rats (409). 
Seen in this context the novel results of the present study were that the post-contraction 
hyperaemia in the older subjects was accompanied by a significant increase in the venous 
concentrations / efflux of vasodilator PGE2 and PGI2; COX inhibition attenuated the hyperaemia 
for both types of contraction. Moreover, as in young men, COX inhibition and 40% O2 similarly 
attenuated venous the PGE2 and PGI2 efflux. This contrasts with the report of Schrage et al. 
(358) that the contribution of PGs to exercise hyperaemia is greatly attenuated or lost in older 
subjects. The present findings demonstrate that in fact a substantial contribution of PGs to 
exercise hyperaemia associated with medium-intensity exercise is maintained in older 
recreationally active men. This raises the possibility that the contribution of PGs is lost with 
sedentariness, rather than with ageing per-se. Indeed in support of this argument is the work 
performed by the Seals group which showed that not only does the central arterial compliance 
improve in older individuals who undergo a simple endurance training regimen of 30 min walking 
3 – 4 days per week (395), but such regular aerobic exercise prevents the age-related decline in 
forearm’s endothelium-dependent dilatation (87). 
It must be acknowledged that Schrage et al. (358) only used a light level of rhythmic contraction 
(10% MVC) rather than 60% MVC, as used in the present study. Thus the disparity may partly be 
explained by the intensity of exercise, particularly as the release of PGs was shown to be 
exercise intensity-dependent (29, 198, 447, 448). However, Schrage et al. (358) reported that 
their older subjects did not perform regular physical exercise but only engaged in routine 
household tasks. Thus, an alternative explanation for their results could be the deterioration of 
endothelial function that occurs when relative-inactivity is combined with aging. Endurance 
exercise is associated with increased shear stress (403, 405, 406) which in itself has been linked 
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to increased mRNA expression of eNOS (439). Further, Trott et al. noticed that ACh-induced 
dilatation was attenuated in older sedentary rats but the use of superoxide-dismutase in these 
rats increased endothelial dilatation to values that were comparable with young (409). Therefore, 
it is possible that the contribution of PGs might have been compromised by the lack of regular 
exercise and/or by the increased oxidative-stress associated with aging (214). 
The present finding showed that despite similar venous efflux of PGE2 and PGI2 in young and 
older men, the magnitude of their contribution to exercise-associated vasodilatation declined with 
age (~ 15 vs. 30%). This suggests age-associated changes in the action of vasodilator PGs, 
rather than an inability to synthesise PGs in response to exercise. As in young men, the 
combination of 40% O2 and aspirin did not add further to the attenuation of exercise hyperaemia 
or venous PG efflux evoked by either type of contraction suggesting that the synthesis and 
release of PGs was completely O2-dependent. 
It should also be noted that the increase in venous lactate efflux was also smaller in older than 
young men; this was expected considering the age-related change in the predominant muscle 
type (i.e., slow-twitch vs. fast-twitch respectively) (49, 115). However as in the young subjects, 
breathing 40% O2 had no significant effect on these effluxes. 
4.4.3 Mechanism of action of 40% O2 on PG generation 
The observation that breathing 40% O2 only during the period of exercise attenuates post-
contraction hyperaemia (123) lends support to the argument that the stimulus for O2-dependent 
release of PGs lies within the exercising muscles. However, exercise is not only associated with 
profound decline in intramuscular / interstitial PO2 (143, 337-339), but similarly peri-venular PO2 
(226) also declines during this time. The observation of an increase in the PGI2 concentrations 
when intravascular PO2 declines (45, 46, 266) is consistent with the idea that this decline in peri-
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venular / capillary structures during exercise is the source of O2-dependent PGI2 release. 
Therefore the present finding that 40% O2 attenuated the release of PGI2 to levels that were 
similar to those observed with COX inhibition raises the possibility that the increase PO2 with 
40% O2 directly influenced / attenuated the release of vasodilator PGI2 from venular endothelium: 
this does not exclude the possibility that PGE2 is also released from venular endothelium. 
An alternative explanation for the observed responses involves adenosine and/or ATP. Release 
of these compounds has been linked to hypoxia (24, 70, 71, 88, 142, 186, 244, 331) and 
exercise-intensity (142, 253). Based on the discussion in section 1.2.3.7 (interdependency and 
redundancy), it is clear that adenosine and ATP influence the production of PGs (286, 289, 304, 
306). Thus, O2 supplementation might be affecting the release of adenosine and/or ATP, thereby 
attenuating their contribution towards the release of vasodilator PGs. It is possible that the 
increased PO2 inhibits the production of adenosine from any of its known sources (i.e., intra-
muscular, interstitial, and ATP released by de-oxygenated RBCs). Moreover, increased PO2 
might attenuate the change in RBC profile (oxygenated to deoxygenated), thereby inhibiting their 
direct contribution towards the release of PGs.  
Importantly, it is unclear whether adenosine and/or ATP have a direct impact on PGE2 
production. However, given that PGE2 can be synthesised by skeletal muscle fibres (400), it is 
possible that breathing 40% O2 attenuated synthesis and release from this site. Whether 
activation of COX in skeletal muscle fibres is O2-dependent has not been tested. Figure 4.24 
attempts to elucidate this complicated relationship and shows different, but not necessarily 





Figure 4.24 Possible mechanisms by which 40% O2 attenuates the release of vasodilator 
PGs. Compartment A is intra-vascular, B is showing endothelium, C represents interstitium while 
D represents skeletal muscle. Different coloured arrows represent four distinct but not exclusive 
pathways that could be affecting the release of PGI2 and PGE2 during exercise. The blue → 
shows a pathway where the fall in PO2 directly influences the release of PGI2 and PGE2 which is 
counteracted by 40% O2. The red → pathway shows that as RBCs become deoxygenated, they 
release ATP which directly and/or via adenosine stimulates the endothelial release of PGI2. The 
green → and purple → pathways shows that increase in PO2 could be attenuating interstitial 
adenosine concentrations and thereby attenuating the release of vasodilator PGs.  
 
In conclusion, this is the first study to show that vasodilator PGs (PGI2 and PGE2) are released in 
response to rhythmic and isometric handgrip contractions, in both, young and older men. 
Moreover, their release and contribution to exercise (post-exercise) hyperaemia is and remains 
























4.4.4 Limitations and Future Work 
A basic limitation to this work is that oral aspirin was used to COX enzyme: this rather blunt 
approach must have affected the systemic vascular responses and in turn, the responses of the 
exercising arm. Although intra-arterial COX inhibitor infusion during or just before 
commencement of exercise would have provided a more localized COX inhibition, this (i.e., 
arterial-line) would have made the protocol more risky and required medical cover. Further, the 
principal reason this approach was not adopted was because one of the PGs under investigation 
is primarily released by the skeletal muscle fibres (i.e., PGE2) (400). It was not clear whether 
such a short lasting / abrupt infusion during or just prior to exercise, so as to avoid a systemic 
dose being given, would effectively lead to COX inhibition in the extra-vascular compartment.  
Another limitation to this study is that venous samples of 6 randomly selected individuals were 
assayed for PGs. Although assay of these samples for PG concentrations revealed fairly 
consistent data; for a more thorough experimental approach, not only would it have been better 
to analyse venous samples from all individuals for PG concentrations, but it would have given 
temporal resolution if PGs had been measured at other time intervals. This approach could have 
further elucidated the apparently tight relationship already observed in this study between the O2-
dependent PGs and the exercise / post-exercise vasodilatation. Ideally, arterial samples would 
have aided in this understanding by allowing arterio-venous differences to be calculated. 
Furthermore, in order to examine the contribution of 40% O2 to oxidative-stress, its markers (i.e., 
isoprostane, nitro-tyrosine, etc) could have been measured. However, these interventions were 
not done due to financial, time, and technical restraints. 
Another limitation to this study is that the order of rhythmic and isometric handgrip contractions 
was not randomized, but arranged so that isometric contraction always occurred second. Ideally, 
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randomization should have been done but it was quickly observed that 3 min of isometric 
handgrip was more intense and fatiguing for participants than 3 min rhythmic contractions. Thus, 
the selected order of handgrip exercise bouts helped to ensure that the effect of the second 
exercise was not affected by the consequence of the first.  
Separately, an important limitation is that all the hyperaemia responses presented here are post-
exercise responses. Use of a duplex Doppler-ultrasound would have provided a continuous 
record of blood flow in the exercising arm; providing brachial artery diameter could be imaged 
successfully during isometric and rhythmic contractions at 60% MVC (see Chapter 3 Discussion). 
Interestingly, the data of Kagaya and Homma showed that brachial artery blood flow increased 
by ~ 60% from baseline during incremental isometric handgrip contractions ranging from 10 – 
70% MVC (196). It was after contraction that the magnitude of post-contraction hyperaemia was 
proportional to the size / intensity of the contraction. Thus, it could be argued that the post-
contraction hyperaemia was most likely, the component of vasodilatation induced by isometric 
handgrip contraction to be affected by the interventional treatments employed in the present 
study. However, it is the case that had successful imaging proved possible during rhythmic 
contractions at 60% MVC, despite the local tissue movement that inevitably occurs with medium-
intensity rhythmic contraction, duplex Doppler-ultrasound could have elucidated the contribution 
of O2-dependent PGs to the time course of vasodilatation during exercise. Moreover, the use of 
Doppler-ultrasound could also have allowed comparison of the influence of 60% MVC isometric 
handgrip contractions in restricting FBF in young and older men, as well as revealed any 
differences in the time course of the contribution of vasoactive PGs with age.  
Lastly, a limitation of this study is partly related to experiments performed by Schrage et al. 
(358). As their subjects did not perform any regular exercise but only indulged in household 
tasks; an older group of healthy but sedentary individuals would have allowed comparison of the 
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relationship between PG release, and their contribution to the exercise / post-exercise 
hyperaemia of medium-intensity contractions in older people of different physical activity levels. 
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Following the principal findings of Chapter 4, the next logical question was to investigate whether 
O2-dependent COX products are involved in the reflex vasoconstriction of exercise? 
It is established that exercise is accompanied by an increase in blood flow to the exercising 
muscles along with systemic cardiovascular responses: increased HR, MABP, MSNA, and 
peripheral vasoconstriction (72, 119, 172, 371, 421, 437). As mentioned in Chapter 1 (See 
Section 1.2.6), the two neural mechanisms contributing to these changes are central command 
(i.e., feed-forward) and muscle (afferent) / pressor reflex (i.e., feedback). Parallel activation of 
muscle contractile activity and the cardiovascular responses, defines central command; while the 
feedback mechanism is defined by contraction-induced mechano and/or metabo-afferent 
activation and thence, reflex sympathetic activation (173, 271). The thinly myelinated group III 
and un-myelinated group IV afferents are generally attributed with the respective mechanical and 
metabolic inputs of the exercise pressor reflex (172, 201, 203, 271).  
A number of metabolites have been implicated as contributing factors to the reflex. These include 
bradykinin (201, 207, 261), K+ (261), lactic acid (347, 372), and those involved in COX pathway; 
AA, PGE2, and TXA2 (207, 231, 262, 347). Recently, Leal et al. have shown that thromboxane-
receptors are stimulated by both muscle stretch and 30 s of isometric contraction in freely 
perfused muscle; their inhibition attenuates the pressor response (231). This is an important 
finding considering not just TXA2, but isoprostane, PGE2, and PGI2 can all stimulate the 
thromboxane-receptors (141). Consistent with the results of Chapter 4, concentrations of PGs 
(PGE2 and PGI2) increase in the interstitium of exercising muscle (79, 390, 435, 447, 448), and 
COX inhibition attenuates exercise hyperaemia by blocking the production of these PGs (74, 
209, 437). Studies showing that AA and/or its subsequent products stimulate group III and IV 
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afferents (207, 262, 347) raise the possibility that these products might also contribute to the 
exercise pressor reflex / reflex vasoconstriction. For example, Rotto and Kaufman showed that 
the stimulation of group III and IV afferents in cats by arterial AA injections was almost 
completely abolished if indomethacin were given 30 min prior to AA (347). In another study, ~ 
60% of group IV afferents located in triceps-surae were stimulated by 60 s of isometric 
contractions; a response which was abolished with either indomethacin or aspirin, suggesting 
that PGs facilitate activation of these afferents (346). Subsequent injection of 40 µg PGE2 
restored the response of group IV afferents to isometric contractions (346). 
In humans, isometric handgrip contractions (25, 50, and 75% MVC) evoked reflex 
vasoconstriction in the relaxed contralateral arm when there was no electromyograph activity 
(72). Further, low level rhythmic handgrip contractions performed at 20% MVC for 3 min; a 
protocol that was designed to sensitise mechanoreceptors, evoked an increase in leg (peroneal 
nerve) MSNA activity which was abolished after COX inhibition with indomethacin (267). It was 
therefore argued that COX metabolites sensitise the mechanoreceptors that contribute to the 
exercise reflex. Subsequently, Cui et al. showed that progressive isometric handgrip exercise 
performed at 15% (1 min), 25% (1 min), and 30% MVC (until fatigue), followed by 2.5 min of 
PECO led to an increase in leg MSNA which was maintained during PECO; ketorolac attenuated 
these changes during exercise and during PECO (79). They therefore proposed that prostanoids 
contribute to the reflex activation of MSNA by stimulating metaboreceptors, as well as sensitising 
mechanoreceptors.  
However, observations of a correlation between synthesis of COX products and reflex changes 
in MSNA and systemic cardiovascular responses are not a consistent finding. Doerzbacher and 
Ray (96) reported that oral administration of the COX inhibitor ketoprofen had no effect on the 
reflex increase in MSNA evoked either by isometric handgrip or rhythmic handgrip at 30% MVC 
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to exhaustion, even when PECO was maintained after exercise. As both, the release of PGs (29, 
198, 447) and the increase in MSNA (158, 159, 421) during exercise are intensity-dependent, it 
seemed reasonable to investigate this relationship with handgrip contractions that are more 
intense (i.e., 60% MVC). 
It has been shown that the pressor response to exercise is much greater when the arterial supply 
to the exercising limb is occluded, compared to unrestricted blood flow, suggesting either a direct 
role of O2 or an O2-dependency of metaboreceptor stimulating metabolites (5, 67). For example, 
Kaufman et al. showed that isometric contractions evoked in anesthetized cats under ischemic 
conditions compared to unrestricted blood flow resulted in greater stimulation of group IV 
afferents than group III afferents (although their activity also increased by ~ 12% under ischemia) 
(203). Similar results were obtained when rhythmic contractions were evoked in cats under 
ischemic and non-ischemic conditions (4, 174). The same group also showed that systemic 
hypoxia (3 – 5% O2 for 3 – 3.5 min) led to greater stimulation of group IV afferents than group III 
at rest in anesthetized cats, despite no effect on venous pH and lactate efflux (174). Subsequent 
isometric contractions further increased the activity of group III and IV afferents (174).  
These results are all consistent with the idea that activation of group IV afferents is COX and O2-
dependent. However, 100% O2 has previously failed to attenuate the increase in peroneal MSNA 
of handgrip exercise (183, 361); possible reasons for this apparent disparity are discussed later 
in the Chapter. Nevertheless, following the results of Chapter 4, an investigation into the role of 
COX products and the O2-dependency of metaboreceptor activation in exercise-evoked reflex 
vasoconstriction was warranted using COX inhibition and 40% O2. 
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5.1.1 Aims and hypotheses 
We hypothesized that the COX products (PGs and/or TX) produced in the exercising muscle 
during contractions at moderate intensity contribute to exercise-induced reflex vasoconstriction in 
resting limbs. We further hypothesized that their contribution to reflex vasoconstriction is O2-
dependent and would therefore be attenuated by breathing 40% O2. We tested these hypotheses 
by recording the changes in vascular resistance of resting calf while subjects performed 
isometric handgrip contractions at 60% MVC for 2 min without and with 40% O2 and COX 
inhibition. PECO was used to differentiate the effects of central command and mechanoreceptor 





Eleven young (18 – 21 years) men were recruited to participate in the study. All were healthy, 
recreationally active, non-smoking individuals. None were on medication for any medical 
conditions. All subjects were required to adhere to dietary, medicinal, and exercise restrictions as 
previously described in Chapter 2 (See Section 2.1). Administration of medical air or 40% O2, 
and placebo or aspirin treatment along with measurements of MVC, TTI, HR, MABP, CBF, and 
CVR were done as described in Chapter 2. 
5.2.1 Protocol 
Subjects visited the laboratory on four occasions. The initial familiarization visit was used to 
complete health and activity questionnaire, consent form, familiarization of the subject with the 
protocol, and to record their MVC (See Section 2.3). The subsequent 3 experiment visits were 
carried out in a single-blind randomized manner. These visits involved administration of placebo 
(P) or aspirin (A) – both during air breathing and 40% O2. 
On experimental days, the handgrip dynamometer was set for the subject’s MVC before the 
experiment began. On arrival, subject consumed the treatment drink (P or A; 600 mg) and then 
all recording equipment (CBF and MABP) was connected to the subject as previously described 
(See Section 2.5). As shown in Figure 5.1 and Figure 5.2, CBF was recorded from the ipsilateral 
leg. In order to ensure subjects did not move their leg / foot during the periods of rest or exercise, 
electromyograph activity was recorded with plate-electrodes connected via a dual bio-amp 
(FE135, AD Instruments) to the Power-lab. The electrodes were placed on tibialis-anterior and 




After ~ 25 min of rest, the facemask was put on the subject and secured with elastic-straps which 
encircled the head to deliver medical air or 40% O2. Subject was asked to breathe normally and 
after 5 min of gas inhalation, resting CBF measurements were made with venous occlusion 
plethysmography. The subject was then asked to perform an isometric handgrip contraction for 2 
min at 60% MVC. As shown in Figure 5.3 (protocol schematic), CBF was measured at 1 min 
intervals for 6 min, beginning from the start of isometric handgrip contraction. However, instead 
of 2 and 4 min measurements, CBF was recorded at 1 min 45 s and 3 min 45 s. The gas flow 
was then turned off and the facemask was taken off while the subject rested for further 10 min. 
Following this, gas flow of either air or 40% O2 was again turned on and resting CBF 
measurements were taken after 5 min. This was followed by a comparable isometric handgrip 
contraction and CBF measurements as just described. The only difference between the two 
periods of contraction was that PECO was applied following one of the contractions in a 
randomized manner. PECO was applied by inflating the sphygmomanometer cuff to > 240 
mmHg around the upper arm of the exercising arm 5 s before the end of contraction; it remained 
inflated for 2 min 5 s. At the end of experiment, all recording equipment was disconnected and 
subjects were allowed to rest for 5 – 10 min before they left the laboratory. 
5.2.3 Statistical analysis 
Factorial ANOVA was used to identify time, treatment, exercise bout (i.e., NO PECO and PECO), 
and their interaction effects. The data of each treatment condition were also analyzed using 1-
way repeated measures ANOVA to detect within time effects. Effect of exercise bout, treatment, 
and their interaction on exercise time and TTI were analyzed using 2-way ANOVA. Once a 
statistically significant effect was detected, Tukey’s HSD (post-hoc test) was used to detect the 




Figure 5.1 Experiment setup showing arrangement of equipment. Subjects performed 
isometric handgrip contraction using their dominant hand (A) while MABP and HR were recorded 
from contra-lateral hand (B). CBF was recorded from the ipsilateral side (C) using venous 
occlusion plethysmography. PECO (D) was applied using a sphygmomanometer cuff 5 s before 
cessation of exercise. Medical air and O2 cylinders (E) were placed behind the subjects to keep 
them blinded to the treatment. 
 
Figure 5.2 Venous occlusion plethysmography and EMG electrodes. Venous occlusion cuff 
(A) was inflated using an automatic rapid inflation system and the strain-gauge was placed 
around the widest part of the calf (B). In order to exclude foot circulation, a paediatric cuff was 
inflated above systolic pressure (C). Electrodes (D) were placed on the tibialis-anterior and 
lateral-gastrocnemius. 
 
Figure 5.3 Schematic diagram of the protocol. Initial ↓ (orange) represents consumption of 
treatment drink (either P or with 600 mg A). ↓ (black) represents times at which CBF was 
measured and blue areas represent air or 40% O2 inhalation. Air or O2 flow was turned on 5 min 

































Anthropometric data of individual subjects are shown in Table 5.1. 
The TTI generated by subjects during isometric handgrip contraction is shown in Table 5.2; TTI 
were not different between treatments or between NO PECO and PECO conditions. All subjects 
managed to perform the isometric handgrip contraction at 60% MVC for the full 2 min and no 
difference was detected for duration between treatments during NO PECO or PECO conditions 
(Table 5.2). 
As can be seen from Figure 5.4, HR increased significantly with contraction, but by 3 min post-
contraction it returned to baseline during all treatments under NO PECO and PECO conditions 
(Figure 5.4; See above and below). Overall HR was different between treatment conditions; it 
was slightly higher with placebo than with aspirin and with 40% O2 during both NO PECO and 
PECO (Figure 5.4). Further, MABP increased significantly during contraction in all treatment 
conditions of NO PECO and PECO (Figure 5.5). By 3 min (post-exercise) MABP had returned 
back to baseline during NO PECO; addition of PECO maintained the increase in MABP during all 
treatments (Figure 5.5; upper and lower panels) which returned to respective baselines upon its 
removal.  
Table 5.3 and Table 5.4 show the absolute baseline CBF and CVR values during NO PECO and 
PECO conditions; no treatment effect was detected between them. Table 5.5 shows the absolute 
values for CBF and CVR before, during, and after isometric handgrip contractions performed at 
60% MVC. Delta (∆) CVR was calculated by subtracting each CVR during contraction (and post-
contraction) from the baseline CVR; these values are shown in Figure 5.6 and Figure 5.7. During 
NO PECO exercise bout, ∆ CVR increased by ~ 12 and 21 RU at 1 min and 1 min 45 s 
respectively into contraction during placebo treatment. This increase in CVR was significantly 
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attenuated during contraction with both 40% O2 and aspirin (Figure 5.6). During the post-
exercise NO PECO period, ∆ CVR was not different between treatments (Figure 5.6). However 
during PECO application, ∆ CVR of placebo treatment still remained significantly elevated 









Table 5.2 TTI and time recorded from NO PECO and PECO conditions while subjects 
performed isometric handgrip contractions at 60% MVC for 2 min. TTI and time were not 
significantly different between treatments or the two exercise bouts (i.e., NO PECO and PECO). 
Age (yr) Weight (Kg) Height (m) BMI (Kg/m2) MVC (N) Calf C (cm)
21 80 1.76 25.83 245 37
20 79 1.76 25.50 196 39
20 64 1.61 24.69 147 36
21 85 1.86 24.57 255 37
18 65 1.82 19.62 216 30
20 75 1.82 22.64 216 34
19 60 1.68 21.26 177 34
19 70 1.67 25.10 206 35
20 59 1.70 20.42 245 32
20 60 1.69 21.01 206 35
21 80 1.79 24.97 196 42
Mean 19.91 70.64 1.74 23.24 209.58 35.55
SEM 0.28 2.87 0.02 0.69 9.56 0.99
P 40% O2 A
TTI (N.s)
NO PECO 12957.53±1096.85 13280.42±965.46 13046.89±908.72
PECO 12664.50±1163.70 12991.93±1003.63 13281.40±889.08
P Value
Exercise bouts = 0.72 Treatment = 0.86
Exercise bout*Treatment = 0.97
Time (s)
NO PECO 120.55±0.42 121.06±0.33 120.77±0.35
PECO 120.77±0.52 121.26±0.67 121.68±0.92
P Value
Exercise bouts = 0.34 Treatment = 0.55




Figure 5.4 HR responses to isometric handgrip contractions performed at 60% MVC for 2 
min during NO PECO (upper panel) and PECO conditions (lower panel). Significant 
treatment effect was detected between placebo (blue), 40% O2 (red), and aspirin (green; vs. 
placebo). */†/‡ show placebo, 40% O2, and aspirin values significantly different from their 








































Figure 5.5 MABP responses to isometric handgrip contractions performed at 60% MVC for 
2 min during NO PECO (upper panel) and PECO conditions (lower panel). No treatment 
effect was detected between placebo (blue), 40% O2 (red), and aspirin (green) during NO PECO 
but overall MABP was slightly higher with interventional treatments during PECO conditions (P < 
0.05 vs. placebo). */†/‡ show values significantly different (P < 0.001) from respective baselines 




























Table 5.3 Baseline CBF responses during NO PECO and PECO conditions. No time or 
treatment affect was found between them. 
 
 
Table 5.4 Baseline CVR responses during NO PECO and PECO conditions. No time or 
treatment effect was found between them. 
CBF (ml dl-1 min-1) Treatment Baseline 1 Baseline 2 Baseline 3 Mean P Value
P 6.34±0.72 5.57±0.75 5.03±0.54 5.65±0.65 0.46
NO PECO 40% O2 4.21±0.72 3.93±0.49 4.23±0.59 4.12±0.57 0.97
A 6.15±0.94 5.37±0.88 5.34±0.89 5.62±0.89 0.80
P Value Treatment = 0.23
P 6.05±0.76 5.60±0.73 5.56±0.77 5.74±0.70 0.87
PECO 40% O2 4.94±0.87 4.70±0.87 4.44±0.75 4.65±0.78 0.91
A 5.38±0.67 4.97±0.73 4.73±0.73 5.03±0.69 0.77
P Value
Treatment = 0.58
Exercise bout = 0.99 Exercise bout*Treatment = 0.74
CVR (RU) Treatment Baseline 1 Baseline 2 Baseline 3 Mean P Value
P 15.73±2.24 17.65±2.20 18.37±1.87 17.25±1.20 0.66
NO PECO 40% O2 23.03±4.52 24.18±4.50 24.25±2.45 23.82±2.26 0.78
A 18.01±2.47 19.90±2.54 19.59±2.49 19.17±1.40 0.85
P Value Treatment = 0.28
P 16.27±2.12 18.12±2.58 18.17±2.84 17.52±1.41 0.83
PECO 40% O2 21.14±4.36 22.92±5.25 23.26±4.63 23.77±2.64 0.67
A 18.02±2.41 20.36±2.80 21.04±2.63 19.81±1.48 0.70
P Value
Treatment = 0.34




Table 5.5 CBF and CVR responses to isometric handgrip contractions performed at 60% MVC for 2 min during NO PECO and PECO conditions. 




Exercise NO PECO / PECO Rest
P Value
1 min 1 min 45 s 3 min 3 min 45 s 5 min 6 min
NO 
PECO
CBF (ml dl-1 min -1)
P 5.65±0.65 4.53±1.13 3.84±0.85 4.87±0.42 4.71±0.38 5.07±0.40 5.05±0.52 0.59
40% O2 4.12±0.57 5.03±0.90 5.01±0.80 4.00±0.48 3.87±0.24 4.53±0.59 4.23±0.56 0.70
A † 5.62±0.89 6.45±0.94 6.81±1.23 5.45±0.54 4.90±0.63 4.50±0.49 4.96±0.72 0.34
P Value †Treatment = 0.01               Time*Treatment = 0.52
CVR (RU)
P 17.25±1.20 29.81±4.99 * 38.82±7.99 * 19.61±2.53 18.98±1.94 17.64±1.40 18.94±2.37 < 0.001
40% O2 23.82±2.26 29.79±6.16 29.16±4.95 26.20±3.39 23.88±1.19 22.55±3.17 23.29±3.02 0.69
A † 19.17±1.40 19.20±3.12 19.30±2.74 18.17±1.77 19.44±2.23 21.62±3.03 21.25±3.12 0.97
P Value † Treatment = 0.004 Time*Treatment = 0.08
PECO
CBF (ml dl-1 min -1)
P 5.74±0.70 4.22±0.82 3.87±0.89 4.18±0.63 3.87±0.34 5.23±0.77 5.12±0.73 0.42 
40% O2 † 4.65±0.78 5.27±1.14 5.73±0.99 4.93±0.60 5.19±1.11 4.63±0.71 4.91±0.57 0.99
A † 5.03±0.69 7.25±1.43 6.90±1.21 5.80±0.69 6.41±1.03 4.91±0.55 4.91±0.44 0.34
P Value
† Treatment = 0.01 Exercise bout = 0.25
Time*Treatment = 0.41 Exercise bout*Treatment = 0.32
CVR (RU)
P 17.52±1.41 29.88±3.42 * 38.82±9.82 * 31.27±4.21 * 31.02±2.38 * 21.26±3.57 20.47±2.75 0.01
40% O2 23.77±2.64 28.10±5.58 25.53±3.96 26.38±4.32 28.93±4.24 25.62±4.31 23.93±3.28 0.92
A † 19.81±1.48 20.95±3.95 21.67±3.03 22.36±2.73 21.45±2.52 20.61±2.42 19.26±1.66 0.99
P Value
† Treatment = 0.003 Exercise bout = 0.07




Figure 5.6 ∆ CVR responses to isometric handgrip contractions performed at 60% MVC for 
2 min during NO PECO trial. Treatment effect was detected during period of exercise between 
placebo (blue), 40% O2 (red), and aspirin (green). 
 
 
Figure 5.7 ∆ CVR responses to isometric handgrip contractions performed at 60% MVC for 
2 min during PECO trial. Treatment effect was detected during exercise and during PECO 

























There are two novel findings of the present study. Firstly, the results of the study indicate that 
during isometric handgrip contraction, COX products produced in the exercising arm contribute 
towards exercise-evoked reflex vasoconstriction in the resting calf and secondly, that their 
contribution to this vasoconstriction is O2-dependent. 
5.4.1 Systemic cardiovascular responses 
Concentrations of PGs in the skeletal muscle interstitium increase during exercise (198, 199, 
302, 390, 435) and their presence contributes towards the exercise pressor reflex (79, 207, 231, 
347). The exercise-related increase in HR is more widely believed to be under the influence of 
central autonomic pathways (119, 123). However, Leal et al. noticed that thromboxane-receptor 
activation, the same receptors that are stimulated by COX products (141), led to an increase in 
HR and MABP while their inhibition attenuated this response (231). Moreover, the isometric 
exercise-related increase in HR was attenuated by receptor inhibition but that associated with 
muscle stretch remained intact. The increase in MABP however was attenuated by receptor 
inhibition during both exercise and muscle stretch.  
Based on such observations, COX blockade in the present study might have been anticipated to 
attenuate the systemic MABP, MSNA, and HR responses by inhibiting the release of COX 
products that stimulate afferents in contracting muscle. Therefore, the small attenuation of the 
increase in HR that occurred during muscle contraction following COX blockade and during 40% 
O2 is consistent with the idea that mechano- and metaboreceptors are stimulated by PGs that 
are released in the contracting muscles (347). This does not take away from the observations of 
Fisher and White that the increase in HR tends to be greater with voluntary isometric 
contractions than those evoked by electrical stimulation (119). 
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It is somewhat surprising that attenuation of the HR response was not observed in the 
experiments of Chapter 4 when a comparable dose of aspirin and 40% O2 were used. However, 
as the effect of aspirin and O2 on the HR response was relatively small, the disparity may simply 
reflect variability between subject groups. The decrease in HR that occurred immediately after 
cessation of handgrip exercise both during NO PECO and PECO is consistent with the results of 
Chapter 4 and with the proposal that the influence of vagal tone on HR returns immediately after 
cessation of contractions (67, 255). It is not surprising that HR was not affected by aspirin or O2 
during this period.  
The fact that the increase in MABP was not significantly different between treatments during the 
forearm contraction is also not surprising given it reflects the combined effects of changes in HR, 
stroke volume, and TPR (29, 74). This result corroborates the findings of the previous Chapter 
and other published data (74, 437). However during PECO, overall MABP was slightly higher 
with aspirin and 40% O2. The slight increase during PECO trial possibly reflects a contribution of 
ROS generated within the hypoxic / ischemic arm to the pressor reflex (51, 62, 245). 
5.4.2 Calf vasoconstriction 
Baseline CBF and CVR were not affected by aspirin or 40% O2. However, the idea that COX 
products contribute towards the exercise pressor reflex by stimulating muscle afferents is 
supported by our novel findings on the ∆ CVR evoked by forearm contraction. The present 
findings showed that COX blockade with aspirin significantly attenuated the increase in CVR 
during the 2 min period of isometric handgrip exercise. PECO exercise bout’s MABP and ∆ CVR 
data shows that central command and/or mechanoreceptors contribute to exercise-evoked 
vasoconstriction. However, as the application of PECO excludes the contribution of 
mechanoreceptors and central command from the observed responses, the fact that the ∆ CVR 
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was maintained during the 2 min of PECO and this effect was attenuated by aspirin indicates that 
COX products produced during exercise (390, 435, 447, 448) accumulate during this period, 
stimulate metaboreceptors (79, 346), and thereby contribute to the reflex vasoconstriction. The 
second novel finding that a similar attenuation of the increase in ∆ CVR occurred with 40% O2 is 
consistent with the finding of Kaufman et al. that not only were group III and IV afferents 
stimulated by AA (347) and their activity attenuated by COX blockade (346), but they were also 
stimulated under hypoxic and ischemic conditions (4, 174, 203). Taken together with the results 
of Chapter 4, the present results are consistent with the hypothesis that breathing 40% O2 also 
attenuated the reflex vasoconstriction by inhibiting the production of O2-dependent PGs in the 
contracting forearm.   
Before accepting this hypothesis, alternative explanations for the present findings should be 
considered. Firstly, it might be argued that systemic COX blockade attenuated the calf 
vasoconstriction response by affecting the ability of an increase in resting calf’s MSNA. However, 
previous studies have shown that PGs that are locally synthesised and released blunt the 
evoked sympathetic vasoconstriction; i.e., local PG concentrations and sympathetic 
vasoconstriction are inversely correlated with each other (362). Further, there is evidence that 
locally synthesised PGs inhibit the release of noradrenaline from sympathetic varicosities (385). 
Thus if either of these mechanisms were dominant during forearm contraction, then COX 
inhibition with aspirin would have been expected to augment, rather than attenuate the 
vasoconstriction in calf. Secondly, it might be argued that breathing 40% O2 attenuated the calf 
vasoconstriction by unloading peripheral chemoreceptors and reducing their contribution to the 
reflex activation of MSNA (386, 387). Although this cannot be completely ruled out, the 
observation that ∆ CVR was attenuated to similar extent with 40% O2 and COX inhibition 
supports the contribution of O2-dependent COX products to exercise-evoked reflex 
167 
 
vasoconstriction. Moreover, if hyperoxia were the sole factor responsible for attenuating 
peripheral sympathetic activity, reflex vasoconstriction during PECO with 40% O2 would not have 
increased over time (3 min vs. 3 min 45 s; Figure 5.7). 
It may be noted that in an apparent contrast with the present results, Houssiere et al. reported 
that breathing 100% O2 throughout isometric handgrip at 30% MVC augmented the evoked 
increase in systemic MABP and MSNA (peroneal nerve) (183). Further, Seals et al. showed that 
breathing 100% O2 decreased MSNA at rest but not the increase evoked by rhythmic handgrip 
exercise (0.5 Hz; 50% MVC) (361). However, breathing 100% O2 has been shown to increase 
ROS generation and to decrease baseline blood flow and vascular conductance at least in part 
by decreasing the vasodilator contributions of NO and PGs (75, 256). Moreover, centrally-
generated and reflex changes in sympathetic activity are known to be influenced by ROS 
molecules (51). Therefore, it seems likely that the effects of 100% O2 on exercise-evoked 
increase MSNA reported by Houssiere et al. (183) and Seals et al. (361) reflect the combined 
outcome of increased ROS concentrations acting centrally and peripherally.  
If it is assumed that breathing 40% O2 in the present study did not increase ROS generation, the 
most obvious interpretation of the results is as hypothesised that O2-dependent PGs that are 
released in the contracting forearm, stimulate muscle afferents, including mechano and 
metaboreceptors to contribute to the reflex increase in MSNA that causes vasoconstriction in the 
resting calf. The issue of whether 40% O2 generates ROS is addressed in Chapter 8. 
In summary, Chapter 4 showed that PG production during exercise is O2-dependent. The results 
of the present Chapter extend these observations to provide indirect evidence that COX products 
released during handgrip contraction contribute to reflex vasoconstriction in the ipsilateral leg in 
an O2-dependent manner. Therefore, the hypotheses proposed are accepted. 
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5.4.3 Limitations and Future Work 
The principal limitation to this study is that the conclusions are based only on evoked changes in 
CVR. Although, Chapter 4 shows that the production of vasodilator PGs in the exercising limb is 
indeed O2-dependent, nonetheless, had venous samples been taken in the present study, they 
could have shed light on actual concentrations of PGs and TXs in both the exercising and resting 
limbs. Moreover, as this study proposes that the observed vasoconstriction response was a 
reflection of an attenuated exercise-evoked increase in MSNA; neural recordings from the resting 
leg (peroneal) during NO PECO and PECO would have further elucidated the role of O2-
dependent COX products to exercise-evoked vasoconstriction in the resting muscles. Any future 
studies should address these issues. 
Lastly, it was observed that the increase MABP and ∆ CVR decreased following cessation of 
voluntary isometric exercise during PECO. Nonetheless, they still remain elevated during post-
exercise PECO compared to the post-exercise NO PECO; reflecting the contribution of 
metaboreceptors and perhaps some minor contribution from the metabolite sensitized 
mechanoreceptors (79, 267, 347, 372). However, had the protocol been repeated with additional 
electrically-stimulated muscle contractions, such experiments would have separated the 
contribution of central command from the mechano- and metaboreceptor contributions of the 
observed responses during exercise. These additional experiments would have helped further 
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The results of previous two Chapters raised a number of questions. 
It was discussed previously that exercise was associated with a decline in intra-muscular (337-
339) and peri-venular (226) PO2. As the release of PGs is associated with both, the decline in 
PO2 (45, 46, 264, 266) and exercise (198, 199, 302, 390, 435), it seemed logical that the 
exercise-related increase in vasodilator PGs might be O2-dependent. The results of Chapter 4 
indeed showed that to be true; the venous efflux of both PGE2 and PGI2 evoked by either 
rhythmic or isometric handgrip contractions performed at 60% MVC was O2-dependent. 
However, these observations raised questions regarding tissue oxygenation / local circulation 
under the treatment conditions. The profound decline in muscle oxygenation from ~ 34 to ~ 3 
mmHg observed by Richardson et al. occurred within a few seconds of dynamic knee-extension 
exercise in both trained and untrained individuals (337-339). However, when muscle contraction 
is isometric in nature, an exercise model which is traditionally understood to compromise tissue 
perfusion (22, 234), more questions are raised regarding the local tissue oxygenation / perfusion 
during this period. Such exercise might be expected to further enhance the decline in local tissue 
oxygenation. However, the results of Chapter 4 failed to observe any major difference in the 
efflux of O2-dependent PGE2 and PGI2 between the two exercise types. This must imply that 
besides an increase in muscle-metabolism / VO2 (211), tissue perfusion increases during 
isometric exercise such that it provides adequate oxygenation for the period of exercise. 
Fordy and Marshall had noticed attenuation in the post-exercise hyperaemia of isometric 
contraction with 40% O2 only when it was breathed during the period of exercise (123). 
Moreover, as lactate efflux was attenuated if subjects breathed 40% O2 during isometric 
exercise, their results not only imply that tissue perfusion is relatively maintained during isometric 
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exercise but in contrast to the earlier conclusion, this hyperaemia is not sufficient to meet the 
demands to tissue oxygenation. Together with the results of Chapter 4 it can be assumed that 
40% O2 alleviates this “decline” in tissue oxygenation. However, if the influence of 40% O2 on 
attenuating exercise-related PG production is to be better understood, this relationship clearly 
needed further investigating. 
A separate question is raised regarding the affect of COX inhibition on tissue oxygenation and 
local circulation. COX inhibitors attenuate exercise and post-exercise hyperaemia (73, 74, 100, 
209, 437), an effect that by itself would be expected to cause an even greater decline in tissue 
oxygenation, than during air breathing conditions. Some evidence for this assumption lies in the 
observation that vasoconstriction brought on by vasopressin and noradrenaline is associated 
with an increase in arteriolar VO2 (443). However this issue is complicated by the observations 
that COX inhibition attenuates skeletal muscle mitochondrial respiration (28, 222, 270, 281). 
Therefore, if exercise-related O2-dependent production of COX products is to be understood, the 
impact of COX inhibition on isometrically exercising muscle’s oxygenation / VO2 and its perfusion 
clearly warrant investigation. 
Lastly, the results of Chapter 4 showed that despite some decline in the contribution of PGE2 and 
PGI2 to exercise hyperaemia with aging, their venous efflux was not attenuated. This is a 
particularly interesting observation considering the age-associated change in the predominance 
of skeletal muscle fibre types (i.e., change in the proportion and/or size of fibres favouring slow-
oxidative type) (408). Aniansson et al. (8) recorded no change in the vastus-lateralis and biceps-
brachii enzymatic activity of triose-phosphate-dehydrogenase, 3-hydroxy-CoA-dehydrogenase, 
and citrate-synthase in older men who remained active over the years. This suggests that under 
the particular circumstances of isometric exercise, VO2 of healthy recreationally active older 
individuals ought to be greater. This is supported by the Kime et al. who noticed that the 
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exercise-related VO2 was greater in oxidative fibres (211). However maintenance of the 
predominance of type-1 fibres with age, even in legs, is not a consistent finding (129). 
Separately, it is unclear whether age itself equally affects the activity patterns of human arms 
and legs, but aging has been correlated to the decrease in activity / preference of the dominant 
arm, compared to the non-dominant one (197). Therefore, it is possible that age-associated 
decline in activity is not just restricted to legs; a hypothesis indirectly supported by the 
observation that in men, age associated decline in unit muscle mass strength occurs similarly in 
arms and legs (240). Therefore, if O2-dependent production of vasodilator PGs is to be better 
appreciated in older, recreationally active individuals, the effect of exercise on local oxygenation 
and tissue perfusion required investigation.  
The results of Chapter 5 also raised their own questions that require addressing. It is clear from 
previous studies that metabolites, particularly COX products stimulate the mechano and 
metaboreceptors to elicit reflex increase in sympathetic vasoconstriction (207, 261, 262, 267, 
347, 372). However, the results of the previous two Chapters indicate that the COX products of 
exercise are produced in an O2-dependent manner and then elicit an O2-dependent reflex 
vasoconstriction response, at least in young men. These results raise a question regarding the 
tissue perfusion profile in resting muscles going through the exercise-evoked vasoconstriction. 
Another question is raised regarding the exercise-evoked vasoconstriction in healthy older men. 
Studies have indicated that plasma concentrations of noradrenaline (sympathetic 
neurotransmitter) increase with age (190, 446), raising the possibility there may be an age-
related exaggeration in the exercise pressor reflex. For example, Taylor et al. noticed that during 
dynamic cycling exercise at 45, 65, and 85% VO2-max, the vasoconstriction evoked in the 
forearm and the venous efflux of noradrenaline were greater in older than younger men (399). 
Similarly, Momen et al. showed that fatiguing isometric handgrip contractions at 40% MVC led to 
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an increase in renal vascular resistance in older subjects that was two-fold greater than that 
observed in young subjects; application of PECO maintained ~ 50% of this response (275, 276). 
However, other investigations have revealed conflicting results. Roseguini et al. observed no 
difference in the calf vasoconstriction evoked by 30% MVC isometric handgrip between young 
and older men (342) while Ng et al. failed to observe any age-related difference in the unit 
increase in MSNA evoked by fatiguing isometric handgrip at 40% MVC (299). On the other hand, 
Markel et al. observed attenuated increases in peroneal MSNA in older individuals compared 
with young, when they performed incrementally ischemic rhythmic handgrip contractions at 30% 
MVC (247). 
It is possible that the results obtained in some of these studies reflect the intensity-dependent 
production (29, 198, 447) of mechano / metaboreceptor stimulating (207, 262, 267, 347) COX 
products. Indeed, Hansen et al. also showed that in contrast to rhythmic handgrip exercise 
performed at 45% MVC, lower intensity contractions did not evoke sympathetic activation in 
peroneal nerve (158). Thus, it may be that the presence or magnitude of a mechano / 
metaboreceptor-mediated exercise pressor reflex in the elderly is dependent on the intensity of 
exercise performed. Therefore, extending the results of Chapter 5, the study described in this 
Chapter sought to investigate the contribution of O2-dependent factors and COX products to the 
vasoconstriction evoked by isometric handgrip contractions performed at 60% MVC in both age 
groups. 
6.1.1 NIRS 
Over the years NIRS has become an important tool for measuring tissue perfusion and 
oxygenation in a non-invasive manner. The technique was forged in 1930s by Millikan who 
developed the dual-wavelength oximeter for muscles (268) and Jobsis who noticed the 
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differential absorption of light by haemoglobin (189). The principle of the technique is similar to 
the conventional photo-plethysmography, pulse-oximetry and laser-Doppler; calculations are 
made based on the difference between emitted and detected light which reflects the property / 
quantity of the absorbing material. The range over which NIRS operates is between 700 - 1100 
nm, allowing deeper penetration of photons into the tissue (189, 292). Importantly, it is within this 
range that haemoglobin and myoglobin are detected; their concentration and oxygenation state 
determines light absorption (i.e., the difference between emitted and detected light) (292). The 
principal mathematical foundation for the technique is the Beer-Lambert law; light passing 
through a compound is absorbed, decreasing the intensity of the detected light (152, 292, 308). 
However as light is also scattered in tissue and the exact path-length of a photon is not always 
known, the NIRS equipment uses algorithms of modified Beer-Lambert law (308). The modern 
NIRS machines such as the one used in the present study (NIRO 200NX; Hamamatsu 
Photonics) also employ spatially-resolved spectroscopy, method which reliably measures the 
relative concentrations by using the two light detection probes that are a known distance apart 
from one another (152). In the present study, the light emission and detection probes used were 
4 cm apart and as the penetration depth of the NIRS light is roughly half the distance between 
them (152, 416), this allowed for penetration depth of ~ 2 cm. Recordings were made of the 
tissue oxygenation index (TOI) which reflects tissue O2 saturation, total haemoglobin index (THI) 
which provides an index of local blood flow and deoxy-haemoglobin (HHb) which reflects tissue 
O2 uptake (145, 427).  
6.1.2 Aims and hypotheses 
Apart from examining the effect of the physical act of contraction on muscle perfusion; the 
present study investigated the affect of interventional treatments on muscle haemodynamics and 
tissue oxygenation during a period of isometric handgrip contraction performed at 60% MVC. 
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The effect of such isometric contraction on exercise-evoked vasoconstriction in young and older 
men has not been compared. Thus, the study also investigated the contribution of O2-dependent 
COX products to this vasoconstriction in the contralateral (resting) arm in both age groups. 
Firstly, in relation to the results of Chapter 4, we hypothesized that 40% O2 and aspirin would 
similarly attenuate the hyperaemia that occurs during isometric handgrip contraction in both age 
groups, but would perhaps have different effects on tissue oxygenation; i.e., VO2 responses 
during COX inhibition would be attenuated despite a decrease in tissue perfusion. Moreover, we 
hypothesized that isometric handgrip contractions at 60% MVC does not completely occlude the 
muscle perfusion of the contracting muscle in either age group. Lastly, we hypothesized that 
despite different tissue oxygenation profiles, exercise-evoked vasoconstriction in resting arms of 




Ten young (18 – 25 years) and eleven older (65 – 78 years) men were recruited; all were 
recreationally active non-smoking adults (two older subjects quit smoking over forty years ago). 
Medication history included occasional use of salbutamol by two young subjects, occasional use 
of cetirizine by one older subject, and the use of statins and low-dose aspirin by two older men. 
Supplemental medications included use of multivitamins by two older subjects, glucosamie by 
one older subject while seven young and ten older men reported consuming either oily-fish or 
fish-oil supplements at least once a week. All subjects were required to adhere to dietary, 
medicinal, and exercise restrictions previously described in Chapter 2 (See Section 2.1): older 
subjects on statins and low-dose aspirin voluntarily offered and agreed to go without medication 
for 10 days prior to experiments. Subjects were also asked to stop taking multivitamins / fish-oil 
for at least 7 days prior to the experiments. Administration of air or 40% O2, and placebo or 
aspirin along with measurements of MVC, TTI, HR, MABP, FBF, and FVC were done as 
described in Chapter 2.  
6.2.1 Protocol 
Subjects visited the laboratory on three occasions. The initial visit was used to complete the 
health and activity questionnaire, consent form, to familiarize the subject with the experimental 
protocol, and to record the subject’s MVC (See Section 2.3). The following two experimental 
visits were carried out in a single-blind, partially randomized manner: the randomized visits were 
placebo (P) and aspirin (A); with the 40% O2 always following the air breathing handgrip trial 
(See Figure 6.1 for protocol’s schematic). 
On experimental days, handgrip dynamometer was set up for the subject’s MVC. On arrival, the 
subject consumed the treatment drink (P or A; 600 mg). This dose of aspirin has previously been 
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shown to affectively inhibit the COX enzyme for 30 – 90 min (161). After cleaning the skin with 
alcohol wipes and allowing the area to dry, NIRS probes were then placed on the cleaned 
forearm sites over flexor digitorum-superficialis of both exercising and resting arms to record 
local muscle oxygenation and hemodynamic responses: black plastic sheets were used to 
protect the probes from external light (Figure 6.2 and Figure 6.3). The recording equipment for 
HR and MABP was then connected to the subject’s non-dominant hand (See Chapter 2). After ~ 
25 min of rest, the facemask was put on the subject to deliver medical air and made secure with 
elastic-straps around the head. The subject was asked to breathe normally and after 5 min, they 
performed isometric handgrip contractions for 2 min at 60% MVC. Following the cessation of 
exercise, the recordings of systemic cardiovascular and muscle hemodynamic variables were 
continued for a further 2 min. Gas flow was then ceased and the facemask was removed; the 
subject rested for a further 25 min. Following this, gas flow of 40% O2 was turned on and after 5 
min was followed by a comparable isometric handgrip contraction. Post-exercise responses were 
again measured for a further 2 min; following which all recording equipment was disconnected. 
The subject rested for 5 – 10 min before leaving the lab. Figure 6.4 shows an example of NIRS 
and ABP trace recordings while a subject performed isometric handgrip exercise at 60% MVC for 
2 min. 
6.2.2 Statistical analysis 
NIRS and TTI data were collected in 5 s sections; THI and HHb reflect relative changes from an 
arbitrary point-zero (0 s), which lies immediately prior to the start of 1 min of baseline recording. 
TOI was expressed in percentage where 1 V represents 100% saturation, THI was expressed in 
arbitrary units (AU) where 1 V represents 1 AU, and HHb was expressed in µmol.cm where 1 V 
of NIRS signal represents 200 µmol.cm. TTI of the full 2 min of contraction was also collected as 
explained earlier. Factorial mixed-model ANOVA was used to identify time, treatment, forearm, 
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age, and their interaction effects. The data of each treatment condition were also individually 
analyzed using 1-way repeated measures ANOVA to detect within time effects. Once a 
statistically significant effect was detected, Tukey’s HSD was used as a post-hoc test to detect 





Figure 6.1 Schematic diagram of the protocol. Initial ↓ (orange) represents the consumption of 
treatment drink (P or A), black ↓ represents the duration during which cardiovascular and 
hemodynamic responses were measured (1 min baseline, 2 min during exercise, and 2 min post-
exercise); air treatment always preceded the 40% O2 trial (blue). Gas flow through the mask was 
always turned on 5 min prior to the start of isometric handgrip contractions (60% MVC; 2 min). 
 
Figure 6.2 Arrangement of the NIRS probes (upper and lower panel). NIRS probes (A) were 
placed over the flexor digitorum-superficialis on both exercising and resting forearms. Isometric 
handgrip contractions (60% MVC; 2 min) were performed using a handgrip dynamometer (B) 
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Figure 6.3 Experiment setup showing the arrangement of the equipment. Subjects 
performed isometric handgrip contraction using their dominant hand (A) while MABP and HR 
were recorded from contra-lateral hand (B); both arms rested at the level of the heart. Voltage 
monitor (C) was used as a visual aid to help with the generating and maintain the appropriate 
level of force. Muscle hemodynamic responses were measured using NIRS; probes were 
covered using black sheets (D). Air or 40% O2 were delivered via facemask (E) to keep the 










Figure 6.4 An original trace showing NIRS, isometric handgrip exercise tension, and ABP. This example raw trace shows NIRS (TOI, THI, and 
HHb) traces from the exercising and resting forearm (flexor digitorum-superficialis) while the subject performed isometric handgrip contraction at 60% 
















Anthropometric data of the young (22.30±0.65 years) and older (71.64±1.54 years) men are 
shown in Table 6.1. 
Average MVC is shown in Table 6.1; all subjects performed handgrip contractions for the 
required 2 min. TTI was not affected by time and/or treatments (Figure 6.5) but the TTI of older 
men was lower than young men (Figure 6.5). HR and MABP increased with exercise; after 
cessation of contraction, HR returned to baseline quicker than MABP. Baseline HR and MABP 
were not affected by treatments in either age group but the absolute increase in HR and MABP 
was less in older men after aspirin (Table 6.2). 
6.3.1 Exercising arm 
Changes in TOI, THI, and HHb of young and older men performing isometric handgrip 
contractions are shown in Figure 6.6 and Figure 6.7 respectively. In young men, at the onset of 
contraction there was an immediate decrease in TOI to reach its lowest level at ~ 35 s and a 
concomitant increase in HHb to reach a peak at ~ 1 min 15 s; both variables remained more or 
less steady after that during contraction and returned towards their baseline after cessation of 
contraction. The exercise-related decrease in TOI and the increase in HHb were similarly 
attenuated by interventional treatments and were significantly different from placebo (Figure 6.6). 
THI increased gradually during the period of isometric contraction indicating increased muscle 
perfusion and remained elevated during the 2 min of post-contraction. All three interventional 
treatments similarly attenuated this increase (Figure 6.6).  
In older men, onset of contraction decreased TOI, reaching its lowest point at ~ 45 s while HHb 
peaked around ~ 1 min 10 s; the values remained stable for rest of the contraction and similar to 
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that seen in young, only returned back to baseline after contraction ceased (Figure 6.7). 
Similarly, the decrease in TOI and the increase in HHb were equally attenuated by all three 
treatments. The THI responses were also similar to those recorded in young. However these 
changes were smaller than in young subjects (Figure 6.7). 
6.3.2 Non-exercising arm 
The changes in TOI, THI, and HHb of non-exercising arm of young and older men are shown in 
Figure 6.8 and Figure 6.9 respectively. Under placebo, muscle contraction decreased THI in the 
contralateral arm of young men, indicating decreased muscle perfusion; this response became 
significantly different from its respective baseline at ~ 20 s into the handgrip contraction and was 
similarly attenuated by the interventional treatments (40% O2, aspirin, and their combination). 
During this period, VO2 also decreased, reflected by a decrease in HHb values while TOI 
showed a parallel increase.  
In older men, handgrip contraction was also accompanied by a small decline in muscle perfusion 
of the non-exercising arm and this was attenuated by the 3 treatments (Figure 6.9). However, 
when compared to the response seen in young men, this decline in muscle perfusion was 
significantly smaller even though the older men were performing the same relative-intensity (i.e., 
60% MVC) contractions (Figure 6.9). There was also a small decrease in HHb which was 




Table 6.1 Anthropometric data of young (n=10) and older (n=11) men. 



































25 54 1.67 19.36 245 24 24 68 67 1.83 20.01 196 24 24
22 81 1.81 24.72 275 27 27 66 73 1.83 21.80 275 26 26
25 79 1.8 24.38 314 27 27 78 64 1.82 19.32 118 23 23
21 67 1.76 21.63 226 23 23 68 77 2.03 18.69 147 26 26
18 62 1.76 20.02 235 23 23 65 93 1.92 25.23 157 29 29
23 70 1.8 21.60 314 26 26 76 77 1.8 23.77 324 25 25
22 90 1.92 24.41 177 26 26 77 61 1.71 20.86 177 24 24
23 86 1.87 24.59 294 26 26 76 89 1.88 25.18 196 28 28
21 67 1.75 21.88 343 26 26 66 75 1.76 24.21 255 27 27
23 80 1.8 24.69 216 26 26 76 74 1.75 24.16 167 27 27
72 88 1.91 24.12 255 27 27
Mean 22.30 73.60 1.79 22.73 263.89 25.40 25.40 71.64 76.18 1.84 22.49 206.01 26.00 26.00




Figure 6.5 TTI recorded for isometric handgrip contractions performed by young and older 
men. Placebo is represented in blue while 40% O2 is red, aspirin is green, and their combination 
(A+O2) is purple. No treatment effect was detected but † represents significant difference 
between age groups. All subjects performed handgrip contraction for the full 2 min. 
Young TTI (N s)
P 17835.86 ± 1389.47
40% O2 18454.49 ± 1234.76
A 18242.75 ± 1180.13







































Older ‡ TTI (N s)
P 15381.39 ± 1454.59
40% O2 14879.49 ± 1393.82
A 15332.38 ± 1510.51




Table 6.2 HR and MABP recorded from young and older men. No treatment effect was detected between placebo, 40% O2, aspirin, and A + O2; * 
represents significant difference from respective baseline; ‡ represents difference between age groups (P < 0.05). 
Age Treatment
Baseline Exercise Post Exercise Responses P Value
(Within)- 60 s 5 s 30 s 60 s 90 s 120 s 125 s 150 s 180 s 210 s 240 s
Young
HR (b min-1)
P 61 ± 3 76 ± 4 * 76 ± 7 * 76 ± 5 * 80 ± 6 * 82 ± 4 * 68 ± 2 57 ± 2 57 ± 2 57 ± 2 52 ± 5 * < 0.001
40% O2 60 ± 2 75 ± 5 * 76 ± 6 * 78 ± 5 * 77 ± 6 * 88 ± 5 * 71 ± 3 55 ± 1 55 ± 2 51 ± 4 56 ± 3 < 0.001
A 61 ± 3 74 ± 4 * 79 ± 4 * 80 ± 5 * 85 ± 4 * 82 ± 6 * 66 ± 5 55 ± 5 58 ± 4 59 ± 3 59 ± 3 < 0.001
A + O2 59 ± 2 73 ± 5 * 82 ± 5 * 84 ± 4 * 88 ± 5 * 90 ± 9 * 75 ± 6 * 52 ± 4 53 ± 2 56 ± 3 52 ± 5 < 0.001
P Value Treatment = 029               Time*Treatment = 0.69
MABP 
(mmHg)
P 79 ± 2 83 ± 2 95 ± 3 * 106 ± 4 * 114 ± 4 * 127 ± 7 * 115 ± 8 * 86 ± 4 * 86 ± 4 * 86 ± 4 * 87 ± 5 * < 0.001
40% O2 84 ±2 87 ± 3 100 ± 4 * 112 ± 4 * 122 ±5 * 132 ± 4 * 117 ± 3 * 91 ± 2 * 91 ± 3 * 91 ± 3 * 90 ± 2 < 0.001
A 80 ± 3 89 ± 3 * 96 ± 3 * 108 ± 4 * 120 ± 4 * 132 ± 5 * 116 ± 5 * 90 ± 4 * 89 ± 4 * 88 ± 4 * 86 ± 3 < 0.001
A + O2 87 ± 4 93 ± 3 103 ± 3 * 117 ± 4 * 126 ± 4 * 131 ± 11 * 118 ± 7 * 96 ± 5 * 93 ± 4 93 ± 4 93 ± 4 < 0.001
P Value Treatment = 0.08              Time*Treatment = 0.96
Older ‡
HR (b min-1)
P 62 ± 4 67 ± 5 68 ± 4 * 69 ± 4 * 70 ± 4 * 69 ± 3 * 64 ± 3 62 ± 4 62 ± 3 65 ± 2 62 ± 3 < 0.05
40% O2 60 ± 4 65 ± 2 67 ± 3 68 ± 3 * 69 ± 5 * 71 ± 4 * 64 ± 2 60 ± 3 61 ± 3 60 ± 3 61 ± 3 0.002
A 64 ± 2 70 ± 2 * 68 ± 5 68 ± 3 * 72 ± 2 * 70 ± 3 * 64 ± 3 61 ± 2 60 ± 2 59 ± 3 60 ± 4 0.001
A + O2 61 ± 3 68 ± 2 * 66 ± 3 66 ± 5 68 ± 4 * 69 ± 3 * 63 ± 4 62 ± 3 63 ± 4 60 ± 3 59 ± 5 < 0.05
P Value
Treatment = 0.26 ‡ Age = <0.001
Time*Treatment = 0.84 Age*Treatment = 0.83
MABP 
(mmHg)
P 87 ± 5 97± 4 99 ± 4 * 104 ± 4 * 109 ± 5 * 109 ± 6 * 105 ± 5 * 89 ± 4 88 ± 3 91 ± 3 90 ± 4 < 0.001
40% O2 92 ± 4 97 ± 4 103 ± 4 * 107 ± 5 * 112 ± 7 * 116 ± 7 * 110 ±8 * 94 ± 5 96 ± 5 93 ± 5 94 ± 4 < 0.001
A 89 ± 4 96 ± 3 * 98 ± 4 * 98 ± 5 * 105 ± 6 * 110 ± 6 * 103 ± 7 * 87 ± 3 89 ± 3 88 ± 3 88 ± 4 < 0.001
A + O2 88 ± 4 94 ± 4 * 96 ± 5 * 100 ± 4 * 108 ± 6 * 115 ± 7 * 110 ± 7 * 93 ± 5 91 ± 4 93 ± 4 92 ± 5 0.002
P Value
Treatment = 0.06 ‡ Age = 0.02




Figure 6.6 Changes in TOI, THI, and HHb recorded from exercising arm of young men. 
Placebo is represented in blue, 40% O2 is red, aspirin is green, and their combination (A+O2) is 
purple. */†/‡/§ represents time effect for placebo, 40% O2, aspirin, and A + O2 (i.e., vs. respective 










































Treatment = < 0.001
Time*Treatment = 0.001
Treatment = < 0.001
Time*Treatment = < 0.001





Figure 6.7 Changes in TOI, THI, and HHb recorded from exercising arm of older men. 
Placebo is represented in blue, 40% O2 is red, aspirin is green, and their combination (A+O2) is 
purple. */†/‡/§ represents time effect for placebo, 40% O2, aspirin, and A + O2 (i.e., vs. respective 

















































Age = < 0.001
Age*Treatment = 0.03
Treatment = < 0.001
Time*Treatment = 0.004
Age = 0.82
Age*Treatment = < 0.001
Treatment = 0.03
Time*Treatment = 0.001





Figure 6.8 Changes in TOI, THI, and HHb recorded from non-exercising arm of the young 
men. Placebo is represented in blue, 40% O2 in red, aspirin (A) is shown in green, and their 
combination (A+O2) in purple. */†/‡/§ represents time effect for placebo, 40% O2, aspirin, and A + 















































Arm = < 0.001
Arm*Treatment = < 0.001
Treatment = < 0.001
Time*Treatment = 0.001
Arm = < 0.001
Arm*Treatment = < 0.001
Treatment = < 0.001
Time*Treatment = 0.001
Arm = < 0.001




Figure 6.9 Changes in TOI, THI, and HHb recorded from non-exercising arm of the older 
men. Placebo is represented in blue, 40% O2 is red, aspirin is green, and their combination 
(A+O2) is purple. */†/‡/§ represents time effect for placebo, 40% O2, aspirin, and A + O2 (i.e., vs. 














































Arm*Treatment = < 0.001




Arm = < 0.001
Arm*Treatment = < 0.001
Age = 0.003
Age*Treatment = 0.03
Treatment = < 0.001








This study produced several novel findings. Firstly, isometric handgrip contraction at 60% MVC 
for 2 min does not occlude muscle perfusion in either age group. Secondly, as the treatments 
similarly attenuated the increase in perfusion during contraction, this study showed for the first 
time that O2-dependent COX products are involved in the exercise hyperaemia that occurs 
during isometric handgrip contraction in both age groups. Concerning the non-exercising arm, 
this study shows that the exercise-evoked vasoconstriction in the resting arm was similarly 
attenuated by COX inhibition or 40% O2. Thus, O2-dependent COX products are involved in the 
exercise-evoked vasoconstriction in both young and older men. Lastly, as TOI and HHb 
responses increased while THI was in decline in the non-exercising (resting) arm, this study has 
also unexpectedly revealed that isometric exercise decreases muscle metabolism (i.e., VO2) in 
the resting arm during exercise. 
6.4.1 Responses in the exercising arm of young men 
Studies in the past have suggested that isometric handgrip contractions at 20% MVC decrease 
muscle perfusion (234), while at around 60% MVC they can completely occlude flow (22). 
However, our group have in the past observed attenuation in post-exercise hyperaemia with 40% 
O2 when isometric contractions have been performed at 60 (437) or 100% (123) MVC, 
suggesting the presence of some muscle perfusion. Indeed, the fact that attenuation of post-
exercise hyperaemia with 40% O2 occurred only if it were breathed during exercise suggests this 
(123). Moreover the Doppler-ultrasound data from Kagaya and Homma shows that the brachial 
artery blood flow increased to the same level during isometric handgrip contractions of different 
incremental intensities (i.e., between 10 – 70% MVC); implying some restriction on blood flow, 
but no indication of occlusion (196). The THI results of the present study show that muscle 
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perfusion is not only maintained during isometric handgrip contraction of 60% MVC, but also 
shows a constant / persistent increase in perfusion (i.e., exercise hyperaemia). These 
observations were made from NIRS probes that were placed over the flexor digitorum-
superficialis, but as the NIRS light used in this study penetrated ~ 2 cm of tissue (152), it can be 
reasonably proposed that isometric handgrip contractions at 60% were accompanied by a 
hyperaemic response. Importantly, this does not signify completely unhindered muscle perfusion, 
but just an overall increase during 60% MVC isometric contraction. 
These same recordings showed that isometric exercise is accompanied by a profound decline in 
tissue oxygenation with a substantial increase in muscle VO2 (indicated by a simultaneous 
increase in HHb). This observation agrees with Van-Beekvelt et al. who also observed a 
substantial increase in muscle VO2 evoked by only 10% MVC isometric handgrip contractions 
(416). However as the THI kept increasing considerably while the HHb stabilised at ~ 1 min, this 
suggests continuous increase in muscle VO2 during exercise. Previous studies of our group 
(123, 437), including those of Chapter 4, indicated that 40% O2 supplied during isometric 
handgrip exercise ameliorated tissue oxygenation and thereby, attenuated the exercise / post-
exercise hyperaemia. The results of the present Chapter show that to be true as not only was the 
increase in THI attenuated by 40% O2 but tissue oxygenation also improved; the fall in TOI 
decreased, accompanied by an attenuated increase in HHb. It is possible that the attenuated 
increase in HHb observed with 40% O2 was the result of decreased VO2. However, there is no 
reason to believe that 40% O2 per-se would decrease VO2 in the exercising muscle when a 
similar amount of isometric work was performed between placebo and O2 trials. 
It was also suggested in the introduction to this Chapter that COX inhibition might augment the 
decline in tissue oxygenation by attenuating exercise hyperaemia. There was also a possibility 
that COX inhibition with aspirin would inhibit skeletal muscle metabolism (28, 222, 270, 281). The 
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results of the present study show an attenuated decline in TOI and increase in HHb; and 
therefore seem to favour the second possibility. However these explanations do not explain why 
the increase in HHb with combination of aspirin and 40% O2 was similar to their individual 
effects. Nonetheless, as the increase in THI was equally attenuated by the two treatments alone 
or combine, these results, with those of Chapter 4, strongly indicate that O2-dependent COX 
products are indeed mediating the exercise and post-exercise hyperaemia of isometric handgrip 
contraction. Moreover, the added observation of similar attenuation of the changes in THI and 
HHb suggests that COX products are released due to the decline in tissue oxygenation during 
isometric exercise, and that their production is inhibited by added O2 and separately by 
decreased metabolism secondary to COX inhibition with NSAIDs (28, 222, 270, 281). 
6.4.2 Responses in the exercise arm of older men 
Before discussing the responses obtained from older subjects, it is important to mention that 
although an age-related difference in the muscle mass can be expected, which might itself 
influence tissue perfusion through the exercising muscle; however, as shown in the 
anthropometric data (Table 6.1), the forearm circumference of subjects was not different 
between the age groups making the comparison between them relatively simple. 
The results obtained from the older men during placebo showed a similar increase in tissue 
perfusion during isometric handgrip contraction. However the magnitude of this response 
appears to be attenuated with increased age. Age is generally associated with a proportional 
shift towards oxidative muscle metabolism (408), which would decrease the concentrations of 
vasodilator metabolites of glycolysis. However the age-related increase in VO2 should produce 
more O2-dependent vasodilators. Therefore on this basis, the increase in HHb was expected to 
be greater than that observed in the young. However, some longitudinal studies have observed 
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an age-related decline in the VO2 kinetics (16, 23, 81), perhaps reflecting decreased O2 delivery 
to the working muscles as capillary to fibre ratio also declines with age (129). Moreover, Coggan 
et al. observed an age-related decline in the activity of succinate-dehydrogenase, citrate-
synthase, and β-hydroxyacyl-CoA-dehydrogenase in gastrocnemius samples of individuals who 
indulged in normal to low-intensity recreational activities (64). The discrepancy between the 
findings of Coggan et al. (64) and Aniansson et al. (8) perhaps reflects the activity status of their 
volunteers and indeed there is some evidence suggesting this; i.e., the age-related decrease in 
VO2 kinetics is limited to muscles that are normally inactive (61). These observations are in 
agreement with our findings and those of Bell et al. (23) in showing that supplementary O2 per-se 
does not improve VO2 in older individuals.  
Despite these observations it is clear from the present study that isometric handgrip contractions 
at 60% MVC do elicit some strain on the tissue oxygenation that is alleviated by 40% O2, such 
that the increase in THI is attenuated by supplementary O2. The effect of COX inhibition in older 
men on the exercise hyperaemia of isometric contraction was similar to that in young men. 
Therefore, the similar attenuation in THI during isometric handgrip exercise with the two 
treatments alone or combine, confirms, and extends the findings of Chapter 4. The finding that 
the magnitude of exercise hyperaemia that was attenuated with use of 40% O2 and/or COX 
inhibition is negatively affected by aging is also in agreement with conclusions of Chapter 4. 
6.4.3 Responses in the resting arm of young men 
In young men, isometric handgrip contractions evoked a decline in the perfusion of resting 
muscles which was similarly inhibited by 40% O2, aspirin, and their combination. These results 
not only show O2-dependent vasoconstriction in the resting contralateral arm but add to the 
results of Chapter 5 in showing for the first time that combination of aspirin and 40% O2 equally 
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attenuated the decrease in THI. The mechanism by which these later effects occur has already 
been the subject of discussion in the previous Chapter. 
The findings on O2 saturation, tissue perfusion, and HHb data obtained in the resting arm are of 
particular interest here (Figure 6.8). Despite a decrease in the THI of the resting arm under 
placebo condition, HHb values also declined sharply during contraction, reflecting an exercise-
related decrease in the VO2 of the resting muscles. Despite presence of some evidence in 
animals to suggest that VO2 is related to the O2 delivery; i.e., the decline in O2 delivery beyond a 
critical point leads to decrease in VO2 (107, 108, 355), the observations made in this study are 
independent of this relationship. This fall in HHb remained as such for the initial ~ 55 s of 
isometric exercise before starting to recover while THI was still in decline (See Figure 6.8). 
Importantly, the relationship between tissue oxygenation and sympathetic vasoconstriction has 
been the subject of investigation in previous studies. Hansen and colleagues evoked 
sympathetic vasoconstriction in the resting muscles by the use of lower body negative pressure 
and observed a decline in tissue oxygenation / perfusion; i.e., greater decline in oxygenated 
haemoglobin and some increase in HHb (59, 157, 158). Although this shows that tissue 
oxygenation declines with sympathetic vasoconstriction, VO2 is still maintained during this time, 
reflected by an increase in HHb. However, the relationship between tissue oxygenation of resting 
muscles during exercise and sympathetic vasoconstriction observed in this study is novel; it 
shows that the decline in tissue oxygenation / perfusion during exercise in resting muscles is 
accompanied by attenuation in its VO2. The exact reason for this attenuation at the moment is 
not known. However this decline in VO2 in the resting muscles is unrelated to O2 delivery; i.e., 
40% O2 does not inhibit this response. The finding that 40% O2 inhibited the decline in THI and 
only partly inhibited the decline in HHb may be a reflection of the fact that 40% O2 increased O2 
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availability to the working muscle fibres from plasma instead of being off-loaded from 
haemoglobin; rather than an attenuated decline in VO2 with 40% O2 per-se. 
However, COX inhibition which attenuated the decline in tissue perfusion during isometric 
handgrip contractions also resulted in a decrease in HHb suggesting a decrease in VO2. This 
was not completely surprising and could partly be explained by the effect of COX inhibition on 
muscle metabolism (28, 222, 270, 281). Although why the magnitude of this decrease in HHb 
was similar to that observed during placebo and why was the recovery was delayed is not clear. 
However, the combination of aspirin and 40% O2 alleviated the decline in HHb during exercise, 
but the effect of COX inhibition on HHb and presumably on VO2 was still evident; i.e., the 
recovery was delayed with COX inhibition. These observations indicate that the decline in VO2 is 
not just the result of inhibited muscle metabolism secondary to COX inhibition with NSAIDs but is 
a separate novel finding; a conclusion that is strengthened by the observation of increase in TOI 
exactly when HHb was declining. Therefore, these present findings indicate an isometric 
exercise-related / mediated decline in muscle metabolism of resting muscles which is 
independent of COX inhibition mediated decline in muscle metabolism; and that may be partially 
O2-dependent.  
6.4.4 Responses in the resting arm in older men 
Similar to young men, isometric exercise was accompanied by decrease in muscle perfusion of 
the resting arm of older men. However the data presented here shows that this vasoconstriction 
was less intense in the older group; thereby, contrasting with those who show an age-related 
increase in the pressor reflex (275, 276, 399). However, it should be noted that some 
researchers have observed results that are similar to those of the present study (247, 299). 
Moreover, α1-adrenergic vasoconstriction evoked by tyramine which stimulates endogenous 
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noradrenaline release is attenuated in healthy sedentary men (91). Therefore, this decrease in 
sympathetic vasoconstriction might be the reason for the age-related attenuation in the 
magnitude of exercise-evoked vasoconstriction observed in this study. 
Nonetheless, the observations of Markel et al. are particularly relevant; they used rhythmic 
handgrip contractions at 30% MVC with incremental ischemia of the exercising arm to investigate 
their effects on peroneal MSNA (247). Their results showed that while resting and non-ischemic 
MSNA were higher in older individuals, muscle ischemia attenuated MSNA in older individuals. 
This appears to contrast with the evidence showing metabolites stimulate group III and IV 
afferents (207, 261, 262, 347, 372); but they proposed that their response were a reflection of 
increased oxidative metabolism by the older skeletal muscles, or perhaps reflected a decreased 
VO2. Taken together with results obtained in the exercising arm of older individuals in the present 
study, it seems likely that their results and those presented here are explained by an age-related 
decline in VO2. This raises questions regarding the O2-dependent contribution of COX products 
to exercise hyperaemia and exercise-evoked vasoconstriction. Nonetheless, the data presented 
here show that the vasoconstriction evoked in response to isometric handgrip contraction of 
older men was similarly attenuated by 40% O2, aspirin, and their combination; thus, indicating a 
reflex vasoconstriction response that is mediated by O2-dependent COX products as in young 
men.  
However, if the exercise-related VO2 is different between both age groups, a question is raised 
regarding the similar efflux of O2-dependent PGE2 and PGI2 in young and older men (Chapter 4). 
The answer to this question perhaps lies in the observations made by Tang and Vanhoutte that 
the gene-expression of PGE2-synthase and prostacyclin-synthase along with other enzymes of 
COX pathway are all increased with age (396). Another consideration that needs bearing in mind 
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is that if the exercise-evoked efflux of O2-dependent COX products does not change with age (as 
shown in Chapter 4), their contribution to exercise-evoked vasoconstriction is attenuated. 
The present study further showed that although an exercise-related decline in VO2 of the resting 
muscles did occur in the older men, it was clearly also attenuated by age (See THI and HHb 
changes in young vs. old; Figure 6.8 and Figure 6.9). These observations have to be separate 
from the generalized decrease in VO2 kinetics of the older individuals, as firstly it does not 
explain the decrease in HHb of the resting arm during isometric exercise but further, it also fails 
to explain the responses in young men. Separately, but rather surprisingly, the exercise-related 
decline in VO2 of the resting arm of older men was completely inhibited by 40% O2, aspirin, and 
their combination. This observation lends its support to the idea that this decrease in VO2 of 
resting muscles is not similar to that observed with COX inhibition. 
In conclusion, the novel findings of the present study confirm that O2-dependent COX products 
are important mediators of exercise and post-exercise hyperaemia of isometric contraction and 
that of exercise-evoked vasoconstriction in resting muscles in both young and older men. 
However, their contribution to both exercise hyperaemia and vasoconstriction decreases with 
age. This study also presented novel findings that exercise is associated with a decrease in 
resting muscle’s metabolism; a response that in itself is attenuated with age. The hypotheses of 
this study are accepted. 
6.4.5 Limitations and Future Work 
A principal limitation of this study lies in the fact that NIRS does not distinguish between 
cutaneous and deeper perfusion / oxygenation profiles (177, 377-379). In fact, recently, 
Sørensen et al. have shown that ~ 30% of NIRS signals reflect cutaneous perfusion / 
oxygenation profiles (377, 378). This is despite the fact the spatially-resolved spectroscopy 
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suppresses the influence of surface layers (125). As the homogenous models used for 
development of NIRS equipment cannot fully account for the heterogeneous composition of the 
forearm, a possibility has to be considered that the responses observed and presented here 
reflect the combined responses of both cutaneous and muscular compartments. 
The observation that cutaneous sympathetic activity increases with exercise (232, 423, 424) then 
becomes an important issue, for it is possible that the NIRS responses of this study may have 
been influenced by cutaneous vasoconstriction caused by the increase in cutaneous sympathetic 
activity. However, firstly, it is important to mention that a comparison between the Fick method 
and NIRS technique showed that despite its limitations, NIRS is an effective tool for measuring 
perfusion and oxygenation / VO2 profiles in exercising muscle (416). Therefore, it seems fair to 
assume that despite some contamination from the surface layers, the data reported here do 
predominantly reflect responses of perfusion and oxygenation profiles of deeper muscle tissue. 
Secondly, the responses recorded in the resting arm during exercise of the contra-lateral arm are 
relevant, for Vissing et al. showed that the increase in cutaneous sympathetic activity that occurs 
during exercise is mainly attributable to central command, with little or no reflex contribution from 
the muscle metaboreceptors (423). Metabolites and COX products sensitize and/or activate both 
mechano- and metaboreceptors (3, 267, 347, 372), and as both O2 and COX inhibition 
attenuated the exercise-induced fall in THI in the resting arm, it is fair to assume that the 
observed response was predominantly reflex rather than central command in nature. In other 
words, it is likely the resting arm’s responses predominantly reflected vasoconstriction in muscle 
rather than skin; and that the interventions affected exercise-evoked vasoconstriction induced in 
skeletal muscle. This proposal / argument is supported by the observation that the decrease in 
resting arm’s THI increased overtime, becoming significantly different from baseline after ~ 15 to 
20 s of continuous isometric contraction (Figure 6.8). However, this proposal could be 
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investigated / elucidated by recording cutaneous perfusion with laser-Doppler flowmetry, for if 
any cutaneous vasoconstriction occurring in the resting arm persists during treatment with O2 or 
COX inhibition, then this would add weight to the idea that the NIRS data are attributable to 
responses in the skeletal muscle. A future study that incorporates recordings of both skin and 
MSNA, and uses NIRS equipment could also help clarify the contribution of O2-dependent and 
PG-mediated mechanisms to exercise-evoked vasoconstriction. 
Lastly, although the data presented here of exercising flexor digitorum-superficialis suggests 
hyperaemia rather than obstruction of tissue perfusion; however, it is possible that some 
perfusion was hindered. Thus, future work with combined use of Doppler-ultrasound with NIRS 




40% O2 attenuates exercise hyperaemia of twitch 


















Following the results of the previous three Chapters and the knowledge that adenosine has been 
implicated in the production of vasodilator PGs, questions arise regarding the O2-dependent 
nature of adenosine’s contribution to the exercise hyperaemia. 
The enzyme 5’nucleotidase produces adenosine intracellularly and on either side of the vascular 
wall (interstitial or intravascular) from its nucleotides (112, 164, 314, 315). Exercise increases 
interstitial and venous concentrations of adenosine which remain elevated during the initial 
minutes of post-exercise rest (18, 237). Ballard et al. electrically-evoked contractions (4 Hz) in 
dog gracilis-muscle while collecting samples from the arterial supply and venous drainage to 
assay for adenosine (18). They deduced that ~ 15% of the hyperaemia in the 1st min of exercise 
was dependent on adenosine’s vasodilator contributions. By the 5 th min, this contribution had 
reached ~ 40% and from then on remained stable. Moreover, adenosine was also a significantly 
important factor in the post-exercise hyperaemia (18). Using Wistar rats, Ray and Marshall 
reported similar exercise and post-exercise related vasodilator contributions of adenosine by 
observing the effect of selective inhibition of adenosine A2A-receptors (333).  
In humans, Hellsten et al. observed a near 5 fold increase in the concentrations of interstitial 
adenosine and its precursor nucleotides with 10 W knee-extension exercise; modest further 
increases with greater workload (~ 50 W) (165). Nonetheless, rate of increase in interstitial 
adenosine and blood flow were found to have a good correlation (r = 0.98); causally implicating 
adenosine in vasodilatation of exercise. The observation of modest increase in interstitial 
adenosine at higher workload however suggests that the contribution of other intensity-
dependent metabolites increases at these intensities; for example, vasodilator PGs (29, 198, 
447, 448). The results of the previous Chapters show that PGs work in an O2-dependent manner 
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to cause dilatation during exercise. Indirect evidence regarding adenosine leads to similar 
conclusions. For example, Costa et al. observed a larger increase in interstitial adenosine 
concentrations if 15% MVC handgrip contractions were performed under ischemia (70). 
Consistent with these results are the observations that venous efflux of adenosine is greatly 
increased during systemic hypoxia (71, 274). 
In addition, Mortensen et al. showed that in humans, the attenuation of exercise hyperaemia 
following combined NO and COX inhibition was not added to by further inhibition of adenosine-
receptors with theophylline (289). Although theophylline and aminophylline are weak adenosine-
receptor antagonists with no selectivity between receptor subtypes; and inhibit 
phosphodiesterase activity (249), Mortensen et al.’s (289) data did suggest that adenosine’s 
contribution to exercise hyperaemia may be mediated by or dependent on NO and/or PGs. 
Similar conclusions were reached by Nyberg et al. when they noticed that adenosine infusion in 
either interstitial or intravascular compartments increased concentrations of vasodilator PGs 
(306).  
Thus, taken together, questions are raised regarding the relationships between adenosine and 
PGs, their O2-dependency, and their importance during the early and later part of exercise 
hyperaemia. Moreover, it was appropriate to carry out this study on rats as this allowed strong 
competitive adenosine-receptor antagonists to be used. As indicated above, adenosine’s 
contribution to exercise hyperaemia is understood to be mediated by A2A-receptors rather than 
by any other adenosine-receptor (324, 333). Therefore an A2A-receptor inhibitor was used. 
7.1.1 Aims and Hypotheses 
This study aimed to investigate the direct and indirect relationship between tissue oxygenation, 
O2-dependent COX products and adenosine in relation to exercise-related vasodilatation. We 
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hypothesized that adenosine’s direct contribution to exercise hyperaemia is O2-dependent; i.e., 
supplementary O2 would ameliorate tissue oxygenation causing similar attenuation in exercise 
hyperaemia as that observed with adenosine-receptor inhibition. We also hypothesized that 





Experiments were performed on eight young male Wistar rats (252 – 300 g) in accordance with 
the UK legislation (Animals Scientific Procedures Act 1986): Home Office project license 
30/2894; personal license 40/10794. Anaesthesia was induced with Isoflurane (3.5% with O2); 
surgical level was marked by the absence of pedal withdrawal-reflex. A jugular vein was 
cannulated to deliver intra-venous Alfaxan (20 - 23 mg/kg/h) for the maintenance of anaesthesia; 
adequacy judged by absence of pedal withdrawal-reflex and stability of ABP (335). At the end of 
the experiment, animals were euthanized using an anaesthetic (Euthatal) overdose and 
confirmed by cervical dislocation. 
7.2.1 Surgical Preparation 
The surgical preparations used have previously been employed by our group (333, 335). Briefly, 
the rat breathed spontaneously via a cannula in the trachea; a t-tube connected to this allowed 
the percentage of inhaled O2 to be controlled (air or 40% O2). A cannula placed in the brachial 
artery was connected to a pressure transducer which was calibrated against a manual 
sphygmomanometer to monitor the ABP; MABP and HR were recorded online from this data. 
The right femoral artery was isolated, its blood flow (FABF) was measured continuously using a 
peri-vascular flow-probe (0.5 V; Transonic systems Inc.) connected to a flow-meter (TI06, small 
animal flow-meter; Transonic systems Inc.). The tail artery was cannulated for administration of 
pharmacological agents.  
The extensor digitorum-longus (EDL) was chosen for the study as the blood flow through this 
mixed-muscle is similar per gram of tissue as the whole hindlimb, both during rest and exercise 
(12). Moreover, our group have previously used it to show that the adenosine released during 
exercise, acts specifically on the A2A-receptors to induce vasodilatation (333). The right EDL was 
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isolated, tendons sectioned distally and attached to the isometric force transducer (TRI-201 
Letica Scientific, Spain) using an inextensible suture. The ankle was immobilized using a clamp 
so that the developed tension could be recorded; baseline level was 0.05 N (5 g). The right 
sciatic nerve was isolated, sectioned proximally, and attached to a hook-electrode. 
Data were collected on an Apple computer using Power-lab (AD Instruments, USA): femoral 
artery vascular conductance (FAVC) was derived online by dividing FABF by ABP. 
Approximately 60 min were allowed for stabilization before beginning of the experimental 
protocol. 
7.2.2 Protocol 
Maximal twitch of EDL was established by stimulating the sciatic nerve with increasing voltage (1 
– 6 V). Maximal twitch voltage at 4 Hz for 5 min (1200 pulses; pulse-duration 0.1 s) was used to 
evoke all muscle contractions. Our group’s previous work in rats has shown that when employing 
successive stimulations, the responses to the first stimulation differed from those evoked by 
subsequent stimulations (333, 335). Similar results were also obtained in cats (324). Therefore 
Stimulation-2 was used as the control (placebo) and was initiated 30 min after cessation of 
Stimulation-1. Simulation-3 was evoked ~ 35 min later following 5 min of breathing 40% O2 
through the tracheal cannula; and subsequent stimulations were all done during 40% O2 
supplementation. 30 min after cessation of Stimulation-3, the control cardiovascular responses to 
intra-vascular adenosine (1.2 mg/kg/min for 5 min) infusion were recorded; followed by A2A-
receptor inhibitor ZM241385 (0.05 mg/kg). 15 min later, A2A inhibition was confirmed by another 
intra-vascular infusion of adenosine. This was followed Stimulation-4. 15 min later, diclofenac 
was infused (1 mg/kg) for COX inhibition, and after further 20 min, Stimulation-5 was applied. 
These doses of pharmacological agents have previously been shown to be effective (331, 333, 
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335). Figure 7.1 and Figure 7.2 briefly show the schematic diagrams of the surgical preparation 
and experimental protocol. 
7.2.3 Statistical analysis 
Cardiovascular / hemodynamic data were averaged over 60 s. Adenosine infusion data are 
shown as 1 min pre-infusion, 5 min during, and 1 min post-infusion; while muscle contraction 
data are shown as 1 min before, 5 min during, and 7 min post-contraction. 2-way repeated-
measures ANOVA was used to identify time, treatment, and their interaction effects. Each 
treatment’s data were further analyzed using 1-way repeated measures ANOVA. Once a 
statistically significant effect was detected, Tukey’s HSD was used to detect the exact point of 





Figure 7.1 Schematic diagram of surgical preparations for protocol. 
 
 
Figure 7.2 Schematic diagram of the protocol. Stimulation-2 is the control stimulation (air + no 
pharmacological agents) while the subsequent stimulations were carried out under hyperoxia 
(40%; blue area). O2 supplementation was always started for 5 min before stimulation and 
carried out for 7 min while the post-contraction responses were being recorded. Orange ↓ 
represents adenosine infusion, green ↓ represents ZM241385 infusion and purple ↓ represents 
diclofenac infusion. Each stimulation lasted 5 min (4 Hz – 1200 pulses; 0.1 s). 
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Before examining the affects of different interventions on exercise hyperaemia, Figure 7.3 shows 
that adenosine A2A-receptor inhibition with ZM241385 substantially attenuated the increase in 
FAVC induced by intra-vascular adenosine infusion. 
Sciatic nerve stimulation at 4 Hz for 5 min produced rhythmic twitch contractions of the hindlimb. 
Table 7.1 shows that time and/or treatments did not influence the generated TTI. HR and MABP 
were also not affected by the treatments (Figure 7.4) and were maintained throughout, allowing 
FAVC conductance to follow the changes in FABF (Figure 7.5). Twitch contractions increased 
FABF and FAVC significantly under placebo conditions (Figure 7.5). This increase in FABF and 
FAVC both during and after hindlimb exercise was significantly attenuated by 40% O2; during 
exercise this attenuation was ~ 20% compared to control. The combination of hyperoxia and A2A-
receptor inhibition following ZM241385 administration did not add to the attenuation of the 
exercise-related increases in FABF and FAVC. Moreover, similar responses were observed 
following added COX inhibition with diclofenac. During Stimulations 4 and 5, the attenuation in 




Figure 7.3 Hyperaemia responses following intra-vascular adenosine infusion. FAVC 
increased with adenosine infusion under control condition (blue) but this increase was attenuated 
following A2A-receptor inhibition with ZM241385 (red). * represents significant interaction effect; 
includes all the data points within bracket. 
 
 
Table 7.1 TTI responses of rhythmic twitch contractions. Sciatic nerve was stimulated at 
maximum twitch contraction voltage at 4 Hz for 5 min. Neither time nor treatments had an effect 


























Placebo 4.52±0.56 4.60±0.45 4.62±0.46 4.60±0.43 4.44±0.45 0.93 22.73±2.22
40% O2 4.48±0.44 4.68±0.41 4.57±0.45 4.55±0.43 4.63±0.45 0.33 22.49±1.80
40% O2 + ZM241385 4.40±0.51 4.57±0.45 4.57±0.46 4.47±0.49 4.41±0.38 0.29 23.06±2.58
40% O2 + ZM241385 
+ Diclofenac
4.35±0.51 4.45±0.54 4.44±0.53 4.39±0.57 4.44±0.55 0.85 23.01±3.01
P Value





Figure 7.4 HR (upper panel) and MABP (lower panel) recorded before, during, and after 
rhythmic twitch contractions of the hindlimb. No treatment affect was detected between 
placebo (blue), 40% O2 (red), 40% O2 + A2A-receptor inhibition (green), and 40% O2 + A2A-



















































Figure 7.5 FABF (upper panel) and FAVC (lower panel) recorded before, during, and after 
rhythmic twitch contractions of the hindlimb. Placebo is represented in blue, 40% O2 is red, 
40% O2 + A2A-receptor inhibition is green, and 40% O2 + A2A-receptor inhibition + COX inhibition 
is shown in purple; FABF and FAVC increased with twitch contractions during all conditions. 
Interventional treatments equally attenuated FABF and FACV compared to placebo response. 
*/†/‡/§ represents time effect for placebo, 40% O2, 40% O2 + A2A-receptor inhibition, and 40% O2 









































Time = < 0.001
Treatment = < 0.001
Time*Treatment = 0.44
Time = < 0.001




















Our group have used a similar exercise protocol before in rats and showed that systemic and 
limb specific cardiovascular / hemodynamic responses of electrically-evoked EDL twitch 
contractions for 5 min each are not different between stimulations 2 to 5 (i.e., no time or 
stimulation effect was detected) (333, 335). Therefore, time control experiments were not 
performed in the present study. Moreover, TTI during stimulation-2 to stimulation-5 in the present 
study were consistently comparable with our group’s earlier work (333, 335). This allows for a 
simpler comparison between vascular responses evoked by different stimulations. As 
demonstrated in Figure 7.3, a substantial inhibition of the dilatation induced by adenosine 
infusion was achieved with the highly selective A2A-receptor inhibitor (ZM241385) (323). 
7.4.1 Exercise responses 
During placebo, by the end of low frequency twitch contractions, FAVC had increased by ~ 3 
fold; values that are comparable to that achieved in earlier work (18, 324, 333). Hyperoxia or the 
addition of pharmacological agents did not affect the baselines; and any exercise-related 
changes in HR and MABP were minor. However, hyperoxia attenuated the exercise hyperaemia 
during the period of contractions by ~ 20%, as well as the post-contraction hyperaemia. This 
decrease was greater than that previously observed with lone A2A-receptor inhibition; in that it 
mainly affected the post-contraction hyperaemia (333). However, the addition of ZM241385 to 
hyperoxia in the present study caused no further attenuation of exercise hyperaemia. Thus, 
taken together with the results of Ray and Marshall (333), the present results suggest that 
although adenosine participates late in the exercise hyperaemia, 40% O2 attenuates hyperaemia 
from the very beginning of the contraction. Moreover as the combination of 40% O2 and 
ZM241385 did not add to this attenuation and revealed an effect that was very similar to O2 
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alone (stimulation-3), it implies that adenosine’s contribution to exercise hyperaemia is O2-
dependent; i.e., added O2 inhibits adenosine’s contribution to hyperaemia. The fact that 
subsequent COX inhibition had no further effect in the presence of 40% O2 and ZM241385 
indicates that any contribution of O2-dependent PGs had already been prevented. 
The data here shows that the attenuation in hyperaemia occurs during both exercise and post-
exercise periods. This observation confirms and extends the observations of the previous 
chapters; i.e., attenuated hyperaemia responses of previous chapters reflected attenuated 
exercise hyperaemia, not just the post-exercise hyperaemic response. This study also confirms 
the findings of Chapter 6 in showing that attenuation in exercise hyperaemia with 40% O2 occurs 
from early periods of exercise. The results of the previous Chapters strongly suggest that O2-
dependent metabolites that attenuate exercise hyperaemia belong to the COX pathway, and as 
40% O2 also attenuates this hyperaemia early on during contraction (here and in Chapter 6), an 
obvious possibility is that the COX pathway is activated early during exercise to generate dilator 
PGs. Indeed, it could be that early in the exercise, adenosine neither contributes to exercise 
hyperaemia nor mediates the release of vasodilator PGs; i.e., these early COX products are 
produced independently of adenosine. Alternatively, looking at the results of Ray and Marshall 
(333), and those of Ballard et al. (18), it is possible that adenosine released early does not 
directly participate in the exercise hyperaemia but rather is the main precursor of further 
vasodilator metabolites. Indeed, Nyberg et al. have observed increased NO and PG 
concentrations in both interstitial and intravascular compartments with adenosine infusion (306). 
Moreover, Mortensen et al. have also revealed an interdependent relationship between these 
three metabolites (289).  
In conclusion the results of this study show for the first time that adenosine as well as vasodilator 
COX products contribute to exercise hyperaemia in an O2-dependent manner. As such, the 
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hypotheses of this are accepted. However, whether these metabolites work independent of one 
another or participate in an interdependent mediation of exercise hyperaemia is a question that 
remains unanswered.  
7.4.2 Limitations and future work 
An important limitation to this study is that efficacy of COX blockade with diclofenac was not 
actually tested. However, the concentration used in this study has previously been used by our 
group; and was found to effectively attenuate the adenosine evoked increase in PGI2 (331). 
However, in the absence of a test of efficacy in the present study, we cannot be sure that 
diclofenac achieved effective COX inhibition to block the contribution of O2-dependent PGs to 
exercise hyperaemia. 
This issue is important because the changes in THI recorded in the exercising arm before and 
after COX inhibition shown in the previous Chapter clearly demonstrated that vasodilator PGs 
are involved in exercise hyperaemia from the beginning of handgrip contraction (60% MVC). A 
similar pattern of change in the hyperaemia was observed with hyperoxia. As argued above, the 
results of the present Chapter indicate that adenosine and vasodilator COX products act in an 
O2-dependent manner to regulate exercise hyperaemia. Nonetheless, it would have been better 
if a series of COX inhibition experiments had been performed using a rat model. Such 
experiments on their own and in combination with 40% O2, and A2A-receptor inhibition would 
have further aided the understanding of exercise hyperaemia responses of O2-dependent 
adenosine and PGs. They could have shown whether COX inhibition in rats also attenuates 
exercise hyperaemia from the very beginning of exercise and/or whether the contributions of 
adenosine and PGs to exercise hyperaemia are interdependent. Moreover, analysis of PGs and 
adenosine from arterial and venous samples would have also helped with this understanding. 
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Although such experiments were planned and indeed attempted, technical and time limitations 
prevented their completion. 
Additionally, it is important to remember that Ray and Marshall (333) suggested that adenosine’s 
contribution to exercise hyperaemia is mediated only by A2A-receptors and that these are on the 
smooth muscle rather than endothelium; i.e., adenosine released only from the skeletal muscles 
contributes to the exercise hyperaemia. This conclusion was mainly based on their finding that 
the A2A-dependent component of exercise hyperaemia was not mediated by NO (335); and 
therefore, they concluded that adenosine was acting from the interstitium on the smooth muscle 
A2A-receptors, rather than from the intraluminal side on endothelial adenosine-receptors. Our 
group had previously shown that during systemic hypoxia, the adenosine component of hypoxic 
dilatation is mediated by endothelial A1-receptors, which stimulate NO synthesis and release (34, 
334, 373). Moreover, the observations that interstitial adenosine concentrations remain 
unaffected by systemic hypoxia (273), and that the endothelium acts as effective barrier between 
intra and extra-vascular compartments for adenosine and its nucleotides, contributed to this 
understanding (237, 249, 333). However, as they did not use a specific A1-receptor inhibitor (for 
example, DPCPX) in their study (333), their results may not actually show the complete 
contribution of adenosine to exercise hyperaemia. Therefore a study clearly needs to be 
performed with specific A1-receptor inhibition during exercise. As the intravascular concentrations 
of adenosine increase during systemic hypoxia (273) and A1-receptors are involved in hypoxic 
dilatation (334), their contribution to O2-dependent hyperaemia during exercise also needs 
investigating. Moreover, as adenosine increases concentrations of other metabolites (289, 306, 
331), intravascular adenosine’s relationship to PGs would also need investigating. 
Lastly, ATP has recently been shown to influence the production of NO and vasodilator PGs 
(304). Moreover, as RBCs work as O2 sensors and the change in ligand structure of RBCs from 
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oxygenated to deoxygenated results in ATP release (111, 112), a future study also needs to 
investigate the relationship between hyperoxia, ATP (purigenic-receptors), adenosine (A1 and 





Acetylcholine (ACh) induced endothelial 
dilatation is blunted by 60% and 100% O2, but 

















Following the results of the past 4 Chapters, it was important to determine whether breathing 
40% O2 enhances oxidative-stress to a level that affects endothelium-dependent dilatation; and 
thereby, the endothelium-dependent component of exercise hyperaemia. 
Furchgott and colleagues discovered that ACh-evoked vasodilatation is endothelium-dependent 
(133, 134). The exact mechanism by which ACh produces its dilatation remains unclear, but its 
presence in the cutaneous circulation is known to stimulate the NOS, COX, and non-NOS and 
COX vasodilator pathways (182, 206, 301, 350). The relevance of ACh-induced endothelium-
dependent dilatation to this thesis lies in the observations that hyperoxia interferes with the 
processes that mediate its vasodilatation (263, 291, 349, 350, 442). For example, Messina et al. 
observed that removal of the endothelium, or COX inhibition with indomethacin eliminated the 
vasoconstriction evoked by increased PO2 (263). Further, Yamazaki et al. showed that NOS and 
COX inhibition attenuated the decrease in cutaneous blood flow induced when their subjects 
breathed 100% O2 (442); indicating that 100% O2 disrupted the production and/or action of the 
endothelium derived vasodilators (NO and PGI2). CO2 values during this time remained 
unaffected. Similar conclusions were drawn by Rousseau et al. when they noticed that ACh-
induced increase in cutaneous circulation was attenuated by ~ 30% with 100% O2; this response 
was partially restored by oral Vitamin-C which is an anti-oxidant (350). Moreover, COX inhibition 
abolished the difference in ACh-induced responses between air and 100% O2 breathing 
indicating that hyperoxia acts directly and/or indirectly to interfere with the vasodilating function of 
PGs. 
ROS, are produced by non-enzymatic (398) and enzymatic pathways; i.e., via NADPH-oxidase, 
xanthine-oxidase, mitochondrial respiration, lipoxygenase, COX, cytochrome-P450 pathway, 
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NOS uncoupling, and lipid-peroxidation (48, 69, 320, 398, 419, 420, 449). Their relevance to 
ACh-induced dilatation is evident from the observations of Rubanyi and Vanhoutte (353). They 
noticed that the in-vitro ACh-induced dilatation of canine coronary and femoral arteries increased 
with superoxide-dismutase. Further, Cooke et al. noticed that methacholine-induced 
vasorelaxation of mesenteric vessels from superoxide-dismutase knockout mice was significantly 
attenuated relative to the wild-type mice: immunohistochemistry showed substantial increase in 
peroxynitrate formation in the knockout mice (66).  
The importance of these observations to this thesis is increased by the studies that link different 
levels of hyperoxia to increased oxidative-stress. Turrens et al. observed a linear increase in 
ROS in isolated lung mitochondria from 0 to 60% O2 (415). Beyond 60%, the increase in ROS 
was much more dramatic and steep. In-vivo, McNulty et al. showed that coronary blood flow and 
conductance decreased substantially (by ~ 30 – 40%); ACh-mediated dilatation was inhibited 
and the efflux of nitro-tyrosine increased when patients with stable coronary disease breathed 
100% O2 for only 15 min (256). As the deleterious effects of hyperoxia on hemodynamics are 
linked to oxidative-stress, a study was warranted to find out if a relatively safe range of O2 
concentration exists; i.e., is ACh-induced endothelium-dependent dilatation similarly affected by 
lower hyperoxia levels (i.e., 40 and 60%) as it is with 100% O2? 
Similar to the observations made for limb blood flow (358), aging is associated with a decline in 
the contributions of vasodilator PGs to cutaneous circulation (182). Holowatz et al. (182) 
observed that the peak ACh-induced increase in cutaneous blood flow was not different between 
age groups. However in contrast to young subjects, baseline cutaneous blood flow was 
augmented in older individuals by COX inhibition, and the ACh-induced dilatation was also 
attenuated less by COX inhibition in the older individuals. This suggests a decreased role of 
vasodilator PGs with ageing. Moreover, they showed that reflex cutaneous vasodilatation 
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induced by body heating of older individuals was enhanced by ascorbate microdialysis; so 
implicating ROS (181). This finding is consistent with much evidence that oxidative-stress is 
implicated in the very process of aging. Studies show that ROS causes greater damage to the 
aging DNA and in a vicious cycle, damaged DNA produce more ROS (114, 118, 259). As 
oxidative-stress within the cardiovascular system is a key component of the age-associated 
decline in endothelial function (181, 214, 417), it was particularly important to determine whether 
breathing different O2 concentrations affected endothelium-dependent dilatation in the older 
individuals. As ascorbate is a potent ROS scavenger (13, 14, 54, 181, 233), the burden of 
oxidative-stress on cutaneous circulation with different O2 concentrations was investigated using 
oral Vitamin-C. 
8.1.1 Aims and hypotheses 
The primary aim to the study was to determine whether endothelium-dependent dilatation would 
be similarly affected by breathing different supplementary O2 concentrations? The study aimed to 
address this question in both young and older individuals. Based on the results of the previous 
four Chapters, it was hypothesized that 40% O2 would not attenuate endothelium-dependent 






Before proceeding, it is important to acknowledge that the experiments on young subject were 
conducted by Florentyna D’Souza for her 3rd year Biomedical Science project (82). However, the 
data presented in this thesis were separately extracted from the original traces and analyzed. All 
experiments on older subject were carried out independently. 
Twenty four young (19 – 25 years) men and twenty seven older (60 – 76 years) men and women 
were recruited; all were recreationally active non-smoking adults (8 older subjects were ex-
smokers; quit at least 25 years ago). The female subjects had reached menopause at least 15 
years before the study.  
The medication history for the 40% O2 group included occasional use of salbutamol by 2 young 
subjects for asthma, alfazosin-hydrochloride by 1 older male for benign prostatic-hyperplasia and 
mesalazine for maintenance of remission from ulcerative-colitis by a further older male. Another 
older male was previously a patient of aplastic-leukaemia. In the 60% O2 group, 2 older men 
were using statins while 1 had a history of discontinued use of ramipril and bendroflumethiazide. 
In the 100% O2 group, 1 subject was prophylactically using low-dose aspirin while another was 
using statins and clopidogrel for prevention of cardiovascular events. The responses of all these 
individuals appeared consistent with others in their respective groups. Multivitamins were used 
occasionally by 1 young and 6 older subjects, while omega-3 supplements were used 
occasionally by 1 young and 4 older subjects. All subjects were required to adhere to dietary, 
medicinal, and exercise restrictions previously described in Chapter 2 (See section 2.1). Subjects 
were also asked to stop taking multivitamins / fish-oil and NSAIDs for at least 7 days prior to the 
experiment. This included voluntary restriction of vasoactive drugs for ~ 2 weeks prior to the 
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experiments. Administration of air or O2 and the recordings of HR and MABP were done as 
described in Chapter 2. In addition, cutaneous red cell flux (RCF) was monitored continuously by 
using a laser-Doppler probe as described below. 
8.2.2 Laser-Doppler 
The basic principles behind Laser-Doppler technique are similar to those used in photo-
plethysmography and NIRS (31). In laser-Doppler technique, monochromatic laser light is shown 
on an object; the change in its frequency and optical density is measured from the back scatter 
and used to calculate the quantitative estimate of the object (31, 179, 280). As the objects in 
question in the skin are RBCs, the moving cells produce a doppler-shift in the frequency of the 
back scattered light which is used to calculate their velocity (31, 179). Therefore the resultant 
RCF calculated by laser-Doppler is a product of RBC concentration and their velocity; 
represented in arbitrary perfusion units (PU) (280). The technique has been compared with 
others and is known to provide an accurate representation of perfusion that correlates well with 
volume flow (179).  
The low powered red light laser-Doppler probes used in this study with the laser-Doppler monitor 
(DRT4, Moor Instruments Ltd, UK) allowed for tissue penetration of ~ 1 mm (280). Probes were 
attached to the iontophoresis wells; careful consideration was given to avoiding their placement 
directly over any superficial veins, abrasions, skin conditions, and/or hair. 
8.2.3 Iontophoresis 
Iontophoresis is a method of delivering ions (salts) to different tissues of the body in a non-
invasive manner. The 260 year old technique involves passing small electrical-current through 
the ionized solution and the subject; allowing the “ions” (i.e., drug) to be delivered into the 
subject’s tissue (374). The technique is widely used in the dermatological practice to deliver 
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different drugs for the treatment of skin conditions (374). This study used this well established 
technique to deliver ACh into the skin (166, 258, 350, 382); its affects on cutaneous RCF were 
then studied as described below. 
8.2.4 Protocol 
Subjects visited the laboratory on three occasions; the initial visit was used to fill in the health 
and activity questionnaire, consent form, and for familiarization to the experimental protocol. 
Subjects in each age group were randomly assigned into one of the three sub-groups; each 
receiving air (21% O2) and one of the 3 different O2 concentrations during the experiment (40, 
60, or 100%: hyperoxia responses of each sub-group were compared to their own placebo / 
Vitamin-C data). The two experiment visits were carried out in a single-blind cross-over manner; 
order of placebo and Vitamin-C was randomized. As the effect of high O2 levels on 
cardiovascular variables can persist for an hour (426), hyperoxia always followed air breathing 
(Figure 8.1). 
On experiment days, each subject was provided with a 200 ml orange-flavoured drink (placebo 
or Vitamin-C; 2 g). Vitamin-C was chosen as it acts as an effective anti-oxidant (13, 14, 54, 233); 
2 g oral dose significantly increases plasma ascorbate concentrations to ~ 200 µmol/L; values 
that peak and plateau 2 hours after oral administration, remaining as such for at least further 3 
hours (233, 310). Therefore, subjects were asked to visit the laboratory three hours after 
consuming the drink. Upon arrival they were asked to rest in a chair with their forearms 
uncovered for ~ 20 min to acclimatize to the room temperature (21 – 27 °C). The variation in the 
recorded room temperature was the result of weather conditions; i.e., young and older subject 
experiments were conducted at different times during the year. However, within these age 
groups, the skin and room temperature measured were reasonably consistent and there were no 
225 
 
significant changes in temperature during experiments. Recording equipment was set up while 
the subject acclimatized to the room. This included Finapres for MABP and HR as previously 
described in Chapter 2; right hand rested on the chest. In addition, after cleaning the ventral-side 
of the left forearm with isopropyl-alcohol, iontophoresis electrodes (anode; contained within a 
Perspex ring) and an indifferent electrode were placed on it and made secure with double-sided 
tape. Careful consideration was given to avoid hair or any visible veins directly underneath the 
electrode wells. The wells were then filled with 1% ACh solution prepared using ACh-chloride 
and sterile-water; ~ 0.6 ml solution was placed in each well. The laser-Doppler probes were 
inserted into the wells for RCF recording. A schematic of the arrangement of electrodes on the 
arm is shown in Figure 8.2 while Figure 8.3 shows the arrangement of equipment on one of the 
subjects. Initial pilot trials showed that ACh-induced increase in cutaneous circulation took at 
least 30 min to return to baseline, and as each visit included air and hyperoxia runs, two different 
electrode-containing wells were used in each experiment. The ventral-side of the left arm faced 
up throughout the experiment.  
A facemask was put on the subject to deliver air and made secure with elastic-straps around the 
head; he/she were asked to breathe normally (See Section 2.4). Stable baseline recording were 
made for ~ 10 min and then the iontophoresis protocol was started; eight pulses, seven at 100 
µA and eighth at 200 µA all at 60 s intervals (166). 5 min after the end of iontophoresis protocol, 
the gas flow was discretely switched to a designated concentration of hyperoxia (40, 60, or 
100%). An appropriate Venturi-valve was used to deliver 40% and 60% O2 while 100% O2 was 
delivered via a modified valve (the openings for atmospheric air were sealed; See Section 2.4 for 
gas flow rates). The flow rate was kept similar to that achieved during air breathing with the aim 
of ensuring the subject was treatment blinded. After 10 min of hyperoxia, the iontophoresis 
protocol was repeated by using the second iontophoresis well. At the end of the protocol, 
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recordings were made for a further 5 min before the equipment was disconnected and the 
subject left the laboratory. Figure 8.4 shows the raw trace recorded during one of the 
experiments. 
8.2.5 Data Extraction and Statistical analysis 
HR, MABP, and RCF data were extracted over 60 s periods (averaged data; i.e., baseline and 60 
s after each iontophoresis pulse). RCF was expressed in perfusion units where 1 V of Laser-
Doppler meter represents 100 PU (166). Responses of each hyperoxia sub-group were 
compared to their own placebo and Vitamin-C runs; age comparison was also done to the 
corresponding hyperoxia sub-group. As placebo and Vitamin-C (air breathing) runs were 
performed by every subject, their comparison within each age group contained all participating 
individuals. Baseline HR, MABP, and RCF were analyzed using 2-way ANOVA for age, 
treatment, and their interaction effect. Within each age group, HR, MABP, and RCF data were 
analyzed using 2-way repeated-measures ANOVA for time, treatment, and their interaction 
effects. However, between age group comparison was done using Factorial ANOVA to identify 
time, treatment, age, and their interaction effects. The data for each treatment were also 
individually analyzed using 1-way repeated-measures ANOVA to detect within time effects. Upon 
detection of within and/or between significant effects, Tukey’s HSD was used as a post-hoc. The 
area under curve (AUC) for the ACh-evoked change in RCF was computed to represent the full 
response to ACh-iontophoresis; and expressed as AU. This data were analyzed using 2-way 






Figure 8.1 Schematic of the protocol. Each subject received air and one of the 3 different O2 
concentrations (40, 60, or 100%). The two experiment visits were carried out in a single-blind 
cross-over manner. Order of placebo and Vitamin-C was randomized; but hyperoxia followed air 
breathing during each experiment. 
 
 
Figure 8.2 Schematic showing the arrangement of iontophoresis electrodes and Laser-
Doppler probes. 2 anodes (1 each for different O2 concentrations) were placed on the ventral 
surface of the left forearm, each well was filled with 1% ACh-solution for iontophoresis. Laser-
















Figure 8.3 Arrangement of equipment on the subject. Iontophoresis electrodes were placed 
on the ventral surface of the left arm (A). Careful consideration was given to avoiding hair or any 
visible veins underneath the electrode wells. Finapres cuff was wrapped around the right middle 
finger for MABP measurement (B; the hand which rested on the chest). Different O2 
concentrations were delivered using a facemask connected to the venturi-valve (C). For subjects 







Figure 8.4 Original trace recorded during one of the experiments. Top (red) trace shows RCF recording, middle (blue) trace shows BP, while the 
bottom (green) trace shows iontophoresis current which was applied in eight 20 s pulses; seven at 100 µA (A) and eighth at 200 µA at 60 s intervals (B). 
Data were extracted for analysis over 60 s periods (Baseline, during iontophoresis, and post-iontophoresis; See trace). AUC was collected from the area 





Anthropometric data of the young and older subjects are shown in Table 8.1. The age and BMI of 
the subjects were not different between the three O2 sub-groups of each age group. 
8.3.1 Systemic cardiovascular responses 
Baseline hemodynamic values were not affected by treatment condition in either age group 
(Table 8.2 and Table 8.3). Moreover there were no age-dependent differences in baselines 
(Table 8.3). HR was maintained close to baseline levels during the protocol and remained largely 
unaffected by the treatment conditions in either age groups (Table 8.4 and Table 8.5). Similarly, 
MABP values also remained largely unchanged both within and between treatments (Table 8.6 
and Table 8.7). However, despite being within the normal physiological range, MABP were 
always higher in the older subjects (Table 8.7). 
8.3.2 Cutaneous vascular responses 
8.3.2.1 Young subjects 
As shown in Table 8.2, Baseline RCF was not different between treatments. Under placebo 
condition, cutaneous RCF increased significantly from baseline values of ~ 11 PU to 198 PU 
following ACh-iontophoresis. As shown in Figure 8.5, Vitamin-C did not affect the ACh-evoked 
response as RCF values increased from ~ 11 PU to 187 PU. 
Figure 8.6 shows RCF and AUC recorded while breathing different O2 concentrations. 40% O2 
had no effect on the ACh-induced increase in RCF but both 60 and 100% O2 attenuated the 
peak increase in RCF to 180 and 160 PU, respectively. The AUC during placebo was ~ 14 AU 
which was attenuated to 10.24 and 8.89 AU with 60 and 100% O2, respectively. By contrast as 
Figure 8.7 shows, after Vitamin-C the RCF and AUC values recorded during 60% O2 (i.e., 
231 
 
Vitamin-C + 60% O2) were similar to those recorded during the placebo / Vitamin-C trials; RCF 
and AUC of 100% O2 (i.e., Vitamin-C + 100% O2) still remained significantly attenuated. 
8.3.2.2 Older subjects 
Under placebo condition of air breathing and orange-flavoured drink, cutaneous RCF increased 
from baseline values of ~ 14 PU to 131 PU. As shown in Figure 8.8, the ACh-evoked increase in 
RCF after Vitamin-C was very similar, from ~ 13 PU to 136 PU. However, these ACh responses, 
whether considered as RCF or AUC, were much smaller than in young subjects (See Figure 8.5 
and Figure 8.8). 
As in young subjects, the ACh-induced increases in RCF responses recorded in older subjects 
were not attenuated by 40% O2, but were attenuated with both 60 and 100% O2 to 73 and 68 PU, 
respectively (Figure 8.9). Similarly, the AUC during placebo was ~ 9 AU and was attenuated to 
6.6 and 4.8 AU with 60 and 100% O2. After Vitamin-C the ACh-induced increases in RCF and 
AUC were augmented during both 60 and 100% O2, but they were still significantly attenuated 





Table 8.1 Anthropometric data of young and older subjects. Female participants were included only in the older group. 
Young Subjects Older Subjects

























20♂ 19.5 20♂ 21.6 21♂ 21.9 68♂ 20.2 66♂ 22.3 77♂ 23.8
21♂ 21.6 20♂ 24.3 21♂ 18.1 68♂ 25.7 78♂ 21.3 65♂ 24.8
21♂ 21.0 21♂ 22.1 21♂ 22.4 70♂ 22.8 77♂ 20.9 76♂ 23.8
21♂ 20.6 21♂ 21.0 22♂ 22.0 77♂ 24.2 76♂ 24.2 72♂ 24.1
20♂ 24.7 20♂ 20.9 21♂ 24.1 66♂ 24.5 66♂ 20.7 69♂ 22.4
20♂ 20.7 21♂ 24.8 21♂ 24.4 62♂ 24.4 65♂ 19.0 67♀ 23.1
21♂ 21.9 21♂ 21.5 20♂ 21.0 78♀ 24.0 67♂ 24.6 68♂ 23.1
22♂ 22.1 22♂ 23.9 20♂ 19.0 68♀ 17.8 66♀ 25.1 68♀ 21.6
68♂ 25.5 76♀ 24.5 70♀ 22.4
Mean 20.75 21.51 20.75 22.51 20.88 21.61 69.44 23.23 70.78 22.52 70.22 23.24




Table 8.2 Baseline haemodynamic values of young subjects. Baseline values were recorded 







Placebo 65 ± 3 86 ± 2 11.37 ± 0.47
Vitamin C 65 ± 2 85 ± 2 11.35 ± 0.37
P Value (Treatment) 0.97 0.70 0.41
8
Placebo 66 ± 5 88 ± 3 11.92 ± 3.86
Vitamin C 63 ± 4 85 ± 2 11.48 ± 4.06
40% O2 63 ± 3 88 ± 1 10.98 ± 4.91
40% O2 + Vitamin C 63 ± 3 87 ± 3 13.59 ± 4.78
P Value (Treatment) 0.71 0.34 0.27
8
Placebo 64 ± 8 84 ± 3 11.80 ± 3.81
Vitamin C 62 ± 3 83 ± 2 11.28 ± 3.99
60% O2 59 ± 2 89 ± 4 11.53 ± 4.08
60% O2 + Vitamin C 58 ± 3 87 ± 2 11.62 ± 3.76
P Value (Treatment) 0.20 0.13 0.74
8
Placebo 63 ± 5 88 ± 3 12.39 ± 3.38
Vitamin C 62 ± 4 86 ± 4 11.29 ± 3.99
100% O2 61 ± 2 88 ± 2 13.64 ±3.82
100% O2 + Vitamin C 59 ± 2 80 ± 2 11.66 ± 3.12




Table 8.3 Baseline haemodynamic values of older subjects. Baseline values were recorded 
before iontophoresis and were not affected by treatment within each hyperoxia sub-group. 






Placebo 65 ± 2 88 ± 3 14.04 ± 4.24
Vitamin C 64 ± 2 88 ± 2 13.06 ± 3.92
P 
Value
Treatment 0.66 0.78 0.21
Age 0.59 0.07 0.37
Interaction 0.89 0.61 0.17
9
Placebo 66 ± 3 85 ± 3 14.77 ± 8.04
Vitamin C 64 ± 2 88 ± 2 14.85 ± 6.20
40% O2 61 ± 3 88 ± 4 13.25 ± 2.48
40% O2 + Vitamin C 62 ± 3 87 ± 2 10.67 ± 1.79
P 
Value
Treatment 0.52 0.56 0.14
Age 0.83 0.07 0.13
Interaction 0.91 0.62 0.26
9
Placebo 66 ±3 88 ± 6 12.90 ± 6.04
Vitamin C 66 ± 2 88 ± 3 11.86 ± 6.93
60% O2 63 ± 3 92 ± 6 9.31 ± 1.30
60% O2 + Vitamin C 63 ± 3 92 ± 3 11.41 ± 3.11
P 
Value
Treatment 0.71 0.84 0.84
Age 0.16 0.08 0.36
Interaction 0.83 0.99 0.63
9
Placebo 62 ± 2 92 ± 4 12.45 ± 6.83
Vitamin C 63 ± 3 92 ± 3 12.14 ± 7.30
100% O2 60 ± 3 90 ± 5 9.65 ± 1.87
100% O2 + Vitamin C 61 ± 3 91 ± 4 9.38 ± 1.15
P 
Value
Treatment 0.91 0.99 0.28
Age 0.78 0.06 0.24




Table 8.4 Baseline and post ACh-iontophoresis HR of young men. No significant affect was detected within and between treatments. 
Young
Baseline
Iontophoresis P Value 
(within)n Treatment 1st 2nd 3rd 4th 5th 6th 7th 8th
HR (b.min-1)
24
Placebo 65 ± 3 65 ± 3 66 ± 3 65 ± 3 67 ± 3 65 ± 3 67 ± 3 67 ± 3 66 ± 3 1.00
Vitamin C 65 ± 2 64 ± 2 65 ± 2 65 ± 2 65 ± 2 64 ± 2 65 ± 2 65 ± 2 66 ± 2 1.00
P Value Time = 0.98                Treatment = 0.12                Time*Treatment = 1.00
8
Placebo 64 ± 5 64 ± 6 66 ± 6 65 ± 6 68 ± 7 65 ± 6 65 ± 7 64 ± 5 65 ± 6 1.00
Vitamin C 62 ± 4 62 ± 4 62 ± 4 63 ± 4 63 ± 4 62 ± 4 61 ± 4 62 ± 4 62 ± 3 1.00
40% O2 63 ± 3 63 ± 4 65 ± 3 65 ± 4 64 ± 5 68 ± 4 66 ± 4 66 ± 4 65 ± 4 0.96
40% O2 + 
Vitamin C
62 ± 3 61 ± 3 62 ± 3 66 ± 4 63 ± 3 64 ± 3 63 ± 4 64 ± 4 63 ± 4 0.99
P Value Time = 1.00               Treatment = 0.12 Time*Treatment = 1.00
8
Placebo 65 ± 7 64 ± 7 67 ± 6 67 ± 6 63 ± 5 64 ± 7 64 ± 3 66 ± 6 63 ± 6 0.77
Vitamin C 62 ± 3 64 ± 4 66 ± 3 64 ± 4 64 ± 4 63 ± 4 65 ± 4 63 ± 5 66 ± 7 1.00
60% O2 59 ± 2 61 ± 3 59 ±1 60 ± 2 58 ± 2 58 ± 2 64 ± 3 60 ± 3 62 ± 4 0.79
60% O2 + 
Vitamin C
58 ± 3 61 ± 2 58 ± 2 60 ± 2 60 ± 3 60 ± 2 62 ± 3 63 ± 4 63 ± 3 0.61
P Value Time = 0.20               Treatment = 0.15               Time*Treatment = 0.99
8
Placebo 63 ± 5 63 ± 4 63 ± 4 63 ± 4 63 ± 4 63 ± 4 62 ± 3 60 ± 2 61 ± 3 0.98
Vitamin C 62 ± 4 66 ± 3 66 ± 3 65 ± 4 65 ± 2 65 ± 1 66 ± 3 66 ± 3 66 ± 2 0.69
100% O2 61 ± 2 62 ± 2 63 ±2 59 ± 2 64 ± 3 62 ± 1 61 ± 2 62 ± 1 59 ± 2 0.95
100% O2 + 
Vitamin C
59 ± 2 58 ± 2 61 ± 3 59 ± 2 60 ± 3 60 ± 3 59 ± 3 62 ± 3 58 ± 2 1.00




Table 8.5 Baseline and post ACh-iontophoresis HR values of older subjects. No significant affect was detected within and between treatments. 
Moreover, no age effect was detected.  
Older
Baseline
Iontophoresis P Value 
(within)n Treatment 1st 2nd 3rd 4th 5th 6th 7th 8th
HR (b.min-1)
27
Placebo 65 ± 2 65 ± 2 64 ± 2 65 ± 2 65 ± 2 65 ± 2 64 ± 2 66 ± 2 65 ± 2 1.00
Vitamin C 64 ± 2 63 ± 2 64 ± 2 65 ± 2 64 ± 2 63 ± 2 64 ± 2 64 ± 2 65 ± 2 0.99
P Value
Time = 0.99               Treatment = 0.51               Age = 0.47
Time*Treatment = 0.99               Age*Treatment = 0.81
9
Placebo 66 ± 4 64 ± 4 65 ± 3 65 ± 3 65 ± 3 66 ± 4 65 ± 3 67 ± 4 65 ± 4 1.00
Vitamin C 64 ± 2 64 ± 2 64 ± 3 66 ± 3 63 ± 3 61 ± 2 64 ± 3 63 ± 3 65 ± 3 0.95
40% O2 61 ± 3 62 ± 3 62 ± 3 64 ± 3 64 ± 3 65 ± 3 62 ± 2 64 ± 3 63 ± 3 0.99
40% O2 + 
Vitamin C
62 ± 3 61 ± 2 64 ± 2 64 ± 3 63 ± 2 62 ± 2 64 ± 2 63 ± 2 63 ± 2 1.00
P Value
Time = 1.00               Treatment = 0.07               Age = 0.88
Time*Treatment = 1.00               Age*Treatment = 0.14
9
Placebo 66 ± 2 66 ± 3 65 ± 3 66 ± 3 66 ± 2 66 ± 3 65 ± 3 66 ± 3 66 ± 2 0.99
Vitamin C 66 ± 3 65 ± 3 66 ± 3 67 ± 3 67 ± 4 66 ± 3 67 ± 3 65 ± 3 66 ± 4 1.00
60% O2 63 ± 3 62 ± 3 63 ± 2 63 ± 3 64 ± 2 62 ± 3 64 ± 3 64 ± 3 63 ± 2 1.00
60% O2 + 
Vitamin C
63 ± 3 63 ± 3 63 ± 3 63 ± 3 63 ± 3 61 ± 3 62 ± 3 62 ± 3 63 ± 3 1.00
P Value
Time = 0.99               Treatment = 0.05               Age = 0.14
Time*Treatment = 1.00 Age*Treatment = 0.33
9
Placebo 62 ± 2 63 ± 2 62 ± 2 62 ± 3 63 ± 3 63 ± 2 63 ± 3 65 ± 3 64 ± 3 1.00
Vitamin C 63 ± 3 59 ± 3 59 ± 2 63 ± 3 62 ± 3 63 ± 3 62 ± 3 62 ± 3 62 ± 3 0.98
100% O2 60 ± 3 59 ± 2 60 ± 3 60 ± 3 61 ± 3 60 ± 3 62 ± 4 63 ± 3 60 ± 2 0.99
100% O2 + 
Vitamin C
61 ± 3 61 ± 3 62 ± 3 61 ± 3 61 ± 3 60 ± 3 61 ± 3 60 ± 3 61 ± 3 0.99
P Value
Time = 0.99               Treatment = 0.30               Age = 0.52




Table 8.6 Baseline and post ACh-iontophoresis MABP values of young men. No significant affect was detected within and between treatments. 
Young
Baseline
Iontophoresis P Value 




Placebo 86 ± 2 86 ± 2 86 ± 2 85 ± 2 86 ± 2 85 ± 2 86 ± 2 85 ± 2 85 ± 2 1.00
Vitamin C 85 ± 2 85 ± 2 85 ± 2 86 ± 2 85 ± 2 85 ± 1 86 ± 2 86 ± 1 86 ± 2 1.00
P Value Time = 1.00 Treatment = 0.61                Time*Treatment = 0.98
8
Placebo 88 ± 3 87 ± 3 87 ± 3 87 ± 3 87 ± 3 87 ± 3 87 ± 3 87 ± 3 87 ± 2 0.97
Vitamin C 85 ± 2 84 ± 2 85 ± 2 85 ± 2 84 ± 2 85 ± 2 85 ± 2 86 ± 2 86 ± 2 0.99
40% O2 88 ± 1 86 ± 1 87 ± 1 89 ± 2 90 ± 2 90 ± 2 89 ± 2 89 ± 2 91 ± 2 0.69
40% O2 + 
Vitamin C
87 ± 3 87 ± 2 87 ± 2 86 ± 3 86 ± 3 88 ± 3 87 ± 3 89 ± 3 87 ± 4 0.09
P Value Time = 0.99               Treatment = 0.11 Time*Treatment = 1.00
8
Placebo 80 ± 2 82 ± 2 81 ± 2 81 ± 2 81 ± 3 80 ± 3 84 ± 4 82 ± 3 80 ± 2 0.28
Vitamin C 83 ± 2 84 ± 2 84 ± 2 84 ± 2 85 ± 2 85 ± 2 86 ± 2 85 ± 2 85 ± 2 1.00
60% O2 89 ± 4 88 ± 4 88 ± 4 89 ± 4 89 ± 4 88 ± 4 88 ± 4 87 ± 3 88 ± 3 1.00
60% O2 + 
Vitamin C
87 ± 2 85 ± 3 85 ± 3 86 ± 3 84 ± 2 87 ± 2 87 ± 2 87 ± 2 86 ± 2 1.00
P Value Time = 1.00               Treatment = 0.05               Time*Treatment = 1.00
8
Placebo 85 ± 3 86 ± 3 87 ± 3 88 ± 3 86 ± 3 85 ± 3 87 ± 3 85 ± 3 84 ± 2 1.00
Vitamin C 86 ± 4 86 ± 5 86 ± 4 87 ± 3 88 ± 4 86 ± 3 86 ± 5 87 ± 3 87 ± 4 1.00
100% O2 87 ± 1 89 ± 2 88 ± 2 89 ± 2 89 ± 2 88 ± 2 87 ± 1 86 ± 2 85 ± 2 0.65
100% O2 + 
Vitamin C
80 ± 2 81 ± 2 81 ± 2 82 ± 2 83 ± 2 83 ± 3 84 ± 3 85 ± 3 86 ± 3 1.00




Table 8.7 Baseline and post ACh-iontophoresis MABP values of older subjects. No significant affect was detected within and between treatments. 
However, overall MABP values were higher in older men. 
Older
Baseline
Iontophoresis P Value 




Placebo 88 ± 3 87 ± 3 87 ± 3 88 ± 2 88 ± 2 89 ± 3 90 ± 3 89 ± 3 89 ± 3 0.99
Vitamin C 88 ± 2 88 ± 2 90 ± 2 90 ± 2 91 ± 2 90 ± 2 90 ± 2 90 ± 2 90 ± 2 0.98
P Value
Time = 0.96                Treatment = 0.29               Age = 0.001
Time*Treatment = 1.00               Age*Treatment = 0.96
9
Placebo 86 ± 3 84 ± 4 84 ± 4 83 ± 4 84 ± 4 86 ± 4 86 ± 4 85 ± 4 84 ± 4 1.00
Vitamin C 85 ± 3 84 ± 3 84 ± 3 86 ± 3 87 ± 3 84 ± 3 85 ± 3 85 ± 3 86 ± 4 0.99
40% O2 88 ± 4 89 ± 4 87 ± 4 88 ± 4 88 ± 4 87 ± 4 88 ± 4 88 ± 4 89 ± 4 0.99
40% O2 + 
Vitamin C
87 ± 2 87 ± 3 89 ± 2 88 ± 3 90 ± 2 89 ± 3 91 ± 4 90 ± 3 92 ± 3 0.99
P Value
Time = 0.94               Treatment = 0.12 Age = < 0.001
Time*Treatment = 1.00               Age*Treatment = 0.01
9
Placebo 88 ± 6 88 ± 5 86 ± 5 88 ± 4 88 ± 4 91 ± 5 90 ± 6 88 ± 6 91 ± 6 1.00
Vitamin C 88 ± 3 90 ± 3 92 ± 4 91 ± 3 93 ± 3 94 ± 3 94 ± 3 93 ± 4 93 ± 3 0.94
60% O2 92 ± 6 92 ± 5 91 ± 4 91 ± 4 92 ± 5 92 ± 4 92 ± 5 92 ± 5 92 ± 5 1.00
60% O2 + 
Vitamin C
92 ± 3 88 ± 3 90 ± 4 92 ± 4 91 ± 4 93 ± 4 93 ± 4 94 ± 3 94 ± 3 0.93
P Value
Time = 0.86               Treatment = 0.07 Age = < 0.001
Time*Treatment = 1.00               Age*Treatment = 0.001
9
Placebo 93 ± 4 91 ± 5 91 ± 5 94 ± 4 92 ± 4 92 ± 4 95 ± 4 95 ± 3 94 ± 3 1.00
Vitamin C 92 ± 3 92 ± 4 94 ± 4 94 ± 4 93 ± 4 93 ± 3 92 ± 4 93 ± 4 93 ± 4 1.00
100% O2 90 ± 5 92 ± 4 93 ± 4 94 ± 3 93 ± 4 94 ± 4 94 ± 5 95 ± 4 94 ± 4 1.00
100% O2 + 
Vitamin C
91 ± 4 90 ± 4 90 ± 5 91 ± 4 91 ± 4 93 ± 4 91 ± 4 94 ± 5 94 ± 5 0.63
P Value
Time = 0.97               Treatment = 0.17               Age = < 0.001




Figure 8.5 Cutaneous vasodilator responses evoked by ACh-iontophoresis in young men 
(n = 24). Upper panel shows RCF values while the lower panel shows AUC. Placebo is shown by 
solid line and column while Vitamin-C is shown by dashed line and open column. Cutaneous 
RCF increased significantly in response to ACh-iontophoresis, but the magnitude of this increase 
was not affected by Vitamin-C (AUC data). *,† represent placebo and Vitamin-C values that were 


































Figure 8.6 Cutaneous vasodilator responses evoked by ACh-iontophoresis in young men during placebo, 40, 60, and 100% O2. Each hyperoxia 
sub-group’s data are compared to their own placebo data; n = 8 in each sub-group. Cutaneous RCF increased significantly in response to ACh-
iontophoresis but both 60 and 100% O2 significantly attenuated this increase. */†/‡/§ represent placebo, 40, 60, and 100% O2 values that were 












































Time = < 0.001
Treatment = 0.36
Time*Treatment = 0.97
Time = < 0.001
Treatment = 0.04
Time*Treatment = 0.99













































Figure 8.7 Cutaneous vasodilator responses evoked by ACh-iontophoresis in young men during combination of Vitamin-C and different O2 
concentrations. Each hyperoxia sub-group’s data are compared to their own Vitamin-C data; n = 8 in each sub-group. Vitamin-C prevented significant 
decline in cutaneous RCF with 60% O2 but responses of 100% O2 still remained largely unaffected. */†/‡/§ represents Vitamin-C, Vitamin-C + 40%, 
Vitamin-C + 60%, and Vitamin-C + 100% O2 values that were significantly different from respective baselines (P < 0.001). # represents significant 











































Time = < 0.001
Treatment = 0.32
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Treatment = 0.14
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Time = < 0.001
Treatment = < 0.001
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Figure 8.8 Cutaneous vasodilator responses evoked by ACh-iontophoresis in older 
individuals (n = 27). Upper panel shows RCF while the lower panel shows AUC during placebo 
(solid line and filled brick column) or Vitamin-C (dashed line and open brick column). Cutaneous 
RCF increased significantly in response to ACh-iontophoresis but the magnitude of this increase 
was unaffected by Vitamin-C. However, ACh’s responses were significantly less in older 
participants during both placebo and Vitamin-C trials. *,† represent time effect of placebo and 




























Age = < 0.001
Age*Treatment = 0.37
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Figure 8.9 Cutaneous vasodilator responses evoked by ACh-iontophoresis in older participants during placebo, 40, 60, and 100% O2. Each 
hyperoxia sub-group’s data are compared to their own placebo data; n = 9 in each sub-group. Cutaneous RCF increased significantly in response to ACh-
iontophoresis; 60 and 100% O2 attenuated this increase. */†/‡/§ represents placebo, 40, 60, and 100% O2 values that were significantly different from 
respective baselines. # represents significant treatment affect (P < 0.001 vs. respective placebo). The magnitude of ACh-induced increase in RCF was 













































Time = < 0.001
Treatment = 0.33
Time*Treatment = 0.78
Age = < 0.001
Age*Treatment = 0.01
Time = < 0.001
Treatment = < 0.001
Time*Treatment = 0.07
Age = < 0.001
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Age = < 0.001
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Figure 8.10 Cutaneous vasodilator responses evoked by ACh-iontophoresis in older participants during combination of Vitamin-C and different 
O2 concentrations. Each hyperoxia sub-group’s data are compared to their own Vitamin-C data; n = 9 in each sub-group. The attenuated increase in 
RCF during 60 and 100% O2 was not completely reversed by Vitamin-C. */†/‡/§ represent Vitamin-C, Vitamin-C + 40%, Vitamin-C + 60%, and Vitamin-C 
+ 100% O2 values that were significantly different from respective baselines. # represents significant treatment affect (P < 0.01; i.e., vs. respective 
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The principal novel finding of the present study is that breathing 40% O2 did not affect ACh-
mediated endothelium-dependent dilatation in forearm cutaneous circulation in either young or 
older individuals. Secondly, higher O2 concentrations attenuated ACh-mediated dilatation in a 
dose-dependent manner in both age groups; and thirdly, Vitamin-C partially reversed this 
attenuation. 
8.4.1 Systemic cardiovascular responses 
HR and MABP values were not affected by treatment conditions within either age group. This is 
an interesting observation considering the ability of hyperoxia to attenuate endothelium-
dependent vasodilatation and to raise ABP. However, Rousseau et al. who recorded a decrease 
in limb and cutaneous perfusion with 15 min of 100% O2, also failed to record any change in the 
MABP in their studies (17, 348). It may be that any effect hyperoxia had in causing 
vasoconstriction was counteracted by a decrease in stroke volume (17). The exact reason for the 
disparity among studies regarding the systemic affects of hyperoxia is unclear, but it perhaps 
reflects between subject variability (17). Importantly, as MABP responses did not change 
significantly between treatments in the present study, it is reasonable to assume that the 
changes in RCF evoked by ACh were due to changes in vascular conductance within the 
cutaneous circulation. 
8.4.2 Cutaneous responses of young subjects 
Before ACh-induced changes to cutaneous blood flow can be discussed, it is important to 
remember that although baseline RCF values were similar between treatments, the recordings 
were made from two different cutaneous sites during each visit. Therefore, this study cannot 
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indicate whether hyperoxia or Vitamin-C affected baseline values in either age group, and 
therefore the primary focus is on the effect of different treatments on ACh-induced vasodilatation 
(i.e., AUC data). 
As mentioned above, ACh-induced endothelium-dependent dilatation is mediated by NO, PGs, 
and non NO / PG relaxing factors (182, 206, 301, 350). The evidence available already indicates 
that hyperoxia can attenuate this dilatation by increasing the oxidative-stress which interferes 
with the production / action of these endothelial vasodilators (66, 256, 350, 353, 415). In the 
present study, during placebo ACh-iontophoresis induced an endothelium-dependent dilator 
response which significantly increased forearm cutaneous RCF in a progressive manner, before 
achieving a plateau. This is consistent with the results of others (166, 257, 283, 301). The finding 
that ACh-evoked increase in cutaneous blood flow with Vitamin-C was similar to that evoked 
under placebo suggests that during air breathing, ROS did not interfere with the dilatation; similar 
findings have been made by others (350). Although some in-vitro evidence suggests that 
Vitamin-C reacts with iron among other metals to produce radicals (27, 30, 269, 366), and its 
own oxidation also induces oxidative damage (366), no such effects were observed in the 
present study; ACh-evoked increase in cutaneous blood flow was similar between Vitamin-C and 
placebo. 
The influence of hyperoxia and endothelium-dependent dilatation was investigated using 
different O2 concentrations. Breathing 100% O2 attenuated the ACh-evoked dilatation by ~ 35%. 
The magnitude of this attenuation was similar to that observed by Rousseau et al., (349, 350). 
Given their evidence that vasodilator responses of SNP iontophoresis were not affected by 100% 
O2 (350), and that hyperoxia increases oxidative load (187, 256, 321, 348, 350, 415), the results 
of the present study are consistent with the proposal that attenuation of the endothelium-
dependent dilatation was the result of oxidative-stress caused by 100% O2. However, the 
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present study also yielded novel findings that ACh-evoked dilatation of cutaneous vessels was 
attenuated in a dose-dependent manner by O2, in that the effect of 60% inspired O2 was less 
than that of 100% O2 (~ 25%) and 40% O2 failed to attenuate ACh-evoked increase in cutaneous 
RCF. Previously, Rousseau et al. have shown that resting CBF declined progressively with 
increasing PO2 concentrations (348). The results of this study are consistent with their findings, 
but add to them in showing a graded effect on endothelium-dependent ACh-mediated dilatation. 
The influence of ROS was investigated with help of Vitamin-C; the dose used in this study has 
previously been used effectively to attenuate oxidative-stress (54, 233). Moreover, as its plasma 
concentrations peak 2 hours after oral dosage remaining stable for at least further 3 hours (233, 
310), it should have acted as an effective antioxidant during the period of this study. Vitamin-C 
reduced the attenuation in ACh-evoked dilatation caused by 100% O2 in agreement with the 
work of Rousseau et al. (350), and reversed the attenuating effect of 60% O2. By contrast, 
responses evoked by ACh during 40% O2 were similar without and with Vitamin-C. These results 
are therefore consistent with 60 and 100% O2 attenuating the ACh-evoked response by inducing 
an increase in ROS that counteracted the endothelium-dependent dilatation. On the other hand, 
they indicate a lack of a significant effect of 40% O2 on ROS generation. 
The mechanisms by which ROS might interfere with endothelium-dependent dilatation have 
briefly been discussed (See this Chapter’s Introduction). However, the present study does not 
elucidate on any of these mechanisms. Studies show that ROS react with NO and PGs to reduce 
their bioavailability. In fact, interaction between NO and O2- occurs between the rates of 1.9 x 109 
mol/L/s (215) to 6.7 x 109 mol/L/s (404) to produce peroxynitrite; at the higher end, the response 
is three times faster than O2- reaction rate with superoxide-dismutase (48). Further, ROS are 
known to affect the COX pathway, such that their action can stimulate the production of 
vasoconstrictors PGH2 / TXA2 (69). Indeed, Rousseau et al. observed that the effect of 100% O2 
248 
 
in attenuating ACh-induced increase in cutaneous blood flow was eliminated by COX inhibition 
(350). Thus, any and/or all these factors might be contributing to the attenuation of ACh-induced 
increase in cutaneous blood flow with 60% and 100% O2. It is important to mention here that 
experiments performed by Furchgott and colleagues make it clear ACh-induced dilatation is 
endothelium-dependent in nature: removal of endothelium abolishes ACh-induced dilatation 
(131-134). However, given the effects of 40, 60, and 100% O2 on responses evoked by SNP, an 
endothelium-independent dilator (217, 283), were not tested in the present study, we do not 
know whether 60 and 100% O2 affected the ability of vascular smooth muscle to dilate in 
response to endothelium-independent or dependent substances. Nonetheless, the novel results 
of this study suggest that supplementary O2 attenuates endothelium-dependent dilatation in a 
dose-dependent manner. 
8.4.3 Cutaneous responses of older individuals 
Despite similar baseline RCF values, the magnitude of the ACh-evoked increase in RCF was 
significantly less in older individuals than that observed in young (AUC ~ 8.6 vs. 13.6 AU). This 
age-related decline in ACh-evoked dilatation of the cutaneous vessels is consistent with the 
findings of others (6, 182, 401, 402). For example, Tew et al. measured changes to cutaneous 
circulation evoked by ACh iontophoresis in young, sedentary older, and exercise trained older 
subjects (402). Their results showed that peak ACh-induced hyperaemia in the cutaneous 
circulation was higher in young and unrelated to the VO2-max status of their older participants. 
Moreover, before considering the effect of other treatments on ACh-induced endothelium-
dependent dilatation, it is important to note that there was no difference between the ACh 
responses observed in older men and women in the present study. In agreement, Algotsson et 
al. observed that ACh-induced changes to cutaneous circulation were not different between post-
menopausal women and elderly men (6). However as the responses to SNP were not compared 
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in the present study, it is unclear from our results whether the attenuated responses of older 
individuals reflected blunted endothelial-dependent dilatation or blunted relaxation of the vascular 
smooth muscle. However, as Holowatz et al. showed that the PG component of ACh-induced 
cutaneous dilatation was substantially attenuated in older individuals (182), it seems reasonable 
to assume that the blunted responses seen in older subjects of the present study at least partly 
reflect reduced endothelium-dependent dilatation mediated by vasodilator PGs. 
Despite evidence that oxidative-stress increases with age (181, 214, 417), oral dose of 2 g of 
Vitamin-C failed to significantly increase the ACh-induced dilatation of cutaneous vessels. This 
observation differs from the observations of Holowatz et al. who noticed that ascorbate 
microdialysis augmented the reflex heating induced increase in cutaneous blood flow in older 
individuals; combination of ascorbate supplementation and arginase inhibition completely 
eliminated the age-associated differences (181). It is unclear why the results of the present study 
differ from those of Holowatz et al. (181). However, it may be that oral supplementation of 
Vitamin-C did not raise the levels of antioxidant high enough in the cutaneous tissue to reveal an 
effect of aging induced oxidative-stress on ACh-induced dilatation.  
Nevertheless, the effects of different O2 concentration on ACh-evoked responses in the 
cutaneous circulation of older individuals are completely novel. Importantly, similar to the 
observations made in young, ACh-evoked dilatation was attenuated by 100% O2 in the older 
subjects and this attenuation was slightly greater as a percentage of the control response (~ 
44%); consistent with the idea of an age-related increase in oxidative-stress (181, 214, 417). 
Moreover, the percentage attenuation in cutaneous RCF with 60% O2 was also greater in older 
individuals (~ 25%), but again, importantly 40% O2 did not cause any attenuation in their ACh-
mediated increase in cutaneous RCF. Further, Vitamin-C supplementation attenuated the decline 
in endothelium-dependent dilatation observed with 60% and 100% O2 but did not completely 
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reverse this decline. These results are in agreement with the findings of Holowatz et al. that 
oxidative-stress is increased in the cutaneous circulation of the older individuals. However, in 
order to test that the dose of Vitamin-C used in this study was effective as an antioxidant, 
markers of oxidative-stress should have been measured. This remains another limitation to this 
study. 
8.4.4 Relevance to the results of previous Chapters 
The observations made in the present study regarding the relationship between inhaled O2 
concentrations and endothelial-dilation in both young and older subjects are of profound 
importance to the results of the earlier Chapters. Holowatz et al. have reviewed substantial 
evidence to show that human cutaneous circulation can be used as a valid model to study 
systemic vascular responses (180). Moreover, it is relevant to this project that the contribution of 
PGs to vasodilatation in limbs (300), cutaneous circulation (182), and to exercise hyperaemia 
(358) decreases with age. Therefore, collectively these observations support the use of 
cutaneous circulation as a valid model for study in this project. Assuming the argument of 
Holowatz et al. (180) to be valid, the present results indicate that the attenuation in exercise 
hyperaemia observed in Chapters 4 and 6 with 40% O2 are not a reflection of increased 
oxidative-stress blunting endothelium-dependent dilatation; but rather, genuinely reflect 
attenuation in the release / action of O2-dependent vasodilators. Thus, the present results help to 
validate the findings of previous Chapters that 40% O2 attenuates exercise hyperaemia by 
improving tissue oxygenation (See Chapters 4 and 6). Indeed, on the basis of the results of this 
Chapter, it could be argued that the use of a higher O2 concentrations would not only have 
increased the oxidative-stress and resulted in vasoconstriction in the exercising muscles; but 
might have increased reflex sympathetic vasoconstrictor responses in parallel (See Chapters 5 
and 6). This proposal is in agreement with findings of Caruana and Marshall who noticed that the 
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attenuation in post-exercise hyperaemia of isometric handgrip contraction with 40% O2 was not 
different without or with acute Vitamin-C supplementation (54). 
In conclusion, this novel study using different O2 concentrations shows for the first time that 
endothelium-dependent dilatation is attenuated by supplementary O2 at 60 and 100% in a dose-
dependent manner: an effect that is consistent in both young and old. Moreover, this study also 
provides the important observation that 40% O2 does not affect ACh-mediated endothelial 
dilatation; suggesting it does not increase the oxidative load significantly. Therefore in 
conclusion, the hypotheses of this study are accepted. 
8.4.5 Limitations and future work 
Some of the limitations of this study have already been discussed. However, for completeness, 
they are again briefly discussed here along with others. 
Firstly, although the skin temperate did not vary between subjects, it would have been better if 
the variation in the room temperature been kept to a bare-minimum for all of the experiments. 
Unfortunately, available laboratory facilities precluded this as the air-conditioning at times was 
inadequate. 
Secondly, as the results of this study indicate that the inhaled hyperoxia had a dose-dependent 
effect in increasing the oxidative load, it would be good in future studies to take blood samples to 
measure markers of oxidative-stress. A related limitation is the lack of Vitamin-C’s effect on ACh-
induced dilatation under air breathing conditions in the older subjects. This is important given 
Holowatz et al. have shown improved heat-induced cutaneous dilatation in older subjects with 
ascorbate microdialysis (181); for it implies that oral Vitamin-C did not completely attenuate 
oxidative-stress, or at least, age-related oxidative-stress. In future, it would be good to repeat the 
protocol of the present study with ascorbate microdialysis to see whether this achieves a higher 
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local concentration of antioxidant and acts more effectively to attenuate the effects of hyperoxia 
on ACh-induced dilatation in young and older individuals. Separately, as SNP responses were 
not tested, another limitation of this study remains our inability to be sure whether the attenuated 
older responses were the result of age-associated endothelial or vascular smooth muscle 
dysfunction. Future work should address this limitation. 
It might be argued that an important limitation to this whole study is the use of iontophoresis – 
passing current into the skin in various vehicle solutions has been shown to cause cutaneous 
vasodilatation; a response that is abolished by local / topical anaesthesia (102, 103, 149, 283, 
284). Özbebit et al. showed that ACh-induced cutaneous vasodilatation has two components; 
one of which is removed following topical anaesthesia (309).However interestingly, Durand et al. 
observed that the current-induced vasodilatation is primarily the result of COX-dependent 
vasodilators (102-104). As experiments with local anaesthesia and/or control experiments with 
de-ionized water were not performed in the present study, the ACh-evoked vasodilator response 
should be considered with this in mind. Nonetheless, iontophoresis of vasoactive agents without 
the use of these added protocols has been successfully used in many studies to elucidate 
endothelium-dependent dilatation (166, 258, 382, 402); even if dilatation induced by nerve 
stimulation is a persistent contributor to the response. Indeed, as 40% O2 did not inhibit the 
observed cutaneous vasodilatation but higher O2 concentrations did, it can be argued that 40% 
O2 does not inhibit / interfere with COX-dependent vasodilatation by increasing oxidative-stress. 
Nevertheless, in future, it would be important to test the effects of hyperoxia on dilator responses 
of ACh-iontophoresis in presence and absence of local anaesthetic. This would provide 
robustness to the ideas / conclusions of this study. Although, the technique of iontophoresis may 
carry disadvantages, it does provide a non-invasive way of testing endothelium-dependent 
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dilatation as compared with the widely used alternatives of microdialysis into skin and/or intra-






















9.1 Exercise and post-exercise hyperaemia 
Physical activity requires harmony between physiological systems; an important part of this 
accord is the ability of blood vessels to change their diameter. It is now recognised that exercise 
increases muscle VO2 (143) and leads to a profound decline in the intracellular PO2 in both 
trained and un-trained individuals (47, 337-339, 376). The idea of metabolic regulation of 
vascular tone is not new. However O2-linked regulation of the vascular tone (143, 184, 221, 226, 
352), and the release of similar vasodilator PGs under hypoxic (45, 46, 266) and exercise (73, 
74, 100, 209, 302, 303, 359, 390) conditions suggest that the vasodilatation of exercise 
hyperaemia might itself be O2-dependent. Gorczynski and Duling while performing experiments 
on rhythmically contracting hamster cremaster muscles observed a decline in tissue PO2 with a 
concomitant increase in arteriolar diameter (143). Superfusion of the exposed muscle with 
hyperoxic solution increased tissue PO2, attenuated the increase in arteriolar diameter, and led to 
the proposal that approximately half of the observed exercise hyperaemia was the result of the 
decline in tissue PO2. This study was supported by the observations of Lash and Bohlen who 
showed that perivenular PO2 exhibited a maintained fall during muscle contraction; and therefore 
proposed that vasodilator metabolites released from perivenular tissues when local PO2 falls 
make an important contribution to exercise hyperaemia (226).  
Such observations were the foundation for the work performed by Thet Su Win (437) and 
Graham Fordy (122, 123) under the supervision of Janice Marshall; investigators who’s work 
underpins the questions that are raised and addressed in this thesis. In brief, Win and Marshall 
showed that post-exercise hyperaemia of 60% MVC isometric handgrip contractions performed 
by young men was partly dependent on COX products (437): an observation that in itself was not 
novel (73, 74, 100, 209, 302, 303, 359, 390). However importantly, their results also indicated 
that COX vasodilator products were acting in an O2-dependent manner because the blockade of 
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COX enzyme attenuated post-exercise hyperaemia to a similar extent as 40% O2, with no added 
attenuation upon their combined use. This finding was later confirmed by Fordy while working on 
his doctorate (122). However, Fordy and Marshall also discovered that the attenuation in post-
exercise hyperaemia only occurred if 40% O2 was provided during the period of isometric 
contractions and not during the post-exercise recovery (122, 123). These observations therefore 
suggested that the O2-dependent metabolites are generated during contraction and raised new 
questions that required further investigation. 
Firstly, there is evidence that both isometric (122, 209, 390, 437) and dynamic exercise (73, 74, 
100, 209, 302, 303, 359, 435) are accompanied by the release of vasodilator PGs (PGE2 and 
PGI2); and that COX blockade attenuates their hyperaemia (73, 74, 122, 209, 437). There is also 
evidence suggesting that the signal for the release of these vasodilating PGs originates 
somewhere within the skeletal muscle tissue (123, 198, 199) and that PGs are released in an 
intensity-dependent manner (29, 198, 199, 447). While our group has proposed that the exercise 
(post-exercise) hyperaemia associated with isometric handgrip contraction is regulated by O2-
dependent COX products (122, 437), it was not known whether this is also the case for the 
hyperaemia of rhythmic (dynamic) handgrip exercise. Secondly, the conclusions of our group 
were based on the FBF and FVC data. Blood samples were not taken to conclusively test 
whether there actually is an O2-dependent release of vasodilator PGs during exercise.  
The aim of Chapter 4 was to address these questions: the results clearly showed that the post-
exercise hyperaemia of both isometric and rhythmic handgrip contractions performed at 60% 
MVC by young men is equally attenuated by COX inhibition, and 40% inspired O2. Importantly, 
as this attenuation was accompanied by attenuated concentrations of vasodilating PGs (PGE2 
and PGI2) in the venous efflux, the results of Chapter 4 provide new evidence that confirms the 
O2-dependent nature of the COX pathway and its contribution to exercise (post-exercise) 
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hyperaemic response. In addition, the results of Chapter 4 shed some light on the site of hypoxic 
stimulus that leads to the release of these PGs during exercise. Although hypoxia leads to the 
release of PGI2 from endothelium (45, 46), the primary vasodilator PG released from the skeletal 
muscles belongs to the E2 series (400). Chapter 4’s PG data shows that PGE2 as well as PGI2 
are released in an O2-dependent manner during either exercise. The mechanism by which O2 
could be affecting their release is discussed below. 
Another aim of Chapter 4 was to investigate the contribution of PGs to exercise (post-exercise) 
hyperaemia in healthy older individuals; and to establish whether their release is still O2-
dependent? This question was of interest, particularly because of the work of Schrage et al. 
(358). In order to investigate the contribution of COX pathway to exercise hyperaemia, they 
infused ketorolac into the brachial artery of healthy older individuals who were performing 
rhythmic handgrip contractions at 10% MVC (1 s contraction: 2 s relaxation). In contrast to young 
subjects (359), PGs were found not to contribute to exercise hyperaemia in the older subjects. 
However, as the release of PGs is exercise / contraction intensity-dependent (29, 198, 199, 447), 
the lack of any observable contribution of PGs to exercise hyperaemia in the older individuals 
might have reflected the low intensity of exercise used in the protocol. Alternatively, studies have 
shown that lifelong activity prevents the age-related decline in the contribution of NO to exercise 
hyperaemia (285, 305, 391). The older subjects of Schrage et al. (358) only performed 
household tasks as part of their physical activity regimen. Moreover, recently Zoladz et al. have 
shown that the venous efflux of PGI2 evoked by cycling exercise shows a net increase in young 
men who have gone through a five week endurance training regimen (448). Therefore, the 
results of Schrage et al., (358) might also have reflected a decreased generation of PGs 
associated with the sedentary life style of their healthy older subjects.  
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The data of Chapter 4 clearly shows that when recreationally active, healthy older men perform 
isometric and rhythmic handgrip contractions at 60% MVC (1:1 s duty-cycle), their post-exercise 
hyperaemia, and the contribution of PGs to it are both maintained. Moreover, as in young men, 
post-exercise hyperaemia and the contribution of PGs to it were found to be O2-dependent in the 
older men. However, despite releasing very similar PGE2 and PGI2 concentrations into the 
venous efflux as young men; judging from the attenuating effect of COX inhibition, the magnitude 
of their contribution to exercise hyperaemia was smaller in older subjects (~ 30% vs. ~ 18% for 
isometric and ~ 25% vs. ~ 15% for rhythmic handgrip). This perhaps reflects an age-related 
increase in the production of vasoconstrictors (396), increased ROS production (114, 118, 214, 
305, 358, 391, 393, 417), and/or an age-associated decline in the ability of the vasculature to 
respond to the vasodilators (114, 118, 259). Nonetheless, confirmation of any of these pathways 
requires further investigation. 
The recordings of THI (an index of change in haemoglobin; i.e., blood flow) obtained in the NIRS 
study (Chapter 6) on the exercising arm of young and older men, confirms that COX products are 
involved in the hyperaemia that occurs during muscle contraction and that their effect is O2-
dependent, as shown for post-exercise hyperaemia. These results indicated that at least in the 
flexor digitorum-superficialis, blood flow is not only maintained, but increases during isometric 
handgrip contraction at 60% MVC. Moreover, not only did 40% O2 attenuate the increase in THI, 
but it also reduced the fall in TOI, and the increase in HHb. Thus, these results provided direct 
evidence that breathing 40% O2 ameliorates tissue / muscle oxygenation during exercise; and 
that COX inhibition and 40% O2 have similar non-additive effects on tissue perfusion. This 
observation lends support to the conclusion that O2-dependent COX products are generated 
during exercise, contribute to the hyperaemia that occurs during this time, as well as to post-
contraction hyperaemia in both age groups. This also supports Fordy and Marshall’s observation 
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(122, 123) that supplementary O2 provided only during the period of isometric handgrip 
contractions (60 and 100% MVC) attenuates the post-contraction hyperaemia. 
9.2 Exercise-evoked vasoconstriction 
Vasodilatation is not the only influence on skeletal muscle vasculature during exercise; there is 
also a vasoconstrictor influence on exercising and non-exercising muscle. The novel findings of 
Chapter 4 raised questions regarding the O2-dependence of reflex-vasoconstriction. This 
question is appropriate considering that not only is AA (347) implicated in the activation of group 
III and IV afferents but so too are its derivatives (202, 207, 262): inhibition of COX pathway 
abolishes the afferent activation (346, 347). Further, the pressor response evoked during both 
isometric and dynamic exercise is attenuated by COX inhibition (72, 79, 246, 267, 346), and the 
exercise-evoked vasoconstriction is exercise intensity-dependent (399). It has also been shown 
that systemic hypoxia caused greater stimulation of metabolic than mechanical afferents in 
resting muscles (174). Moreover during ischemic exercise, group IV afferents were stimulated 
more than group III afferents (4, 174, 203). Together, these results point to the local metabolic 
control of exercise-evoked reflex vasoconstriction.  
Therefore, based on the results of Chapter 4, it was hypothesized that the pathway of exercise-
evoked reflex vasoconstriction was also O2 and PG-dependent. The studies of Chapters 5 and 6 
aimed to shed light on this. In the study of Chapter 5, the finding that the increase in ∆ CVR 
evoked by forearm exercise was similarly attenuated by COX inhibition, and 40% O2, whether or 
not post-exercise circulatory occlusion (PECO) was applied was entirely consistent with 
contribution of COX products to reflex vasoconstriction in an O2-dependent manner. The 
observations in Chapter 6 were made in the resting arm only during the period of contraction 
(i.e., without PECO application). Therefore, although they reflect the combined contribution of 
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central command and reflex afferent activated vasoconstriction, the additional observations of a 
similarly attenuated decrease in THI responses in the resting arm of young men under COX 
inhibition, 40% O2, and their combination are consistent with the results of earlier Chapter 5. 
Metabolites not only activate metaboreceptors, but are also known to activate / sensitize 
mechanoreceptors (3, 79, 267, 347, 372). However their relative importance / input cannot be 
deduced from these results. Nonetheless, Chapter 5’s finding that the reflex vasoconstriction was 
maintained with PECO and gradually declined with NO PECO indicates that the stimulus for the 
exercise-evoked reflex vasoconstriction lies within the exercising muscles; and persists when the 
circulation is occluded. An idea that is supported by the observation that ∆ CVR responses of 
40% O2 increase near the end of PECO. This idea is also supported by the observations of 
Chapter 6; the decline in resting arm’s THI increases over time during exercise, reflecting 
exercise-evoked vasoconstriction that is independent of central command. These results 
therefore show for the first time that the O2-dependent attenuation of COX products in the 
exercising arm not only attenuates exercise hyperaemia in the same arm, but also makes a 
major contribution to the attenuation of exercise-evoked reflex vasoconstriction that occurs in the 
contralateral arm, and calf muscles, and presumably to the other components (276). 
In view of the inconsistent findings in the literature of age-related changes in exercise-evoked 
vasoconstriction (204, 247, 298, 299, 342), the study of Chapter 6 recruited healthy, 
recreationally active older men with the aim of avoiding some of the variability. Although the data 
was collected during exercise only, and PECO was not applied, this study aimed to address the 
O2-dependence of exercise-evoked / reflex vasoconstriction in older subjects. In previous 
studies, Ng et al. showed that resting MSNA in older individuals was higher than in young 
subjects (298); while Taylor et al. observed an intensity-dependent and age-related increase in 
the exercise-evoked vasoconstriction; a response that was linked to increased sympathetic 
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activity in this age group (399). By contrast, Markel et al. observed an attenuated increase in 
peroneal nerve MSNA in older individuals when they performed incrementally ischemic handgrip 
exercise (247); observations that were in agreement with those of other studies (204, 299). The 
results and conclusion of Chapter 6 lend support to the findings of age-related attenuation in the 
magnitude of the exercise-evoked reflex vasoconstriction; at least in healthy, recreationally active 
older men while they perform isometric handgrip exercise at 60% MVC. In addition, the results of 
Chapter 6 showed for the first time that age does not affect the O2-dependent nature of this 
vasoconstriction. Thus, the change in THI recorded from the flexor digitorum-superficialis of the 
resting arm was similarly attenuated with COX inhibition, 40% O2, and their combination. 
It is not clear how, or why the magnitude of this vasoconstriction is attenuated in older 
individuals. However, a few possible reasons for this observation can be advanced. As indicated 
above, animal (202, 207, 262, 346, 347) and human studies (267, 276) indicate that both 
mechanical and metabolic pathways are involved in the pressor response; and that the 
contribution of metaboreceptors to the pressor reflex is significant above a certain threshold 
(158, 276, 421, 422). As the TTI of isometric exercise was significantly smaller in the older 
subjects, the smaller vasoconstriction might simply reflect a smaller stimulation of the mechano 
and/or metaboreceptors. This hypothesis is consistent with the evidence that the attenuated 
increase in THI in the exercising arm of the older individuals in Chapter 6 was also associated 
with attenuated TTI responses (unlike Chapter 4). 
An alternative explanation is offered by comparing the data of Chapter 6 with the findings of 
Markel et al. (247). Their subjects performed rhythmic handgrip contractions (30% MVC; 0.5 Hz) 
while blood flow in the exercising arm was gradually restricted. The results showed that under 
resting and unrestricted blood flow, the increase in peroneal nerve MSNA was greater in the 
older group, but restriction of blood flow reversed this age-related effect. These data appear 
262 
 
completely counter-intuitive but are consistent with those of Kawano et al. (204): at both absolute 
and relative exercise intensities, the evoked increase in ABP was attenuated with increasing age. 
As explained in Chapter 6, although studies suggest an age-related shift towards the oxidative 
metabolism with aging (8, 225, 389, 408), which should bring about a relative increase in their 
VO2, quite a few studies have shown an age-related decline in the VO2 kinetics (16, 23, 81), 
particularly in the muscles that are not normally active (61). The observations in Chapter 6 that 
the increase in HHb in the exercising arm of older men was less than that of young men, 
suggests attenuated VO2 kinetics in the flexor digitorum-superficialis of older subjects. This might 
be expected to lead to an attenuated increase in the concentrations of the metabolites that 
stimulate muscle afferents; and thereby mediate the reflex vasoconstriction. However, it might 
also reflect the observation that the afferent-sympathetic reflex responses from oxidative fibres 
are considerably less than those from the glycolytic type (436). 
Another, but not a mutually exclusive, possibility is that the smaller vasoconstrictor responses 
reflected the activity status of the older participants; i.e., recreational rather than endurance 
trained. Nyberg et al. found that the preservation of NO bioavailability in their recreationally 
active older individuals was between that of the sedentary and endurance exercise trained 
individuals (305). Therefore, it might be that the VO2 responses of our older individuals were not 
high enough to lead to a sufficient decline in the local tissue oxygenation to elicit enough release 
of metaboreceptor-stimulating O2-dependent metabolites. Nevertheless as their release did elicit 
a substantial O2-dependent exercise hyperaemia response in the exercising arm, it is clear that 
metabolite accumulation was not insignificant. Moreover, this interpretation would raise a 
question regarding the similar efflux of PGE2 and PGI2 between young and older men in study of 
Chapter 4. Thus, it may be that the muscle afferents become less sensitive to PGs with age. 
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9.3 O2-induced generation of ROS 
The important question that is fundamental to the studies described in this thesis is whether 40% 
O2 actually has its effects by increasing O2 delivery to exercising muscle as argued; or whether 
its influences are explained by other effects. ROS are quick acting, highly reactive molecules 
(215, 404) that are produced by enzymatic and non-enzymatic pathways (48, 69, 320, 398, 419, 
420, 449); and work to attenuate the blood flow by scavenging endothelium-dependent 
vasodilators (66, 256, 350, 353, 415). Their relevance to this entire project is evident from the 
observation that increased superoxide-dismutase activity improves ACh-induced dilatation (353); 
elimination of the superoxide-dismutase gene significantly attenuates the vasorelaxation (66). Of 
further relevance to this project are the observations of McNulty et al. that the ACh-evoked 
increases in coronary blood flow and conductance are substantially decreased while nitrotyrosine 
efflux increases when subjects breathe 100% O2 for only 15 min (256). Although the PG venous 
efflux data of Chapter 4 suggested it unlikely that the attenuation of exercise hyperaemia 
observed during Chapters 4 and 6 were the result of increased oxidative-stress, rather than any 
other route; this question still needed investigating. The novel results of Chapter 8 are important 
in this respect. ACh-evoked endothelium-dependent cutaneous vasodilatation was attenuated by 
breathing 60 and 100% O2 in both young and older individuals; but 40% O2 had no such effects. 
Moreover the antioxidant, Vitamin-C, did not affect the vasodilator response to ACh during air 
breathing or 40% O2 conditions; but reversed the attenuating effects of 60 and 100% O2. This 
indicates that higher O2 concentrations do indeed generate enough ROS to effect endothelium-
dependent dilatation whereas 40% O2 does not. Based on these results, it can be concluded that 
the attenuated exercise and post-exercise hyperaemia responses of earlier Chapters were 
indeed a reflection of attenuated generation of O2-dependent vasoactive metabolites (i.e., PGs); 
not just additional oxidative-stress inhibiting the vasodilatation by decreasing the bioavailability or 
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action of NO and PGI2. This is supported by the observations of Caruana and Marshall, who 
noticed that the attenuation in post-exercise hyperaemia of isometric handgrip contraction with 
40% O2 was not different without or with acute Vitamin-C supplementation (54). 
It is interesting to note that while the results of Chapters 5 and 6 showed the exercise-evoked 
reflex vasoconstriction is O2-dependent, earlier studies that utilized 100% O2 failed to observe 
any such attenuation (183, 361); i.e., the increase in leg MSNA was either maintained or 
increased when their subjects performed handgrip exercise with supplementary O2. As 
discussed, 100% O2 increases the generation of ROS (256, 348-350); and these molecules not 
only decrease the bioavailability of endothelial vasodilators (256), but they are also involved in 
directly evoking central and peripheral sympathetic responses (51). 
9.4 Contribution of other factors to exercise hyperaemia 
The findings of Chapter 4, 5, and 6 are internally consistent; and implicate COX products as O2-
dependent substances that contribute to the exercise hyperaemia and exercise-evoked reflex 
vasoconstriction of handgrip exercise. However, published studies show that adenosine and its 
nucleotides also contribute to exercise hyperaemia (18, 304, 333) and that they can influence the 
production of NO and PGs (286, 289, 304, 306). Thus, the contribution of PGs to hyperaemia 
may be at least partially dependent on other metabolites (289). As both localized and systemic 
hypoxia augment adenosine concentrations (70, 71, 274), a study was needed to investigate the 
relationship of adenosine, O2, and O2-dependent COX products in exercise hyperaemia. This 
study was carried out using rats as an effective, specific, adenosine-receptor antagonist is 
unavailable for use in humans (249). The results of Chapter 7 showed that 40% O2, and the 
combination of 40% O2 and adenosine A2A-receptor inhibition caused similar attenuation of the 
exercise hyperaemia associated with electrically induced twitch contractions in the anaesthetised 
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rat. Further COX inhibition had no added attenuating effect. However, as the attenuation in 
exercise hyperaemia with 40% O2 alone or in combination with A2A-receptor inhibition was 
greater than that previously observed with lone A2A-receptor inhibition (333), it suggested that 
some other factors were also contributing to exercise hyperaemia independent of adenosine 
pathway, particularly in the initial periods of exercise. Both Ballard et al. (18) and Ray and 
Marshall (333) observed that adenosine’s contribution to exercise hyperaemia increased 
gradually over time while the results of Chapters 6 and 7 showed that COX inhibition and/or 40% 
O2, attenuated exercise hyperaemia from the very start of exercise. 
9.5 Mechanism of action of 40% O2 on PG generation 
The discussion at the end of Chapter 4 (See Section 4.4.3) proposed a tentative mechanism by 
which the release of O2-dependent vasodilating PGs may be regulated; directly, or indirectly, by 
40% O2. Based on the results of Chapter 7, the following discussion presents multiple pathways 
that might be contributing to the O2-dependent release of PGs during exercise; perhaps in 
unison. 
Firstly, exercise is associated with a profound decline in the concentrations of intra-muscular / 
interstitial PO2 concentrations (143, 337-339), and the major PG produced by the skeletal 
muscles is of PGE series (400). The attenuated venous efflux of PGE2 with 40% O2 in both 
isometric and rhythmic handgrip exercise conditions suggested that added O2 ameliorates tissue 
oxygenation; and thereby directly inhibits its release. However, the observations made by Lash 
and Bohlen (226) showed that exercise was also accompanied by a significant decline in the 
peri-venular PO2; and the decline in intravascular PO2 is associated with an increase in PGI2 
concentrations (45, 46, 266). Thus, it is possible that the 40% acts on these peri-venular / 
capillary structures and inhibits the PGI2 production; observation supported by the venous efflux 
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data of Chapter 4. It is not being suggested here that this added O2, only attenuates PGE2 
production in the extra-vascular compartment, and PGI2 efflux in the intravascular compartment. 
Rather, this proposal implies a direct action of 40% inspired O2 in attenuating the O2-dependent 
release of these vasodilators. The blue arrows in Figure 9.1 show this pathway. 
The alternative explanation for the effect of 40% O2 involves adenosine and/or ATP. Before 
proceeding, it is important to remember that the release of these compounds is linked to hypoxia 
(24, 70, 71, 88, 142, 186, 243, 331), and exercise-intensity (142, 253). Moreover, they also 
influence the production of NO and PGs (286, 289, 304, 306). Therefore, in theory adenosine in 
the intra (306) and extra-vascular (306) compartments might affect the release of vasodilating 
PGs. The results of Chapter 7 show that although the contribution of adenosine to exercise 
hyperaemia via A2A-receptors is not added to by 40% O2 and COX inhibition, the pattern of this 
attenuation in hyperaemia is not the same as observed with lone A2A-receptor inhibition (333). 
This implies that during the initial period of exercise, adenosine release does not contribute to 
exercise hyperaemia, but that other O2-dependent pathways do. The importance of testing the 
contribution of A1-receptors to exercise hyperaemia is discussed in section 7.4.2. However, 
whether early release of adenosine contributes to the release of PGs or whether their release 
occurs independently is not clear at this time. Nonetheless, given the relationship between 
hypoxia and adenosine concentrations (24, 70, 71, 243, 331), its association with the release of 
NO and PGs (289, 306), and the fact that its interstitial concentrations reach near-maximum with 
relatively low-workload (165), it is possible that 40% O2 ameliorates tissue oxygenation and 
prevents the release of adenosine; and thereby attenuates the release of O2-dependent PGs 
during exercise. 
It is also important to remember that not only does ATP release occur from RBCs as the 
haemoglobin structure changes from oxygenated to deoxygenated (88, 142, 186), but ATP 
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concentrations also increase in response to exercise (290). Moreover, an increase in the ATP 
concentration is linked to the release of NO and PGI2 (306). The importance of this 
interdependent pathway is evident from the observation that the increase in blood flow induced 
by ATP infusion was attenuated by COX inhibition (286, 290). Therefore, as ATP can be acted 
on by 5’ectonucleotidase to release adenosine (164, 314, 315), its contribution to the O2-
dependent release of PGs during exercise could be direct (i.e., increased PO2 attenuating the 
increase in the numbers of deoxygenated RBCs) or indirect (via adenosine). Although the 
contribution of indirect pathway cannot be denied, the observations in Chapter 6 of an attenuated 
increase in HHb with 40% O2 lend support to the direct pathway. Purple, red, and green arrows 
in Figure 9.1 show this complicated relationship between adenosine, ATP, and O2-dependent 
vasodilating PGs. These same mechanisms would also explain the PG and O2-dependency of 
the exercise-evoked reflex vasoconstriction. The yellow arrows in Figure 9.1 show stimulation of 
group III and IV afferents by these O2-dependent PGs. 
In summary, it is clear from the data presented in this thesis that the exercise / post-exercise 
hyperaemia of isometric and rhythmic handgrip contractions at 60% MVC and the exercise-
evoked reflex vasoconstriction of similar-intensity isometric handgrip contractions have an O2-
dependent component: vasoactive COX products. Moreover, the O2-dependent nature of this 
pathway, and the contribution of COX products to exercise / post-exercise hyperaemia and 





Figure 9.1 Possible mechanisms by which 40% O2 attenuates the release of vasodilator 
PGs. Compartment A is intra-vascular compartment, B is endothelium, C represents interstitium 
while D represents skeletal muscle. Different coloured arrows represent four distinct, but not 
mutually exclusive pathways that could be affecting the release of vasoactive PGE2 and PGI2 
during exercise in an O2-dependent manner. The presence or absence of these COX products 
affects local and peripheral vascular diameter (i.e., exercise / post-exercise hyperaemia and 

























9.6 Future Work 
The limitations and future work sections of previous Chapters raised questions that need 
addressing in future studies. Although, all of these issues are not raised here again, some that 
remain at the end of this project are briefly discussed below. 
Firstly, there is evidence that the exercise-related release of PGs is not a universal finding (i.e., 
responders and non-responders) (448). Moreover, certain individuals do not respond to 
exogenous adenosine and their exercise hyperaemia is not attenuated by theophylline (251-
253). Thus, the relationship between exercise, 40% O2, and its dependent vasoactive 
metabolites needs investigation in such individuals. Based on the results of Chapter 4 and 6, 
questions are also raised regarding the responsiveness of older vasculature to vasoactive 
metabolites (particularly COX products). Series of experiments involving intra-arterial infusion of 
COX products in-vivo and/or myograph techniques on isolated vessels would shed more light on 
these issues. Moreover, as endothelium-dependent dilatation appears to be maintained with 
lifelong activity, a clear comparative study between sedentary and lifelong active older individuals 
with regards to O2-dependent metabolites would shed more light on the effects of healthy aging 
on the contributions of O2-dependent PGs to exercise hyperaemia / reflex vasoconstriction. 
Separately, as de-oxygenation of RBCs leads to release of ATP (111, 112), and the nucleotides 
stimulate synthesis and release of NO and PG from endothelium (304), a future is study is 
needed to investigate the contribution and interdependent relationship between O2, adenosine, 
ATP, and vasodilator COX products in exercise hyperaemia. 
In addition, the results of Chapter 5 and 6 raise the obvious question of whether 40% O2 
attenuates MSNA during rest and exercise? Based on the observations that metaboreceptors are 
stimulated by derivates of the COX pathway (202, 207, 262, 347) and by ROS (51), the results of 
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Chapters 5, 6, and 8 along with the venous efflux data of Chapter 4, would indeed suggest that 
the increase in MSNA is attenuated with 40% O2. However, these experiments would not only 
confirm this hypothesis, but could form an integral part of the investigation into the neural and 
local control of cardiovascular system in CHF and COPD patients. They could also help address 
the question whether 40% O2 would have beneficial exercise promoting and fatigue delaying 
affects in these patient groups. 
Finally, the VO2 data from the resting arm of young and older men while they performed 
isometric handgrip exercise has revealed a completely novel phenomenon. Clearly, experiments 
involving the neural and local control of haemodynamics, and VO2, in the resting muscles during 
exercise need to be performed. These experiments will help further elucidate / investigate this 
novel response. 
Clearly, the results of this entire project have important implications: they not only help advance 
our understanding regarding the role of vasoactive COX products to exercise and post-exercise 
hyperaemia; but they also increase our understanding of their contribution to exercise-evoked 
reflex vasoconstriction, both in young and older individuals. Moreover, this project provides novel 
data that clearly shows that their relationship to exercise-linked vasoactive changes is O2-
dependent. This advancement in scientific understanding regarding the COX-linked control of 
vasculature will certainly help any future scientific work. In addition, the observations that 
breathing 40% O2 can ameliorate tissue oxygenation in exercising muscle while not inhibiting 
endothelium-dependent dilatation may be of potential value to the medical profession; 
particularly in the rehabilitation and care of patients with cardiovascular and/or respiratory 
disease who have reduced exercise tolerance; for example, those with COPD or heart failure. 
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School of Clinical and Experimental Medicine 
College of Medical and Dental Sciences 
University of Birmingham 
 
Healthy Volunteer Screening Questionnaire 
 




Subject No (for researcher only):     
Name:        
Date of Birth:     BMI:             Kg/m2 
Address:     Resting Heart Rate:           B/min 
      Resting Blood Pressure:         mm HG 
      Dominant Arm:                (R or L) 
      Arm Circumference (Dominant):  cm 
Phone No:     Arm Circumference (Resting):  cm 
Email Address:     Maximum Voluntary Contraction 1: Kg  
Height:    Cm   Maximum Voluntary Contraction 2: Kg 




How would you assess your present level of fitness?   POOR / AVERAGE / HIGH / 
TRAINED 
 
Leisure time questionnaire; 
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Month of activity Average time 
per week 
No Yes Week 1 Week 2 Week 3 Week 4 hrs min 
Walking for pleasure         
Walking to work         
Walking during work 
breaks 
        
Cycling         
Using stairs when lift 
is available 
        
Carrying – 
loading/unloading 
        
Gardening         
Household tasks 
(cooking / cleaning / 
Vacuuming, etc) 
        
Home repairs         
Occupational manual 
Labour (Building / 
Mining / Farming / 
Machine tooling, 
Nursing, etc) 
        
Fishing/Hunting         
 
If yes, please provide the details of the activities.       
            
 
Do you do any other exercise regularly?      Yes / No 
 
   
277 
 
If yes, how regularly do you take part in physical activity? Please state the type of physical 
activity and how often? If you have multiple exercise schedules, please do not forget to list them 
all. 
            
 
            
Approximately, how long do you exercise for on each occasion? 
            
 
How long have you been exercising regularly? 
            
 
On a Scale of 1 to 10, with 10 being highest, how strenuous would you say your each exercise 
routine is? 
       
Do you take part any sport activities? If yes, please provide the details to these activities and 
how often do you participate in them? 
            
On a Scale of 1 to 10, with 10 being highest, how strenuous would you say your sports regimen 
is? 
       
Do you take part in other activities? Please tick the appropriate one from the list provided. If the 
activity is not present, please specify. 
 Rowing / Canoeing / Kayaking 
 Corps training 
 Cycling – for pleasure 
 Dancing 
 Martial arts 
 Mountaineering 
 Rock climbing 
 Sailing 
 Skiing / Snowboarding 
 Swimming 
 Other      
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Please specify the duration and regularity of your outdoor physical activity? 
            
MEDICAL / DIET HISTORY 
Do you currently smoke?        Yes / No 
Have you ever smoked?        Yes / No 
If yes, Please provide details of when you quit? 
       
Do you or have you ever used ANY drugs for recreational purposes?   Yes / No 
Are you taking ANY medication?       Yes / No 
If yes, please give details: 
            
Are you allergic to non steroidal anti-inflammatory drugs (NSAIDs) e.g. Aspirin, Nurofen, 
Ibuprofen, Naproxen, etc?  
Yes / No 
If yes, please give details: 
            
Do you or have you ever suffered from any of the following? 
 Cardiovascular Disease        Yes / No 
 Hemodynamic / Clotting Disorder      Yes / No  
 Metabolic Disease (e.g. Diabetes)     Yes / No 
 Respiratory Disease       Yes / No 
 Liver Disease         Yes / No 
 Kidney Disease         Yes / No 
 Ulcers (e.g. Stomach)       Yes / No 
 Any Other Chronic Medical Condition      Yes / No 
If yes to any of the above, please give details: 
            
Have you ever fainted (e.g. on standing, following fasting, during exercise)?  Yes / No 
If yes, please give details:          
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Do you consume alcohol?        Yes / No 
If yes, how many units of alcohol do you consume per week? 
      Units 
Note: Half a pint of ordinary strength larger/beer/cider, or one small glass of vine, or one pub 
measure of spirits (e.g. a shot of tequila), or half a bottle of alcopop (e.g. Smirnoff Ice) is equal to 
1 Unit. 
Roughly, how many cups of coffee, tea, cola or any other caffeinated / energy drink (e.g. Red 
Bull) do you drink in a day? 
      Cups 
Do you take dietary supplementation (Vitamins, Botanicals, Amino-acids, etc)?  Yes / No 
If yes, what do you take and how regularly? 
            
How often do you eat citrus fruits? 
            
How many portions of fruit and vegetable do you have daily? 
            
How often do you eat fish rich in oil (Omege 3) or consume Fish oil supplements? 
            
Have you taken part, or do you intend to take part, in any other trial within the three months prior 
to and following this particular study (e.g. other studies, blood donor)? 
If yes, please give details?       Yes / No 
            
 
DECLARATION: 
I declare that all of the above information is correct to the best of my knowledge. I understand 
that this information will be treated in the strictest of confidence. 
Signature:       Date:    
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School of Clinical and Experimental Medicine 
College of Medical and Dental Sciences 
University of Birmingham 
 
Healthy Volunteer Screening Questionnaire 
 





Subject No (for researcher only):     
Name:        
Date of Birth:     BMI:             Kg/m2 
Address:     Resting Heart Rate:           B/min 
      Resting Blood Pressure:         mm HG 
      Ethnicity; Please tick the most appropriate: 
       Caucasian 
Phone No:      African / Afro-Caribbean  
Email Address:      South Asian 
Height:     Cm   East Asian 




How would you assess your present level of fitness?   POOR / AVERAGE / HIGH / 
TRAINED 
 
Leisure time questionnaire; 
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Month of activity Average time 
per week 
No Yes Week 1 Week 2 Week 3 Week 4 hrs min 
Walking for pleasure         
Walking to work         
Walking during work 
breaks 
        
Cycling         
Using stairs when lift 
is available 
        
Carrying – 
loading/unloading 
        
Gardening         
Household tasks 
(cooking / cleaning / 
Vacuuming, etc) 
        
Home repairs         
Occupational manual 
Labour (Building / 
Mining / Farming / 
Machine tooling, 
Nursing, etc) 
        
Fishing/Hunting         
 
If yes, please provide the details of the activities.       
            
Do you do any other exercise regularly?      Yes / No 
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If yes, how regularly do you take part in physical activity? Please state the type of physical 
activity and how often? If you have multiple exercise schedules, please do not forget to list them 
all. 
            
 
Approximately, how long do you exercise for on each occasion? 
            
 
How long have you been exercising regularly? 
            
 
On a Scale of 1 to 10, with 10 being highest, how strenuous would you say your each exercise 
routine is? 
       
Do you take part any sport activities? If yes, please provide the details to these activities and 
how often do you participate in them? 
            
            
On a Scale of 1 to 10, with 10 being highest, how strenuous would you say your sports regimen 
is? 
       
Do you take part in other activities? Please tick the appropriate one from the list provided. If the 
activity is not present, please specify. 
 Rowing / Canoeing / Kayaking 
 Corps training 
 Cycling – for pleasure 
 Dancing 
 Martial arts 
 Mountaineering 
 Rock climbing 
 Sailing 
 Skiing / Snowboarding 
 Swimming 
 Other      
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Please specify the duration and regularity of your outdoor physical activity? 
            
MEDICAL / FOOD INTAKE HISTORY 
Do you currently smoke?        Yes / No 
Have you ever smoked?        Yes / No 
If yes, Please provide details of when you quit? 
       
Do you or have you ever used ANY drugs for recreational purposes?   Yes / No 
For female participants; 
How long ago did you reach menopause? 
            
Are you taking ANY medication (this includes hormone replacement therapy)?  Yes / No 
If yes, please give details: 
            
Do you or have you ever suffered from any of the following? 
 Cardiovascular Disease (e.g. Hypertension, Raynaud’s Disease, etc) Yes / No 
 Hemodynamic / Clotting Disorder      Yes / No  
 Metabolic Disease (e.g. Diabetes)     Yes / No 
 Respiratory Disease       Yes / No 
 Liver Disease         Yes / No 
 Kidney Disease         Yes / No 
 Skin Disorders (e.g. Eczema, etc)     Yes / No 
 Any Other Chronic Medical Condition      Yes / No 
If yes to any of the above, please give details: 
            
 
Do you consume alcohol?        Yes / No 
If yes, how many units of alcohol do you consume per week? 
      Units 
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Note: Half a pint of ordinary strength larger/beer/cider, or one small glass of vine, or one 
measure of spirits (e.g. a shot of tequila), or half a bottle of alcopop (e.g. Smirnoff Ice) is equal to 
1 Unit. 
Roughly, how many cups of coffee, tea, cola or any other caffeinated / energy drink (e.g. Red 
Bull) do you drink in a day? 
      Cups 
Do you currently take any vitamin supplements     Yes         No 
What is your average weekly intake of the following foods? 
Citrus Fruits and soft fruit (not tinned)   None     a few times a week   everyday 
Fruit Juice (e.g orange, grapefruit, tomato, etc)   None     a few times a week   everyday  
Vitamin C enriched cordials    None     a few times a week   everyday 
Potatoes (incl. instant)      None     a few times a week   everyday 
Green Vegetables     None     a few times a week   everyday 
Other fruits (incl. tinned)     None     a few times a week   everyday 
Do you currently take fish oil supplements     Yes         No 
Average Weekly Fish Intake    None     1 or 2 times   3 or more times 
 
DECLARATION: 
I declare that all of the above information is correct to the best of my knowledge. I understand 
that this information will be treated in the strictest of confidence. 
 
Signature:      Date:     
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School of Clinical and Experimental Medicine 
College of Medical and Dental Sciences 
University of Birmingham 
 
Healthy Volunteer’s Consent Form 
 
Please read this form carefully and sign it after the aims and procedures of the study have been 
explained to you. 
 I have voluntarily agreed to take part in this study. 
 I confirm that the aims of the study have been explained and that I have read and 
understood the information sheet given to me. 
 I have been given the opportunity to ask questions and discuss the study on all aspects of 
the study and have understood the advice and information given as a result. 
 I agree to comply with the reasonable instructions of the investigators and will notify them 
immediately of any unexpected unusual symptoms. 
 I understand that any data and/or samples collected will be strictly used for scientific 
research/study. 
 I authorize the investigators to disclose the results of my participation in the study. 
 I understand that the information about me recorded during the study will be kept secure. 
 I understand that the data collected and/or results of the study may be published in a 
scientific journal and Thesis and that if published, my personal details will be protected. 
 I authorize the investigators to disclose to me any abnormal test results. 
 I understand that I can ask for further instructions and/or explanations at any time. 
 I understand that I am free to withdraw from the study at any time, without having to give a 
reason for withdrawing. I also understand that any data / samples collected during the 
course of my participation will not be discarded due to my withdrawal from the study. 
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Volunteer’s Name:       
 
Signature:        
Date:         
 
Investigator’s Name:       
 
Signature:        
Date:         
Subject Number (for researcher only):      
  



















   




Figure 1 HR, MABP, FBF and FVC responses of rhythmic handgrip contractions performed by young men. * represent values significantly different 
from respective baselines while † represents values different from placebo (P) condition (P < 0.05). Significant time x treatment interaction is denoted by 
‡ (vs. Placebo) 
Young - Rhythmic Exercise
Mean 
Baseline
Exercise Post Exercise Responses
Treatment 1st min 2nd min 3rd min 0 s 30 s 1 min 2 min 3 min 4 min 5 min 6 min 7 min
P
HR (b.min-1) 64.38±1.43 87.77±6.10 * 89.61±6.55 * 89.00±4.26 * 70.98±4.32 65.30±3.23 62.50±1.55 64.15±2.27 61.38±2.28 62.87±2.31 61.21±2.33 66.55±2.80 62.11±2.24
MABP (mmHg) 78.52±3.07 96.50±5.67 * 108.37±6.15 * 116.61±6.42 * 101.72±6.04 * 95.13±5.98 * 86.51±5.25 86.24±4.81 84.88±4.48 85.89±4.20 83.92±4.77 83.26±4.74 82.97±4.56
FBF (ml.dl-1.min-1) 4.45±0.43 --- 56.18±4.87 * 48.80±3.43 * 40.62±4.25 * 33.51±4.80 * 29.76±5.45 * 26.34±4.58 * 22.51±4.26 * 22.58±3.26 * 18.76±3.52 *
FVC (CU) 0.06±0.01 --- 0.55±0.08 * 0.51±0.05 * 0.47±0.07 * 0.39±0.05 * 0.35±0.05 * 0.30±0.05 * 0.27±0.04 * 0.27±0.03 * 0.23±0.03 *
40% O2
HR (b.min-1) 62.29±1.53 80.93±2.62 * 81.49±2.35 * 85.24±2.51 * 66.64±2.69 61.94±3.15 64.57±3.33 60.43±2.51 60.32±1.88 62.74±3.22 60.97±2.79 62.23±3.34 61.77±2.02
MABP (mmHg) 76.17±3.13 91.87±4.90 * 104.99±5.32 * 112.06±5.16 * 99.36±3.68 * 90.90±5.05 * 85.38±4.67 82.84±4.94 83.12±4.63 82.52±4.49 82.67±4.58 82.87±4.57 80.63±4.77
FBF (ml.dl-1.min-1) † 4.34±0.38 --- 40.63±3.97 *‡ 35.93±2.41 *‡ 34.18±1.88 *‡ 25.58±2.14 *‡ 20.51±1.87 *‡ 19.72±1.93 *‡ 15.86±1.57 *‡ 16.39±1.77 *‡ 12.68±1.34 *‡
FVC (CU) † 0.06±0.01 --- 0.41±0.04 *‡ 0.39±0.03 *‡ 0.39±0.02 *‡ 0.31±0.03 *‡ 0.27±0.02 *‡ 0.24±0.02 *‡ 0.19±0.02 *‡ 0.20±-0.02 *‡ 0.16±0.02 *‡
A
HR (b.min-1) 67.20±1.93 86.12±4.19 * 86.25±3.76 * 88.96±4.52 * 70.24±3.14 64.27±2.03 63.69±1.90 63.12±2.51 63.58±2.94 65.92±2.64 65.65±2.61 64.70±2.19 65.29±2.70
MABP (mmHg) 77.53±2.75 96.34±4.58 * 107.26±4.68 * 112.47±4.65 * 95.56±4.66 * 92.07±5.57 * 85.28±5.19 81.63±4.48 81.64±4.07 82.58±5.13 81.32±4.39 82.31±5.02 81.97±5.02
FBF (ml.dl-1.min-1) † 4.78±0.45 --- 41.95±3.63 *‡ 37.61±3.54 *‡ 31.86±3.45 *‡ 25.92±2.86 *‡ 19.92±2.46 *‡ 19.18±2.78 *‡ 16.39±1.69 *‡ 15.91±1.71 *‡ 12.84±1.30 *‡
FVC (CU) † 0.06±0.01 --- 0.44±0.04 *‡ 0.40±0.02 *‡ 0.37±0.04 *‡ 0.32±0.02 *‡ 0.25±0.02 *‡ 0.23±0.02 *‡ 0.20±0.02 *‡ 0.19±0.02 *‡ 0.16±0.02 *‡
A + O2
HR (b.min-1) 62.04±1.61 79.90±3.29 * 81.01±2.90 * 84.37±3.94 * 65.99±2.05 59.53±2.57 59.99±3.00 61.57±2.33 60.61±2.61 60.49±2.04 60.65±2.01 62.46±3.68 60.14±2.63
MABP (mmHg) 73.32±2.20 83.10±3.87 * 100.22±5.04 * 107.31±5.50 * 92.99±4.72 * 91.08±4.94 * 81.47±4.74 81.89±4.27 80.53±4.57 80.17±5.80 80.34±5.14 78.13±4.84 81.48±5.24
FBF (ml.dl-1.min-1) † 4.59±0.41 --- 41.85±2.35 *‡ 34.28±4.44 *‡ 28.03±2.66 *‡ 23.67±1.74 *‡ 20.95±2.74 *‡ 18.94±2.25 *‡ 16.56±2.35 *‡ 16.62±1.56 *‡ 14.73±1.88 *‡
FVC (CU) † 0.06±0.01 --- 0.45±0.03 *‡ 0.38±0.04 *‡ 0.34±0.03 *‡ 0.29±0.02 *‡ 0.26±0.04 *‡ 0.24±0.03 *‡ 0.21±0.02 *‡ 0.21±0.02 *‡ 0.18±0.02 *‡




Figure 2 HR, MABP, FBF and FVC responses of isometric handgrip contractions performed by young men. * represent values significantly 
different from respective baselines while † represents values different from placebo (P) condition (P < 0.05). Significant time x treatment interaction is 
denoted by ‡ (vs. Placebo). 
Young – Isometric Exercise Mean 
Baseline
Exercise Post Exercise Responses
Treatment 1st min 2nd min 3rd min 0 s 30 s 1 min 2 min 3 min 4 min 5 min 6 min 7 min
P
HR (b.min-1) 66.72±3.31 84.67±3.97 * 87.12±4.05 * 93.04±4.55 * 75.51±3.91 * 62.52±2.71 62.61±3.17 62.26±1.77 62.13±1.70 61.12±2.13 61.93±1.73 62.94±1.97 60.98±2.43
MABP (mmHg) 80.27±2.72 94.38±4.69 * 108.77±5.73 * 122.89±7.12 * 104.68±5.56 * 90.85±5.32 90.18±4.47 84.08±4.65 83.17±4.62 79.58±4.62 76.31±5.57 78.48±4.91 76.07±5.64
FBF (ml.dl-1.min-1) 5.92±0.55 --- 63.32±6.09 * 48.47±4.50 * 43.14±5.43 * 40.36±4.72 * 32.93±3.68 * 29.97±3.84 * 24.92±3.89 * 22.82±2.78 * 19.86±3.05 *
FVC (CU) 0.08±0.01 --- 0.61±0.06 * 0.54±0.06 * 0.48±0.07 * 0.48±0.07 * 0.40±0.05 * 0.38±0.06 * 0.33±0.05 * 0.29±0.04 * 0.26±0.04 *
40% O2
HR (b.min-1) 63.67±2.00 85.99±5.62 * 87.72±4.59 * 91.29±3.50 * 75.35±2.48 * 60.23±2.12 58.72±2.17 58.05±2.35 60.00±2.74 61.98±3.42 58.71±3.30 57.04±1.34 58.11±2.08
MABP (mmHg) 79.73±2.90 97.54±4.45 * 116.18±6.62 * 123.19±8.85 * 100.93±4.42 * 91.55±3.97 84.83±5.48 87.24±4.12 87.71±4.23 87.61±3.80 86.33±4.56 86.01±4.64 85.29±4.57




FVC (CU) † 0.08±0.01 --- 0.42±0.05 *‡ 0.40±0.03 *‡ 0.36±0.05 *‡ 0.34±0.02 *‡ 0.27±0.02 *‡ 0.27±0.03 *‡ 0.22±0.02 *‡ 0.19±0.01 *‡ 0.17±0.01 *‡
A
HR (b.min-1) 68.69±1.80 87.78±4.81 * 90.23±5.01 * 94.19±7.17 * 83.75±5.50 * 69.09±4.28 66.58±2.63 61.90±2.09 64.57±2.68 65.58±3.61 63.92±3.44 66.03±3.04 66.24±3.07
MABP (mmHg) 78.72±2.14 95.91±3.50 * 111.60±4.95 * 120.12±6.88 * 99.55±6.22 * 96.38±6.03 90.73±3.77 87.51±4.26 86.18±4.02 82.74±3.54 79.34±3.08 82.05±2.84 82.47±3.29




FVC (CU) † 0.09±0.01 --- 0.44±0.07 *‡ 0.38±0.06 *‡ 0.37±0.04 *‡ 0.33±0.03 *‡ 0.29±0.04 *‡ 0.25±0.03 *‡ 0.23±0.02 *‡ 0.21±0.02 *‡ 0.16±0.02 *‡
A + O2
HR (b.min-1) 62.47±1.13 79.70±4.18 * 82.47±4.05 * 93.09±6.21 * 77.59±4.63 * 63.45±1.98 62.04±1.85 60.74±1.61 57.63±1.63 58.59±1.42 57.29±1.57 59.28±2.60 60.62±2.53
MABP (mmHg) 75.50±2.69 96.41±5.12 * 118.89±8.47 * 124.33±8.64 * 103.42±6.54 * 93.59±5.37 82.51±5.97 84.37±6.27 86.03±4.53 82.87±4.80 80.98±3.87 82.62±3.84 81.29±4.58




FVC (CU) † 0.09±0.01 --- 0.43±0.04 *‡ 0.38±0.04 *‡ 0.35±0.03 *‡ 0.35±0.05 *‡ 0.26±0.04 *‡ 0.26±0.04 *‡ 0.21±0.02 *‡ 0.20±0.01 *‡ 0.17±0.01 *‡




Figure 3 HR, MABP, FBF and FVC responses of rhythmic handgrip contractions performed by older men. * represent values significantly different 
from respective baselines while † represents values different from placebo (P) condition (P < 0.05). Significant time x treatment interaction is denoted by 
‡ (vs. Placebo). 
Older - Rhythmic Exercise
Mean 
Baseline
Exercise Post Exercise Responses
Treatment 1st min 2nd min 3rd min 0 s 30 s 1 min 2 min 3 min 4 min 5 min 6 min 7 min
P
HR (b.min-1) 64.93±1.83 73.46±3.21 * 74.67±3.44 * 77.91±3.51 * 68.78±3.85 62.72±3.16 62.29±3.25 63.40±3.30 63.79±3.33 63.08±3.26 65.48±3.50 64.82±3.23 65.51±3.18
MABP (mmHg) 83.75±1.70 98.84±4.14 * 106.81±4.40 * 112.47±4.92 * 100.52±4.19 * 88.35±4.07 86.09±4.13 84.35±3.23 84.82±3.24 83.50±3.49 83.23±3.38 84.10±3.38 84.93±4.25
FBF (ml.dl-1.min-1) 6.59±0.77 --- 64.26±5.81 * 47.28±4.45 * 37.65±3.75 * 32.64±3.54 * 24.92±2.13 * 22.87±1.55 * 20.57±1.64 * 17.15±1.71 * 12.58±1.05
FVC (CU) 0.08±0.01 --- 0.64±0.06 * 0.54±0.06 * 0.44±0.05 * 0.39±0.05 * 0.29±0.03 * 0.27±0.03 * 0.25±0.03 * 0.20±0.02 * 0.15±0.01 *
40% O2
HR (b.min-1) 62.61±1.69 71.95±3.54 * 73.53±3.52 * 73.78±3.43 * 66.30±3.98 63.84±3.20 62.29±3.08 62.34±3.19 62.41±2.83 64.39±3.64 62.73±3.43 62.27±2.92 62.12±3.37
MABP (mmHg) 86.25±2.64 102.55±4.38 * 112.20±5.55 * 117.20±6.56 * 107.95±7.64 * 92.46±5.06 89.36±4.70 87.26±4.22 86.47±4.24 88.61±4.60 88.85±5.14 87.02±4.40 86.98±4.47
FBF (ml.dl-1.min-1) † 6.04±0.53 --- 48.46±4.33 *‡ 38.91±3.51 *‡ 29.70±2.90 *‡ 23.40±2.17 *‡ 18.50±2.24 *‡ 17.17±2.15 *‡ 16.45±1.91 *‡ 13.60±1.50 * 11.02±0.78
FVC (CU) † 0.07±0.01 --- 0.49±0.06 * ‡ 0.42±0.05 *‡ 0.33±0.05 *‡ 0.26±0.03 *‡ 0.21±0.03 *‡ 0.19±0.03 *‡ 0.18±0.03 *‡ 0.16±0.02 * 0.13±0.01
A
HR (b.min-1) 62.01±1.55 73.94±3.52 * 74.51±3.62 * 75.06±3.49 * 67.50±4.23 62.65±3.09 62.22±3.18 62.90±3.21 62.33±2.82 61.87±2.99 61.63±3.07 62.62±3.25 62.51±2.72
MABP (mmHg) 88.37±2.13 106.98±4.33 * 115.38±4.42 * 121.82±5.22 * 117.32±3.77 * 96.91±3.64 96.92±4.27 92.00±4.77 92.73±4.66 91.15±4.23 91.52±4.19 90.18±3.55 87.91±3.70
FBF (ml.dl-1.min-1) † 5.12±0.50 --- 52.79±5.48 *‡ 38..93±3.56 *‡ 30.85±3.49 *‡ 24.30±2.58 *‡ 22.07±2.09 *‡ 20.14±2.22 * 17.58±2.42 * 15.25±2.05 * 13.83±1.74
FVC (CU) † 0.06±0.01 --- 0.45±0.05 * ‡ 0.40±0.04 *‡ 0.31±0.05 *‡ 0.26±0.03 *‡ 0.24±0.03 *‡ 0.22±0.03 * 0.19±0.03 * 0.17±0.02 * 0.16±0.02 *
A + O2
HR (b.min-1) 61.57±1.72 72.06±4.03 * 72.73±3.87 * 72.65±3.71 * 64.87±3.94 61.04±3.30 59.60±3.22 60.50±3.38 60.37±3.42 61.35±3.41 61.10±3.40 60.47±3.20 62.05±3.25
MABP (mmHg) 84.57±2.22 103.59±4.98 * 114.14±5.31 * 118.23±5.16 * 112.20±5.39 * 93.93±4.18 91.94±4.36 87.31±3.33 86.80±3.47 86.38±3.54 86.12±3.54 84.24±4.50 86.12±4.75
FBF (ml.dl-1.min-1) † 5.02±0.30 --- 55.26±5.74 *‡ 38.52±3.86 *‡ 30.36±3.42 *‡ 23.75±2.42 *‡ 18.70±2.17 *‡ 16.43±1.80 *‡ 15.37±1.56 *‡ 14.81±1.49 * 12.40±1.00 *
FVC (CU) † 0.06±0.00 --- 0.49±0.06 * ‡ 0.41±0.06 *‡ 0.33±0.05 *‡ 0.27±0.04 *‡ 0.22±0.04 *‡ 0.19±0.03 *‡ 0.18±0.02 *‡ 0.18±0.02 * 0.14±0.01




Figure 4 HR, MABP, FBF and FVC responses of isometric handgrip contractions performed by older men. * represent values significantly different 
from respective baselines while † represents values different from placebo (P) condition (P < 0.05). Significant time x treatment interaction is denoted by 
‡ (vs. Placebo). 
Older – Isometric Exercise
Mean 
Baseline
Exercise Post Exercise Responses
Treatment 1st min 2nd min 3rd min 0 s 30 s 1 min 2 min 3 min 4 min 5 min 6 min 7 min
P
HR (b.min-1) 61.82±1.37 70.33±3.66 * 74.35±4.45 * 75.89±4.10 * 67.00±3.31 * 62.11±3.01 60.93±3.62 61.36±2.37 61.41±3.63 61.44±2.98 62.34±3.21 62.14±3.26 61.25±2.88
MABP (mmHg) 81.53±1.92 98.60±4.78 * 109.41±5.45 * 117.89±5.99 * 108.26±5.08 * 97.48±4.39 * 87.79±4.01 88.39±4.61 87.70±4.88 85.48±4.09 85.36±4.64 82.97±4.39 85.73±4.67
FBF (ml.dl-1.min-1) 6.67±0.67 --- 71.45±6.52 * 56.54±5.14 * 47.42±3.70 * 38.04±4.41 * 28.56±2.81 * 22.01±1.63 * 18.22±1.94 * 15.72±1.86 13.55±1.65
FVC (CU) 0.08±0.01 --- 0.66±0.06 * 0.58±0.08 * 0.54±0.05 * 0.43±0.06 * 0.32±0.05 * 0.26±0.03 * 0.21±0.03 * 0.19±0.03 * 0.16±0.02
40% O2
HR (b.min-1) 59.84±1.56 70.39±4.15 * 72.04±3.88 * 74.53±3.48 * 66.18±3.11 * 59.64±2.79 59.37±3.14 59.30±3.13 58.72±3.13 59.38±3.06 58.79±2.74 59.60±3.09 59.87±2.84
MABP (mmHg) 85.42±2.14 101.25±5.07 * 113.46±6.44 * 121.14±7.03 * 105.51±5.57 * 94.08±5.91 * 89.76±4.69 89.07±3.60 88.78±3.92 88.26±2.82 90.13±3.76 89.49±3.68 88.77±3.82
FBF (ml.dl-1.min-1) † 6.09±0.37 --- 51.54±4.03 *‡ 41.65±4.24 *‡ 33.41±4.13 *‡ 24.35±3.55 *‡ 18.90±3.05 *‡ 15.53±1.83 *‡ 11.62±1.62 ‡ 11.65±1.29 10.32±1.30
FVC (CU) † 0.07±0.01 --- 0.48±0.05 *‡ 0.44±0.06 *‡ 0.37±0.05 *‡ 0.27±0.05 *‡ 0.21±0.04 *‡ 0.18±0.03 *‡ 0.14±0.02 ‡ 0.13±0.2 0.12±0.02
A
HR (b.min-1) 60.77±1.45 69.91±3.82 * 72.31±4.05 * 75.72±4.27 * 68.42±3.12 * 60.90±2.88 57.87±2.88 59.33±2.70 58.94±2.96 58.95±2.85 59.00±2.97 59.91±3.02 59.44±2.89
MABP (mmHg) 85.26±2.22 102.30±5.21 * 117.01±6.35 * 124.50±5.20 * 113.31±4.90 * 95.26±4.28 * 91.18±4.06 87.62±3.13 89.63±4.20 88.19±4.16 88.45±4.61 89.82±4.66 88.79±4.90
FBF (ml.dl-1.min-1) † 6.91±0.33 --- 52.98±7.53 *‡ 38.59±5.43 *‡ 33.80±5.49 *‡ 28.59±4.29 *‡ 22.96±3.17 *‡ 19.03±2.28 * 16.74±2.20 13.88±1.79 11.93±1.34
FVC (CU) † 0.08±0.01 --- 0.47±0.07 *‡ 0.41±0.06 *‡ 0.37±0.07 *‡ 0.33±0.05 *‡ 0.26±0.04 *‡ 0.22±0.03 * 0.19±0.03 * 0.16±0.02 * 0.13±0.02
A + O2
HR (b.min-1) 60.59±1.64 69.27±3.89 * 73.65±3.73 * 75.74±3.59 * 65.22±3.27 * 58.17±3.17 59.50±3.27 57.37±3.17 59.16±3.81 59.28±3.33 59.77±3.19 60.56±3.39 59.51±3.35
MABP (mmHg) 82.76±1.94 100.98±4.20 * 113.59±4.86 * 118.98±4.66 * 103.20±3.20 * 93.86±4.15 * 89.59±3.88 86.52±3.36 86.98±3.29 84.82±3.45 84.96±4.21 85.29±3.88 84.63±3.56
FBF (ml.dl-1.min-1) † 6.85±0.46 --- 55.13±5.03 *‡ 45.93±6.04 *‡ 37.60±5.93 *‡ 29.69±2.70 *‡ 22.11±2.22 *‡ 18.61±1.94 * 15.08±1.47 * 14.55±1.85 13.36±1.69
FVC (CU) † 0.08±0.01 --- 0.53±0.05 *‡ 0.48±0.08 *‡ 0.42±0.07 *‡ 0.34±0.04 *‡ 0.25±0.03 *‡ 0.22±0.03 * 0.17±0.03 * 0.17±0.03 * 0.16±0.03
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